concept_id	concept_synonym_name	language_concept_id
40761454	人类抗人类 抗体:质量浓度:时间点:血浆:定量型	4182948
40761455	HAHA Ab Plas-sCnc	4180186
40761455	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chemistry; HAHA; Human anti-human Ab; Human anti-human Ab protein; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40761455	人类抗人类 抗体:物质的量浓度:时间点:血浆:定量型	4182948
40761456	#; ABS; absolute; absolutes; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Imm; Imm Plasma Cells; Immat; Myeloma cells; Number concentration; Number Concentration (count/vol); Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761456	Imm Plasma Cells # Bld	4180186
40761456	浆细胞.不成熟:计数型浓度:时间点:全血:定量型	4182948
40761457	Alc; Alcohol; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761457	Ethanol/Creat Ur	4180186
40761457	乙醇/肌酐:质量比率:时间点:尿液:定量型	4182948
40761459	Methamphet/Creat Ur	4180186
40761459	CR; Crea; Creat; Desoxyn; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Methamphet; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761459	甲基苯丙胺/肌酐:质量比率:时间点:尿液:定量型	4182948
40761461	Buprenorphine/Creat Ur	4180186
40761461	BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Finobrin; Mass concentration ratio; Mass ratio; MCRto; Norspan; Point in time; Prefin; QNT; Quan; Quant; Quantitative; Random; Suboxone; Subutex; Temgesic; UA; UCr; UR; Urn	4180186
40761461	丁丙诺啡/肌酐:质量比率:时间点:尿液:定量型	4182948
40761463	Addiction; Buprenorphine metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; NBU; norBUP; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761463	Norbuprenorphine Ur Ql Cfm	4180186
40761463	去甲基丁丙诺啡:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761468	Nordiazepam/Creat Ur	4180186
40761468	Calmday; Chlordiazepoxide metabolite; CR; Crea; Creat; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Madar; Mass concentration ratio; Mass ratio; MCRto; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; UA; UCr; UR; Urn; Vegesan	4180186
40761468	去甲基安定/肌酐:质量比率:时间点:尿液:定量型	4182948
40761469	Oxazepam/Creat Ur	4180186
40761469	Alepam; Chlordiazepoxide metabolite; CR; Crea; Creat; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; UA; UCr; UR; Urn	4180186
40761469	去甲羟安定/肌酐:质量比率:时间点:尿液:定量型	4182948
40761472	Carisoprodol/Creat Ur	4180186
40761472	Carisoma; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Flexartal; Isopropylmeprobamate; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; UA; UCr; UR; Urn	4180186
40761472	异丙基甲丁双脲/肌酐:质量比率:时间点:尿液:定量型	4182948
40761473	Meprobamate/Creat Ur	4180186
40761473	Carisoprodol metabolite; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Equanil; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761473	氨甲丙二酯/肌酐:质量比率:时间点:尿液:定量型	4182948
40761475	Addiction; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761475	Meprobamate Ur Cfm-mCnc	4180186
40761475	氨甲丙二酯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761477	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; Gluc; Glucouronide; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761477	Ethyl glucuronide/Creat Ur	4180186
40761477	乙基葡糖苷酸/肌酐:质量比率:时间点:尿液:定量型	4182948
40761478	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; GCMS; Gluc; Glucouronide; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761478	Ethyl glucuronide Ur Ql Cfm	4180186
40761478	乙基葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761479	Ethyl glucuronide Ur Cfm-mCnc	4180186
40761479	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; GCMS; Gluc; Glucouronide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761479	乙基葡糖苷酸:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761480	Actiq; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; Fentanyl metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sublimaze; UA; UR; Urn	4180186
40761480	fentaNYL+Norfentanyl Ur Ql Scn	4180186
40761480	芬太尼+去甲基芬太尼:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761481	Actiq; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Sublimaze; UA; UCr; UR; Urn	4180186
40761481	fentaNYL/Creat Ur	4180186
40761481	芬太尼/肌酐:质量比率:时间点:尿液:定量型	4182948
40761482	Actiq; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sublimaze; UA; UR; Urn	4180186
40761482	fentaNYL Ur Cfm-mCnc	4180186
40761482	芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761483	Norfentanyl/Creat Ur	4180186
40761483	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Fentanyl metabolite; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761483	去甲基芬太尼/肌酐:质量比率:时间点:尿液:定量型	4182948
40761484	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761484	Norfentanyl Ur Cfm-mCnc	4180186
40761484	去甲基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761485	6MAM/Creat Ur	4180186
40761485	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Heroin metabolite; MAM; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761485	6-单乙酰吗啡/肌酐:质量比率:时间点:尿液:定量型	4182948
40761486	Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Meperidine metabolite; Norpethidine; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
40761486	Meperidine+Nor Ur Ql Scn	4180186
40761486	哌替啶+去甲哌替啶:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761487	Meperidine/Creat Ur	4180186
40761487	Algil; Alodan; Centralgine; CR; Crea; Creat; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Pethidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761487	哌替啶/肌酐:质量比率:时间点:尿液:定量型	4182948
40761490	Normeperidine Ur Cfm-mCnc	4180186
40761490	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Meperidine metabolite; Norpethidine; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761490	去甲基哌替啶:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761492	Codeine/Creat Ur	4180186
40761492	c260; C300; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Methylmorphine; Morphine methyl ether; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761492	可待因/肌酐:质量比率:时间点:尿液:定量型	4182948
40761494	Anexsia; CR; Crea; Creat; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Vicodin	4180186
40761494	HYDROcodone/Creat Ur	4180186
40761494	氢可酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40761495	HYDROmorphone/Creat Ur	4180186
40761495	CR; Crea; Creat; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Hydromorphinone; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761495	二氢吗啡酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40761496	oxyCODONE/Creat Ur	4180186
40761496	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Lortab; Mass concentration ratio; Mass ratio; MCRto; OxyContin; Percocet; Percodan; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Vicodin	4180186
40761496	羟考酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40761498	PCP/Creat Ur	4180186
40761498	Angel dust; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; PCP; Point in time; QNT; Quan; Quant; Quantitative; Random; Sernylan; UA; UCr; UR; Urn	4180186
40761498	苯环利定/肌酐:质量比率:时间点:尿液:定量型	4182948
40761502	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Nucynta; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tapal; UA; UR; Urn	4180186
40761502	Tapentadol Ur Ql Cfm	4180186
40761502	他喷他多:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761503	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; UA; UR; Urn	4180186
40761503	Tapentadol Ur Cfm-mCnc	4180186
40761503	他喷他多:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761504	Antidepres; Antidepressant; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; TCA; Tricyclics; UA; UCr; UR; Urn	4180186
40761504	Tricyclics/Creat Ur	4180186
40761504	三环类抗抑郁药/肌酐:质量比率:时间点:尿液:定量型	4182948
40761505	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramal; UA; UCr; Ultram; UR; Urn	4180186
40761505	traMADol/Creat Ur	4180186
40761505	曲马多/肌酐:质量比率:时间点:尿液:定量型	4182948
40761506	ABS; Aby; Antby; Anti; Antibodies; Antibody; anti-HBsAg; Autoantibodies; Autoantibody; co; cut off; HBs; HBsAB; HBV; HBV surface; HBV surface Ab s/co; Hep; Hep B; Hep Bs; Hepatis; Hepatit; HepB; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Serum; SR; Surf	4180186
40761506	HBV surface Ab s/co Ser	4180186
40761506	乙型肝炎病毒表面 抗体信号值/截止点:相对任意型浓度:时间点:血清:定量型	4182948
40761508	WBC morphology pnl Bld	4180186
40761508	Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocytes; Lkcs; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; WB; WBC; WBC morphology pnl; WBCs; White blood cell; White blood cells; Whole blood	4180186
40761508	白细胞形态学组套:-:时间点:全血:-	4182948
40761511	Auto; Automated detection; Blood; CBC Pnl; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Hemogram; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; UniversalLabOrders; WB; Whole blood	4180186
40761511	CBC Pnl Bld Auto	4180186
40761511	全血细胞计数 (血象) 组套:-:时间点:全血:-:自动化计数方法	4182948
40761515	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40761515	HSV1+2 DNA Amn Ql NAA+probe	4180186
40761515	单纯疱疹病毒 1+2 型 DNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
40761516	BRAF p.V600E; B-Raf proto-oncogene, serine/threonine kinase; BRAF1; B-RAF1; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NS7; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; RAFB1; Random; Screen; Tissue; Tissue, unspecified; v-raf	4180186
40761516	BRAF p.V600E Tiss Ql	4180186
40761516	BRAF 基因 p.V600E:存在情况或阈值:时间点:组织与涂片:序数型:分子遗传学类实验室方法	4182948
40761522	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
40761523	Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40761524	Ethyl sulfate/Creat Ur	4180186
40761524	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UCr; UR; Urn	4180186
40761524	硫酸乙酯/肌酐:质量比率:时间点:尿液:定量型	4182948
40761525	DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
40761525	Ethyl sulfate Ur Ql Scn	4180186
40761525	硫酸乙酯:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40761529	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; Methadone metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40761529	EDDP Ur Ql Cfm	4180186
40761529	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40761534	Crystals Pnl UrnS	4180186
40761534	Crys; Cryst; Crystal; Crystals Pnl; Pan; PANEL.URINALYSIS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761534	结晶组套:-:时间点:尿沉渣:定量型	4182948
40761537	Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Point in time; Random; Renal; Typ; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761537	Casts UrnS Micro	4180186
40761537	管型类尿液成分:类型:时间点:尿沉渣:名义型:显微镜检查.光学	4182948
40761539	Cell; Cellularity; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Point in time; Random; Renal; Typ; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761539	Cells UrnS Micro	4180186
40761539	细胞:类型:时间点:尿沉渣:名义型:显微镜检查.光学	4182948
40761543	Identity or presence; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Nominal; Othr; Point in time; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761543	Other elements UrnS Micro	4180186
40761543	其他成分:存在与否或特征标识:时间点:尿沉渣:名义型:显微镜检查.光学	4182948
40761544	Other cells # Bld Auto	4180186
40761544	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761544	其他细胞:计数型浓度:时间点:全血:定量型:自动化计数方法	4182948
40761547	1 day; 24 hours; 24HR; Bdy surface; bod; Bodies; BSA; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; CR; Crea; Creat; Creat Cl BSA adj Pnl; Kidney; Nephrology; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; QNT; Quan; Quant; Quantitative; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf; UA; UCr; UniversalLabOrders; UR; Ur+SerPl; Urn	4180186
40761547	Creat 24H Cl BSA adj Pnl Ur+SerPl	4180186
40761547	经过针对体表面积而校正的肌酐肾脏清除率组套:-:24小时:尿液+血清/血浆:定量型	4182948
40761548	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Creat ratio pnl; Kidney; Microalbumin/creat Pnl; Nephrology; Pan; PANEL.CHEMISTRY; Panl; Pnl; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UniversalLabOrders; UR; Urn	4180186
40761548	Microalbumin/creat Pnl 24H Ur	4180186
40761548	微量白蛋白/肌酐比率组套:-:24小时:尿液:定量型	4182948
40761549	1 day; 24 hours; 24HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; mcg; Micro albumin; Microalbumin; Minimal; minimum; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UniversalLabOrders; UR; Urn	4180186
40761549	Microalbumin ug/min 24H Ur-mRate	4180186
40761549	白蛋白 微克/最小值:质量速率:24小时:尿液:定量型:检测极限 <= 20 mg/L	4182948
40761550	#/area; Discocyte; Erc; Erythrocytes; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBC clumps; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761550	RBC clumps #/area UrnS HPF	4180186
40761550	红细胞团块:单位面积数量或计数:时间点:尿沉渣:定量型:显微镜检查.光学.高倍视野	4182948
40761553	Antigen; Antigens; Arbitrary concentration; Australia antigen; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Surf	4180186
40761553	HBV surface Ag Ser-aCnc	4180186
40761553	乙型肝炎病毒表面 抗原:任意型浓度:时间点:血清:定量型	4182948
40761554	Hemoccult Stl IA-mCnc	4180186
40761554	Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; iFOBT; Level; Low; Mass concentration; MEIA; Occult blood; Occult blood in stool; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; SUDS	4180186
40761554	血红蛋白.胃肠道.下段:质量浓度:时间点:大便:定量型:免疫测定法	4182948
40761557	Cell; Cellularity; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40761557	Bladder Cells UrnS Ql Micro	4180186
40761557	膀胱细胞:存在情况或阈值:时间点:尿沉渣:序数型:显微镜检查.光学	4182948
40761561	Endothelial cell Ab Titr SerPl	4180186
40761561	内皮细胞 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40761561	ABS; Aby; AECA; Antby; Anti; Antibodies; Antibody; Anti-endothelial cell Ab; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40761562	Intestinal goblet cell Ab Titr Ser	4180186
40761562	肠道杯状细胞 抗体:滴定度:时间点:血清:定量型	4182948
40761562	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Intest; Intestine; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40761563	Comp functional activity SerPl IA-aCnc	4180186
40761563	Activ; Actvty; Arbitrary concentration; Comp; Comp functional activity; Complement screening; Complmt; EIA; ELFA; ELISA; Enzyme immunoassay; HEMATOLOGY/CELL COUNTS; IAA; MEIA; Movements; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
40761563	补体功能活性:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40761564	Alzheimer disease; Alzheimer's disease; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Mass Fraction; Neuro; Neurology; Percent; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; TP	4180186
40761564	Tau Prot MFr CSF	4180186
40761564	Tau 蛋白/蛋白质.总计:质量分数:时间点:脑脊液:定量型	4182948
40761565	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761565	Campesterol SerPl-sCnc	4180186
40761565	菜油固醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761568	Horse Bot Fly IgG4-mCnc	4180186
40761568	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Horse bot fly; i201; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761568	马蝇 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40761569	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Anise; Aniseed; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f271; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf271; Serum; SR	4180186
40761569	Anise IgG4-mCnc	4180186
40761569	茴芹 抗体.IgG4:质量浓度:时间点:血清:定量型	4182948
40761574	FDA label Cosmetic	4180186
40761574	DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
40761574	化妆品:-:-:^FDA 产品标签:叙述型	4182948
40761576	DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
40761576	FDA label Dietary supplement	4180186
40761576	膳食补充剂:-:-:^FDA 产品标签:叙述型	4182948
40761577	肺功能检查:发现:时间点:^患者:文档型:肺功能	4182948
40761577	Document; FCN; Finding; Findings; Func; Funct; Lung; Point in time; Pulm; Pulmonary; Pulmonology; Random; Respiratory; Study report	4180186
40761580	NEFA sp6 p fast SerPl-sCnc	4180186
40761580	Acd; Acid; After; Aliphatic carboxylate C10-C26; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; Fatty acid; FFA; Free Fatty Acids; Level; Lipid; NEFA; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p fast; Spec; SR; Substance concentration	4180186
40761580	脂肪酸类.非酯化型^在热量型禁食之后的第6个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761586	^7th spec pst XXX chal; 17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR	4180186
40761586	Estradiol sp7 p chal SerPl HS-mCnc	4180186
40761586	雌二醇^在XXX刺激之后的第7个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761588	Estradiol sp5 p chal SerPl HS-mCnc	4180186
40761588	17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR	4180186
40761588	雌二醇^在XXX刺激之后的第5个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761590	Estradiol sp3 p chal SerPl HS-mCnc	4180186
40761590	17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR	4180186
40761590	雌二醇^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761592	17-beta estradiol; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; E2; First; HS; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR	4180186
40761592	Estradiol sp1 p chal SerPl HS-mCnc	4180186
40761592	雌二醇^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型:高灵敏度方法	4182948
40761596	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp10; sp10 p chal; Spec; SR	4180186
40761596	C peptide sp10 p chal SerPl-mCnc	4180186
40761596	C 肽^在XXX刺激之后的第10个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761597	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp11; sp11 p chal; Spec; SR	4180186
40761597	C peptide sp11 p chal SerPl-mCnc	4180186
40761597	C 肽^在XXX刺激之后的第11个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761598	C peptide sp12 p chal SerPl-mCnc	4180186
40761598	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp12; sp12 p chal; Spec; SR	4180186
40761598	C 肽^在XXX刺激之后的第12个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761601	15M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; Pept; Pl; Plasma; Plsm; Point in time; pre chal; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761601	C peptide 15M pre chal SerPl-mCnc	4180186
40761601	C 肽^在XXX刺激之前15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761605	C peptide 2.5h p Glc SerPl-mCnc	4180186
40761605	2.5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761605	C 肽^在剂量葡萄糖之后2.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761606	C peptide 2.5h p Glc SerPl-sCnc	4180186
40761606	2.5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761606	C 肽^在剂量葡萄糖之后2.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761610	30M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761610	C peptide 30M p Glc SerPl-mCnc	4180186
40761610	C 肽^在剂量葡萄糖之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761611	3h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761611	C peptide 3h p Glc SerPl-mCnc	4180186
40761611	C 肽^在剂量葡萄糖之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761612	270 min; 4 1/2 hours; 4.5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761612	C peptide 4.5h p Glc SerPl-mCnc	4180186
40761612	C 肽^在剂量葡萄糖之后4.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761613	270 min; 4 1/2 hours; 4.5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761613	C peptide 4.5h p Glc SerPl-sCnc	4180186
40761613	C 肽^在剂量葡萄糖之后4.5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761615	C peptide 45M p Glc SerPl-sCnc	4180186
40761615	45M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761615	C 肽^在剂量葡萄糖之后45分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761618	5h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761618	C peptide 5h p Glc SerPl-mCnc	4180186
40761618	C 肽^在剂量葡萄糖之后5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761621	After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; sp9 p chal; Spec; SR	4180186
40761621	C peptide sp9 p chal SerPl-mCnc	4180186
40761621	C 肽^在XXX刺激之后的第9个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761622	C peptide pre Glc SerPl-mCnc	4180186
40761622	Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pept; Pl; Plasma; Plsm; Point in time; pre Glc; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761622	C 肽^在给予剂量葡萄糖之前:质量浓度:时间点:血清/血浆:定量型	4182948
40761626	1 1/2 hours; 1 1/2 HR; 1.5h p Gc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761626	ACTH 1.5h p Gc Plas-mCnc	4180186
40761626	促肾上腺皮质激素^在给予剂量胰高血糖素之后1.5小时:质量浓度:时间点:血浆:定量型	4182948
40761627	ACTH 1.5h p Gc Plas-sCnc	4180186
40761627	1 1/2 hours; 1 1/2 HR; 1.5h p Gc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761627	促肾上腺皮质激素^在给予剂量胰高血糖素之后1.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761628	ACTH 1.5h p Glc Plas-mCnc	4180186
40761628	1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761628	促肾上腺皮质激素^在剂量葡萄糖之后1.5小时:质量浓度:时间点:血浆:定量型	4182948
40761629	ACTH 1.5h p Glc Plas-sCnc	4180186
40761629	1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761629	促肾上腺皮质激素^在剂量葡萄糖之后1.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761632	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Tumor marker	4180186
40761632	ACTH 10 AM Plas-mCnc	4180186
40761632	促肾上腺皮质激素^上午10点标本:质量浓度:时间点:血浆:定量型	4182948
40761636	ACTH 105M p Ins IV Plas-mCnc	4180186
40761636	105M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761636	促肾上腺皮质激素^在静脉注射剂量胰岛素之后105分钟:质量浓度:时间点:血浆:定量型	4182948
40761637	ACTH 105M p Ins IV Plas-sCnc	4180186
40761637	105M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761637	促肾上腺皮质激素^在静脉注射剂量胰岛素之后105分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761639	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp10; sp10 p chal; Spec; Substance concentration; Tumor marker	4180186
40761639	ACTH sp10 p chal Plas-sCnc	4180186
40761639	促肾上腺皮质激素^在XXX刺激之后的第10个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761640	ACTH sp11 p chal Plas-mCnc	4180186
40761640	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp11; sp11 p chal; Spec; Tumor marker	4180186
40761640	促肾上腺皮质激素^在XXX刺激之后的第11个标本:质量浓度:时间点:血浆:定量型	4182948
40761641	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp11; sp11 p chal; Spec; Substance concentration; Tumor marker	4180186
40761641	ACTH sp11 p chal Plas-sCnc	4180186
40761641	促肾上腺皮质激素^在XXX刺激之后的第11个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761643	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; Level; Noon; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761643	ACTH 12 PM Plas-sCnc	4180186
40761643	促肾上腺皮质激素^中午12点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761644	ACTH sp12 p chal Plas-mCnc	4180186
40761644	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp12; sp12 p chal; Spec; Tumor marker	4180186
40761644	促肾上腺皮质激素^在XXX刺激之后的第12个标本:质量浓度:时间点:血浆:定量型	4182948
40761648	15M p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761648	ACTH 15M p Ins IV Plas-sCnc	4180186
40761648	促肾上腺皮质激素^在静脉注射剂量胰岛素之后15分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761649	15M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761649	ACTH 15M p chal Plas-sCnc	4180186
40761649	促肾上腺皮质激素^在XXX刺激之后15分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761651	15M pre Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761651	ACTH 15M pre Ins IV Plas-mCnc	4180186
40761651	促肾上腺皮质激素^在静脉注射剂量胰岛素之前15分钟:质量浓度:时间点:血浆:定量型	4182948
40761652	15M pre Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761652	ACTH 15M pre Ins IV Plas-sCnc	4180186
40761652	促肾上腺皮质激素^在静脉注射剂量胰岛素之前15分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761653	ACTH 1h p 1 ug/kg CRH IV Plas-sCnc	4180186
40761653	1 hour; 1.0Hr; 1h p 1 ug/kg CRH IV; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761653	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后1小时:物质的量浓度:时间点:血浆:定量型	4182948
40761655	ACTH 1h p Gc Plas-sCnc	4180186
40761655	1 hour; 1.0Hr; 1h p Gc; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761655	促肾上腺皮质激素^在给予剂量胰高血糖素之后1小时:物质的量浓度:时间点:血浆:定量型	4182948
40761656	1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761656	ACTH 1h p Glc Plas-mCnc	4180186
40761656	促肾上腺皮质激素^在剂量葡萄糖之后1小时:质量浓度:时间点:血浆:定量型	4182948
40761657	1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761657	ACTH 1h p Glc Plas-sCnc	4180186
40761657	促肾上腺皮质激素^在剂量葡萄糖之后1小时:物质的量浓度:时间点:血浆:定量型	4182948
40761659	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761659	ACTH 1h p chal Plas-sCnc	4180186
40761659	促肾上腺皮质激素^在XXX刺激之后1小时:物质的量浓度:时间点:血浆:定量型	4182948
40761661	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Tumor marker	4180186
40761661	ACTH 2 PM Plas-mCnc	4180186
40761661	促肾上腺皮质激素^下午2点标本:质量浓度:时间点:血浆:定量型	4182948
40761662	ACTH 2 PM Plas-sCnc	4180186
40761662	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Evening; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Spec; Substance concentration; Tumor marker	4180186
40761662	促肾上腺皮质激素^下午2点标本:物质的量浓度:时间点:血浆:定量型	4182948
40761663	ACTH 2.5h p Gc Plas-mCnc	4180186
40761663	2.5h p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761663	促肾上腺皮质激素^在给予剂量胰高血糖素之后2.5小时:质量浓度:时间点:血浆:定量型	4182948
40761665	2.5h p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761665	ACTH 2.5h p Ins IV Plas-mCnc	4180186
40761665	促肾上腺皮质激素^在静脉注射剂量胰岛素之后2.5小时:质量浓度:时间点:血浆:定量型	4182948
40761666	2.5h p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761666	ACTH 2.5h p Ins IV Plas-sCnc	4180186
40761666	促肾上腺皮质激素^在静脉注射剂量胰岛素之后2.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761667	2.5h p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761667	ACTH 2.5h p Glc Plas-mCnc	4180186
40761667	促肾上腺皮质激素^在剂量葡萄糖之后2.5小时:质量浓度:时间点:血浆:定量型	4182948
40761668	ACTH 2.5h p Glc Plas-sCnc	4180186
40761668	2.5h p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761668	促肾上腺皮质激素^在剂量葡萄糖之后2.5小时:物质的量浓度:时间点:血浆:定量型	4182948
40761669	ACTH 1D p MTP Plas-mCnc	4180186
40761669	1D p MTP; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761669	促肾上腺皮质激素^在给予剂量美替拉酮之后1天:质量浓度:时间点:血浆:定量型	4182948
40761670	ACTH 1D p MTP Plas-sCnc	4180186
40761670	1D p MTP; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761670	促肾上腺皮质激素^在给予剂量美替拉酮之后1天:物质的量浓度:时间点:血浆:定量型	4182948
40761671	ACTH 2h p 1 ug/kg CRH IV Plas-sCnc	4180186
40761671	120 min; 120 minutes; 120min; 2 hours; 2h p 1 ug/kg CRH IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761671	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后2小时:物质的量浓度:时间点:血浆:定量型	4182948
40761672	120 min; 120 minutes; 120min; 2 hours; 2h p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761672	ACTH 2h p Gc Plas-mCnc	4180186
40761672	促肾上腺皮质激素^在给予剂量胰高血糖素之后2小时:质量浓度:时间点:血浆:定量型	4182948
40761674	ACTH 2h p Glc Plas-mCnc	4180186
40761674	120 min; 120 minutes; 120min; 2 hours; 2h p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761674	促肾上腺皮质激素^在剂量葡萄糖之后2小时:质量浓度:时间点:血浆:定量型	4182948
40761676	ACTH 2h p Ins IV Plas-mCnc	4180186
40761676	120 min; 120 minutes; 120min; 2 hours; 2h p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761676	促肾上腺皮质激素^在静脉注射剂量胰岛素之后2小时:质量浓度:时间点:血浆:定量型	4182948
40761677	120 min; 120 minutes; 120min; 2 hours; 2h p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Substance concentration; Tumor marker; Ultralente	4180186
40761677	ACTH 2h p Ins IV Plas-sCnc	4180186
40761677	促肾上腺皮质激素^在静脉注射剂量胰岛素之后2小时:物质的量浓度:时间点:血浆:定量型	4182948
40761678	ACTH 2h p chal Plas-sCnc	4180186
40761678	120 min; 120 minutes; 120min; 2 hours; 2h p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761678	促肾上腺皮质激素^在XXX刺激之后2小时:物质的量浓度:时间点:血浆:定量型	4182948
40761679	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Convalescent; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Second; sp2; sp2 p chal; Spec; Substance concentration; Tumor marker	4180186
40761679	ACTH sp2 p chal Plas-sCnc	4180186
40761679	促肾上腺皮质激素^在XXX刺激之后的第2个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761680	ACTH 30M p 1 ug/kg CRH IV Plas-sCnc	4180186
40761680	30M p 1 ug/kg CRH IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761680	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761681	30M p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761681	ACTH 30M p Gc Plas-mCnc	4180186
40761681	促肾上腺皮质激素^在给予剂量胰高血糖素之后30分钟:质量浓度:时间点:血浆:定量型	4182948
40761684	ACTH 30M p Glc Plas-sCnc	4180186
40761684	30M p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761684	促肾上腺皮质激素^在剂量葡萄糖之后30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761686	ACTH 30M p chal Plas-sCnc	4180186
40761686	30M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761686	促肾上腺皮质激素^在XXX刺激之后30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761687	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761687	ACTH 30M pre 1 ug/kg CRH IV Plas-mCnc	4180186
40761687	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前30分钟:质量浓度:时间点:血浆:定量型	4182948
40761688	ACTH 30M pre 1 ug/kg CRH IV Plas-sCnc	4180186
40761688	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761688	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761690	ACTH 30M pre Gc Plas-sCnc	4180186
40761690	30M pre Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761690	促肾上腺皮质激素^在给予剂量胰高血糖素之前30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761692	30M pre chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761692	ACTH 30M pre chal Plas-mCnc	4180186
40761692	促肾上腺皮质激素^在XXX刺激之前30分钟:质量浓度:时间点:血浆:定量型	4182948
40761693	ACTH 30M pre chal Plas-sCnc	4180186
40761693	30M pre chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761693	促肾上腺皮质激素^在XXX刺激之前30分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761694	3h p Gc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761694	ACTH 3h p Gc Plas-mCnc	4180186
40761694	促肾上腺皮质激素^在给予剂量胰高血糖素之后3小时:质量浓度:时间点:血浆:定量型	4182948
40761697	ACTH 3h p Glc Plas-sCnc	4180186
40761697	3h p Glc; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761697	促肾上腺皮质激素^在剂量葡萄糖之后3小时:物质的量浓度:时间点:血浆:定量型	4182948
40761698	ACTH 3h p Ins IV Plas-mCnc	4180186
40761698	3h p Ins IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Semilente; Sliding; Tumor marker; Ultralente	4180186
40761698	促肾上腺皮质激素^在静脉注射剂量胰岛素之后3小时:质量浓度:时间点:血浆:定量型	4182948
40761702	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp3; sp3 p chal; Spec; Substance concentration; Tumor marker	4180186
40761702	ACTH sp3 p chal Plas-sCnc	4180186
40761702	促肾上腺皮质激素^在XXX刺激之后的第3个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761705	ACTH 45M p 1 ug/kg CRH IV Plas-sCnc	4180186
40761705	45M p 1 ug/kg CRH IV; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761705	促肾上腺皮质激素^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后45分钟:物质的量浓度:时间点:血浆:定量型	4182948
40761711	ACTH sp6 p chal Plas-sCnc	4180186
40761711	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp6; sp6 p chal; Spec; Substance concentration; Tumor marker	4180186
40761711	促肾上腺皮质激素^在XXX刺激之后的第6个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761714	^7th spec pst XXX chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp7; sp7 p chal; Spec; Substance concentration; Tumor marker	4180186
40761714	ACTH sp7 p chal Plas-sCnc	4180186
40761714	促肾上腺皮质激素^在XXX刺激之后的第7个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761717	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp8; sp8 p chal; Spec; Substance concentration; Tumor marker	4180186
40761717	ACTH sp8 p chal Plas-sCnc	4180186
40761717	促肾上腺皮质激素^在XXX刺激之后的第8个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761721	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c350; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Decadron; Dexameth; Dexone; Hexadrol; Level; Pl; Plasma; Plsm; Point in time; Pre Dex; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761721	ACTH Pre Dex Plas-sCnc	4180186
40761721	促肾上腺皮质激素^在给予地塞米松之前:物质的量浓度:时间点:血浆:定量型	4182948
40761722	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; HGF; Hyperglycemic factor; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761722	ACTH pre Gc Plas-mCnc	4180186
40761722	促肾上腺皮质激素^在给予剂量胰高血糖素之前:质量浓度:时间点:血浆:定量型	4182948
40761724	ACTH pre Glc Plas-mCnc	4180186
40761724	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761724	促肾上腺皮质激素^在给予剂量葡萄糖之前:质量浓度:时间点:血浆:定量型	4182948
40761727	ACTH pre MTP Plas-mCnc	4180186
40761727	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre MTP; QNT; Quan; Quant; Quantitative; Random; Rc206; Tumor marker	4180186
40761727	促肾上腺皮质激素^在给予剂量美替拉酮之前:质量浓度:时间点:血浆:定量型	4182948
40761728	ACTH pre MTP Plas-sCnc	4180186
40761728	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; pre MTP; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761728	促肾上腺皮质激素^在给予剂量美替拉酮之前:物质的量浓度:时间点:血浆:定量型	4182948
40761730	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40761730	ACTH pre chal Plas-sCnc	4180186
40761730	促肾上腺皮质激素^在 XXX 刺激之前:物质的量浓度:时间点:血浆:定量型	4182948
40761732	1 1/2 hours; 1 1/2 HR; 1.5h p 1 ug/kg CRH IV; 1.5Hr; 17-Hydroxycorticosterone; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761732	Cortis 1.5h p 1 ug/kg CRH IV Sal-sCnc	4180186
40761732	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后1.5小时:物质的量浓度:时间点:唾液:定量型	4182948
40761733	Cortis 10 AM SerPl-mCnc	4180186
40761733	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
40761733	皮质醇^上午10点标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761734	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Substance concentration	4180186
40761734	Cortis 10 AM SerPl-sCnc	4180186
40761734	皮质醇^上午10点标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761735	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
40761735	Cortis 10 PM SerPl-mCnc	4180186
40761735	皮质醇^晚上10点标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761736	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Substance concentration	4180186
40761736	Cortis 10 PM SerPl-sCnc	4180186
40761736	皮质醇^晚上10点标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761737	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp10; sp10 p chal; Spec	4180186
40761737	Cortis sp10 p chal Sal-mCnc	4180186
40761737	皮质醇^在XXX刺激之后的第10个标本:质量浓度:时间点:唾液:定量型	4182948
40761738	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp10; sp10 p chal; Spec; Substance concentration	4180186
40761738	Cortis sp10 p chal Sal-sCnc	4180186
40761738	皮质醇^在XXX刺激之后的第10个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761741	Cortis sp11 p chal Sal-sCnc	4180186
40761741	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp11; sp11 p chal; Spec; Substance concentration	4180186
40761741	皮质醇^在XXX刺激之后的第11个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761742	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Midnight; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec	4180186
40761742	Cortis 12 AM Sal-mCnc	4180186
40761742	皮质醇^晚上12点标本:质量浓度:时间点:唾液:定量型	4182948
40761748	15M p 1 ug/kg CRH IV; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761748	Cortis 15M p 1 ug/kg CRH IV Sal-mCnc	4180186
40761748	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后15分钟:质量浓度:时间点:唾液:定量型	4182948
40761749	15M p 1 ug/kg CRH IV; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761749	Cortis 15M p 1 ug/kg CRH IV Sal-sCnc	4180186
40761749	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后15分钟:物质的量浓度:时间点:唾液:定量型	4182948
40761753	1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p 1 ug/kg CRH IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761753	Cortis 1h p 1 ug/kg CRH IV Sal-sCnc	4180186
40761753	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后1小时:物质的量浓度:时间点:唾液:定量型	4182948
40761754	17-Hydroxycorticosterone; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; First; hydrocortisone; Level; Oral fluid; p chal; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp1; sp1 p chal; Spec; Substance concentration	4180186
40761754	Cortis sp1 p chal Sal-sCnc	4180186
40761754	皮质醇^在XXX刺激之后的第1个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761756	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Substance concentration	4180186
40761756	Cortis 2 PM SerPl-sCnc	4180186
40761756	皮质醇^下午2点标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761757	120 min; 120 minutes; 120min; 17-Hydroxycorticosterone; 2 hours; 2h p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761757	Cortis 2h p 1 ug/kg CRH IV Sal-mCnc	4180186
40761757	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后2小时:质量浓度:时间点:唾液:定量型	4182948
40761758	120 min; 120 minutes; 120min; 17-Hydroxycorticosterone; 2 hours; 2h p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761758	Cortis 2h p 1 ug/kg CRH IV Sal-sCnc	4180186
40761758	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后2小时:物质的量浓度:时间点:唾液:定量型	4182948
40761761	Cortis 30M pre 1 ug/kg CRH IV Sal-mCnc	4180186
40761761	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761761	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前30分钟:质量浓度:时间点:唾液:定量型	4182948
40761763	Cortis 30M pre 1 ug/kg CRH IV SerPl-mCnc	4180186
40761763	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761763	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761768	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec	4180186
40761768	Cortis 4 PM Sal-mCnc	4180186
40761768	皮质醇^下午4点标本:质量浓度:时间点:唾液:定量型	4182948
40761771	17-Hydroxycorticosterone; 45M p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Oral fluid; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
40761771	Cortis 45M p 1 ug/kg CRH IV Sal-sCnc	4180186
40761771	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后45分钟:物质的量浓度:时间点:唾液:定量型	4182948
40761773	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp4; sp4 p chal; Spec; Substance concentration	4180186
40761773	Cortis sp4 p chal Sal-sCnc	4180186
40761773	皮质醇^在XXX刺激之后的第4个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761777	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Evening; F; hydrocortisone; Level; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Spec; Substance concentration	4180186
40761777	Cortis 8 PM Sal-sCnc	4180186
40761777	皮质醇^晚上8点标本:物质的量浓度:时间点:唾液:定量型	4182948
40761778	Cortis pre 1 ug/kg CRH IV Sal-mCnc	4180186
40761778	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
40761778	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前:质量浓度:时间点:唾液:定量型	4182948
40761780	17-Hydroxycorticosterone; Before; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hi dose; hydrocortisone; II; Level; Pl; Plasma; Plsm; Point in time; pre 2 mg Dex high; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761780	Cortis pre 2 mg Dex high SerPl-sCnc	4180186
40761780	皮质醇^在2 mg地塞米松 口服 2.5天 大剂量 每6小时之前:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761781	Temp Ur	4180186
40761781	Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Temp; Temperature; UA; UR; Urn	4180186
40761781	温度:温度:时间点:尿液:定量型	4182948
40761782	Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40761782	Sulfatides Ur-mCnc	4180186
40761782	硫脂:质量浓度:时间点:尿液:定量型	4182948
40761784	Chemistry; CR; Crea; Creat; i; Isom; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Urophorph; Uropor1; Uroporphyrin I	4180186
40761784	Uropor1/Creat Ur-sRto	4180186
40761784	尿卟啉 I 同分异构体/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40761785	B-OH-Butyr Vitf-sCnc	4180186
40761785	3-hydroxybutyrate; 3-hydroxybutyric acid; B; Beta hydroxy butyrate; Beta hydroxybutyric acid; Betahydroxybutyrate; Betahydroxybutyric acid; BHB; BOHB; B-OH-Butyr; Chemistry; Hydroxybutyric acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vitf; Vitreous fluid; Vitreous humor; Vitreous humour	4180186
40761785	Beta 羟基丁酸:物质的量浓度:时间点:玻璃体液:定量型	4182948
40761787	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; sp9; sp9 p chal; Spec; Substance concentration; Tumor marker	4180186
40761787	ACTH sp9 p chal Plas-sCnc	4180186
40761787	促肾上腺皮质激素^在XXX刺激之后的第9个标本:物质的量浓度:时间点:血浆:定量型	4182948
40761790	Cortis sp12 p chal SerPl-mCnc	4180186
40761790	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp12; sp12 p chal; Spec; SR	4180186
40761790	皮质醇^在XXX刺激之后的第12个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761796	Cortis sp8 p chal Sal-sCnc	4180186
40761796	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp8; sp8 p chal; Spec; Substance concentration	4180186
40761796	皮质醇^在XXX刺激之后的第8个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761797	Cortis sp9 p chal Sal-mCnc	4180186
40761797	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp9; sp9 p chal; Spec	4180186
40761797	皮质醇^在XXX刺激之后的第9个标本:质量浓度:时间点:唾液:定量型	4182948
40761798	17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp9; sp9 p chal; Spec; Substance concentration	4180186
40761798	Cortis sp9 p chal Sal-sCnc	4180186
40761798	皮质醇^在XXX刺激之后的第9个标本:物质的量浓度:时间点:唾液:定量型	4182948
40761799	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Ceftaz; Forj; Fortaz; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazicef; Tazj; TB; Tuberculosis	4180186
40761799	cefTAZidime Islt SlowMyco	4180186
40761799	头孢他啶:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40761800	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin A; Immunoglobulin A; MEIA; Ordinal; Outer membrane porin of E coli; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40761800	OmpC IgA Ser Ql IA	4180186
40761800	OmpC 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40761801	Ephedrin+Pseudo Ur Cfm-mCnc	4180186
40761801	Cenafed; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ectasule; Ephedrin+Pseudo; GCMS; Level; Mass concentration; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; Sudafed; UA; UR; Urn	4180186
40761801	麻黄碱+伪麻黄碱:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40761802	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Enzootic pneumonia; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40761802	M pneumo IgM Ser Ql IF	4180186
40761802	肺炎支原体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40761803	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; Deamidated gliadin peptide; Deaminated gliadin; DGP; F98; Gastro; Gastroenterology; GI; Gliadine; Immune globulin A; Immunoglobulin A; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40761803	Gliadin peptide IgA Ser-aCnc	4180186
40761803	麦醇溶蛋白肽 抗体.IgA:任意型浓度:时间点:血清:定量型	4182948
40761805	ANTIBIOTIC SUSCEPTIBILITIES; AST; Doribax; Epsilometer; Estrip; E-strip; Finibax; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40761805	Doripenem Islt Grad strip	4180186
40761805	多尼培南:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
40761807	ADB; ASO; ASOT; Group B Strep ab; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; Strep; Strep DNAse B; Strep DNAse B+ ASO Ab pnl; Strept; Streptococcal antibodies panel; Streptococcal Deoxyribonuclease; Streptodornase	4180186
40761807	Strep DNAse B+ ASO Ab pnl Ser	4180186
40761807	DNAse B 抗体.链球菌性与链球菌溶血素 O 抗体组套:-:时间点:血清:-	4182948
40761808	Oxidants Ur Ql	4180186
40761808	Adulterant; Ordinal; Oxidant; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
40761808	氧化剂:存在情况或阈值:时间点:尿液:序数型	4182948
40761809	Adulterants Pnl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
40761809	Adulterants Pnl Ur	4180186
40761809	混伪品组套:-:时间点:尿液:-	4182948
40761813	LPT 5 ug CA Act/Nor Bld	4180186
40761813	Act/Nor; Blood; conconavalin; Control; LPA; LPT; LPT 5 ug CA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761813	淋巴细胞增殖. 5 ug 伴刀豆球蛋白 A 丝裂原刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761815	LPT .5 ug CA Act/Nor Bld	4180186
40761815	Act/Nor; Blood; conconavalin; Control; LPA; LPT; LPT .5 ug CA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761815	淋巴细胞增殖. 0.5 ug 伴刀豆球蛋白 A 刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761816	LPT PW Bld-Imp	4180186
40761816	Blood; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LPA; LPT; LPT PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Nominal; PHA; Point in time; Random; Serology; Stim; WB; Whole blood	4180186
40761816	淋巴细胞增殖.美洲商陆丝裂原刺激:印象:时间点:全血:名义型	4182948
40761817	Act/Nor; Blood; Control; LPA; LPT; LPT 10 ug PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761817	LPT 10 ug PW Act/Nor Bld	4180186
40761817	淋巴细胞增殖. 10 ug 美洲商陆丝裂原刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761819	Act/Nor; Blood; Control; LPA; LPT; LPT 1.0 ug PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761819	LPT 1.0 ug PW Act/Nor Bld	4180186
40761819	淋巴细胞增殖. 1.0 ug 美洲商陆丝裂原刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761820	LPT 0.50 ug PW Act/Nor Bld	4180186
40761820	Act/Nor; Blood; Control; LPA; LPT; LPT 0.50 ug PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761820	淋巴细胞增殖. 0.50 ug 美洲商陆丝裂原刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761822	Act/Nor; Blood; Control; LPA; LPT; LPT 5 ug PHA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761822	LPT 5 ug PHA Act/Nor Bld	4180186
40761822	淋巴细胞增殖. 5.0 ug 植物血凝素刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761823	Act/Nor; Blood; Control; LPA; LPT; LPT 2.5 ug PHA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40761823	LPT 2.5 ug PHA Act/Nor Bld	4180186
40761823	淋巴细胞增殖. 2.5 ug 植物血凝素刺激 实际的/正常的:相对比率:时间点:全血:定量型	4182948
40761827	Enzootic pneumonia; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; M pneumo; M pneumo IgG+IgM pnl; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pan; PANEL.MICROBIOLOGY; Panl; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Pnl; Point in time; Random; Serum; SR; UniversalLabOrders	4180186
40761827	M pneumo IgG+IgM pnl Ser	4180186
40761827	肺炎支原体抗体.IgG 与 IgM 组套:-:时间点:血清:-	4182948
40761828	Collect Date Amn	4180186
40761828	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Coll; Collect; Collect Date; Collected; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Time stamp; Timestamp	4180186
40761828	采集日期:时间戳:时间点:羊水:定量型	4182948
40761833	Agg; Agglut; Agglutination; H flu; H influenza; H influenzae; Haem influ; Haem influ serotyp; Haemoph; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Islt; Isol; Microbiology; Nominal; Point in time; Random; Sertyp	4180186
40761833	Haem influ Sertyp Islt Aggl	4180186
40761833	流感嗜血杆菌 血清型:存在与否或特征标识:时间点:分离株:名义型:凝集试验法	4182948
40761834	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; Contr; Contra; Contrst; Document; Endoscopic guidance; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Liver+BD+Pancreas; Magnetic resonance cholangiopancreatography; Mitral regurgitation maximum velocity; MR Angiogram; MRCP; MRI; MRI angiogram; Pancr; Pancreatc; Pancreatic; Point in time; Rad; RADIOLOGY; Random; without contrast	4180186
40761834	MRCP Abd WO contr	4180186
40761834	旨在内镜检查的引导^不采用对比剂:发现:时间点:腹部>肝脏+胆管类+胰:文档型:MR	4182948
40761835	bod; Bodies; Cranial; Cranium; Document; Femoral; Femur; Finding; Findings; Head; Imaging; Lower extremity; PET Scan; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; RN; RNC; Scan; Skull to thigh; Skull.base; W RNC IV; WB	4180186
40761835	PT Skull to thigh W RNC IV	4180186
40761835	多层^采用静脉注射放射性核素:发现:时间点:全身>颅底至大腿中部:文档型:PT	4182948
40761836	Brain; Cranial; Cranium; Document; Finding; Findings; Imaging; Intracranial; PET Scan; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; RN; RNC; Scan; Skull; W RNC IV	4180186
40761836	PT Head+Neck W RNC IV	4180186
40761836	多层^采用静脉注射放射性核素:发现:时间点:头部+颈部:文档型:PT	4182948
40761837	Document; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40761837	US Guided Ablation	4180186
40761837	旨在组织切除术的引导:发现:时间点:XXX:文档型:超声	4182948
40761839	+3DR; Ang; Angio; Angiography; Angm; Arteriogram; c; CA; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Imaging; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
40761839	Deprecated Chest>CA CT.Angio +3DR W cont	4180186
40761840	Arteriovenous Fistula; AVF; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Hemodialysis access; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; View; VWS; W contr IV; WC	4180186
40761840	RFA AVF Views W contr IV	4180186
40761840	多重视图^采用静脉注射对比剂:发现:时间点:XXX>动静脉瘘:文档型:放射荧光透视法.血管造影术	4182948
40761841	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40761841	CT Guided Ablation	4180186
40761841	旨在组织切除术的引导:发现:时间点:XXX:文档型:CT	4182948
40761842	Brain; Cerebral; Cerebrum; Cranial; Cranium; Document; Finding; Findings; fMR; fMRI; Functional MRI; Head; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; MRI.function; Neuro; Neurology; Point in time; Rad; Radiology; Random; Skull	4180186
40761842	fMR Brain	4180186
40761842	多层:发现:时间点:头部>脑部:文档型:MR.功能成像	4182948
40761843	c; Cardiac; Cardio; Cardiology; Contr; Contra; Contrst; CorePlaybook; Document; Exercise; Finding; Findings; Heart Disease; Hrt; Imaging; Mitral regurgitation maximum velocity; MRI; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; W stress+WO+W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
40761843	MR Hrt W stress+WO+W contr IV	4180186
40761843	多层^采用应激+不采用 & 采用静脉注射对比剂:发现:时间点:胸部>心脏:文档型:MR	4182948
40761846	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f004; f4; f416; Fast omega gliadin; Immune globulin E; Immunoglobulin E; Omega-5 gliadin; Point in time; QNT; Quan; Quant; Quantitative; Random; rTri a 19 Omega-5 Gliadin, Wheat; Serum; SR; Triticum sativum; Wheat; Wheat (rTri a) 19	4180186
40761846	Wheat (rTri a) 19 IgE Qn	4180186
40761846	小麦 重组 (rTri a) 19 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761847	Hazelnut (rCor a) 8 IgE Qn	4180186
40761847	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; f017; f17; f425; Filbert; Hazel nut; Hazelnut; Hazelnut (rCor a) 8; Immune globulin E; Immunoglobulin E; LTP; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761847	榛子 重组 (rCor a) 8 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761850	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B19 virus; B19V; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Fifth Disease; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Parvo; Parvo virus; Parvov; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761850	B19V IgM CSF IA-aCnc	4180186
40761850	细小病毒 B19 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761851	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B19 virus; B19V; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Fifth Disease; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Parvo; Parvo virus; Parvov; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761851	B19V IgG CSF IA-aCnc	4180186
40761851	细小病毒 B19 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761853	ECV Ab Titr CSF CF	4180186
40761853	艾柯病毒 抗体:滴定度:时间点:脑脊液:定量型:补体结合试验	4182948
40761853	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
40761855	C burnet Ph2 IgG Titr CSF IF	4180186
40761855	贝氏柯克斯体 2 相 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40761855	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnet Ph2; C burnetii; Cerebral spinal fluid; Cerebrospinal Fl; Coxiella burnetii phase II; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Q fev; Q fever; Qfever; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761856	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C burnet; C burnet Ph2; C burnetii; Cerebral spinal fluid; Cerebrospinal Fl; Coxiella burnetii phase II; Coxiella burnettii; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; Q fev; Q fever; Qfever; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761856	C burnet Ph2 IgG CSF IA-aCnc	4180186
40761856	贝氏柯克斯体 2 相 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761858	1 day; 24 hours; 24HR; Chemistry; Immune globulin M; Immunoglobulin M; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761858	IgM 24h Ur-mRate	4180186
40761858	IgM:质量速率:24小时:尿液:定量型	4182948
40761863	Chemistry; Fetal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Patau syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk; Ts; Ts 13 risk	4180186
40761863	Ts 13 risk Fetus	4180186
40761863	胎儿三体型 13 风险:似然性:时间点:^胎儿:定量型	4182948
40761864	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; C tetani; C tetani Toxoid; c12; c208; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc208; Serum; SR; Tet; Tetanus; Tetanus toxoid; Time Resolved Fluorescence; TRF; Ttx	4180186
40761864	C tetani Toxoid IgG Ser IF-aCnc	4180186
40761864	破伤风梭菌类毒素 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫荧光法	4182948
40761868	A alternata; A alternata (rAlt a) 1; A tenuis; ABS; Aby; AH-1; Allergen; Allergens; ALLERGY TESTING; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; Immune globulin E; Immunoglobulin E; m006; m229; m6; Point in time; QNT; Quan; Quant; Quantitative; Random; Rm229; Serum; SR	4180186
40761868	A alternata (rAlt a) 1 IgE Qn	4180186
40761868	链格孢 重组 (rAlt a) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761870	Peach (rPru p) 1 IgE Qn	4180186
40761870	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f095; f419; f95; i; Immune globulin E; Immunoglobulin E; P prime; Peach; Peach (rPru p) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761870	桃子 重组 (rPru p) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761874	CV B IgG Titr Ser	4180186
40761874	柯萨奇病毒 B 型 抗体.IgG:滴定度:时间点:血清:定量型	4182948
40761874	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; CBV; Coxsackie; Coxsackie virus; CV; CV B; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40761878	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus 1 Ab; Herpes simplex virus 1 antibody; Herpes simplex virus 1 IgM; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761878	HSV1 IgM CSF IA-aCnc	4180186
40761878	单纯疱疹病毒 1 型 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761879	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761879	HSV2 IgG CSF IA-aCnc	4180186
40761879	单纯疱疹病毒 2 型 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761880	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40761880	HSV1 IgG CSF IA-aCnc	4180186
40761880	单纯疱疹病毒 1 型 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40761881	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C diphtheriae; Diphtheria; Diptheria; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders	4180186
40761881	C diphtheriae IgG Ser IA-aCnc	4180186
40761881	白喉棒状杆菌 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40761882	C jejuni IgM Titr Ser IF	4180186
40761882	空肠弯曲菌 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40761882	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C jejuni; Campy; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761883	C jejuni IgG Titr Ser IF	4180186
40761883	空肠弯曲菌 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40761883	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C jejuni; Campy; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761885	CV A9 IgM Titr Ser IF	4180186
40761885	柯萨奇病毒 A9 型 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40761885	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761886	CV A9 IgG Titr Ser IF	4180186
40761886	柯萨奇病毒 A9 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40761886	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761888	1 day; 24 hours; 24HR; 5-HTP; 5-Hydroxy tryptophan; 5OH-Tryptophan; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40761888	5OH-Tryptophan 24h Ur-mCnc	4180186
40761888	5-羟色氨酸脱羧醇:质量浓度:24小时:尿液:定量型	4182948
40761889	GBM IgG Titr Ser IF	4180186
40761889	肾小球基底膜 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40761889	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GBM; Glom; Goodpastures; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Kidney; Nephrology; Point in time; Random; Renal; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40761891	Y enterocol Ab Titr Ser CF	4180186
40761891	小肠结肠炎耶尔森氏菌 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
40761891	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y enterocol; Y enterocolitica	4180186
40761892	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; L pneumo; L pneumo2; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 2; MEIA; Microbiology; Pneu; pneum; Pneumophilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Togus 1	4180186
40761892	L pneumo2 IgM Ser IA-aCnc	4180186
40761892	嗜肺军团菌 2 型 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40761894	1 day; 24 hours; 24HR; Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; M-spikes; Nephrology; Nominal; PR; Prot; Renal; UA; UR; Urn	4180186
40761894	Oligoclonal Bands 24h Ur IEF-Imp	4180186
40761894	蛋白质成分.寡克隆区带:印象:24小时:尿液:名义型:等电聚焦电泳	4182948
40761895	100WBC; Cell; Cellularity; Diaf; DiafP; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number fraction; Percent; Peritoneal Dialysis fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC; WBC; WBCs; White blood cell; White blood cells	4180186
40761895	Polys/leuk NFr DiafP	4180186
40761895	分叶核白细胞/100 个白细胞:计数型分数:时间点:腹膜透析液:定量型	4182948
40761898	European paper wasp IgE Qn	4180186
40761898	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; European paper wasp; i77; Immune globulin E; Immunoglobulin E; Mediterranean paper wasp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40761898	造纸胡蜂 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761900	Brucella Ab Titr CSF Aggl	4180186
40761900	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Titer; Titered; Titre; Ttr	4180186
40761900	布鲁氏菌属单个未知种 抗体:滴定度:时间点:脑脊液:定量型:凝集试验法	4182948
40761901	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Conalb (nGal d) 3; Dextro; f323; III; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf323; Serum; SR	4180186
40761901	Conalb (nGal d) 3 IgE Qn	4180186
40761901	伴清蛋白 原生 (nGal d) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40761904	CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; Spec; SR; Testo; Testos; Testost	4180186
40761904	Testost sp2 SerPl-mCnc	4180186
40761904	睾酮^第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761905	After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Endocrine; Endocrinology; Heart Disease; Kidney; Level; Mass concentration; Nephrology; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40761905	Renin p chal Plas-mCnc	4180186
40761905	肾素^在 XXX 刺激之后:质量浓度:时间点:血浆:定量型	4182948
40761908	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; Spec; SR	4180186
40761908	17OHP sp3 SerPl-mCnc	4180186
40761908	17-羟孕酮^第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761910	CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Convalescent; Level; Mass concentration; Pept; Pl; Plasma; Plsm; Point in time; Post immunization; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; Spec; SR	4180186
40761910	C peptide sp2 SerPl-mCnc	4180186
40761910	C 肽^第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761912	CHEMISTRY.CHALLENGE TESTING; Convalescent; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; Spec; SR	4180186
40761912	Estrogen sp2 SerPl-mCnc	4180186
40761912	雌激素^第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761916	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp22; Spec; SR	4180186
40761916	Cortis sp22 SerPl-mCnc	4180186
40761916	皮质醇^第22个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761917	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp20; Spec; SR	4180186
40761917	Cortis sp20 SerPl-mCnc	4180186
40761917	皮质醇^第20个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761918	Cortis sp19 SerPl-mCnc	4180186
40761918	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp19; Spec; SR	4180186
40761918	皮质醇^第19个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761921	Cortis sp16 SerPl-mCnc	4180186
40761921	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp16; Spec; SR	4180186
40761921	皮质醇^第16个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761922	Cortis sp14 SerPl-mCnc	4180186
40761922	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp14; Spec; SR	4180186
40761922	皮质醇^第14个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761925	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
40761925	Urea CSF-sCnc	4180186
40761925	尿素:物质的量浓度:时间点:脑脊液:定量型	4182948
40761926	IGF BP3 45M p chal SerPl-mCnc	4180186
40761926	45M p chal; After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40761926	胰岛素样生长因子结合蛋白 3^在XXX刺激之后45分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761927	20M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40761927	TSH 20M pre chal SerPl-mCnc	4180186
40761927	促甲状腺激素^在XXX刺激之前20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761928	15M pre chal; Arbitrary Concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40761928	TSH 15M pre chal SerPl-aCnc	4180186
40761928	促甲状腺激素^在XXX刺激之前15分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
40761930	3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40761930	T4 Free 3h p chal SerPl-mCnc	4180186
40761930	甲状腺素.游离型^在XXX刺激之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761931	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
40761931	T4 Free 2h p chal SerPl-mCnc	4180186
40761931	甲状腺素.游离型^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761933	3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; FR; Free T3; FT3; Level; Mass concentration; Non-protein bound; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T3; T-3; T3Free; thyroid hormone; Total T3; Triodothyrne	4180186
40761933	T3Free 3h p chal SerPl-mCnc	4180186
40761933	三碘甲状腺原氨酸.游离型^在XXX刺激之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761935	5M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761935	C peptide 5M p chal SerPl-mCnc	4180186
40761935	C 肽^在XXX刺激之后5分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40761939	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp19; Spec; SR; STH	4180186
40761939	GH sp19 SerPl-mCnc	4180186
40761939	生长激素^第19个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761942	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp16; Spec; SR; STH	4180186
40761942	GH sp16 SerPl-mCnc	4180186
40761942	生长激素^第16个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761943	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp15; Spec; SR; STH	4180186
40761943	GH sp15 SerPl-mCnc	4180186
40761943	生长激素^第15个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761953	After; Cardio; Cardiology; CHEMISTRY.CHALLENGE TESTING; HCY; Hcys; Hcyst; Heart Disease; homocysteine; homocystine; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40761953	Hcys p chal SerPl-sCnc	4180186
40761953	同型半胱氨酸或同型胱氨酸^在 XXX 刺激之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40761955	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp47; Spec; SR; STH	4180186
40761955	GH sp47 SerPl-mCnc	4180186
40761955	生长激素^第47个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761956	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp46; Spec; SR; STH	4180186
40761956	GH sp46 SerPl-mCnc	4180186
40761956	生长激素^第46个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761958	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp44; Spec; SR; STH	4180186
40761958	GH sp44 SerPl-mCnc	4180186
40761958	生长激素^第44个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761960	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp42; Spec; SR; STH	4180186
40761960	GH sp42 SerPl-mCnc	4180186
40761960	生长激素^第42个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761961	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp41; Spec; SR; STH	4180186
40761961	GH sp41 SerPl-mCnc	4180186
40761961	生长激素^第41个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761962	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp40; Spec; SR; STH	4180186
40761962	GH sp40 SerPl-mCnc	4180186
40761962	生长激素^第40个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761963	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp39; Spec; SR; STH	4180186
40761963	GH sp39 SerPl-mCnc	4180186
40761963	生长激素^第39个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761965	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp37; Spec; SR; STH	4180186
40761965	GH sp37 SerPl-mCnc	4180186
40761965	生长激素^第37个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761966	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp36; Spec; SR; STH	4180186
40761966	GH sp36 SerPl-mCnc	4180186
40761966	生长激素^第36个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761968	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp33; Spec; SR; STH	4180186
40761968	GH sp33 SerPl-mCnc	4180186
40761968	生长激素^第33个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761970	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp31; Spec; SR; STH	4180186
40761970	GH sp31 SerPl-mCnc	4180186
40761970	生长激素^第31个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761972	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp29; Spec; SR; STH	4180186
40761972	GH sp29 SerPl-mCnc	4180186
40761972	生长激素^第29个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761978	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp21; Spec; SR; STH	4180186
40761978	GH sp21 SerPl-mCnc	4180186
40761978	生长激素^第21个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40761979	Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; Mass concentration; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761979	Urea DiafP-mCnc	4180186
40761979	尿素:质量浓度:时间点:腹膜透析液:定量型	4182948
40761986	Calcit BS SerPl-mCnc	4180186
40761986	BS; Chemistry; CT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	4180186
40761986	降钙素^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40761987	Vasopressin 1.5h p chal Plas-mCnc	4180186
40761987	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; VP	4180186
40761987	后叶加压素^在XXX刺激之后1.5小时:质量浓度:时间点:血浆:定量型	4182948
40761988	Vasopressin BS Plas-mCnc	4180186
40761988	ADH; Adiuretin; Antidiuretic hormone; Arginine vasopressin hormone; AVH; BS; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; VP	4180186
40761988	后叶加压素^基线:质量浓度:时间点:血浆:定量型	4182948
40761989	Pyruvate p Exc Bld-mCnc	4180186
40761989	After; Blood; CHEMISTRY.CHALLENGE TESTING; EXCZ; Level; Mass concentration; p Exc; Point in time; PST; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40761989	丙酮酸^在运动之后:质量浓度:时间点:全血:定量型	4182948
40761991	2-Butanone; 3-butanone; Butanone; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; Mass concentration ratio; Mass ratio; MCRto; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40761991	MEK/Creat Ur	4180186
40761991	甲基乙基甲酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40761992	4h p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40761992	Renin 4h p chal Plas-cCnc	4180186
40761992	肾素^在XXX刺激之后4小时:催化浓度:时间点:血浆:定量型	4182948
40761993	4h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40761993	Aldost 4h p chal SerPl-mCnc	4180186
40761993	醛固酮^在XXX刺激之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
40761995	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Prog; URO; Urology	4180186
40761995	Sperm Prog # Smn	4180186
40761995	精子.前向运动型:计数型浓度:时间点:精液:定量型	4182948
40761998	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid	4180186
40761998	Nuc cell # Plr Manual	4180186
40761998	有核细胞类:计数型浓度:时间点:胸膜液:定量型:手工计数方法	4182948
40761999	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40761999	Nuc cell # Pcar Manual	4180186
40761999	有核细胞类:计数型浓度:时间点:心包液:定量型:手工计数方法	4182948
40762000	Nuc cell # CSF Manual	4180186
40762000	#; ABS; absolute; absolutes; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40762000	有核细胞类:计数型浓度:时间点:脑脊液:定量型:手工计数方法	4182948
40762003	11DC 20M p chal SerPl-mCnc	4180186
40762003	11DC; 20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762003	11-脱氧皮质醇^在XXX刺激之后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40762004	11DC 2.5h p chal SerPl-mCnc	4180186
40762004	11DC; 2.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762004	11-脱氧皮质醇^在XXX刺激之后2.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40762005	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e218; f083; f83; Feces; Gallus spp; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Re218; Serum; SR; stool	4180186
40762005	Chicken Drop IgG-mCnc	4180186
40762005	鸡粪便 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762008	A niger; ABS; Aby; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; m207; Mass concentration; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762008	A niger IgG Ser-mCnc	4180186
40762008	黑曲霉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762010	Canary Feather IgG-mCnc	4180186
40762010	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e201; Feathers; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762010	金丝雀羽毛 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762011	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762011	Androstanolone 1h p chal SerPl-mCnc	4180186
40762011	双氢睾酮^在XXX刺激之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40762017	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g005; g5; Immune globulin G; Immunoglobulin G; Italian Ryegrass; Level; Mass concentration; Per rye grass; Perennial ryegrass; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye grass; Ryegrass; Serum; SR	4180186
40762017	Per rye grass IgG-mCnc	4180186
40762017	多年生黑麦草 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762020	Chemistry; CR; Crea; Creat; Formiminoglutamic Acidemia; Gln; His; Histidinemia; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40762020	Glutamine+Histidine/Creat Ur-Rto	4180186
40762020	谷氨酰胺+组氨酸/肌酐:比率:时间点:尿液:定量型	4182948
40762024	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
40762024	M tb DNA Fld Ql NAA+probe	4180186
40762024	结核分枝杆菌 DNA:存在情况或阈值:时间点:体液:序数型:探针法.基因扩增.靶向	4182948
40762025	Bowel movement; Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Mass Content; Point in time; Protoporph; Protoporphrn; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762025	Protopor Stl-mCnt	4180186
40762025	原卟啉:质量含量:时间点:大便:定量型	4182948
40762026	ABS; Aby; ACIF; AECA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-endothelial cell Ab; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
40762026	Endothelial cell Ab SerPl Ql IF	4180186
40762026	内皮细胞 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
40762029	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hep; Hep E; Hepatis; Hepatit; HEV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40762029	HEV Ab Ser Ql IA	4180186
40762029	戊型肝炎病毒 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40762030	beta-factor XIIa part 1; Blood; coagulation factor XII; coagulation factor XII (Hageman factor); coagulation factor XIIa heavy chain; coagulation factor XIIa light chain; EC 3.4.21.38; Genetics; HAE3; HAEX; HAF; Hageman factor; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762030	F12 gene Mut Anl Bld/T	4180186
40762030	F12 基因 突变分析:类型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762031	Blood; Genetics; Heredity; Heritable; Inherited; LAC; Lactase; lactase-glycosylceramidase; Lactase-Phlorizin Hydrolase; lactase-phlorizin hydrolase-1; LPH; LPH1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762031	LCT gene Mut Anl Bld/T	4180186
40762031	LCT 基因 突变分析:类型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762033	Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Total parental nutrition	4180186
40762033	Bacteria TPN Cult	4180186
40762033	细菌 已鉴定的:存在与否或特征标识:时间点:全面父母营养:名义型:培养	4182948
40762037	Acd; Acid fast Stn; Acids; AFB stain; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn; ZN Stn	4180186
40762037	ZN Stn Fld	4180186
40762037	显微镜观察:存在与否或特征标识:时间点:体液:名义型:抗酸染色法.Ziehl-Neelsen	4182948
40762043	Chemistry; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp11; Spec; SR; STH	4180186
40762043	GH sp11 SerPl-mCnc	4180186
40762043	生长激素^第11个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762044	CHEMISTRY.CHALLENGE TESTING; Convalescent; CR; Crea; Creat; Kidney; Level; Mass concentration; Nephrology; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; Renal; Second; sp2; Spec; UA; UCr; UR; Urn	4180186
40762044	Creat sp2 Ur-mCnc	4180186
40762044	肌酐^第2个标本:质量浓度:时间点:尿液:定量型	4182948
40762047	DPD/PYD Ur-sRto	4180186
40762047	Chemistry; DPD; Dpyr; Free lysly-pyridinoline; Lysylpyridinoline; Point in time; PYD; Pyr; Pyradinium collagen crosslinks; Pyridinium collagen crosslinks; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
40762047	脱氧吡啶啉/吡啶啉:物质的量比率:时间点:尿液:定量型	4182948
40762049	Antiglob; BLOOD BANK; Comp; Complmt; DAGT; DAT; DAT C3b+C4d Comp-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
40762049	DAT C3b+C4d Comp-Sp Reag RBC Ql	4180186
40762049	直接抗球蛋白试验.补体 C3b+C4d 特异性试剂:存在情况或阈值:时间点:红细胞:序数型	4182948
40762050	AOEObservation; DRUG DOSES; Gvn; Hep; Hepar; Heparn; Nominal; Point in time; Random; Typ	4180186
40762050	Heparin Gvn	4180186
40762050	肝素 给予的:类型:时间点:^患者:名义型	4182948
40762051	F oxysporum IgG-mCnc	4180186
40762051	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; F oxysporum; F vaxinfectum; Fusarium vasinfectum; Immune globulin G; Immunoglobulin G; Level; m49; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762051	尖镰孢菌 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762052	bi-level positive airway pressure; BIPAP AndOr CPAP setting; biphasic positive airway pressure; continuous positive airway pressure; Finding; Findings; Lung; Ordinal; Point in time; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
40762052	BIPAP AndOr CPAP setting Vent	4180186
40762052	BIPAP和或CPAP设置:发现:时间点:呼吸机:序数型	4182948
40762060	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762060	GM3 IgM Ser IA-aCnc	4180186
40762060	神经节苷脂 GM3 抗体.IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762066	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762066	GM2 Gangl IgG CSF IA-aCnc	4180186
40762066	神经节苷脂 GM2 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762069	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Tetrasialylganglioside	4180186
40762069	GQ1b Gangl IgM CSF IA-aCnc	4180186
40762069	神经节苷脂 GQ1b 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762072	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD3 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762072	GD3 Gangl IgG Ser IA-aCnc	4180186
40762072	神经节苷脂 GD3 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762074	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; g006; g215; g6; Immune globulin E; Immunoglobulin E; P prime; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; rph1; Serum; SR; Timothy; Timothy (rPhl p) 5b; Timothy grass	4180186
40762074	Timothy (rPhl p) 5b IgE Qn	4180186
40762074	梯牧草 重组 (rPhl p) 5b 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762075	Holm oak IgE Qn	4180186
40762075	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Holly oak; Holm oak; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t77	4180186
40762075	刺叶栎 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762076	PLA2 nApi m 1 IgE Qn	4180186
40762076	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honeybee; i; i001; i1; Immune globulin E; Immunoglobulin E; k203; nApi m 1 Phospholipase A2, Bee; PLA2 nApi m 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk203; Serum; SR	4180186
40762076	意大利蜜蜂磷脂酶 A2 原生 (nApi m) 4 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762077	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bromelain; CCD; Cross-reactive carbohydrate determinant; Immune globulin E; Immunoglobulin E; k202; nAna c 2 Bromelin, Pineapple; o214; Pineapple; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk202; Ro214; Serum; SR	4180186
40762077	Bromelin MUXF3 IgE Qn	4180186
40762077	菠萝蛋白酶 MUXF3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762078	11DC; Before; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762078	11DC pre chal SerPl-mCnc	4180186
40762078	11-脱氧皮质醇^在 XXX 刺激之前:质量浓度:时间点:血清/血浆:定量型	4182948
40762079	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f351; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shrimp; Shrimp tm (rPen a) 1; SR; Tm	4180186
40762079	Shrimp tm (rPen a) 1 IgE Qn	4180186
40762079	棕虾原肌球蛋白 重组 (rPen a) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762080	BDPLT16; BDPLT2; Blood; CD61; Genetics; GP3A; GPIIIa; GT; Heredity; Heritable; Identity or presence; Inherited; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762080	ITGB3 Mut Anl Bld/T	4180186
40762080	ITGB3 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762081	Blood; Fibrinogen beta chain; Genetics; HEL-S-78p; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762081	FGB Mut Anl Bld/T	4180186
40762081	FGB 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762083	Urate 18h Ur-mRate	4180186
40762083	18 hours; 18HR; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urates; Uric acid; Urn	4180186
40762083	尿酸:质量速率:18小时:尿液:定量型	4182948
40762086	18 hours; 18HR; Chemistry; i Phos; Inorganic phosphate; Mass rate; mRate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762086	Phosphate 18h Ur-mRate	4180186
40762086	磷酸盐:质量速率:18小时:尿液:定量型	4182948
40762087	Sodium 18h Ur-sRate	4180186
40762087	18 hours; 18HR; Chemistry; Na; Na+; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40762087	钠:物质的量速率:18小时:尿液:定量型	4182948
40762088	Magnesium 18h Ur-mRate	4180186
40762088	18 hours; 18HR; Chemistry; MAG; Magnes; Mass rate; Mg; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762088	镁:质量速率:18小时:尿液:定量型	4182948
40762094	18 hours; 18HR; Alpha amylase; Ams; Amyl; Catalytic Rate; Chemistry; cRate; Diastase; Gastro; Gastroenterology; GI; k87; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762094	Amylase 18h Ur-cRate	4180186
40762094	淀粉酶:催化速率:18小时:尿液:定量型	4182948
40762101	15M p chal; After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40762101	IGF BP3 15M p chal SerPl-mCnc	4180186
40762101	胰岛素样生长因子结合蛋白 3^在XXX刺激之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40762102	Fract excret urea ?Tm Ur+SerPl-Rto	4180186
40762102	?Tm; Chemistry; Fract excret urea; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
40762102	尿素排泄分数:比率:XXX:尿液+血清/血浆:定量型	4182948
40762105	Lactate 15M p chal SerPl-sCnc	4180186
40762105	15M p chal; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762105	乳酸^在XXX刺激之后15分钟:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762107	ENA SS-a 60kD Ab Ser Ql IB	4180186
40762107	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; ENA; ENA SS-A; ENA SS-a 60kD; IMMUNE BLOT; Immunobl; Immunoblot; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Ro; Ro AB; Screen; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; WB; WBLOT; West blot; West blt; Western blot	4180186
40762107	Sjogrens 综合征-a 可提取性核 60kD 抗体:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40762109	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Infared spectoscopy; IR; Mass Content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762109	Water Stl IR-mCnt	4180186
40762109	水:质量含量:时间点:大便:定量型:红外光谱分析法	4182948
40762112	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762112	HLA-DQA1 High Res	4180186
40762112	HLA-DQA1:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
40762115	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40762115	HLA-DRB3	4180186
40762115	HLA-DRB3:类型:时间点:全血/组织:名义型	4182948
40762118	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dynamic; FC; Granulocytic Ab; Hematology; Heme; Neut; Neutr; Neutrophils; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40762118	Neutrophil Ab Ser FC-aCnc	4180186
40762118	嗜中性粒细胞 抗体:任意型浓度:时间点:血清:定量型:流式细胞测量术	4182948
40762119	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonuclear protein; Ribonucleoprotein extractable nuclear 68/70kD Ab; Ribonucleoprotein extractable nuclear 68kD Ab; Ribonucleoprotein extractable nuclear 70kD Ab; RNP; Serology; Serum; snRNP; snRNP70; SR; U1 RNP; U1 snRNP; U1 snRNP70; U1RNP	4180186
40762119	U1 snRNP70 Ab Ser-aCnc	4180186
40762119	U1 小细胞核核糖核蛋白 70kD 抗体:任意型浓度:时间点:血清:定量型	4182948
40762121	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside monosialo; GM1 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40762121	GM1 Gangl IgM CSF IA-aCnc	4180186
40762121	神经节苷脂 GM1 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40762125	Lactate Bld-mCnc	4180186
40762125	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Blood; Chemistry; Lact; Lactic acid; Level; L-lactate; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762125	乳酸:质量浓度:时间点:全血:定量型	4182948
40762126	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40762126	GM3 IgG Ser IA-aCnc	4180186
40762126	神经节苷脂 GM3 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762128	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CD54 Cells; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; ICAM-1; intercellular adhesion molecule-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762128	CD54 Cells NFr Fld	4180186
40762128	细胞.CD54/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40762129	Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Mass concentration; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Tg; Trig; Trigly; Triglycerides; Triglycrides	4180186
40762129	Trigl DiafP-mCnc	4180186
40762129	甘油三酯:质量浓度:时间点:腹膜透析液:定量型	4182948
40762132	Alpha amylase; Ams; Amyl; Catalytic Concentration; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Diastase; k87; Kidney; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
40762132	Amylase DiafP-cCnc	4180186
40762132	淀粉酶:催化浓度:时间点:腹膜透析液:定量型	4182948
40762134	Ashkenazi jewish workup; Blood; BRCA; BRCC2; Breast cancer 2, early onset; BROVCA2; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Gene mut tested; Genetics; GLM3; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; Oncology; PCR; PNCA2; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; XRCC11	4180186
40762134	BRCA1+BRCA2 Mut Tested Bld/T	4180186
40762134	BRCA1+BRCA2 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762135	TCR G-D Cells NFr Tiss	4180186
40762135	Cell; CELL MARKERS; Cellularity; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TCR G-D; TCR G-D Cells; Tissue; Tissue, unspecified	4180186
40762135	细胞.TcR Gamma Delta/100 个细胞:计数型分数:时间点:组织与涂片:定量型	4182948
40762137	ACE1; angiotensin I converting enzyme; Blood; CD143; DCP; DCP1; Gene mut tested; Genetics; Heredity; Heritable; ICH; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; MVCD3; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762137	ACE gene Mut Tested Bld/T	4180186
40762137	ACE 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40762140	Activated protein C cofactor; APC; Blood; Coagulation Factor V - Leiden gene; coagulation factor V (proaccelerin, labile factor); F5 p.H1299R; FVL; Genetics; Heredity; Heritable; Inherited; Labile factor; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PCCF; PCR; Point in time; PR; Proaccelerin gene; QL; Qual; Qualitative; Random; RPRGL1; Screen; THPH2; Thrombophilia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762140	F5 p.H1299R Bld/T Ql	4180186
40762140	F5 基因.p.H1299R:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40762141	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Blood; Chemistry; Lact; Lactic acid; L-lactate; Mass concentration ratio; Mass ratio; MCRto; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762141	Lactate/Pyruvate Bld	4180186
40762141	乳酸/丙酮酸:质量比率:时间点:全血:定量型	4182948
40762143	Chrom analy; Chrom analy interphase; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Karyotype; Misc; Miscellaneous; Molecular pathology; MOLPATH; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40762143	Chrom analy interphase Spec FISH-Imp	4180186
40762143	染色体分析.分裂间期:印象:时间点:XXX:叙述型:FISH	4182948
40762145	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HBV; HCV; Hep; Hep B; Hep C; Hepatis; Hepatit; HepB; HIV 1+HCV; HIV 1+HCV RNA+HBV; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40762145	HIV 1+HCV RNA+HBV DNA SerPl Ql NAA+probe	4180186
40762145	HIV 1 型+丙型肝炎病毒 RNA+乙型肝炎病毒 DNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40762147	Glucagon sp4 p fast SerPl-mCnc	4180186
40762147	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p fast; Spec; SR	4180186
40762147	胰高血糖素^在热量型禁食之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762148	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p fast; Spec; SR	4180186
40762148	Glucagon sp3 p fast SerPl-mCnc	4180186
40762148	胰高血糖素^在热量型禁食之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762151	Cow Whey IgG-mCnc	4180186
40762151	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f236; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf236; Serum; SR	4180186
40762151	乳清 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762153	Dis; Diseases; Dz; IBD; IBD Ab 7; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Serology; Serum; SR	4180186
40762153	IBD Ab 7 Ser-Imp	4180186
40762153	炎症性肠病抗体 7:印象:时间点:血清:名义型	4182948
40762155	Lipoprofile pnl SerPl	4180186
40762155	Chemistry; Lipoprofile pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762155	LipoProfile 组套:-:时间点:血清/血浆:-	4182948
40762156	Blood; LPA; LPT; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Lymphocyte prolif pnl; Pan; PANEL.SEROLOGY; Panl; PHA; Pnl; Point in time; Random; Serology; WB; Whole blood	4180186
40762156	Lymphocyte prolif pnl Bld	4180186
40762156	淋巴细胞增殖组套:-:时间点:全血:-	4182948
40762157	AN; AN2; Aniridia type II protein Oculorhombin; Arbitrary; Blood; D11S812E; FVH1; Genetics; Heredity; Heritable; Inherited; MGC17209; MGDA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Oculorhombin; Ordinal; paired box 6; paired box gene 6; paired box gene 6 (aniridia, keratitis); paired box homeotic gene-6; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WAGR; WB; Whole blood; Whole blood or Tissue	4180186
40762157	PAX6 gene Mut Anl Bld/T Ql	4180186
40762157	PAX6 基因 突变分析:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40762161	40S ribosomal protein S19 Oculorhombin; Arbitrary; Blood; DBA; DBA1; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; ribosomal protein S19; S19; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762161	RPS19 gene Mut Anl Bld/T Ql	4180186
40762161	RPS19 基因 突变分析:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40762162	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40762162	ANA Ser Ql HEp2 subst	4180186
40762162	细胞核 抗体:存在情况或阈值:时间点:血清:序数型:Hep2 细胞底物法	4182948
40762164	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T whippelii; T whippelli; T whipplei; Tropheryma whippelli; Whipple's disease	4180186
40762164	T whipplei Ab Ser Ql	4180186
40762164	Tropheryma whippelii 抗体:存在情况或阈值:时间点:血清:序数型	4182948
40762167	CARD.US; Cardiac; Cardio; Cardiology; CC.transverse; Circumf.transverse; Echography; Girth; Heart Disease; Hrt; Length Ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; TC; Thoracic Circumference; ULS; Ultrasound	4180186
40762167	Hrt CC.transverse/TC US	4180186
40762167	周长.横断面.心脏/周长.胸廓:长度比率:时间点:心脏:定量型:超声	4182948
40762169	Area Ratio; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Xsection; Xsection.transverse; Xsection.transverse.heart	4180186
40762169	Hrt Xsection.transverse.heart/thorax US	4180186
40762169	横截面.横向.心脏/轴位.胸廓:面积比率:时间点:心脏:定量型:超声	4182948
40762170	CARD.US; Cardiac; Cardio; Cardiology; DIA; Diam; Diam AO root; Diam FO; Echography; Heart Disease; Hrt; Length Ratio; OA root; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762170	Hrt Diam FO/OA root US	4180186
40762170	直径.卵圆孔/直径.主动脉根部:长度比率:时间点:心脏:定量型:超声	4182948
40762174	Atrial wave; A-wave; Blood flow.diastolic.atrial wave.max; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Largest; Max V; Maximal; Maximum; Misc; Miscellaneous; Other; Peak; Peak A-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; V max; Velocity; Vmax	4180186
40762174	Valve Peak A-wave US	4180186
40762174	A 波.最大值:速度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762177	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762177	Hrt Isovolumic contraction time US	4180186
40762177	等容收缩时间:时间:时间点:心脏:定量型:超声	4182948
40762178	Before; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; PEP; Point in time; Pre eject time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762178	Valve Pre eject time US	4180186
40762178	在射血时间之前:时间:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762179	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart beat; Heart Disease; HR cor; Hrt; Hrt ventr; L; LT; LV; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
40762179	LV Ejection time HR cor US	4180186
40762179	射血时间^^经过针对心率而校正的:时间:时间点:心脏.心室.左侧:定量型:超声	4182948
40762180	Before; CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart beat; Heart Disease; HR cor; Hrt; Hrt ventr; Misc; Miscellaneous; Other; PEP; Point in time; Pre eject time; Pulse; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Ventricular	4180186
40762180	Hrt ventr Pre eject time HR cor US	4180186
40762180	在射血时间之前^^经过针对心率而校正的:时间:时间点:心脏.心室.XXX:定量型:超声	4182948
40762181	Before; CARD.US; Cardiac; Cardio; Cardiology; Echography; Eject time; Heart Disease; Hrt; Hrt ventr; Misc; Miscellaneous; Other; PEP; Point in time; Pre eject time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; Time ratio; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Ventricular	4180186
40762181	Hrt ventr Pre eject time/Eject time US	4180186
40762181	在射血时间之前/射血时间:时间比率:时间点:心脏.心室.XXX:定量型:超声	4182948
40762184	CARD.US; Cardiac; Cardio; Cardiology; Dextro; Echography; Heart Disease; Hrt; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762184	Valve D-E excursion US	4180186
40762184	D-E 位移:长度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762185	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Length Fraction; Misc; Miscellaneous; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; ROI; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762185	ROI Thickening LenFr US	4180186
40762185	增厚:长度分数:时间点:兴趣区域.XXX:定量型:超声	4182948
40762191	CARD.US; Cardio; Cardiology; Early wave; Echography; E-septal separation; E-wave; Heart Disease; Length; MV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762191	MV E-septal separation US	4180186
40762191	E 波至室间隔的距离:长度:时间点:二尖瓣:定量型:超声	4182948
40762194	Art; CARD.US; Cardio; Cardiology; der US; Echography; Heart Disease; PA; PAP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40762194	PA Press der US	4180186
40762194	压力:压力或压强:时间点:肺动脉:定量型:超声.导出法	4182948
40762195	CARD.US; Cardio; Cardiology; Circ; Circ sys; Dynamic; Echography; Heart Disease; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Upper extremity	4180186
40762195	Flow radius US	4180186
40762195	血流半径:长度:时间点:循环系统.XXX:定量型:超声	4182948
40762196	A-C interval; CARD.US; Cardiac; Cardio; Cardiology; Durat; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762196	Valve A-C interval US	4180186
40762196	A-C 持续时间:时间:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762198	Atrial wave; A-wave; A-wave duration; CARD.US; Cardio; Cardiology; Circ; Circ sys; Durat; Echography; Heart Disease; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762198	A-wave duration US	4180186
40762198	A 波持续时间:时间:时间点:循环系统.XXX:定量型:超声	4182948
40762201	CARD.US; Cardio; Cardiology; Durat; Echography; Envelope duration; Heart Disease; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762201	Body reg Envelope duration US	4180186
40762201	指标持续时间:时间:时间点:XXX:定量型:超声	4182948
40762203	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Length; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; Thick; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762203	Valve Leaflet thickness US	4180186
40762203	瓣叶厚度:长度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762204	Annulus E wave; Bld flow; Bld flow vel; Bld flow.velocity; CARD.US; Cardiac; Cardio; Cardiology; Dynamic; Early wave; Echography; E-wave; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Vel; Velocity ratio	4180186
40762204	Valve E-wave/Annulus E wave US	4180186
40762204	血流 E 波/瓣口 E 波:速度比率:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762205	Atrial wave; A-wave; A-wave duration; CARD.US; Cardio; Cardiology; Circ; Circ sys; Durat; Echography; Heart Disease; MV A dur; Point in time; Pulm; Pulm v A dur; Pulm v A dur - MV A dur; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Time ratio; ULS; Ultrasound; Ven; Venous	4180186
40762205	Circ sys Pulm v A dur/MV A dur US	4180186
40762205	A 波持续时间.肺静脉/A 波持续时间.二尖瓣:时间比率:时间点:循环系统:定量型:超声	4182948
40762206	Atrial wave; A-wave; CARD.US; Cardio; Cardiology; Echography; Heart Disease; Length Ratio; MV; MV VTI; Point in time; Pulm; Pulm v; Pulm v A VTI; PV+MV; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Ven; Venous	4180186
40762206	PV+MV Pulm v A VTI/MV VTI US	4180186
40762206	速度-时间积分.肺静脉 A 波/速度-时间积分.二尖瓣 A 波:长度比率:时间点:肺静脉+二尖瓣:定量型:超声	4182948
40762207	Atrial wave; A-wave; A-wave duration; CARD.US; Cardio; Cardiology; Durat; Echography; Heart Disease; Point in time; Pulm; Pulm v; Pulm v A dur; Pulm v A dur - MV A dur; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Time difference; ULS; Ultrasound; Ven; Venous	4180186
40762207	Pulm v A dur - MV A dur US	4180186
40762207	A 波持续时间.肺静脉 - A 波持续时间.二尖瓣:时间差:时间点:肺静脉:定量型:超声	4182948
40762210	Average; Avg; CARD.US; Cardiac; Cardio; Cardiology; Echography; Fibers; Heart Disease; Hrt; Hrt ventr; L; LT; LV; Mean VcFv; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; V mean; VcF; VcFv; Velocity; Ventricular; Vmean	4180186
40762210	LV Mean VcFv US	4180186
40762210	周径纤维缩短.平均值:速度:时间点:心脏.心室.左侧:定量型:超声	4182948
40762212	CARD.US; Cardiac; Cardio; Cardiology; DFP; Dias; Dias fill period; Diast; Diastoli; Echography; Heart Disease; Hrt; Hrt ventr; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Ventricular	4180186
40762212	Hrt ventr Dias fill period US	4180186
40762212	充盈期.舒张期:时间:时间点:心脏.心室.XXX:定量型:超声	4182948
40762213	CARD.US; Cardio; Cardiology; Circ; Circ sys; Echography; Heart Disease; Misc; Miscellaneous; Other; Point in time; Pressure Rate; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762213	dP/dt US	4180186
40762213	dP/dt:压力或压强速率:时间点:循环系统.XXX:定量型:超声	4182948
40762214	CARD.US; Cardio; Cardiology; Circ; Circ sys; Echography; Heart Disease; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762214	Time to peak US	4180186
40762214	达峰时间:时间:时间点:循环系统.XXX:定量型:超声	4182948
40762216	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Jet Xsection; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Xsection	4180186
40762216	Valve Jet Xsection Area US	4180186
40762216	横截面.射流:面积:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762217	Bld vel; CARD.US; Cardiac; Cardio; Cardiology; Early wave; Echography; E-wave; Heart Disease; Hrt; Hrt ventr; L; Length; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; TVI; ULS; Ultrasound; Vel; Ventricular; VTI; VTI E-wave	4180186
40762217	LV VTI E-wave US	4180186
40762217	血液速度-时间积分.E 波:长度:时间点:心脏.心室.左侧:定量型:超声	4182948
40762221	CARD.US; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified; Velocity	4180186
40762221	Valve E-F slope US	4180186
40762221	E-F 斜率:速度:时间点:心脏.瓣膜.XXX:定量型:超声	4182948
40762222	Atrial wave; A-wave; CARD.US; Cardiac; Cardio; Cardiology; Early wave; Echography; E-wave; Heart Disease; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Velocity ratio; Ventricular	4180186
40762222	LV E-wave/A-wave US	4180186
40762222	E 波/A 波:速度比率:时间点:心脏.心室.左侧:定量型:超声	4182948
40762223	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity	4180186
40762223	Equip Alias vel US	4180186
40762223	锯齿速度:速度:时间点:仪器设备:定量型:超声	4182948
40762225	CARD.US; Cardiac; Cardio; Cardiology; Echography; FS; Heart Disease; Hrt; Length Fraction; Misc; Miscellaneous; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40762225	Heart.XXX FS US	4180186
40762225	分数型缩短程度:长度分数:时间点:心脏.XXX:定量型:超声	4182948
40762229	AlphaX integrin chain; Axb2; BM; BON; Bone marrow; CD11c Cells; CD11c+CD103+ Cells; CD11c-CD103+ Cells; Cell; CELL MARKERS; Cellularity; CR4; Gated cells; HML-1; Human mucosal lymphocyte antigen 1; integrin alphaE chain; ITGAE; leukocyte surface antigen p150,95; LeuM5; Leu-M5; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762229	CD11c+CD103+ Cells NFr Mar	4180186
40762229	细胞.CD11c+CD103+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40762231	CD7+CD34+ Cells NFr Mar	4180186
40762231	BM; BON; Bone marrow; CD7 Cells; CD7+CD34+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; gp105-120; gp40; Hematopoietic stem cell; HSC; Leu9; Leu-9; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells; T-2; TP41	4180186
40762231	细胞.CD7+CD34+/100 个细胞:计数型分数:时间点:骨髓:定量型	4182948
40762235	CD11c-CD25+ Cells NFr Bld	4180186
40762235	AlphaX integrin chain; Axb2; Blood; CD11c Cells; CD11c+CD25+ Cells; CD11c-CD25+ Cells; Cell; CELL MARKERS; Cellularity; CR4; Gated cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; leukocyte surface antigen p150,95; LeuM5; Leu-M5; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tac antigen; WB; Whole blood	4180186
40762235	细胞.CD11c-CD25+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40762236	ADP-ribosyl cyclase; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD38+ Cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; Gated cells; HD-37; Leu12; Leu-12; Leu17; Leu-17; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T10; WB; Whole blood	4180186
40762236	CD19+CD38+ Cells NFr Bld	4180186
40762236	细胞.CD19+CD38+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40762238	CD11c+CD103+ Cells # Bld	4180186
40762238	#; ABS; absolute; absolutes; AlphaX integrin chain; Axb2; Blood; CD11c Cells; CD11c+CD103+ Cells; CD11c-CD103+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CR4; CT; HML-1; Human mucosal lymphocyte antigen 1; integrin alphaE chain; ITGAE; leukocyte surface antigen p150,95; LeuM5; Leu-M5; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762238	细胞.CD11c+CD103+:计数型浓度:时间点:全血:定量型	4182948
40762239	#; ABS; absolute; absolutes; AlphaX integrin chain; Axb2; Blood; CD11c Cells; CD11c+CD25+ Cells; CD11c-CD25+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CR4; CT; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; leukocyte surface antigen p150,95; LeuM5; Leu-M5; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Tac antigen; WB; Whole blood	4180186
40762239	CD11c+CD25+ Cells # Bld	4180186
40762239	细胞.CD11C+CD25+:计数型浓度:时间点:全血:定量型	4182948
40762240	CD19+CD38+ Cells # Bld	4180186
40762240	#; ABS; absolute; absolutes; ADP-ribosyl cyclase; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD38+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Cyclic ADP-ribose hydrolase; HD-37; Leu12; Leu-12; Leu17; Leu-17; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T10; WB; Whole blood	4180186
40762240	细胞.CD19+CD38+:计数型浓度:时间点:全血:定量型	4182948
40762242	CK Macro SerPl Ql	4180186
40762242	Chemistry; CK; CK macro; CPK; Creatine phosphokinase; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762242	肌酸激酶.大分子型:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40762243	Anus; C&S; c162; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rectal specimen; Screen; Spec; VANC; Vancocin; Vancor; VRE; VRE screen	4180186
40762243	VRE Anal Ql Cult	4180186
40762243	肠球菌种.万古霉素耐药性:存在情况或阈值:时间点:肛门:序数型:微生物特异性培养	4182948
40762244	C&S; c162; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; UA; UR; Urn; VANC; Vancocin; Vancor; VRE; VRE screen	4180186
40762244	VRE Ur Ql Cult	4180186
40762244	肠球菌种.万古霉素耐药性:存在情况或阈值:时间点:尿液:序数型:微生物特异性培养	4182948
40762245	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; c162; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; VANC; Vancocin; Vancor; VRE; VRE DNA; VRE screen	4180186
40762245	VRE DNA Spec Ql NAA+probe	4180186
40762245	肠球菌种.万古霉素耐药性 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40762246	17-Hydroxycorticosterone; 5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762246	Cortis 5h p chal SerPl-sCnc	4180186
40762246	皮质醇^在XXX刺激之后5小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762247	Base deficit BldCo-sCnc	4180186
40762247	Base ex neg; Blood - (umbilical) cord; BSE; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762247	碱缺失:物质的量浓度:时间点:脐带全血:定量型	4182948
40762251	Ketones Ur Strip.auto-sCnc	4180186
40762251	酮体:物质的量浓度:时间点:尿液:定量型:试纸条.自动化法	4182948
40762251	Acetest; Acetoacetate; Acetoacetates; Acetone bodies; Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Ketone; Ketone bodies; Level; Point in time; Random; SmQn; Substance Concentration; UA; UR; URINALYSIS; Urn	4180186
40762252	1 day; 24 hours; 24HR; Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Micro albumin; Microalbumin; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Ratios; Renal; Rto; UA; UCr; UR; Urn	4180186
40762252	Microalbumin/Creat 24h Ur-Rto	4180186
40762252	白蛋白/肌酐:比率:24小时:尿液:定量型:检测极限 <= 20 mg/L	4182948
40762253	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Marijuana; Mass content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; THC	4180186
40762253	Cannabinoids Hair-mCnt	4180186
40762253	大麻类:质量含量:时间点:毛发:定量型	4182948
40762254	Phosphate Stl-sCnc	4180186
40762254	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; i Phos; Inorganic phosphate; Level; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration	4180186
40762254	磷酸盐:物质的量浓度:时间点:大便:定量型	4182948
40762255	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; k; K+; Level; Potass; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal; Substance Concentration	4180186
40762255	Potassium 24h Stl-sCnc	4180186
40762255	钾:物质的量浓度:24小时:大便:定量型	4182948
40762256	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Level; Na; Na+; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal; Substance Concentration	4180186
40762256	Sodium 24h Stl-sCnc	4180186
40762256	钠:物质的量浓度:24小时:大便:定量型	4182948
40762261	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate	4180186
40762261	Urea 24h Stl-sRate	4180186
40762261	尿素:物质的量速率:24小时:大便:定量型	4182948
40762263	Celexa; Cipramil; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40762263	Citalopram Ur Ql	4180186
40762263	西酞普兰:存在情况或阈值:时间点:尿液:序数型	4182948
40762265	Methotrimeprazine metabolite Ur Ql	4180186
40762265	DRUG/TOXICOLOGY; Drugs; Hirnamin; Lepurin; Lerium; Levamin; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Metab; Metabolites; Metb; Methotrimeprazine; Milezin; Minozinan; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Ordinal; Point in time; PR; Procrazine; QL; Qual; Qualitative; Random; Ronexine; Screen; Sinogan; Sofmin; Specia 246; Tisercin; Tisercine; Tisercinetta; Tisercinettes; UA; UR; Urn; Veractil	4180186
40762265	左美吗嗪代谢产物:存在情况或阈值:时间点:尿液:序数型	4182948
40762267	QUEtiapine metabolite Ur Ql	4180186
40762267	DRUG/TOXICOLOGY; Drugs; Ketipinor; Metab; Metabolites; Metb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seroquel; UA; UR; Urn; Xeroquel	4180186
40762267	喹硫平代谢产物:存在情况或阈值:时间点:尿液:序数型	4182948
40762268	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Imovane; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zopliclone	4180186
40762268	Zopiclone Ur Ql	4180186
40762268	佐匹克隆:存在情况或阈值:时间点:尿液:序数型	4182948
40762269	B; B2 Microglob; b2-M; Chemistry; CR; Crea; Creat; Hematology; Heme; II; Microglob; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; UA; UCr; UR; Urn	4180186
40762269	B2 Microglob/Creat Ur-Rto	4180186
40762269	Beta-2-微球蛋白/肌酐:比率:时间点:尿液:定量型	4182948
40762270	Chemistry; Cl; Cl-; GAST; Gastric contents; Gastric fluid; Gastro; Gastroenterology; GI; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762270	Chloride Gast-sCnc	4180186
40762270	氯:物质的量浓度:时间点:胃液:定量型	4182948
40762271	Insulin p fast SerPl-sCnc	4180186
40762271	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
40762271	胰岛素^在热量型禁食之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762272	DRUG/TOXICOLOGY; Drugs; Lidocaine metabolite; MEGX; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40762272	MEGX Ur Ql	4180186
40762272	单乙基甘氨酰二甲苯胺:存在情况或阈值:时间点:尿液:序数型	4182948
40762274	Cardiac CRP; Cardio; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; CRP; HS; hsCRP; hs-CRP; Level; Mass concentration; Neuro; Neurology; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40762274	CRP CSF HS-mCnc	4180186
40762274	C 反应蛋白:质量浓度:时间点:脑脊液:定量型:高灵敏度方法	4182948
40762276	Blood; bod; Body; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb H; Hgb H inclusion bodies; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40762276	Hgb H inclusion bodies Bld Ql	4180186
40762276	血红蛋白 H 包涵体:存在情况或阈值:时间点:全血:序数型	4182948
40762277	Cyanide Bld-sCnc	4180186
40762277	Blood; CN; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
40762277	氰化物:物质的量浓度:时间点:全血:定量型	4182948
40762280	MEK/Creat Ur-sRto	4180186
40762280	2-Butanone; 3-butanone; Butanone; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762280	甲基乙基甲酮/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762281	2-Hydroxy caproate; 2-Hydroxycaproic acid; Chemistry; CR; Crea; Creat; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762281	2-Hydroxycaproate/Creat Ur-sRto	4180186
40762281	2-羟基己酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762283	3Me crotonate/Creat Ur-sRto	4180186
40762283	3Me crotonate; 3-Methyl crotonoic acid; Chemistry; CR; Crea; Creat; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tiglic acid; UA; UCr; UR; Urn	4180186
40762283	3-甲基巴豆酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762284	Deoxyuridine/Creat Ur-sRto	4180186
40762284	Chemistry; CR; Crea; Creat; dU; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762284	脱氧尿嘧啶核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762287	3-hydroxyhexadecanoylcarnitine; 3-hydroxy-hexadecanoylcarnitine; 3-hydroxy-palmitoylcarnitine; 3OH-Palmitoylcarn; C16; C16OH; C16-OH; Chemistry; Hexadecanoylcarnitine; III; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762287	3OH-Palmitoylcarn/C16 SerPl-sRto	4180186
40762287	3-羟基棕榈酰肉碱 (C16-OH)/棕榈酰肉碱 (C16):物质的量比率:时间点:血清/血浆:定量型	4182948
40762288	Propionylcarn/C16 SerPl-sRto	4180186
40762288	C16; C3; C3+C16; C3-carntitine; Chemistry; Hexadecanoylcarnitine; Pl; Plasma; Plsm; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762288	丙酰肉碱 (C3)/棕榈酰肉碱 (C16):物质的量比率:时间点:血清/血浆:定量型	4182948
40762289	Propionylcarn/C2 SerPl-sRto	4180186
40762289	C2; C3; C3-carntitine; Chemistry; Pl; Plasma; Plsm; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762289	丙酰肉碱 (C3)/乙酰肉碱 (C2):物质的量比率:时间点:血清/血浆:定量型	4182948
40762291	C2; C8; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762291	Octanoylcarn/C2 SerPl-sRto	4180186
40762291	辛酰肉碱 (C8)/乙酰肉碱 (C2):物质的量比率:时间点:血清/血浆:定量型	4182948
40762294	Adenine/Creat Ur-sRto	4180186
40762294	B4 Hemosan; Chemistry; CR; Crea; Creat; Leuco-4; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn; Vit B4; Vitamin B4	4180186
40762294	腺嘌呤/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762296	Gamma tocopherol SerPl-sCnc	4180186
40762296	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit E; Vitamin E	4180186
40762296	Gamma 生育酚:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762297	Carnitine Free/C16+C18 SerPl-sRto	4180186
40762297	C0; C16; C16+C18; C18; Carnitine Free; Carnitine.total; Chemistry; FC; FR; Hexadecanoylcarnitine; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Steroylcarnitine; Substance concentration ratio; Substance ratio	4180186
40762297	肉碱.游离型 (C0)/棕榈酰肉碱 (C16)+硬脂酰肉碱 (C18):物质的量比率:时间点:血清/血浆:定量型	4182948
40762298	Dicarboxyoleylcarn SerPl-sCnc	4180186
40762298	C18:1DC; C18:1-DC; Chemistry; Dicarboxylic carnitine; Dicarboxyoleoylcarnitine; i; Level; Octadecenediolcarnitine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762298	二羧基油酰肉碱 (C18:1-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
40762299	Octanoylcarn/C10 SerPl-sRto	4180186
40762299	C10; C8; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762299	辛酰肉碱 (C8)/癸酰肉碱 (C10):物质的量比率:时间点:血清/血浆:定量型	4182948
40762300	4-hydroxybutyrate; 4-hydroxybutyric acid; Chemistry; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762300	G-OH-Butyr SerPl-sCnc	4180186
40762300	Gamma 羟基丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762304	?Tm; aIle; alloIle; Allo-isoleucine; Chemistry; MSUD; MSUD (Maple Syrup Urine Disease); QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
40762304	Alloisoleucine ?Tm Ur-sRate	4180186
40762304	别异亮氨酸:物质的量速率:XXX:尿液:定量型	4182948
40762306	Chemistry; CR; Crea; Creat; Deoxythymidine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762306	Thymidine/Creat Ur-sRto	4180186
40762306	胸腺嘧啶脱氧核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762307	Uridine/Creat Ur-sRto	4180186
40762307	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762307	尿嘧啶核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762309	B; B2 Microglob; b2-M; Chemistry; Hematology; Heme; II; Level; Lung; Mass concentration; Microglob; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; thoracentesis fluid	4180186
40762309	B2 Microglob Plr-mCnc	4180186
40762309	Beta-2-微球蛋白:质量浓度:时间点:胸膜液:定量型	4182948
40762310	Chemistry; Level; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Testo; Testos; Testost; thoracentesis fluid	4180186
40762310	Testost Plr-sCnc	4180186
40762310	睾酮:物质的量浓度:时间点:胸膜液:定量型	4182948
40762311	Arbitrary concentration; Cg; CgA; Chemistry; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid	4180186
40762311	CgA Plr-aCnc	4180186
40762311	嗜铬粒蛋白 A:任意型浓度:时间点:胸膜液:定量型	4182948
40762313	Antigen; Antigens; Chemistry; Level; Mass concentration; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; SCC; Sq; Squamous cell associated; thoracentesis fluid; Tumor marker	4180186
40762313	SCC Ag Plr-mCnc	4180186
40762313	鳞状上皮细胞癌 抗原:质量浓度:时间点:胸膜液:定量型	4182948
40762317	CgA Prt-aCnc	4180186
40762317	Arbitrary concentration; Ascites; Ascitic fluid; Ascitis; Cg; CgA; Chemistry; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random	4180186
40762317	嗜铬粒蛋白 A:任意型浓度:时间点:腹膜液:定量型	4182948
40762318	CgA CSF-aCnc	4180186
40762318	Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Cg; CgA; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40762318	嗜铬粒蛋白 A:任意型浓度:时间点:脑脊液:定量型	4182948
40762319	SCC Ag CSF-mCnc	4180186
40762319	Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SCC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Sq; Squamous cell associated; Tumor marker	4180186
40762319	鳞状上皮细胞癌 抗原:质量浓度:时间点:脑脊液:定量型	4182948
40762320	Ascites; Ascitic fluid; Ascitis; Chemistry; Level; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Testo; Testos; Testost	4180186
40762320	Testost Prt-sCnc	4180186
40762320	睾酮:物质的量浓度:时间点:腹膜液:定量型	4182948
40762321	PSA CSF-mCnc	4180186
40762321	Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Kallikrein 3; Level; Mass concentration; P-30 antigen; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tumor marker	4180186
40762321	前列腺特异性 抗原:质量浓度:时间点:脑脊液:定量型	4182948
40762324	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Testo; Testos; Testost	4180186
40762324	Testost CSF-sCnc	4180186
40762324	睾酮:物质的量浓度:时间点:脑脊液:定量型	4182948
40762326	PSA Free MFr CSF	4180186
40762326	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; fPSA; FR; Kallikrein 3; Mass fraction; Non-protein bound; P-30 antigen; Percent; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; Tumor marker	4180186
40762326	前列腺特异性抗原.游离型/前列腺特异性抗原.总计:质量分数:时间点:脑脊液:定量型	4182948
40762329	PSA Free MFr Fld	4180186
40762329	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; fPSA; FR; Kallikrein 3; Mass fraction; Non-protein bound; P-30 antigen; Percent; Point in time; PS; PSA; PSA Free; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tot; Totl; Tumor marker	4180186
40762329	前列腺特异性抗原.游离型/前列腺特异性抗原.总计:质量分数:时间点:体液:定量型	4182948
40762333	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Reduc; Reduc subs; Reducing substance; Stl; Stool = Fecal; Substance Concentration	4180186
40762333	Reducing Subs Stl-sCnc	4180186
40762333	还原性物质:物质的量浓度:时间点:大便:定量型	4182948
40762336	AGT; Ala; Alanine-glyoxylic aminotransferase; Alpha alanine; Catalytic Content; Chemistry; Glyoxylic acid; L-alanine; L-alanine-glycine transaminase; Oxoacetate; Oxoacetic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762336	AGT Tiss-cCnt	4180186
40762336	丙氨酸乙醛酸氨基转移酶:催化含量:时间点:组织与涂片:定量型	4182948
40762345	Acylcarnitine/Acyl+C0 SerPl-sRto	4180186
40762345	Acyl carnitine; Acyl+C0; Acylcarni; C0; Carnitine.total; Chemistry; FC; FR; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
40762345	酰基肉碱/酰基肉碱+游离型肉碱 (C0):物质的量比率:时间点:血清/血浆:定量型	4182948
40762346	+3DR; Ang; Angio; Angiography; Angm; Atrial; c; Cardiac; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT pulmonary vein mapping; CT scan; CT venography; CTA; CTV; Document; Finding; Findings; Heart Disease; Hrt; Ht.LA+Pul vv; Imaging; L; LA; LA+Pulm vv; LT; Point in time; Pulm vv; Rad; Radiology; Random; Thorax; Venogram; Venography; W contr IV; WC	4180186
40762346	Deprecated Cht>Ht.LA+Pul v CT.Angio +3DR	4180186
40762347	CYTOLOGY; Cytology stain; Cytostain; Ident; Identifier; Misc; Miscellaneous; Nominal; Other; Pap Smear; Pap Stain; Papanicolaou smear; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
40762347	Cytologist Spec Cyto	4180186
40762347	细胞学家:标识符:时间点:XXX:名义型:细胞学染色法	4182948
40762348	Cell Cnt + Diff Pnl Pcar	4180186
40762348	Cell Cnt + Diff Pnl; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; PCAR; Pericardial Fluid; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762348	细胞计数与分类组套:-:时间点:心包液:定量型	4182948
40762350	Psychiatric D/C sum	4180186
40762350	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Point in time; Psych; Psychiatric; Psychiatry; Random; Visit note	4180186
40762350	出院摘要记录:发现:时间点:{环境}:文档型:精神病学	4182948
40762352	Blood; Chemistry; Endocrine; Endocrinology; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; International Federation of Clinical Chemistry and Laboratory Medicine; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance fraction; Tot; Totl; WB; Whole blood	4180186
40762352	HbA1c SFr Bld IFCC	4180186
40762352	血红蛋白 A1c/血红蛋白.总计:物质的量分数:时间点:全血:定量型:IFCC	4182948
40762353	Cerebral spinal fluid; Cerebrospinal Fl; Dip stick; Dipstick; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; URINALYSIS; WBC; WBCs; White blood cell; White blood cells	4180186
40762353	Leukocyte esterase CSF Ql Strip	4180186
40762353	白细胞酯酶:存在情况或阈值:时间点:脑脊液:序数型:试纸条	4182948
40762355	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV18; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen	4180186
40762355	HPV18 DNA Cvx Ql Probe+sig amp	4180186
40762355	人乳头瘤病毒 18 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.信号	4182948
40762357	Identity or presence; MCC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40762357	Maternal Cell Contam Spec	4180186
40762357	母体细胞污染:存在与否或特征标识:时间点:XXX:名义型	4182948
40762358	Blood; Chromosome analysis; Fluorescent in situ hybridization; Genetics; Genotype; Heredity; Heritable; Identity or presence; Inherited; Karyogram; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40762358	Karyotyp Bld/T FISH	4180186
40762358	核型:存在与否或特征标识:时间点:全血/组织:叙述型:FISH	4182948
40762360	呼吸系统疾病严重程度评分:压力或压强:时间点:呼吸系统.气道+吸入气体:定量型	4182948
40762360	Breathing; Gases; IhG; Inhaled Gas; Inspired; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
40762362	Hospital discharge summary pnl	4180186
40762362	Disch; Hosp; Hospital discharge summary pnl; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
40762362	医院出院摘要组套:-:时间点:^患者:-	4182948
40762364	17-Hydroxycorticosterone; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; Mass concentration; p 6 mg Dex; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762364	Cortis p 6 mg Dex SerPl-mCnc	4180186
40762364	皮质醇^在6 mg地塞米松口服过夜之后:质量浓度:时间点:血清/血浆:定量型	4182948
40762365	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; Calculation; Chemistry; ctO2; Lung; O2; O2 Ct; O2CT; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volfr; Volume fraction	4180186
40762365	O2 Ct VFr BldA Calc	4180186
40762365	氧含量:体积分数:时间点:动脉全血:定量型:计算法	4182948
40762371	Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; UA; Urate dihyd Cry; Urates; Uric acid; Xray; X-ray	4180186
40762371	Urate dihyd Cry Stone Ql XR diff	4180186
40762371	尿酸盐二水合物结晶:存在情况或阈值:时间点:结石:序数型:X射线衍射分析	4182948
40762374	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
40762374	健康儿童就诊记录:发现:时间点:{环境}:文档型:{角色}	4182948
40762375	DOC.ONT; Document; Finding; Findings; Form; Point in time; Random	4180186
40762375	Consent	4180186
40762375	同意:发现:时间点:{环境}:文档型:患者	4182948
40762377	Addiction; BZP; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; N-Benzylpiperazine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762377	Benzylpiperazine SerPl-mCnc	4180186
40762377	苄基哌嗪:质量浓度:时间点:血清/血浆:定量型	4182948
40762378	Addiction; BZP; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; N-Benzylpiperazine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762378	Benzylpiperazine Ur-mCnc	4180186
40762378	苄基哌嗪:质量浓度:时间点:尿液:定量型	4182948
40762379	BPA; DRUG/TOXICOLOGY; Drugs; Endocrine disruptor; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762379	Bisphenol A Ur-mCnc	4180186
40762379	双酚 A:质量浓度:时间点:尿液:定量型	4182948
40762383	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cocaine cutting agent; DRUG/TOXICOLOGY; Drugs; Ergamisole; Fl; Fld; FLU; Fluid; Levasole; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762383	Levamisole Fld-mCnc	4180186
40762383	左旋咪唑:质量浓度:时间点:体液:定量型	4182948
40762385	Levamisole Tiss-mCnt	4180186
40762385	Cocaine cutting agent; DRUG/TOXICOLOGY; Drugs; Ergamisole; Levasole; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762385	左旋咪唑:质量含量:时间点:组织与涂片:定量型	4182948
40762386	Levamisole Ur-mCnc	4180186
40762386	Cocaine cutting agent; DRUG/TOXICOLOGY; Drugs; Ergamisole; Levasole; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762386	左旋咪唑:质量浓度:时间点:尿液:定量型	4182948
40762387	Lacosamide Bld-mCnc	4180186
40762387	Blood; DRUG/TOXICOLOGY; Drugs; Erlosamide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vimpat; WB; Whole blood	4180186
40762387	拉科酰胺:质量浓度:时间点:全血:定量型	4182948
40762388	DRUG/TOXICOLOGY; Drugs; Erlosamide; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vimpat	4180186
40762388	Lacosamide SerPl-mCnc	4180186
40762388	拉科酰胺:质量浓度:时间点:血清/血浆:定量型	4182948
40762389	Lacosamide Ur-mCnc	4180186
40762389	DRUG/TOXICOLOGY; Drugs; Erlosamide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vimpat	4180186
40762389	拉科酰胺:质量浓度:时间点:尿液:定量型	4182948
40762393	Memantine Bld-mCnc	4180186
40762393	Abixa; Akatinol; Axura; Blood; DRUG/TOXICOLOGY; Drugs; Ebixa; Level; Mass concentration; Memox; Namenda; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762393	美金刚胺:质量浓度:时间点:全血:定量型	4182948
40762396	Abixa; Akatinol; Axura; DRUG/TOXICOLOGY; Drugs; Ebixa; Mass content; Memox; Namenda; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762396	Memantine Tiss-mCnt	4180186
40762396	美金刚胺:质量含量:时间点:组织与涂片:定量型	4182948
40762398	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Skelaxin; WB; Whole blood	4180186
40762398	Metaxalone Bld-mCnc	4180186
40762398	美他沙酮:质量浓度:时间点:全血:定量型	4182948
40762399	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Skelaxin; SR	4180186
40762399	Metaxalone SerPl-mCnc	4180186
40762399	美他沙酮:质量浓度:时间点:血清/血浆:定量型	4182948
40762407	Ramelteon Fld-mCnc	4180186
40762407	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem	4180186
40762407	雷美替胺:质量浓度:时间点:体液:定量型	4182948
40762409	Ramelteon SerPl-mCnc	4180186
40762409	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762409	雷美替胺:质量浓度:时间点:血清/血浆:定量型	4182948
40762413	Ramelteon Ur-mCnc	4180186
40762413	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; UA; UR; Urn	4180186
40762413	雷美替胺:质量浓度:时间点:尿液:定量型	4182948
40762414	Rufinamide SerPl-mCnc	4180186
40762414	Banzel; DRUG/TOXICOLOGY; Drugs; Lennox-Gastaut syndrome; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762414	卢非酰胺:质量浓度:时间点:血清/血浆:定量型	4182948
40762416	Salvinorin B Bld-mCnc	4180186
40762416	2-Methoxymethyl Salvinorin B; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; WB; Whole blood	4180186
40762416	沙维林 B:质量浓度:时间点:全血:定量型	4182948
40762419	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; UA; UR; Urn	4180186
40762419	Salvinorin A Ur-mCnc	4180186
40762419	沙维林 A:质量浓度:时间点:尿液:定量型	4182948
40762421	Norsibutramine Bld-mCnc	4180186
40762421	Blood; Desmethylsibutramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sibutramine metabolite; WB; Whole blood	4180186
40762421	去甲基西布曲明:质量浓度:时间点:全血:定量型	4182948
40762422	Dinorsibutramine Bld-mCnc	4180186
40762422	Blood; Didesmethylsibutramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sibutramine metabolite; WB; Whole blood	4180186
40762422	二去甲基西布曲明:质量浓度:时间点:全血:定量型	4182948
40762423	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Meridia; Point in time; QNT; Quan; Quant; Quantitative; Random; Reductil; WB; Whole blood	4180186
40762423	Sibutramine Bld-mCnc	4180186
40762423	西布曲明:质量浓度:时间点:全血:定量型	4182948
40762429	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Meridia; Point in time; QNT; Quan; Quant; Quantitative; Random; Reductil; UA; UR; Urn	4180186
40762429	Sibutramine Ur-mCnc	4180186
40762429	西布曲明:质量浓度:时间点:尿液:定量型	4182948
40762431	Stiripentol SerPl-mCnc	4180186
40762431	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762431	斯利潘托:质量浓度:时间点:血清/血浆:定量型	4182948
40762432	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762432	Stiripentol Ur-mCnc	4180186
40762432	斯利潘托:质量浓度:时间点:尿液:定量型	4182948
40762434	Cialis; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762434	Tadalafil SerPl-mCnc	4180186
40762434	他达那非:质量浓度:时间点:血清/血浆:定量型	4182948
40762435	Cialis; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762435	Tadalafil Ur-mCnc	4180186
40762435	他达那非:质量浓度:时间点:尿液:定量型	4182948
40762436	4-Hydroxy-N-desmethyltamoxifen; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tamoxifen metabolite; WB; Whole blood	4180186
40762436	Endoxifen Bld-mCnc	4180186
40762436	他莫昔芬:质量浓度:时间点:全血:定量型	4182948
40762437	4OHTamoxifen Bld-mCnc	4180186
40762437	4OHTamoxifen; Blood; DRUG/TOXICOLOGY; Drugs; Hydrox; Level; Mass concentration; Nolvadex; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Tamoxifen metabolite; WB; Whole blood	4180186
40762437	4-羟基-他莫西芬:质量浓度:时间点:全血:定量型	4182948
40762438	Tamoxifen Bld-mCnc	4180186
40762438	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nolvadex; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762438	他莫西芬:质量浓度:时间点:全血:定量型	4182948
40762440	4-Hydroxy-N-desmethyltamoxifen; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tamoxifen metabolite	4180186
40762440	Endoxifen SerPl-mCnc	4180186
40762440	他莫昔芬:质量浓度:时间点:血清/血浆:定量型	4182948
40762441	4OHTamoxifen SerPl-mCnc	4180186
40762441	4OHTamoxifen; DRUG/TOXICOLOGY; Drugs; Hydrox; Level; Mass concentration; Nolvadex; OH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tamoxifen metabolite	4180186
40762441	4-羟基-他莫西芬:质量浓度:时间点:血清/血浆:定量型	4182948
40762443	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; WB; Whole blood	4180186
40762443	Tapentadol Bld-mCnc	4180186
40762443	他喷他多:质量浓度:时间点:全血:定量型	4182948
40762444	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal	4180186
40762444	Tapentadol Fld-mCnc	4180186
40762444	他喷他多:质量浓度:时间点:体液:定量型	4182948
40762445	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Nucynta; Palexia; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tapal	4180186
40762445	Tapentadol SerPl-mCnc	4180186
40762445	他喷他多:质量浓度:时间点:血清/血浆:定量型	4182948
40762447	Desethylvardenafil Bld-mCnc	4180186
40762447	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; Vardenafil metabolite; WB; Whole blood	4180186
40762447	去乙基伐地那非:质量浓度:时间点:全血:定量型	4182948
40762448	Vardenafil Bld-mCnc	4180186
40762448	Blood; DRUG/TOXICOLOGY; Drugs; Level; Levitra; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762448	伐地那非:质量浓度:时间点:全血:定量型	4182948
40762449	Desethylvardenafil SerPl-mCnc	4180186
40762449	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vardenafil metabolite	4180186
40762449	去乙基伐地那非:质量浓度:时间点:血清/血浆:定量型	4182948
40762452	Vardenafil Ur-mCnc	4180186
40762452	DRUG/TOXICOLOGY; Drugs; Level; Levitra; Mass concentration; Phosphodiesterase #5 inhibitor; Phosphodiesterase 5 inhibitor; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762452	伐地那非:质量浓度:时间点:尿液:定量型	4182948
40762455	L inter Pyrogenes Ab Titr Ser Aggl	4180186
40762455	致病性钩端螺旋体致热血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762455	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Pyrogenes; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762457	L inter Sejroe Ab Titr Ser Aggl	4180186
40762457	致病性钩端螺旋体 Sejroe 血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762457	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Sejroe; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762459	L inter Batav Ab Titr Ser Aggl	4180186
40762459	致病性钩端螺旋体 Bataviae 血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762459	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Batav; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762460	L inter Hebdo Ab Titr Ser Aggl	4180186
40762460	致病性钩端螺旋体七日热血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762460	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Hebdo; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762461	L inter Austral Ab Titr Ser Aggl	4180186
40762461	致病性钩端螺旋体澳洲血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762461	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Austral; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762464	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Special Txs/programs - none of above; Survey; SURVEY.MDS; Tx; Txs	4180186
40762465	Finding; Findings; MDS version 3; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Special Txs/programs - none of above; Survey; SURVEY.MDS; Tx; Txs	4180186
40762466	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
40762467	3-Keto, 2-Methylvalerate/Creat Ur-sRto	4180186
40762467	Chemistry; CR; Crea; Creat; II; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762467	3-酮基, 2-甲基戊酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762468	2-Methylacetoacetic acid; Chemistry; CR; Crea; Creat; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
40762468	2-Methylacetoacetate/Creat Ur-sRto	4180186
40762468	2-甲基乙酰乙酸乙酯/肌酐:物质的量比率:时间点:尿液:定量型	4182948
40762469	After; Amikin; Aminoglycosides; Dialy; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762469	Amikacin p dialysis SerPl-mCnc	4180186
40762469	丁胺卡那霉素^在透析之后:质量浓度:时间点:血清/血浆:定量型	4182948
40762470	After; Aminoglycosides; c213; Dialy; DRUG/TOXICOLOGY; Drugs; Garamycin; Genirr; Genj; Gent; Level; Mass concentration; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762470	Gentamicin p dialysis SerPl-mCnc	4180186
40762470	庆大霉素^在透析之后:质量浓度:时间点:血清/血浆:定量型	4182948
40762473	A versicolor IgG-mCnc	4180186
40762473	A versicolor; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Gm25; Immune globulin G; Immunoglobulin G; Level; m019; m19; m25; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; RGm25; Rm215; Serum; SR	4180186
40762473	杂色曲霉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40762475	ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Liver; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tylenol; u209; UA; UR; Urn	4180186
40762475	APAP Ur Ql Scn	4180186
40762475	对乙酰氨基酚:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40762476	N2 Stl IR-mCnt	4180186
40762476	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Infared spectoscopy; IR; Mass Content; N; N2; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762476	氮:质量含量:时间点:大便:定量型:红外光谱分析法	4182948
40762478	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chagas disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
40762478	T cruzi IgG Ser IA-aCnc	4180186
40762478	克氏锥虫 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762480	Androstanolone 1.5h p chal SerPl-mCnc	4180186
40762480	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762480	双氢睾酮^在XXX刺激之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40762481	Hu Ab Titr Ser IF	4180186
40762481	神经元细胞核 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762481	ABS; Aby; ACIF; ANA; ANF; ANNA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Neuro; Neurology; Nuc; Oncology; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762483	1 day; 24 hours; 24HR; Chemistry; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Mass concentration; Ohpro; OH-Proline; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40762483	OH-Proline 24h Ur-mCnc	4180186
40762483	羟基脯氨酸:质量浓度:24小时:尿液:定量型	4182948
40762486	Latex (rHev b) 9 IgE Qn	4180186
40762486	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; Immune globulin E; Immunoglobulin E; k082; k222; k82; Latex (rHev b) 9; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40762486	乳胶 重组 (rHev b) 9 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40762488	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Echo; Echo virus; ECV; EV; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40762488	ECV IgG CSF-aCnc	4180186
40762488	艾柯病毒 抗体.IgG:任意型浓度:时间点:脑脊液:定量型	4182948
40762489	Ascorbic acid; c702; Chemistry; Ejaculate; Genitourinary; GU; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology; Vit C; Vitamin C	4180186
40762489	Vit C Smn-mCnc	4180186
40762489	抗坏血酸:质量浓度:时间点:精液:定量型	4182948
40762491	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; Serology; Serum; SR; SUDS	4180186
40762491	RNA Ab Ser IA-aCnc	4180186
40762491	RNA 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762492	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Echo; Echo virus; ECV; EIA; ELFA; ELISA; Enzyme immunoassay; EV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40762492	ECV IgG Ser IA-aCnc	4180186
40762492	艾柯病毒 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762493	Mi-1+Mi-2 Ab Titr Ser IF	4180186
40762493	Mi-1+Mi-2 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762493	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CHD2; Chromodomain-helicase-DNA-binding protein 2; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MI2; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762495	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; Lung; O2; O2 Cap; O2Cap; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; tO2	4180186
40762495	O2 Cap BldA-sCnc	4180186
40762495	氧容量:物质的量浓度:时间点:动脉全血:定量型	4182948
40762501	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762501	SaO2 room air % BldA PulseOx	4180186
40762501	氧饱和度^采用室内空气:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762502	ABG; After; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; O2; p BD; Percent; Point in time; PST; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762502	SaO2 p BD % BldA PulseOx	4180186
40762502	氧饱和度^在支气管扩张之后:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762503	ABG; After; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; EXCZ; Lung; Mass Fraction; O2; p Exc; Percent; Point in time; PST; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762503	SaO2 p Exc % BldA PulseOx	4180186
40762503	氧饱和度^在运动之后:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762504	ABG; After; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Lung; Mass Fraction; O2; p Tx; Percent; Point in time; PST; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2; Tx	4180186
40762504	SaO2 p Tx % BldA PulseOx	4180186
40762504	氧饱和度^在治疗之后:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762505	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Before; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; pre BD; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762505	SaO2 pre BD % BldA PulseOx	4180186
40762505	氧饱和度^在支气管扩张之前:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762506	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Before; Blood arterial; Lung; Mass Fraction; O2; Percent; Point in time; pre PT; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
40762506	SaO2 pre PT % BldA PulseOx	4180186
40762506	氧饱和度^在物理治疗之前:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
40762509	Bld Postductal; Bld.foot; BldA.foot; Blood; Lung; Mass Fraction; O2; Percent; Point in time; Postductal blood; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2; WB; Whole blood	4180186
40762509	SaO2 % Bld Postductal PulseOx	4180186
40762509	氧饱和度:质量分数:时间点:全血.导管后:定量型:脉搏血氧定量法	4182948
40762510	#; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HC; HIV type 1; HIV type I; HIV1; HPA; Human immunodeficiency virus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Number concentration; Number Concentration (count/vol); Pl; Plasma; Plsm; Point in time; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; Viral load	4180186
40762510	HIV1 RNA # Plas Probe+sig amp	4180186
40762510	HIV 1 型 RNA:计数型浓度:时间点:血浆:定量型:探针法.基因扩增.信号	4182948
40762513	L inter Javani Ab Titr Ser Aggl	4180186
40762513	致病性钩端螺旋体爪哇血清型变种 抗体:滴定度:时间点:血清:定量型:凝集试验法	4182948
40762513	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Javani; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40762514	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV HA; FLUV; Fowl plague; HA; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40762514	FLUAV HA RNA Spec NAA+probe	4180186
40762514	流感病毒 A 型血凝素类型 RNA:标识符:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40762518	Dx; Finding; Findings; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Secondary Dx; Secondary dx present; Survey; SURVEY.MFS	4180186
40762519	Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS	4180186
40762521	Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS	4180186
40762524	Finding; Findings; Levels; Levl; LV; LVL; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS; VTE	4180186
40762525	Clinical biochemist review	4180186
40762525	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40762525	临床生物化学家审核:印象:时间点:XXX:叙述型	4182948
40762527	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified	4180186
40762527	Microbiologist review	4180186
40762527	微生物学家审核:印象:时间点:XXX:叙述型	4182948
40762532	Ca-I BldA-mCnc	4180186
40762532	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762532	钙.离子型:质量浓度:时间点:动脉全血:定量型	4182948
40762533	Ca-I BldV-mCnc	4180186
40762533	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venous	4180186
40762533	钙.离子型:质量浓度:时间点:静脉全血:定量型	4182948
40762540	CA; CS; CS mets at Dx; CS mets at Dx - lung; Dx; Identity or presence; Lung; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762540	CS mets at Dx - lung Cancer	4180186
40762540	协作分期 诊断时转移 - 肺累及:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762541	After; CA; CS; CS post Rx ext; EXT; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762541	CS post Rx ext Cancer	4180186
40762541	协作分期 治疗后蔓延:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762542	After; CA; CS; CS post Rx LN; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762542	CS post Rx LN Cancer	4180186
40762542	协作分期 治疗后淋巴结:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762545	Before; CA; CS; CS pre Rx LN; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762545	CS pre Rx LN Cancer	4180186
40762545	协作分期 治疗前淋巴结:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762546	Before; CA; CS; CS pre Rx mets at Dx; Dx; Identity or presence; Metastases; Mets; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762546	CS pre Rx mets at Dx Cancer	4180186
40762546	协作分期 诊断时治疗前转移:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762552	CA; CS; CS site-specific factor 8; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762552	CS site-specific factor 8 Cancer	4180186
40762552	协作分期 部位特异性因素 8:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762553	CA; CS; CS site-specific factor 9; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762553	CS site-specific factor 9 Cancer	4180186
40762553	协作分期 部位特异性因素 9:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762554	CA; CS; CS site-specific factor 10; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762554	CS site-specific factor 10 Cancer	4180186
40762554	协作分期 部位特异性因素 10:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762555	CA; CS; CS site-specific factor 11; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762555	CS site-specific factor 11 Cancer	4180186
40762555	协作分期 部位特异性因素 11:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762557	CA; CS; CS site-specific factor 13; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762557	CS site-specific factor 13 Cancer	4180186
40762557	协作分期 部位特异性因素 13:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762558	CA; CS; CS site-specific factor 14; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762558	CS site-specific factor 14 Cancer	4180186
40762558	协作分期 部位特异性因素 14:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762561	CA; CS; CS site-specific factor 17; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762561	CS site-specific factor 17 Cancer	4180186
40762561	协作分期 部位特异性因素 17:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762567	CA; CS; CS site-specific factor 23; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762567	CS site-specific factor 23 Cancer	4180186
40762567	协作分期 部位特异性因素 23:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762568	CA; CS; CS site-specific factor 24; Fac; Fact; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762568	CS site-specific factor 24 Cancer	4180186
40762568	协作分期 部位特异性因素 24:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762577	Flag for Date of death - Canada	4180186
40762577	CA; DOD; Expired date; Identity or presence; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762577	死亡日期未填写标志 - 加拿大:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762581	CA; Date of inpt disch; Disch; Flag for Date of inpt disch; Misc; Miscellaneous; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762581	Flag for Date of inpt disch Cancer	4180186
40762581	住院患者出院日期未填写标志:-:时间点:癌.XXX:-	4182948
40762582	Flag for Date last contact	4180186
40762582	CA; Misc; Miscellaneous; Other; Past; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762582	最后一次联系日期未填写标志:-:时间点:癌.XXX:-	4182948
40762583	CA; Date Dx multiple tumors; Date of Dx; Dx; Flag for Date Dx multiple tumors; Misc; Miscellaneous; Mult; Multi; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762583	Flag for Date Dx multiple tumors Cancer	4180186
40762583	多发性肿瘤诊断日期未填写标志:-:时间点:癌.XXX:-	4182948
40762584	AJCC; CA; Derived AJCC-7 M; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762584	Derived AJCC-7 M Cancer	4180186
40762584	派生型美国癌症联合委员会-7 M:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762585	AJCC; CA; Derived AJCC-7 M; Derived AJCC-7 M descript; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762585	Derived AJCC-7 M descript Cancer	4180186
40762585	派生型美国癌症联合委员会-7 M 描述符:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762586	AJCC; CA; Derived AJCC-7 N; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762586	Derived AJCC-7 N Cancer	4180186
40762586	派生型美国癌症联合委员会-7 N:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762588	AJCC; CA; Derived AJCC-7 stg grp; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762588	Derived AJCC-7 stg grp Cancer	4180186
40762588	派生型美国癌症联合委员会-7 期别组合:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762591	CA; Flag for Derived neoadjuv Rx; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762591	Flag for Derived neoadjuv Rx Cancer	4180186
40762591	派生型新辅助疗法日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762594	After; CA; Derived post Rx-7 stg grp; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762594	Derived post Rx-7 stg grp Cancer	4180186
40762594	派生型治疗后-7 期别组合:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762595	After; CA; Derived post Rx-7 T; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; PST; Random; Spec; T prime; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762595	Derived post Rx-7 T Cancer	4180186
40762595	派生型治疗后-7 T:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762597	Before; CA; Derived pre Rx-7 M; Derived pre Rx-7 M descript; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762597	Derived pre Rx-7 M descript Cancer	4180186
40762597	派生型治疗前-7 M 描述符:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762599	Before; CA; Derived pre Rx-7 N; Derived pre Rx-7 N descript; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762599	Derived pre Rx-7 N descript Cancer	4180186
40762599	派生型治疗前-7 N 描述符:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762607	1st; CA; Flag for Recur date; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Recur date; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762607	Flag for Recur date 1st episode Cancer	4180186
40762607	复发日期未填写标志:存在与否或特征标识:病程^第一:癌.XXX:名义型	4182948
40762611	CA; First; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762611	Flag for Date 1st systemic Cancer	4180186
40762611	第 1 次系统治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762612	CA; Date 1st BRM; First; Flag for Date 1st BRM; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762612	Flag for Date 1st BRM Cancer	4180186
40762612	第 1 次免疫疗法治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762613	CA; Chemo; First; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762613	Flag for Date 1st chemo Cancer	4180186
40762613	第 1 次化学疗法治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762615	CA; First; Horm; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762615	Flag for Date 1st hormone Cancer	4180186
40762615	第 1 次激素治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762616	CA; Date 1st other Tx; First; Flag for Date 1st other Tx; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Othr; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Unspecified	4180186
40762616	Flag for Date 1st other Tx Cancer	4180186
40762616	第 1 次其他治疗日期未填写标志:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762619	CA; Identity or presence; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Tx; Tx status; Unspecified	4180186
40762619	Tx status Cancer	4180186
40762619	治疗状态:存在与否或特征标识:时间点:癌.XXX:名义型	4182948
40762624	DNA Index Auto cyto	4180186
40762624	Area Ratio; Auto; Auto cyto; Automated detection; Deoxyribonucleic acid; DI; DNA score; Elec; Elect; Electr; Misc; Miscellaneous; Molecular pathology; MOLPATH; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40762624	DNA 指数:面积比率:时间点:细胞.XXX:定量型:自动化图像细胞仪	4182948
40762626	A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Feto; i; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tumor marker	4180186
40762626	AFP CSF-aCnc	4180186
40762626	Alpha-1-胎儿球蛋白:任意型浓度:时间点:脑脊液:定量型	4182948
40762627	DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Netilimicin; Netromycin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762627	Netilmicin Trough SerPl-sCnc	4180186
40762627	乙基西梭霉素^波谷:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762631	Calcit p chal SerPl-sCnc	4180186
40762631	After; CHEMISTRY.CHALLENGE TESTING; CT; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Thyrocalcitonin; Tumor marker	4180186
40762631	降钙素^在 XXX 刺激之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762632	Blood; Blood urea nitrogen; BUN; Chemistry; Kidney; Level; N; N2; Nephrology; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; UN; WB; Whole blood	4180186
40762632	BUN Bld-sCnc	4180186
40762632	尿素氮:物质的量浓度:时间点:全血:定量型	4182948
40762634	Trigl Ur-sCnc	4180186
40762634	Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tg; Trig; Trigly; Triglycerides; Triglycrides; UA; UR; Urn	4180186
40762634	甘油三酯:物质的量浓度:时间点:尿液:定量型	4182948
40762635	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; THC	4180186
40762635	Cannabinoids Gast Ql	4180186
40762635	大麻类:存在情况或阈值:时间点:胃液:序数型	4182948
40762637	BMI Prctl Per Age	4180186
40762637	BMI; bod; Bodies; BODY WEIGHT.MOLEC; Percentile; Point in time; QNT; Quan; Quant; Quantitative; Quetelet index; Random	4180186
40762637	体质指数:百分位数:时间点:^患者:定量型:按照年龄	4182948
40762639	Glucagon sp7 p fast SerPl-mCnc	4180186
40762639	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p fast; Spec; SR	4180186
40762639	胰高血糖素^在热量型禁食之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762640	Glucagon sp6 p fast SerPl-mCnc	4180186
40762640	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; HGF; Hyperglycemic factor; Level; Mass concentration; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p fast; Spec; SR	4180186
40762640	胰高血糖素^在热量型禁食之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40762643	CV A7 IgM Titr Ser IF	4180186
40762643	柯萨奇病毒 A7 型 抗体.IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762643	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A7; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762645	CV A16 IgG Titr Ser IF	4180186
40762645	柯萨奇病毒 A16 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40762645	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A16; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40762648	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytotoxic-lymphocytic antibody; FA; Fluorescent antibody; Fluoresent; HLA ANTIGEN; Human Leukocyte Antigen; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lymphocyte antibody; Lymphocytotoxic antibody; Ordinal; Panel Reactive AB; Panel Reactive antibody; Point in time; PR; PRA; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40762648	HLA IgG Ser Ql IF	4180186
40762648	HLA 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40762657	7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762657	7Aminoclonazepam SerPl Cfm-mCnc	4180186
40762657	7-氨基氯硝安定:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762658	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762658	7Aminoclonazepam Tiss-mCnt	4180186
40762658	7-氨基氯硝安定:质量含量:时间点:组织与涂片:定量型	4182948
40762659	7-amino clonazepam; 7Aminoclonazepam; Addiction; Cfm; Clonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762659	7Aminoclonazepam Tiss Cfm-mCnt	4180186
40762659	7-氨基氯硝安定:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762664	A-OH Alpraz Fld Cfm-mCnc	4180186
40762664	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Hydroxy alprazolam; Hydroxyalpraz; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762664	Alpha-羟基阿普唑仑:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762665	A-OH Alpraz Mec Cfm-mCnt	4180186
40762665	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; Mass content; Mec; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762665	Alpha-羟基阿普唑仑:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762667	A-OH Alpraz Tiss-mCnt	4180186
40762667	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; Mass content; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762667	Alpha-羟基阿普唑仑:质量含量:时间点:组织与涂片:定量型	4182948
40762668	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; Mass content; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762668	A-OH Alpraz Tiss Cfm-mCnt	4180186
40762668	Alpha-羟基阿普唑仑:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762673	Alpraz SerPl Cfm-mCnc	4180186
40762673	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Niravam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xanax	4180186
40762673	阿普唑仑:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762675	DRUG/TOXICOLOGY; Drugs; Mass content; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Xanax	4180186
40762675	Alpraz Tiss-mCnt	4180186
40762675	阿普唑仑:质量含量:时间点:组织与涂片:定量型	4182948
40762676	Alpraz Tiss Cfm-mCnt	4180186
40762676	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Xanax	4180186
40762676	阿普唑仑:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762677	Alpraz Ur Cfm-mCnc	4180186
40762677	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Xanax	4180186
40762677	阿普唑仑:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40762679	Blood; Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Level; Librium; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762679	Chlordiazep Bld-mCnc	4180186
40762679	甲氨二氮卓:质量浓度:时间点:全血:定量型	4182948
40762680	Chlordiazep Bld Cfm-mCnc	4180186
40762680	Blood; Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Librium; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762680	甲氨二氮卓:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762681	Chlordiazep Fld-mCnc	4180186
40762681	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Librium; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762681	甲氨二氮卓:质量浓度:时间点:体液:定量型	4182948
40762682	Chlordiazep Fld Cfm-mCnc	4180186
40762682	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Librium; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762682	甲氨二氮卓:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762684	Chlordiazep SerPl Cfm-mCnc	4180186
40762684	Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Librium; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762684	甲氨二氮卓:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762685	Bowel movement; Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; Librium; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762685	Chlordiazep Stl Cfm-mCnt	4180186
40762685	甲氨二氮卓:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762689	Blood; Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl; WB; Whole blood	4180186
40762689	cloBAZam Bld Cfm-mCnc	4180186
40762689	氯巴詹:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762690	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Frisium; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl	4180186
40762690	cloBAZam Fld-mCnc	4180186
40762690	氯巴詹:质量浓度:时间点:体液:定量型	4182948
40762692	cloBAZam Mec-mCnt	4180186
40762692	Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Mass content; Mec; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl	4180186
40762692	氯巴詹:质量含量:时间点:胎便:定量型	4182948
40762694	Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; Level; Mass concentration; Noiafren; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Urbadan; Urbanol; Urbanyl	4180186
40762694	cloBAZam SerPl Cfm-mCnc	4180186
40762694	氯巴詹:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762696	cloBAZam Tiss Cfm-mCnt	4180186
40762696	Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; Mass content; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Tissue; Tissue, unspecified; Urbadan; Urbanol; Urbanyl	4180186
40762696	氯巴詹:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762697	cloBAZam Ur Cfm-mCnc	4180186
40762697	Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; UA; UR; Urbadan; Urbanol; Urbanyl; Urn	4180186
40762697	氯巴詹:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40762700	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Klonopin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762700	clonazePAM Fld-mCnc	4180186
40762700	氯硝安定:质量浓度:时间点:体液:定量型	4182948
40762702	clonazePAM SerPl Cfm-mCnc	4180186
40762702	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762702	氯硝安定:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762706	Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Snow; SR	4180186
40762706	Cocaine SerPl Cfm-mCnc	4180186
40762706	可卡因:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762709	Desalkylfluraz Bld-mCnc	4180186
40762709	Blood; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762709	N-去烷基氟胺安定:质量浓度:时间点:全血:定量型	4182948
40762710	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762710	Desalkylfluraz Fld-mCnc	4180186
40762710	N-去烷基氟胺安定:质量浓度:时间点:体液:定量型	4182948
40762714	Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Mass content; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762714	Desalkylfluraz Tiss-mCnt	4180186
40762714	N-去烷基氟胺安定:质量含量:时间点:组织与涂片:定量型	4182948
40762716	Addiction; Blood; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium; WB; Whole blood	4180186
40762716	diazePAM Bld-mCnc	4180186
40762716	安定:质量浓度:时间点:全血:定量型	4182948
40762717	Addiction; Blood; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium; WB; Whole blood	4180186
40762717	diazePAM Bld Cfm-mCnc	4180186
40762717	安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762718	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium	4180186
40762718	diazePAM Fld-mCnc	4180186
40762718	安定:质量浓度:时间点:体液:定量型	4182948
40762719	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium	4180186
40762719	diazePAM Fld Cfm-mCnc	4180186
40762719	安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762720	Addiction; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Mec; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Valium	4180186
40762720	diazePAM Mec Cfm-mCnt	4180186
40762720	安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762721	Addiction; Bowel movement; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; GCMS; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Stl; Stool = Fecal; Valium	4180186
40762721	diazePAM Stl Cfm-mCnt	4180186
40762721	安定:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762723	Addiction; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Stesolid; Tissue; Tissue, unspecified; Valium	4180186
40762723	diazePAM Tiss Cfm-mCnt	4180186
40762723	安定:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762724	Diclofenac Bld-mCnc	4180186
40762724	Blood; c215; c281; C52; Cambia; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltaren optha; Voltaren opthalmic; WB; Whole blood	4180186
40762724	环氟拉嗪:质量浓度:时间点:全血:定量型	4182948
40762727	Estazolam Bld Cfm-mCnc	4180186
40762727	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762727	艾司唑仑:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762730	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; Level; Mass concentration; Nuctalon; Pl; Plasma; Plsm; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762730	Estazolam SerPl Cfm-mCnc	4180186
40762730	艾司唑仑:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762731	Bowel movement; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Faecal; Faeces; Fecal; Feces; GCMS; Mass content; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40762731	Estazolam Stl Cfm-mCnt	4180186
40762731	艾司唑仑:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762732	DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; Mass content; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762732	Estazolam Tiss-mCnt	4180186
40762732	艾司唑仑:质量含量:时间点:组织与涂片:定量型	4182948
40762733	Estazolam Tiss Cfm-mCnt	4180186
40762733	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; Mass content; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762733	艾司唑仑:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762734	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Esilgan; Eurodin; GCMS; Level; Mass concentration; Nuctalon; Point in time; Prosom; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40762734	Estazolam Ur Cfm-mCnc	4180186
40762734	艾司唑仑:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40762736	Flurazepam Bld-mCnc	4180186
40762736	Blood; Dalmane; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762736	氟胺安定:质量浓度:时间点:全血:定量型	4182948
40762737	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762737	Flurazepam Bld Cfm-mCnc	4180186
40762737	氟胺安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762741	Flurazepam Tiss Cfm-mCnt	4180186
40762741	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762741	氟胺安定:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762743	G-OH-Butyr SerPl Ql Scn	4180186
40762743	4-hydroxybutyrate; 4-hydroxybutyric acid; DRUG/TOXICOLOGY; Drugs; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Liquidx; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762743	Gamma 羟基丁酸:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
40762744	OH-Ethylfluraz Bld-mCnc	4180186
40762744	Blood; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762744	羟乙基氟胺安定:质量浓度:时间点:全血:定量型	4182948
40762746	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; Hydroxy ethylflurazepam; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762746	OH-Ethylfluraz Fld-mCnc	4180186
40762746	羟乙基氟胺安定:质量浓度:时间点:体液:定量型	4182948
40762748	OH-Ethylfluraz Mec Cfm-mCnt	4180186
40762748	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; Mass content; Mec; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762748	羟乙基氟胺安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762750	DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; Mass content; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762750	OH-Ethylfluraz Tiss-mCnt	4180186
40762750	羟乙基氟胺安定:质量含量:时间点:组织与涂片:定量型	4182948
40762751	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; Mass content; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762751	OH-Ethylfluraz Tiss Cfm-mCnt	4180186
40762751	羟乙基氟胺安定:质量含量:时间点:组织与涂片:定量型:毒理学确认试验	4182948
40762752	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydroxy triazolam; Illicit; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; WB; Whole blood	4180186
40762752	OH-Triazolam Bld-mCnc	4180186
40762752	羟基三唑仑:质量浓度:时间点:全血:定量型	4182948
40762753	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; WB; Whole blood	4180186
40762753	OH-Triazolam Bld Cfm-mCnc	4180186
40762753	羟基三唑仑:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762754	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Hydroxy triazolam; Illicit; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite	4180186
40762754	OH-Triazolam Fld-mCnc	4180186
40762754	羟基三唑仑:质量浓度:时间点:体液:定量型	4182948
40762756	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; Mass Content; Mec; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite	4180186
40762756	OH-Triazolam Mec Cfm-mCnt	4180186
40762756	羟基三唑仑:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762759	Iodide SerPl-mCnc	4180186
40762759	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762759	碘化物:质量浓度:时间点:血清/血浆:定量型	4182948
40762761	Addiction; Ativan; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762761	LORazepam Bld Cfm-mCnc	4180186
40762761	氯羟安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762762	Addiction; Ativan; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
40762762	LORazepam Fld-mCnc	4180186
40762762	氯羟安定:质量浓度:时间点:体液:定量型	4182948
40762764	Addiction; Ativan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762764	LORazepam SerPl Cfm-mCnc	4180186
40762764	氯羟安定:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762768	Midazolam Bld-mCnc	4180186
40762768	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed; WB; Whole blood	4180186
40762768	咪达唑仑:质量浓度:时间点:全血:定量型	4182948
40762770	Midazolam Fld-mCnc	4180186
40762770	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Versed	4180186
40762770	咪达唑仑:质量浓度:时间点:体液:定量型	4182948
40762775	Blood; DRUG/TOXICOLOGY; Drugs; Laughing gas; Level; Mass concentration; N2O; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762775	N2O Bld-mCnc	4180186
40762775	氧化亚氮:质量浓度:时间点:全血:定量型	4182948
40762776	DRUG/TOXICOLOGY; Drugs; Laughing gas; Level; Mass concentration; N2O; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762776	N2O SerPl-mCnc	4180186
40762776	氧化亚氮:质量浓度:时间点:血清/血浆:定量型	4182948
40762777	Nordiazepam Bld-mCnc	4180186
40762777	Blood; Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan; WB; Whole blood	4180186
40762777	去甲基安定:质量浓度:时间点:全血:定量型	4182948
40762778	Nordiazepam Bld Cfm-mCnc	4180186
40762778	Blood; Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan; WB; Whole blood	4180186
40762778	去甲基安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762779	Nordiazepam Fld-mCnc	4180186
40762779	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan	4180186
40762779	去甲基安定:质量浓度:时间点:体液:定量型	4182948
40762780	Nordiazepam Fld Cfm-mCnc	4180186
40762780	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan	4180186
40762780	去甲基安定:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762781	Nordiazepam Mec Cfm-mCnt	4180186
40762781	Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; Madar; Mass content; Mec; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan	4180186
40762781	去甲基安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762782	Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Pl; Plasma; Plsm; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stilny; Tranxilium N; Vegesan	4180186
40762782	Nordiazepam SerPl Cfm-mCnc	4180186
40762782	去甲基安定:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762786	Oxazepam Bld-mCnc	4180186
40762786	Alepam; Blood; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; WB; Whole blood	4180186
40762786	去甲羟安定:质量浓度:时间点:全血:定量型	4182948
40762787	Alepam; Blood; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; WB; Whole blood	4180186
40762787	Oxazepam Bld Cfm-mCnc	4180186
40762787	去甲羟安定:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762788	Alepam; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite	4180186
40762788	Oxazepam Fld-mCnc	4180186
40762788	去甲羟安定:质量浓度:时间点:体液:定量型	4182948
40762790	Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Mec; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite	4180186
40762790	Oxazepam Mec Cfm-mCnt	4180186
40762790	去甲羟安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762791	Oxazepam SerPl Cfm-mCnc	4180186
40762791	Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Temazepam metabolite	4180186
40762791	去甲羟安定:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762792	Alepam; Bowel movement; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; Mass content; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Stl; Stool = Fecal; Temazepam metabolite	4180186
40762792	Oxazepam Stl Cfm-mCnt	4180186
40762792	去甲羟安定:质量含量:时间点:大便:定量型:毒理学确认试验	4182948
40762793	Oxazepam Tiss-mCnt	4180186
40762793	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; Tissue; Tissue, unspecified	4180186
40762793	去甲羟安定:质量含量:时间点:组织与涂片:定量型	4182948
40762794	DRUG/TOXICOLOGY; Drugs; k; K+; Mass content; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762794	Potassium Tiss-mCnt	4180186
40762794	钾:质量含量:时间点:组织与涂片:定量型	4182948
40762799	Ag; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Silv	4180186
40762799	Silver Fld-mCnc	4180186
40762799	银:质量浓度:时间点:体液:定量型	4182948
40762801	Ag; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Silv	4180186
40762801	Silver RBC-mCnc	4180186
40762801	银:质量浓度:时间点:红细胞:定量型	4182948
40762804	SUMAtriptan Bld-mCnc	4180186
40762804	Blood; DRUG/TOXICOLOGY; Drugs; Imitrex; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762804	舒马曲坦:质量浓度:时间点:全血:定量型	4182948
40762806	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril; WB; Whole blood	4180186
40762806	Temazepam Bld-mCnc	4180186
40762806	羟基安定:质量浓度:时间点:全血:定量型	4182948
40762808	Temazepam Fld-mCnc	4180186
40762808	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril	4180186
40762808	羟基安定:质量浓度:时间点:体液:定量型	4182948
40762810	Temazepam Mec Cfm-mCnt	4180186
40762810	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Mec; Normison; Point in time; QNT; Quan; Quant; Quantitative; Random; Restoril	4180186
40762810	羟基安定:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
40762815	DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; TI	4180186
40762815	Titanium Hair-mCnt	4180186
40762815	钛:质量含量:时间点:毛发:定量型	4182948
40762816	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TI	4180186
40762816	Titanium RBC-mCnc	4180186
40762816	钛:质量浓度:时间点:红细胞:定量型	4182948
40762817	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; TI; Tissue; Tissue, unspecified	4180186
40762817	Titanium Tiss-mCnt	4180186
40762817	钛:质量含量:时间点:组织与涂片:定量型	4182948
40762820	APO-TRIAZO; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Halcion; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40762820	Triazolam Bld Cfm-mCnc	4180186
40762820	三唑苯二氮:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
40762822	Triazolam Fld Cfm-mCnc	4180186
40762822	APO-TRIAZO; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Halcion; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40762822	三唑苯二氮:质量浓度:时间点:体液:定量型:毒理学确认试验	4182948
40762823	Triazolam SerPl Cfm-mCnc	4180186
40762823	APO-TRIAZO; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Halcion; Level; Mass concentration; Novo-triolam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762823	三唑苯二氮:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40762824	APO-TRIAZO; DRUG/TOXICOLOGY; Drugs; Halcion; Mass content; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40762824	Triazolam Tiss-mCnt	4180186
40762824	三唑苯二氮:质量含量:时间点:组织与涂片:定量型	4182948
40762826	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; W; WB; Whole blood	4180186
40762826	Tungsten Bld-mCnc	4180186
40762826	钨:质量浓度:时间点:全血:定量型	4182948
40762828	Blood; DRUG/TOXICOLOGY; Drugs; Geodon; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Zeldox	4180186
40762828	Ziprasidone Bld-mCnc	4180186
40762828	齐拉西酮:质量浓度:时间点:全血:定量型	4182948
40762830	DOC.MISC; Dx; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MISC; Narrative; Point in time; Postprocedure Dx; Random; Report	4180186
40762830	Postprocedure Dx	4180186
40762830	操作后诊断:印象:时间点:^患者:叙述型	4182948
40762831	Bld loss; Blood output; DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762831	Estimated blood loss	4180186
40762831	操作预计失血量:发现:时间点:^患者:叙述型	4182948
40762833	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762833	Planned procedure	4180186
40762833	所计划的操作:发现:时间点:^患者:叙述型	4182948
40762834	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762834	Specimens taken	4180186
40762834	已采集的操作标本:发现:时间点:^患者:叙述型	4182948
40762836	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40762836	Disposition	4180186
40762836	操作处置:发现:时间点:^患者:叙述型	4182948
40762839	Immunization status; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccination; Vaccinations; Vaccine	4180186
40762839	疫苗接种逾期日期:日期:时间点:^患者:定量型	4182948
40762840	Finding; Findings; Immunization status; Nominal; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40762840	所使用的疫苗接种时间表:发现:时间点:^患者:名义型	4182948
40762841	Finding; Findings; Immunization status; Nominal; Point in time; Random; Vaccination; Vaccinations; Vaccine	4180186
40762841	疫苗接种系列:发现:时间点:^患者:名义型	4182948
40762843	# doses primary immunization series; Cnt; Count; Immunization status; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccination; Vaccinations; Vaccine	4180186
40762843	# doses primary immunization series	4180186
40762843	初次疫苗接种系列的剂量数:数量(计数):时间点:^患者:定量型	4182948
40762848	Catechols Plas-sCnc	4180186
40762848	Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762848	儿茶酚胺类:物质的量浓度:时间点:血浆:定量型	4182948
40762849	1 hour; 1.0Hr; 1h NP; 1h p Inc; 60 min; 60 minutes; 60M; 60min; After; Clot; Clottable; Coag; Coagulation assay; Control; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; Fac; Fact; Hematology; Heme; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
40762849	dRVVT 1h NP PPP	4180186
40762849	稀释蝰蛇毒诱导型凝血过程.因子替换^在添加正常血浆后孵育之后1小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40762851	Chemistry; Hematology; Heme; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexa-CP; Hexaporphyrin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762851	Hexa-CP SerPl-sCnc	4180186
40762851	六羧基卟啉:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762856	3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762856	Glucose 3h p chal SerPl-SCDiff	4180186
40762856	葡萄糖^在XXX刺激之后3小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762857	4h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762857	Glucose 4h p chal SerPl-SCDiff	4180186
40762857	葡萄糖^在XXX刺激之后4小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762859	Cytovene; DRUG/TOXICOLOGY; Drugs; GCV; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; Valcyte; Valganciclovir	4180186
40762859	Ganciclovir Peak Plas-mCnc	4180186
40762859	更昔洛韦^波峰:质量浓度:时间点:血浆:定量型	4182948
40762861	Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; Kidney; M Protein; M Protein 2; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; Percent; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
40762861	M Protein 2 MFr Ur Elph	4180186
40762861	蛋白质.单克隆型 区带 2/蛋白质.总计:质量分数:时间点:尿液:定量型:电泳	4182948
40762862	AE1 Anion Exchanger; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; III; Kidney; M Protein; M Protein 3; Mass Fraction; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; Percent; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
40762862	M Protein 3 MFr Ur Elph	4180186
40762862	蛋白质.单克隆型 区带 3/蛋白质.总计:质量分数:时间点:尿液:定量型:电泳	4182948
40762865	1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SCDiff; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762865	Cortis 1h p chal SerPl-SCDiff	4180186
40762865	皮质醇^在XXX刺激之后1小时:物质的量浓度差:时间点:血清/血浆:定量型	4182948
40762866	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; Fl; Fld; FLU; Fluid; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40762866	EBV DNA Fld Ql NAA+probe	4180186
40762866	Epstein Barr 病毒 DNA:存在情况或阈值:时间点:体液:序数型:探针法.基因扩增.靶向	4182948
40762867	120 min; 120 minutes; 120min; 2 hours; 2h NP; 2h p Inc; Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
40762867	aPTT-LA 2h NP PPP	4180186
40762867	表面诱导型凝血过程.狼疮敏感性.因子替换^在添加正常血浆后孵育之后2小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40762869	Lg Gran Lymphs Bld Ql	4180186
40762869	Blood; HEMATOLOGY/CELL COUNTS; Lg Gran Lymphs; LGL; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40762869	淋巴细胞.大颗粒型:存在情况或阈值:时间点:全血:序数型	4182948
40762872	CAFFN; DRUG/TOXICOLOGY; Drugs; Level; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration	4180186
40762872	Caffeine Peak Ser-sCnc	4180186
40762872	咖啡因^波峰:物质的量浓度:时间点:血清:定量型	4182948
40762873	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Morning; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR; Substance concentration	4180186
40762873	Glucose 11 AM SerPl-sCnc	4180186
40762873	葡萄糖^上午11点标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762877	100WBC; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Imm; Immat; Leuc; Leuk; Leukocyte; Lkcs; Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
40762877	Neutrophils.immature/leuk NFr Fld	4180186
40762877	嗜中性粒细胞.不成熟/100 个白细胞:计数型分数:时间点:体液:定量型	4182948
40762882	Copro3/Creat 24h Ur-sRto	4180186
40762882	1 day; 24 hours; 24HR; Chemistry; Copro; Copro3; Coproporph; Coproporphyrin III; Coproporphyrins; CR; Crea; Creat; III; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UCr; UR; Urn	4180186
40762882	粪卟啉 III/肌酐:物质的量比率:24小时:尿液:定量型	4182948
40762885	CN; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40762885	Cyanide Ur Ql	4180186
40762885	氰化物:存在情况或阈值:时间点:尿液:序数型	4182948
40762886	Ordinal; Phenol + p-cresol + o-cresol + m-cresol; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
40762886	Phenols Ur Ql	4180186
40762886	酚类:存在情况或阈值:时间点:尿液:序数型	4182948
40762887	Blood; Chemistry; CR; Crea; Creat; Kidney; Level; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration; WB; Whole blood	4180186
40762887	Creat Bld-sCnc	4180186
40762887	肌酐:物质的量浓度:时间点:全血:定量型	4182948
40762892	BS; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome	4180186
40762892	Gastrin BS SerPl-mCnc	4180186
40762892	胃泌素^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40762894	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Other Antibiotic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40762894	Other Antibiotic Islt MLC	4180186
40762894	抗生素 XXX:抗生素敏感性:时间点:分离株:定量型或序数型:最小致死浓度法	4182948
40762895	Chemistry; CR; Crea; Creat; CRR; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762895	Creatinine reduction ratio MFr SerPl	4180186
40762895	肌酐降低比率:质量分数:时间点:血清/血浆:定量型	4182948
40762898	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40762898	MDA SerPl-mCnc	4180186
40762898	亚甲基二氧苯丙胺:质量浓度:时间点:血清/血浆:定量型	4182948
40762902	Vendor name Spec	4180186
40762902	Chemistry; Ident; Identifier; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40762902	厂商名称:标识符:时间点:XXX:名义型	4182948
40762906	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40762906	FDA insert Instructions for use	4180186
40762906	使用说明小节:-:-:^FDA 包装说明书:叙述型	4182948
40762911	Antigen; Antigens; Arbitrary concentration; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Human lymphatic filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; W bancr; W bancrofti; Wucheria bancrofti	4180186
40762911	W bancr Ag Ser IA-aCnc	4180186
40762911	班氏吴策线虫 抗原:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40762913	CA; Coll; Collect; Collect Date; Collected; Date and time; i; Misc; Miscellaneous; Oncology; Other; Path; Path spec coll date 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Time stamp; Timestamp; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762913	Path spec coll date 1 Cancer	4180186
40762913	病理标本采集日期 1:时间戳:时间点:癌.XXX:定量型	4182948
40762915	CA; Coll; Collect; Collect Date; Collected; Date and time; III; Misc; Miscellaneous; Oncology; Other; Path; Path spec coll date 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Time stamp; Timestamp; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762915	Path spec coll date 3 Cancer	4180186
40762915	病理标本采集日期 3:时间戳:时间点:癌.XXX:定量型	4182948
40762916	CA; Coll; Collect; Collect Date; Collected; Date and time; Misc; Miscellaneous; Oncology; Other; Path; Path spec coll date 4; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Time stamp; Timestamp; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762916	Path spec coll date 4 Cancer	4180186
40762916	病理标本采集日期 4:时间戳:时间点:癌.XXX:定量型	4182948
40762917	CA; Coll; Collect; Collect Date; Collected; Date and time; Misc; Miscellaneous; Oncology; Other; Path; Path spec coll date 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Time stamp; Timestamp; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762917	Path spec coll date 5 Cancer	4180186
40762917	病理标本采集日期 5:时间戳:时间点:癌.XXX:定量型	4182948
40762919	CA; Ident; Identifier; II; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surveillance Epidemiology and End Result; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Unspecified	4180186
40762919	SEER site-specific fact 2 Cancer	4180186
40762919	SEER 部位特异性事实 2:标识符:时间点:癌.XXX:名义型	4182948
40762924	Acetone Gast-sCnc	4180186
40762924	2-propanone; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ketone bodies; Level; Me2CO; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762924	丙酮:物质的量浓度:时间点:胃液:定量型	4182948
40762925	Addiction; Amobarb; Amylobarbitone; Amytal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762925	Amobarbital Ur-sCnc	4180186
40762925	异戊巴比妥:物质的量浓度:时间点:尿液:定量型	4182948
40762926	Addiction; Amobarb; Amylobarbitone; Amytal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762926	Amobarbital Gast-sCnc	4180186
40762926	异戊巴比妥:物质的量浓度:时间点:胃液:定量型	4182948
40762927	Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Level; Moxadil; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762927	Amoxapine Ur-sCnc	4180186
40762927	阿莫沙平:物质的量浓度:时间点:尿液:定量型	4182948
40762928	Amoxapine Gast-sCnc	4180186
40762928	Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Moxadil; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762928	阿莫沙平:物质的量浓度:时间点:胃液:定量型	4182948
40762933	Bromazanil; Brozam; Calmepam; Compendium; Creosedin; DRUG/TOXICOLOGY; Drugs; Durazanil; GAST; Gastric contents; Gastric fluid; Gityl; Lectopam; Level; Lexatin; Lexaurin; Lexonil; Lexotan; Lexotanil; Neo-opt; Normoc; Point in time; QNT; Quan; Quant; Quantitative; Random; Somalium; Substance concentration	4180186
40762933	Bromazepam Gast-sCnc	4180186
40762933	溴吡二氮卓:物质的量浓度:时间点:胃液:定量型	4182948
40762938	Chloral Hydrate Gast-sCnc	4180186
40762938	Chloraldurat; Chloralix; Dormel; DRUG/TOXICOLOGY; Drugs; Elix-node; GAST; Gastric contents; Gastric fluid; Level; Medianox; Noctec; Pediatric chloral elixir; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trichloroethanol; Trichloroethyl alcohol; Trichloroethylalcohol; Welldorm	4180186
40762938	水合氯醛:物质的量浓度:时间点:胃液:定量型	4182948
40762940	Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Librium; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762940	Chlordiazep Gast-sCnc	4180186
40762940	甲氨二氮卓:物质的量浓度:时间点:胃液:定量型	4182948
40762941	Chlorphenir SerPl-sCnc	4180186
40762941	CHL; Chlorphenamine; Chlorphenir; Chlortrimeton; Chlor-tripolon; DRUG/TOXICOLOGY; Drugs; Level; Piriton; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762941	氯苯朴尔敏:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762945	chlorproMAZINE Gast-sCnc	4180186
40762945	Chlopromazine; Chlorpromaz; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Thorazine	4180186
40762945	氯丙嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762946	Celexa; Cipramil; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762946	Citalopram Ur-sCnc	4180186
40762946	西酞普兰:物质的量浓度:时间点:尿液:定量型	4182948
40762947	Citalopram Gast-sCnc	4180186
40762947	Celexa; Cipramil; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762947	西酞普兰:物质的量浓度:时间点:胃液:定量型	4182948
40762949	clomiPRAMINE Gast-sCnc	4180186
40762949	Anafranil; Anofranil; Clom; Clomip; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762949	氯米帕明:物质的量浓度:时间点:胃液:定量型	4182948
40762951	Cotinine SerPl-sCnc	4180186
40762951	DRUG/TOXICOLOGY; Drugs; Level; Nicotine metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762951	可铁宁:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762954	Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762954	D-methorphan SerPl-sCnc	4180186
40762954	右美沙芬:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762956	Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762956	D-methorphan Gast-sCnc	4180186
40762956	右美沙芬:物质的量浓度:时间点:胃液:定量型	4182948
40762959	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762959	Ethylene Glycol Gast-sCnc	4180186
40762959	乙烯乙二醇:物质的量浓度:时间点:胃液:定量型	4182948
40762960	Fenoprofen Ur-sCnc	4180186
40762960	DRUG/TOXICOLOGY; Drugs; Level; Nalfon; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762960	苯氧苯丙酸:物质的量浓度:时间点:尿液:定量型	4182948
40762961	Fenoprofen Gast-sCnc	4180186
40762961	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Nalfon; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762961	苯氧苯丙酸:物质的量浓度:时间点:胃液:定量型	4182948
40762962	DRUG/TOXICOLOGY; Drugs; Level; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762962	FLUoxetine Ur-sCnc	4180186
40762962	氟西汀:物质的量浓度:时间点:尿液:定量型	4182948
40762963	FLUoxetine Gast-sCnc	4180186
40762963	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762963	氟西汀:物质的量浓度:时间点:胃液:定量型	4182948
40762964	DRUG/TOXICOLOGY; Drugs; Fluphenazine Hydrochloride; Level; Point in time; Prolixin; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762964	fluPHENAZine Ur-sCnc	4180186
40762964	氟奋乃静:物质的量浓度:时间点:尿液:定量型	4182948
40762965	DRUG/TOXICOLOGY; Drugs; Fluphenazine Hydrochloride; GAST; Gastric contents; Gastric fluid; Level; Point in time; Prolixin; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762965	fluPHENAZine Gast-sCnc	4180186
40762965	氟奋乃静:物质的量浓度:时间点:胃液:定量型	4182948
40762966	fluvoxaMINE Ur-sCnc	4180186
40762966	DRUG/TOXICOLOGY; Drugs; Level; Luvox; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762966	三氟戊肟胺:物质的量浓度:时间点:尿液:定量型	4182948
40762967	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Luvox; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762967	fluvoxaMINE Gast-sCnc	4180186
40762967	三氟戊肟胺:物质的量浓度:时间点:胃液:定量型	4182948
40762970	Ibuprofen Ur-sCnc	4180186
40762970	Advil; c20; c235; c286; C53; DRUG/TOXICOLOGY; Drugs; Level; Motrin; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762970	对异丁基苯异丙酸:物质的量浓度:时间点:尿液:定量型	4182948
40762971	Ibuprofen Gast-sCnc	4180186
40762971	Advil; c20; c235; c286; C53; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Motrin; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762971	对异丁基苯异丙酸:物质的量浓度:时间点:胃液:定量型	4182948
40762973	Imipramine Gast-sCnc	4180186
40762973	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Imipra; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tofranil	4180186
40762973	丙咪嗪:物质的量浓度:时间点:胃液:定量型	4182948
40762975	Indomethacin Gast-sCnc	4180186
40762975	c282; C54; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Indochron; Indocin; Indometacin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762975	茚甲新:物质的量浓度:时间点:胃液:定量型	4182948
40762977	Ketoprofen Ur-sCnc	4180186
40762977	2-(meta-benzylphenyl) propionate; C16H14O3; c388; DRUG/TOXICOLOGY; Drugs; Level; Orudis; Oruvail; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762977	酮洛芬:物质的量浓度:时间点:尿液:定量型	4182948
40762979	DRUG/TOXICOLOGY; Drugs; Lamictal; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762979	lamoTRIgine Ur-sCnc	4180186
40762979	拉莫三嗪:物质的量浓度:时间点:尿液:定量型	4182948
40762983	C15H15NO2; C56; DRUG/TOXICOLOGY; Drugs; Du-diclo; Forte mefenamic acid; GAST; Gastric contents; Gastric fluid; Level; Mefenamic acid; Mefic; N-(2,3-xylyl)anthranilic acid; Point in time; Ponstan; Ponstel; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762983	Mefenamate Gast-sCnc	4180186
40762983	甲灭酸:物质的量浓度:时间点:胃液:定量型	4182948
40762984	Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pethidine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40762984	Meperidine SerPl-sCnc	4180186
40762984	哌替啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
40762985	DRUG/TOXICOLOGY; Drugs; Level; Mesoridazine besylate; Point in time; QNT; Quan; Quant; Quantitative; Random; Serentil; Substance concentration; UA; UR; Urn	4180186
40762985	Mesoridazine Ur-sCnc	4180186
40762985	美索达嗪:物质的量浓度:时间点:尿液:定量型	4182948
40762987	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; MeOH; Methyl alcohol; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762987	Methanol Gast-sCnc	4180186
40762987	甲醇:物质的量浓度:时间点:胃液:定量型	4182948
40762993	Mexiletine Gast-sCnc	4180186
40762993	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Mexiletene; Mexitil; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762993	美西律:物质的量浓度:时间点:胃液:定量型	4182948
40762994	Naproxen Ur-sCnc	4180186
40762994	Anaprox; c228; c283; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762994	甲氧萘丙酸:物质的量浓度:时间点:尿液:定量型	4182948
40762995	Naproxen Gast-sCnc	4180186
40762995	Anaprox; c228; c283; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762995	甲氧萘丙酸:物质的量浓度:时间点:胃液:定量型	4182948
40762996	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Level; Nicoderm; Nictoine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762996	Nicotine Ur-sCnc	4180186
40762996	烟碱:物质的量浓度:时间点:尿液:定量型	4182948
40762997	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Habitrol; Illicit; Level; Nicoderm; Nictoine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40762997	Nicotine Gast-sCnc	4180186
40762997	烟碱:物质的量浓度:时间点:胃液:定量型	4182948
40762998	Norclobazam Ur-sCnc	4180186
40762998	Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; Level; N-desmethylclobazam; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40762998	去甲基氯巴詹:物质的量浓度:时间点:尿液:定量型	4182948
40763000	Norclomipramine Ur-sCnc	4180186
40763000	Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763000	去甲基氯米帕明:物质的量浓度:时间点:尿液:定量型	4182948
40763001	Norclomipramine Gast-sCnc	4180186
40763001	Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763001	去甲基氯米帕明:物质的量浓度:时间点:胃液:定量型	4182948
40763002	Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Doxepin metabolite; DRUG/TOXICOLOGY; Drugs; Level; N-desmethyldoxepin; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763002	Nordoxepin Ur-sCnc	4180186
40763002	去甲基多虑平:物质的量浓度:时间点:尿液:定量型	4182948
40763004	Normeperidine SerPl-sCnc	4180186
40763004	DRUG/TOXICOLOGY; Drugs; Level; Meperidine metabolite; Norpethidine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40763004	去甲基哌替啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763008	OXcarbazepine Gast-sCnc	4180186
40763008	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; OXC; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trileptal	4180186
40763008	奥卡西平:物质的量浓度:时间点:胃液:定量型	4182948
40763010	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763010	PARoxetine Gast-sCnc	4180186
40763010	帕罗西汀:物质的量浓度:时间点:胃液:定量型	4182948
40763012	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Talwin	4180186
40763012	Pentazocine Gast-sCnc	4180186
40763012	戊唑星:物质的量浓度:时间点:胃液:定量型	4182948
40763015	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trilafon	4180186
40763015	Perphenazine Gast-sCnc	4180186
40763015	奋乃静:物质的量浓度:时间点:胃液:定量型	4182948
40763023	QUEtiapine Ur-sCnc	4180186
40763023	DRUG/TOXICOLOGY; Drugs; Ketipinor; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Seroquel; Substance concentration; UA; UR; Urn; Xeroquel	4180186
40763023	喹硫平:物质的量浓度:时间点:尿液:定量型	4182948
40763025	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40763025	quiNINE SerPl-sCnc	4180186
40763025	奎宁:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763027	quiNINE Gast-sCnc	4180186
40763027	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763027	奎宁:物质的量浓度:时间点:胃液:定量型	4182948
40763028	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40763028	Strychnine SerPl-sCnc	4180186
40763028	番木鳖碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763031	Acetylsulfamethoxazole; c203; c223; C61; DRUG/TOXICOLOGY; Drugs; Gantanol; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SMX; Substance concentration; Sulfa; Sulfamethox; UA; UR; Urn	4180186
40763031	Sulfamethoxazole Ur-sCnc	4180186
40763031	磺胺甲噁唑:物质的量浓度:时间点:尿液:定量型	4182948
40763032	Sulfamethoxazole Gast-sCnc	4180186
40763032	Acetylsulfamethoxazole; c203; c223; C61; DRUG/TOXICOLOGY; Drugs; Gantanol; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SMX; Substance concentration; Sulfa; Sulfamethox	4180186
40763032	磺胺甲噁唑:物质的量浓度:时间点:胃液:定量型	4182948
40763033	DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
40763033	Thiocyanate Ur-sCnc	4180186
40763033	硫氰化物:物质的量浓度:时间点:尿液:定量型	4182948
40763034	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
40763034	Thiocyanate Gast-sCnc	4180186
40763034	硫氰化物:物质的量浓度:时间点:胃液:定量型	4182948
40763035	traZODone Ur-sCnc	4180186
40763035	Desyrel; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trazon; Trialodine; UA; UR; Urn	4180186
40763035	曲唑酮:物质的量浓度:时间点:尿液:定量型	4182948
40763039	4-Hydroxycoumarin; Coumadin; Coumarin; Coumarins; DRUG/TOXICOLOGY; Drugs; Level; Panwarfin; Point in time; QNT; Quan; Quant; Quantitative; Random; Sofarin; Substance concentration; UA; UR; Urn	4180186
40763039	Warfarin Ur-sCnc	4180186
40763039	丙酮苄羟香豆素:物质的量浓度:时间点:尿液:定量型	4182948
40763040	4-Hydroxycoumarin; Coumadin; Coumarin; Coumarins; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Panwarfin; Point in time; QNT; Quan; Quant; Quantitative; Random; Sofarin; Substance concentration	4180186
40763040	Warfarin Gast-sCnc	4180186
40763040	丙酮苄羟香豆素:物质的量浓度:时间点:胃液:定量型	4182948
40763043	Acute specimen; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; sp1; sp1 p chal; Spec; SR; Sulf	4180186
40763043	DHEA-S sp1 p chal SerPl-mCnc	4180186
40763043	硫酸脱氢表雄甾酮^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763047	11DOC; 11-DOC; 21-Hydroxyprogesterone; After; CHEMISTRY.CHALLENGE TESTING; DOC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR	4180186
40763047	11DOC sp5 p chal SerPl-mCnc	4180186
40763047	11-脱氧皮质酮^在XXX刺激之后的第5个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763048	Testost sp8 p chal SerPl-mCnc	4180186
40763048	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763048	睾酮^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763049	^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763049	Testost sp7 p chal SerPl-mCnc	4180186
40763049	睾酮^在XXX刺激之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763050	Testost sp6 p chal SerPl-mCnc	4180186
40763050	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763050	睾酮^在XXX刺激之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763052	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR; Testo; Testos; Testost	4180186
40763052	Testost sp4 p chal SerPl-mCnc	4180186
40763052	睾酮^在XXX刺激之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763056	IGF BP3 sp8 p chal SerPl-mCnc	4180186
40763056	After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp8; sp8 p chal; Spec; SR; Ultralente	4180186
40763056	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763057	^7th spec pst XXX chal; After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp7; sp7 p chal; Spec; SR; Ultralente	4180186
40763057	IGF BP3 sp7 p chal SerPl-mCnc	4180186
40763057	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第7个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763062	After; Bind; CHEMISTRY.CHALLENGE TESTING; Convalescent; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PR; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Second; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp2; sp2 p chal; Spec; SR; Ultralente	4180186
40763062	IGF BP3 sp2 p chal SerPl-mCnc	4180186
40763062	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763063	Bind; BS; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40763063	IGF BP3 BS SerPl-mCnc	4180186
40763063	胰岛素样生长因子结合蛋白 3^基线:质量浓度:时间点:血清/血浆:定量型	4182948
40763064	IGF BP3 sp1 p chal SerPl-mCnc	4180186
40763064	Acute specimen; After; Bind; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; First; HUM; Humulin; IGF; IGF BP; IGF BP3; IGFBP; IH7; III; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PR; Pre immunization; Prot; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; sp1; sp1 p chal; Spec; SR; Ultralente	4180186
40763064	胰岛素样生长因子结合蛋白 3^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763065	After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp8; sp8 p chal; Spec; SR; Ultralente	4180186
40763065	IGF-I sp8 p chal SerPl-mCnc	4180186
40763065	胰岛素样生长因子-I^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763067	After; CHEMISTRY.CHALLENGE TESTING; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp6; sp6 p chal; Spec; SR; Ultralente	4180186
40763067	IGF-I sp6 p chal SerPl-mCnc	4180186
40763067	胰岛素样生长因子-I^在XXX刺激之后的第6个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763071	IGF-I sp2 p chal SerPl-mCnc	4180186
40763071	After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Fac; Fact; Factor 1; FI; HUM; Humulin; IGF; IGF1; IGF-1; IGF-I; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatomedin C; sp2; sp2 p chal; Spec; SR; Ultralente	4180186
40763071	胰岛素样生长因子-I^在XXX刺激之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763074	ACTH BS Plas-sCnc	4180186
40763074	ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; BS; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40763074	促肾上腺皮质激素^基线:物质的量浓度:时间点:血浆:定量型	4182948
40763075	5M p chal; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	4180186
40763075	ACTH 5M p chal Plas-sCnc	4180186
40763075	促肾上腺皮质激素^在XXX刺激之后5分钟:物质的量浓度:时间点:血浆:定量型	4182948
40763077	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; Fl; Fld; FLU; Fluid; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Tumor marker; UniversalLabOrders	4180186
40763077	LDH Fld P to L-cCnc	4180186
40763077	乳酸脱氢酶:催化浓度:时间点:体液:定量型:反应: 丙酮酸至乳酸	4182948
40763078	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Tumor marker	4180186
40763078	LDH Pcar P to L-cCnc	4180186
40763078	乳酸脱氢酶:催化浓度:时间点:心包液:定量型:反应: 丙酮酸至乳酸	4182948
40763081	LDH Plr P to L-cCnc	4180186
40763081	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; thoracentesis fluid; Tumor marker	4180186
40763081	乳酸脱氢酶:催化浓度:时间点:胸膜液:定量型:反应: 丙酮酸至乳酸	4182948
40763085	Urobilinogen Ur Strip.auto-sCnc	4180186
40763085	尿胆素原:物质的量浓度:时间点:尿液:定量型:试纸条.自动化法	4182948
40763085	Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Level; Point in time; Random; SmQn; Substance Concentration; UA; UBG; UR; URINALYSIS; Urn; Urobili; Urobilngn	4180186
40763087	Cardio; Cardiology; Chemistry; Conc; Concentration; Den; Density; Grav; Heart Disease; Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative density; SG; Sp G; Sp Gr; Sp Grav; Spec; Spec grav	4180186
40763087	Sp Gr Pcar	4180186
40763087	比重:相对密度:时间点:心包液:定量型	4182948
40763088	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; WNV	4180186
40763088	WNV IgG Avidity Ser Ql IA	4180186
40763088	西尼罗河病毒 抗体.IgG 亲合力:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40763094	10,11-dihydro-10-hydroxycarbamazepine; 10-Hydroxy carbazepine; 10-hydroxycarbamazepine; 10-Monohydroxyoxcarbazepine; 10-OH-carbazepine; 10OH-Carbazepine; Blood; DRUG/TOXICOLOGY; Drugs; Level; Licarbazepine; Mass concentration; Oxcarbazepine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763094	10OH-Carbazepine Bld-mCnc	4180186
40763094	10-羟基卡马西平:质量浓度:时间点:全血:定量型	4182948
40763095	1Naphthol Bld-mCnc	4180186
40763095	1Naphthol; alpha-naphthol; Blood; Carbaryl metabolite; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Naphthalene metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763095	1-萘酚:质量浓度:时间点:全血:定量型	4182948
40763097	1Naphthol Tiss-mCnt	4180186
40763097	1Naphthol; alpha-naphthol; Carbaryl metabolite; DRUG/TOXICOLOGY; Drugs; i; Mass content; Naphthalene metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763097	1-萘酚:质量含量:时间点:组织与涂片:定量型	4182948
40763098	Acebutolol Bld-mCnc	4180186
40763098	Acecor; ALOL; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Monitan; Neptal; Point in time; Prent; QNT; Quan; Quant; Quantitative; Random; Rhotral; Sectral; WB; Whole blood	4180186
40763098	醋丁洛尔:质量浓度:时间点:全血:定量型	4182948
40763100	Acebutolol Tiss-mCnt	4180186
40763100	Acecor; ALOL; DRUG/TOXICOLOGY; Drugs; Mass content; Monitan; Neptal; Point in time; Prent; QNT; Quan; Quant; Quantitative; Random; Rhotral; Sectral; Tissue; Tissue, unspecified	4180186
40763100	醋丁洛尔:质量含量:时间点:组织与涂片:定量型	4182948
40763107	ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; Blood; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Level; Liver; Mass Concentration; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tylenol; u209; WB; Whole blood	4180186
40763107	APAP Bld-mCnc	4180186
40763107	对乙酰氨基酚:质量浓度:时间点:全血:定量型	4182948
40763109	ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Liver; Mass Content; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Tylenol; u209	4180186
40763109	APAP Tiss-mCnt	4180186
40763109	对乙酰氨基酚:质量含量:时间点:组织与涂片:定量型	4182948
40763111	Alpha pinene; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763111	Alphapinene Bld-mCnc	4180186
40763111	Alpha 蒎烯:质量浓度:时间点:全血:定量型	4182948
40763113	Amiodarone Bld-mCnc	4180186
40763113	Blood; Cordarone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pacerone; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763113	胺碘酮:质量浓度:时间点:全血:定量型	4182948
40763114	Astemizole Fld-mCnc	4180186
40763114	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Hismana; Hismanal; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763114	阿司咪唑:质量浓度:时间点:体液:定量型	4182948
40763117	Bismuth RBC-mCnc	4180186
40763117	BI; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763117	铋:质量浓度:时间点:红细胞:定量型	4182948
40763118	BI; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763118	Bismuth Tiss-mCnt	4180186
40763118	铋:质量含量:时间点:组织与涂片:定量型	4182948
40763125	c617; CO; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763125	Cobalt RBC-mCnc	4180186
40763125	钴:质量浓度:时间点:红细胞:定量型	4182948
40763128	Blood; Dantrium; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763128	Dantrolene Bld-mCnc	4180186
40763128	丹曲林:质量浓度:时间点:全血:定量型	4182948
40763131	Allegra; Blood; DRUG/TOXICOLOGY; Drugs; Fastofen; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Telfast; Tilfur; Vifas; WB; Whole blood	4180186
40763131	Fexofenadine Bld-mCnc	4180186
40763131	非索非那定:质量浓度:时间点:全血:定量型	4182948
40763132	Fexofenadine SerPl-mCnc	4180186
40763132	Allegra; DRUG/TOXICOLOGY; Drugs; Fastofen; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Telfast; Tilfur; Vifas	4180186
40763132	非索非那定:质量浓度:时间点:血清/血浆:定量型	4182948
40763133	Fexofenadine Ur-mCnc	4180186
40763133	Allegra; DRUG/TOXICOLOGY; Drugs; Fastofen; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Telfast; Tilfur; UA; UR; Urn; Vifas	4180186
40763133	非索非那定:质量浓度:时间点:尿液:定量型	4182948
40763134	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Propecia; Proscar; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763134	Finasteride SerPl-mCnc	4180186
40763134	非那雄胺:质量浓度:时间点:血清/血浆:定量型	4182948
40763137	Ganciclovir Ur-mCnc	4180186
40763137	Cytovene; DRUG/TOXICOLOGY; Drugs; GCV; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Valcyte; Valganciclovir	4180186
40763137	更昔洛韦:质量浓度:时间点:尿液:定量型	4182948
40763138	Germanium Bld-mCnc	4180186
40763138	Blood; DRUG/TOXICOLOGY; Drugs; GE; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763138	锗:质量浓度:时间点:全血:定量型	4182948
40763140	DRUG/TOXICOLOGY; Drugs; GE; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763140	Germanium SerPl-mCnc	4180186
40763140	锗:质量浓度:时间点:血清/血浆:定量型	4182948
40763141	AU; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763141	Gold RBC-mCnc	4180186
40763141	金:质量浓度:时间点:红细胞:定量型	4182948
40763143	6-hydroxybupropion; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; OH-bupropion; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763143	OH-bupropion Fld-mCnc	4180186
40763143	羟基丁氨苯丙酮:质量浓度:时间点:体液:定量型	4182948
40763144	6-hydroxybupropion; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; Mass content; OH-bupropion; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763144	OH-bupropion Tiss-mCnt	4180186
40763144	羟基丁氨苯丙酮:质量含量:时间点:组织与涂片:定量型	4182948
40763149	Indium SerPl-mCnc	4180186
40763149	DRUG/TOXICOLOGY; Drugs; In; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763149	铟:质量浓度:时间点:血清/血浆:定量型	4182948
40763150	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nizoral; NZ; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763150	Ketoconazole Bld-mCnc	4180186
40763150	酮康唑:质量浓度:时间点:全血:定量型	4182948
40763151	Ketoconazole Ur-mCnc	4180186
40763151	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nizoral; NZ; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763151	酮康唑:质量浓度:时间点:尿液:定量型	4182948
40763152	Ketoprofen Bld-mCnc	4180186
40763152	2-(meta-benzylphenyl) propionate; Blood; C16H14O3; c388; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Orudis; Oruvail; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763152	酮洛芬:质量浓度:时间点:全血:定量型	4182948
40763154	Loperamide Bld-mCnc	4180186
40763154	Blood; C29H33ClN2O2; DRUG/TOXICOLOGY; Drugs; Immodium; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763154	洛哌丁胺:质量浓度:时间点:全血:定量型	4182948
40763157	Alavert; Claritin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763157	Loratadine Ur-mCnc	4180186
40763157	氯雷他定:质量浓度:时间点:尿液:定量型	4182948
40763158	Blood; DRUG/TOXICOLOGY; Drugs; Level; Loxitane; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763158	Loxapine Bld-mCnc	4180186
40763158	洛沙平:质量浓度:时间点:全血:定量型	4182948
40763159	DRUG/TOXICOLOGY; Drugs; Level; Loxitane; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763159	Loxapine Ur-mCnc	4180186
40763159	洛沙平:质量浓度:时间点:尿液:定量型	4182948
40763161	O-去甲基文拉法新:质量浓度:时间点:全血:定量型	4182948
40763161	ODV Bld-mCnc	4180186
40763161	Blood; Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; Venlafaxine metabolite; WB; Whole blood	4180186
40763163	O-去甲基文拉法新:质量含量:时间点:组织与涂片:定量型	4182948
40763163	ODV Tiss-mCnt	4180186
40763163	Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Mass content; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Venlafaxine metabolite	4180186
40763167	Oxychlordane Fld-mCnc	4180186
40763167	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chlordane metabolite; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Octachlor epoxide; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763167	八氯丹:质量浓度:时间点:体液:定量型	4182948
40763168	Oxychlordane Tiss-mCnt	4180186
40763168	Chlordane metabolite; DRUG/TOXICOLOGY; Drugs; Mass content; Octachlor epoxide; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763168	八氯丹:质量含量:时间点:组织与涂片:定量型	4182948
40763169	Blood; Californit; DRUG/TOXICOLOGY; Drugs; Hydroxyphenylbutazone; Level; Mass concentration; Otone; Oxybutazone; Phenylbutazone metabolite; Phlogont; Point in time; QNT; Quan; Quant; Quantitative; Random; Tanderil chlorampenicol; WB; Whole blood	4180186
40763169	Oxyphenbutazone Bld-mCnc	4180186
40763169	羟基保泰松:质量浓度:时间点:全血:定量型	4182948
40763170	Californit; DRUG/TOXICOLOGY; Drugs; Hydroxyphenylbutazone; Level; Mass concentration; Otone; Oxybutazone; Phenylbutazone metabolite; Phlogont; Point in time; QNT; Quan; Quant; Quantitative; Random; Tanderil chlorampenicol; UA; UR; Urn	4180186
40763170	Oxyphenbutazone Ur-mCnc	4180186
40763170	羟基保泰松:质量浓度:时间点:尿液:定量型	4182948
40763171	Allopurinol metabolite; alloxanthine; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oxyprim; oxypurinol; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763171	Oxipurinol Bld-mCnc	4180186
40763171	奥昔嘌醇:质量浓度:时间点:全血:定量型	4182948
40763172	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763173	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763173	PACLitaxel SerPl-mCnc	4180186
40763173	紫杉醇:质量浓度:时间点:血清/血浆:定量型	4182948
40763176	Palladium Bld-mCnc	4180186
40763176	Blood; c629; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pd; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763176	钯:质量浓度:时间点:全血:定量型	4182948
40763177	Palladium RBC-mCnc	4180186
40763177	c629; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Pd; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763177	钯:质量浓度:时间点:红细胞:定量型	4182948
40763179	Palladium Ur-mCnc	4180186
40763179	c629; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pd; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763179	钯:质量浓度:时间点:尿液:定量型	4182948
40763182	CPAN; DRUG/TOXICOLOGY; Drugs; Mass content; Mioblock; Pavulon; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763182	Pancuronium Tiss-mCnt	4180186
40763182	泮库溴铵:质量含量:时间点:组织与涂片:定量型	4182948
40763185	Papaverine Ur-mCnc	4180186
40763185	CereSer; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pavobid; Plasan; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763185	罂粟碱:质量浓度:时间点:尿液:定量型	4182948
40763187	PMO Ur-mCnc	4180186
40763187	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PMO; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763187	甲乙双酮:质量浓度:时间点:尿液:定量型	4182948
40763188	Paraoxon Bld-mCnc	4180186
40763188	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Parathion metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763188	对氧磷:质量浓度:时间点:全血:定量型	4182948
40763191	Parathion Bld-mCnc	4180186
40763191	Blood; Diethyl parathion; DRUG/TOXICOLOGY; Drugs; Ethyl Parathion; Folidol; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Thiophos; WB; Whole blood	4180186
40763191	对硫磷:质量浓度:时间点:全血:定量型	4182948
40763192	Parathion Fld-mCnc	4180186
40763192	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Diethyl parathion; DRUG/TOXICOLOGY; Drugs; Ethyl Parathion; Fl; Fld; FLU; Fluid; Folidol; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Thiophos	4180186
40763192	对硫磷:质量浓度:时间点:体液:定量型	4182948
40763193	Parathion Tiss-mCnt	4180186
40763193	Diethyl parathion; DRUG/TOXICOLOGY; Drugs; Ethyl Parathion; Folidol; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Thiophos; Tissue; Tissue, unspecified	4180186
40763193	对硫磷:质量含量:时间点:组织与涂片:定量型	4182948
40763195	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763195	PARoxetine Bld-mCnc	4180186
40763195	帕罗西汀:质量浓度:时间点:全血:定量型	4182948
40763196	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763196	PARoxetine Fld-mCnc	4180186
40763196	帕罗西汀:质量浓度:时间点:体液:定量型	4182948
40763197	DRUG/TOXICOLOGY; Drugs; Mass content; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763197	PARoxetine Tiss-mCnt	4180186
40763197	帕罗西汀:质量含量:时间点:组织与涂片:定量型	4182948
40763199	Penciclovir Bld-mCnc	4180186
40763199	Blood; Denavir; DRUG/TOXICOLOGY; Drugs; Famciclovir metabolite; Famvir metabolite; Level; Mass concentration; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763199	喷昔洛韦:质量浓度:时间点:全血:定量型	4182948
40763201	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763201	Pendimethalin Bld-mCnc	4180186
40763201	二甲戊乐灵:质量浓度:时间点:全血:定量型	4182948
40763205	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763205	Pentane SerPl-mCnc	4180186
40763205	戊烷:质量浓度:时间点:血清/血浆:定量型	4182948
40763209	Addiction; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Talwin	4180186
40763209	Pentazocine Fld-mCnc	4180186
40763209	戊唑星:质量浓度:时间点:体液:定量型	4182948
40763211	Addiction; B/F; Barbiturate; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Nembutal; Pentobarb; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
40763211	Pentobarb Fld-mCnc	4180186
40763211	戊巴比妥:质量浓度:时间点:体液:定量型	4182948
40763212	Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mass Content; Nembutal; Pentobarb; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763212	Pentobarb Tiss-mCnt	4180186
40763212	戊巴比妥:质量含量:时间点:组织与涂片:定量型	4182948
40763213	Pentoxifylline Bld-mCnc	4180186
40763213	Blood; DRUG/TOXICOLOGY; Drugs; Flexital; Level; Mass concentration; Pentox; Pentoxil; Pentoxyfylline; Point in time; QNT; Quan; Quant; Quantitative; Random; Trental; WB; Whole blood	4180186
40763213	己酮可可碱:质量浓度:时间点:全血:定量型	4182948
40763214	Pentoxifylline Ur-mCnc	4180186
40763214	DRUG/TOXICOLOGY; Drugs; Flexital; Level; Mass concentration; Pentox; Pentoxil; Pentoxyfylline; Point in time; QNT; Quan; Quant; Quantitative; Random; Trental; UA; UR; Urn	4180186
40763214	己酮可可碱:质量浓度:时间点:尿液:定量型	4182948
40763216	Perfluorooctanoate SerPl-mCnc	4180186
40763216	DRUG/TOXICOLOGY; Drugs; FC-143 component; Level; Mass concentration; Pentadecafluorooctanoic acid; PFOA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763216	全氟辛酸:质量浓度:时间点:血清/血浆:定量型	4182948
40763219	Perphenazine Bld-mCnc	4180186
40763219	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Trilafon; WB; Whole blood	4180186
40763219	奋乃静:质量浓度:时间点:全血:定量型	4182948
40763221	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenurone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763221	Phenacemide Ur-mCnc	4180186
40763221	苯乙酰脲:质量浓度:时间点:尿液:定量型	4182948
40763222	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenolthalein; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763222	Phenolphthalein SerPl-mCnc	4180186
40763222	酚酞:质量浓度:时间点:血清/血浆:定量型	4182948
40763224	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Milontin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763224	Phensuximide Ur-mCnc	4180186
40763224	苯琥胺:质量浓度:时间点:尿液:定量型	4182948
40763225	铂:质量含量:时间点:甲:定量型	4182948
40763225	DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Ungal nail	4180186
40763225	Platinum Nail-mCnt	4180186
40763226	Platinum RBC-mCnc	4180186
40763226	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
40763226	铂:质量浓度:时间点:红细胞:定量型	4182948
40763227	Platinum Tiss-mCnt	4180186
40763227	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
40763227	铂:质量含量:时间点:组织与涂片:定量型	4182948
40763231	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SR; WB; Whole blood	4180186
40763231	Strontium Bld-mCnc	4180186
40763231	锶:质量浓度:时间点:全血:定量型	4182948
40763232	Strontium RBC-mCnc	4180186
40763232	DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; SR	4180186
40763232	锶:质量浓度:时间点:红细胞:定量型	4182948
40763236	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763236	Sulfamethizole Ur-mCnc	4180186
40763236	磺胺甲二唑:质量浓度:时间点:尿液:定量型	4182948
40763237	DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; TE	4180186
40763237	Tellurium Hair-mCnt	4180186
40763237	碲:质量含量:时间点:毛发:定量型	4182948
40763240	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; TE; Tissue; Tissue, unspecified	4180186
40763240	Tellurium Tiss-mCnt	4180186
40763240	碲:质量含量:时间点:组织与涂片:定量型	4182948
40763245	Thiethylperazine Bld-mCnc	4180186
40763245	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Torecan; WB; Whole blood	4180186
40763245	乙巯拉嗪:质量浓度:时间点:全血:定量型	4182948
40763247	Thiethylperazine Ur-mCnc	4180186
40763247	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Torecan; UA; UR; Urn	4180186
40763247	乙巯拉嗪:质量浓度:时间点:尿液:定量型	4182948
40763251	Atracurium besylate; Blood; C12H21NO8S; DRUG/TOXICOLOGY; Drugs; Lennox-Gastaut syndrome; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Qudexy XR; Random; Topamax; Toprimate; Tracrium; Trokendi XR; WB; Whole blood	4180186
40763251	Topiramate Bld-mCnc	4180186
40763251	托吡酯:质量浓度:时间点:全血:定量型	4182948
40763252	Topiramate Ur-mCnc	4180186
40763252	Atracurium besylate; C12H21NO8S; DRUG/TOXICOLOGY; Drugs; Lennox-Gastaut syndrome; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Qudexy XR; Random; Topamax; Toprimate; Tracrium; Trokendi XR; UA; UR; Urn	4180186
40763252	托吡酯:质量浓度:时间点:尿液:定量型	4182948
40763254	TCM Bld-mCnc	4180186
40763254	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCM; Triflumen; WB; Whole blood	4180186
40763254	三氯甲噻嗪:质量浓度:时间点:全血:定量型	4182948
40763257	Trifluralin Bld-mCnc	4180186
40763257	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Triflurali; WB; Whole blood	4180186
40763257	氟乐灵:质量浓度:时间点:全血:定量型	4182948
40763259	Trifluralin Ur-mCnc	4180186
40763259	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Triflurali; UA; UR; Urn	4180186
40763259	氟乐灵:质量浓度:时间点:尿液:定量型	4182948
40763260	Salicylates Bld-mCnc	4180186
40763260	2-Hydroxybenzoate; 2-Hydroxybenzoic Acid; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; o-Hydroxybenzoate; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoate; ortho-Hydroxybenzoic Acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sali; Salicilates; Salicylate; Salicylic acid; WB; Whole blood	4180186
40763260	水杨酸:质量浓度:时间点:全血:定量型	4182948
40763261	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TMO; Tridione; WB; Whole blood	4180186
40763261	TMO Bld-mCnc	4180186
40763261	三甲双酮:质量浓度:时间点:全血:定量型	4182948
40763262	TMO Ur-mCnc	4180186
40763262	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TMO; Tridione; UA; UR; Urn	4180186
40763262	三甲双酮:质量浓度:时间点:尿液:定量型	4182948
40763264	DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; V	4180186
40763264	Vanadium Tiss-mCnt	4180186
40763264	钒:质量含量:时间点:组织与涂片:定量型	4182948
40763265	Venlafaxine Bld-mCnc	4180186
40763265	Blood; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Venlafaxin; WB; Whole blood	4180186
40763265	文拉法辛:质量浓度:时间点:全血:定量型	4182948
40763267	Venlafaxine Tiss-mCnt	4180186
40763267	DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Venlafaxin	4180186
40763267	文拉法辛:质量含量:时间点:组织与涂片:定量型	4182948
40763270	DRUG/TOXICOLOGY; Drugs; Flupyrazapon; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Vet; Veterinary	4180186
40763270	Zolazepam Ur-mCnc	4180186
40763270	唑拉西泮:质量浓度:时间点:尿液:定量型	4182948
40763271	ZOLMitriptan Bld-mCnc	4180186
40763271	AscoTop; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Zolnod; Zomig; Zomigon; Zomigoro	4180186
40763271	佐米曲坦:质量浓度:时间点:全血:定量型	4182948
40763272	ZOLMitriptan Ur-mCnc	4180186
40763272	AscoTop; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Zolnod; Zomig; Zomigon; Zomigoro	4180186
40763272	佐米曲坦:质量浓度:时间点:尿液:定量型	4182948
40763273	Zomepirac Bld-mCnc	4180186
40763273	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood; Zomax	4180186
40763273	氯苯酰二甲基吡咯乙酸:质量浓度:时间点:全血:定量型	4182948
40763276	Ubiquinone10/Prot Tiss-sRto	4180186
40763276	Chemistry; Coenzyme Q10; CoQ10; CO-Q10; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tissue; Tissue, unspecified; Ubiquinone10	4180186
40763276	泛醌 10/蛋白质:物质的量比率:时间点:组织与涂片:定量型	4182948
40763279	B; beta TP; BTP; Cerebrin-28; Chemistry; Glutathione-independent PGD synthase; Level; Lipocalin-type prostaglandin-D synthase; Mass concentration; PGD2 synthase; PGDS2; Point in time; PR; Prostaglandin-D2 synthase; Prostaglandin-H2 D-isomerase; Prot; QNT; Quan; Quant; Quantitative; Random	4180186
40763279	Beta-trace protein Nasal fluid-mCnc	4180186
40763279	Beta-微量蛋白:质量浓度:时间点:鼻腔液体:定量型	4182948
40763284	1 hour; 1.0Hr; 1h p fructose PO; 60 min; 60 minutes; 60M; 60min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763284	Breath H2 1h p fructose PO	4180186
40763284	氢/已呼出的气体^在口服剂量果糖之后1小时:体积分数:时间点:呼出的气体:定量型	4182948
40763286	Breath H2 Pre fructose PO	4180186
40763286	Before; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; Percent; Point in time; Pre fructose PO; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
40763286	氢/已呼出的气体^在口服剂量果糖之前:体积分数:时间点:呼出的气体:定量型	4182948
40763287	2.75h p Lac PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40763287	Breath H2 2.75h p Lac PO	4180186
40763287	氢/已呼出的气体^在口服剂量乳糖之后2.75小时:体积分数:时间点:呼出的气体:定量型	4182948
40763288	135 Minutes; 135M; 2.25h p Lac PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40763288	Breath H2 2.25h p Lac PO	4180186
40763288	氢/已呼出的气体^在口服剂量乳糖之后2.25小时:体积分数:时间点:呼出的气体:定量型	4182948
40763289	1.75 hours; 1.75 Hr; 1.75h p Lac PO; 105 min; 105 minutes; 105min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40763289	Breath H2 1.75h p Lac PO	4180186
40763289	氢/已呼出的气体^在口服剂量乳糖之后1.75小时:体积分数:时间点:呼出的气体:定量型	4182948
40763290	1 1/4 H; 1.25 hours; 1.25 Hr; 1.25h p Lac PO; 75 min; 75 minutes; 75min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
40763290	Breath H2 1.25h p Lac PO	4180186
40763290	氢/已呼出的气体^在口服剂量乳糖之后1.25小时:体积分数:时间点:呼出的气体:定量型	4182948
40763291	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f351; i; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Shrimp; Shrimp tm (rPen a) 1; SR; Tm	4180186
40763291	棕虾原肌球蛋白 重组 (rPen a) 1 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40763291	Deprecated Shrimp tm (rPen a) 1 IgE RAST Ql	4180186
40763292	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European ash; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; t25	4180186
40763292	欧洲梣木 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40763292	Deprecated European Ash IgE RAST Ql	4180186
40763294	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common wasp; Common wasp (rVes v) 5; i209; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40763294	常见黄胡蜂 重组 (rVes v) 5 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40763294	Deprecated Common wasp (rVes v) 5 IgE RAST Ql	4180186
40763297	Clot; Clottable; Coag; Coagulation assay; Ecarin clotting time; ECT; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
40763297	ECT PPP	4180186
40763297	锯鳞蝰蛇毒诱导型凝血过程:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40763298	MMP9 Ser-mCnc	4180186
40763298	Chemistry; Level; Mass concentration; MMP9; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763298	基质金属肽酶 9:质量浓度:时间点:血清:定量型	4182948
40763299	After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR	4180186
40763299	Androstanolone sp8 p chal SerPl-mCnc	4180186
40763299	双氢睾酮^在XXX刺激之后的第8个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763303	After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR	4180186
40763303	Androstanolone sp4 p chal SerPl-mCnc	4180186
40763303	双氢睾酮^在XXX刺激之后的第4个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763305	After; CHEMISTRY.CHALLENGE TESTING; Convalescent; DHT; Dihydrotestosterone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR	4180186
40763305	Androstanolone sp2 p chal SerPl-mCnc	4180186
40763305	双氢睾酮^在XXX刺激之后的第2个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763306	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; DHT; Dihydrotestosterone; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR	4180186
40763306	Androstanolone sp1 p chal SerPl-mCnc	4180186
40763306	双氢睾酮^在XXX刺激之后的第1个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40763309	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; HPIV1+2+3; Human respirovirus 1; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763309	HPIV1+2+3 RNA Spec Ql NAA+probe	4180186
40763309	副流感病毒 1+2+3 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40763311	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UniversalLabOrders; UR; Urn	4180186
40763311	N gonorrhoea rRNA Ur Ql NAA+probe	4180186
40763311	淋病奈瑟菌 rRNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
40763312	Bact; C&S; Cornea; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
40763312	Bacteria Crn Cult	4180186
40763312	细菌 已鉴定的:存在与否或特征标识:时间点:角膜:名义型:培养	4182948
40763318	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763318	EV RNA Islt Ql NAA+probe	4180186
40763318	肠道病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763323	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; O tsut; O tsutsugamushi; Ordinal; Oriental scrub typhus; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; R orienta; R tsutsugamuchi; R tsutsugamushi; Random; Rickettsia orienta; Rickettsia tsutsugamuchi; Rickettsia tsutsugamushi; Screen; Scrub typhus; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763323	O tsut DNA SerPl Ql NAA+probe	4180186
40763323	恙虫病东方体 DNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763324	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763324	HPIV1 RNA Islt Ql NAA+probe	4180186
40763324	副流感病毒 1 型 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763325	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyssavirus; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Rabies; RABV; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763325	RABV RNA Islt Ql NAA+probe	4180186
40763325	狂犬病病毒 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763329	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Congenital rubella syndrome; DNA NUCLEIC ACID PROBE; DNA probe; German measles; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RUBV; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763329	RUBV RNA SerPl Ql NAA+probe	4180186
40763329	风疹病毒 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40763331	14-Hydroxydihydromorphinone; CtO; DRUG/TOXICOLOGY; Drugs; Level; Lortab; Mass concentration; Numorphan; Numorphone; Opana; OxyContin; Percocet; Percodan; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn; Vicodin	4180186
40763331	oxyCODONE+oxyMORphone CtO Ur Scn-mCnc	4180186
40763331	羟考酮+羟吗啡酮 截止点:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
40763332	C3 Ag Tiss Ql IF	4180186
40763332	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Beta 1 C-globulin; Comp; Complmt; DFA; FA; Fluorescent antibody; Fluoresent; HEMATOLOGY/CELL COUNTS; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
40763332	补体 C3 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
40763337	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Niravam; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Xanax	4180186
40763337	Alpraz Spec-sCnc	4180186
40763337	阿普唑仑:物质的量浓度:时间点:XXX:定量型	4182948
40763338	Amitrip Spec-sCnc	4180186
40763338	Amit; Amitrip; Amitriptylene; Amitriptyln; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Trepiline; Tryptanol; Tryptizol; Unspecified	4180186
40763338	阿米替林:物质的量浓度:时间点:XXX:定量型	4182948
40763343	Bromazepam Spec-sCnc	4180186
40763343	Bromazanil; Brozam; Calmepam; Compendium; Creosedin; DRUG/TOXICOLOGY; Drugs; Durazanil; Gityl; Lectopam; Level; Lexatin; Lexaurin; Lexonil; Lexotan; Lexotanil; Misc; Miscellaneous; Neo-opt; Normoc; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Somalium; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763343	溴吡二氮卓:物质的量浓度:时间点:XXX:定量型	4182948
40763348	Chlordiazep Spec-sCnc	4180186
40763348	Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Level; Librium; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763348	甲氨二氮卓:物质的量浓度:时间点:XXX:定量型	4182948
40763350	Celexa; Cipramil; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763350	Citalopram Spec-sCnc	4180186
40763350	西酞普兰:物质的量浓度:时间点:XXX:定量型	4182948
40763352	clomiPRAMINE Spec-sCnc	4180186
40763352	Anafranil; Anofranil; Clom; Clomip; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763352	氯米帕明:物质的量浓度:时间点:XXX:定量型	4182948
40763353	cloZAPine Spec-sCnc	4180186
40763353	Clozaril; DRUG/TOXICOLOGY; Drugs; FazaClo; Leponex; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763353	氯氮平:物质的量浓度:时间点:XXX:定量型	4182948
40763355	Desipramine Spec-sCnc	4180186
40763355	Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipramine metabolite; Level; Misc; Miscellaneous; Norpramin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763355	去甲丙咪嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763358	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Nalfon; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763358	Fenoprofen Spec-sCnc	4180186
40763358	苯氧苯丙酸:物质的量浓度:时间点:XXX:定量型	4182948
40763361	fluvoxaMINE Spec-sCnc	4180186
40763361	DRUG/TOXICOLOGY; Drugs; Level; Luvox; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763361	三氟戊肟胺:物质的量浓度:时间点:XXX:定量型	4182948
40763364	Imipramine Spec-sCnc	4180186
40763364	DRUG/TOXICOLOGY; Drugs; Imipra; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Tofranil; Unspecified	4180186
40763364	丙咪嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763365	Indomethacin Spec-sCnc	4180186
40763365	c282; C54; DRUG/TOXICOLOGY; Drugs; Indochron; Indocin; Indometacin; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763365	茚甲新:物质的量浓度:时间点:XXX:定量型	4182948
40763366	Ketoprofen Spec-sCnc	4180186
40763366	2-(meta-benzylphenyl) propionate; C16H14O3; c388; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Orudis; Oruvail; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763366	酮洛芬:物质的量浓度:时间点:XXX:定量型	4182948
40763367	lamoTRIgine Spec-sCnc	4180186
40763367	DRUG/TOXICOLOGY; Drugs; Lamictal; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763367	拉莫三嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763370	DRUG/TOXICOLOGY; Drugs; Level; Mesoridazine besylate; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Serentil; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763370	Mesoridazine Spec-sCnc	4180186
40763370	美索达嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763371	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Methaqualon; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quaalude; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763371	Methaqualone Spec-sCnc	4180186
40763371	甲喹酮:物质的量浓度:时间点:XXX:定量型	4182948
40763372	DRUG/TOXICOLOGY; Drugs; Hirnamin; Lepurin; Lerium; Levamin; Level; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Methotrimeprazine; Milezin; Minozinan; Misc; Miscellaneous; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Other; Point in time; Procrazine; QNT; Quan; Quant; Quantitative; Random; Ronexine; Sinogan; Sofmin; Spec; Specia 246; Substance concentration; Tisercin; Tisercine; Tisercinetta; Tisercinettes; To be specified in another part of the message; Unspecified; Veractil	4180186
40763372	Methotrimeprazine Spec-sCnc	4180186
40763372	甲氧异丁嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763373	Mexiletine Spec-sCnc	4180186
40763373	DRUG/TOXICOLOGY; Drugs; Level; Mexiletene; Mexitil; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763373	美西律:物质的量浓度:时间点:XXX:定量型	4182948
40763374	Naproxen Spec-sCnc	4180186
40763374	Anaprox; c228; c283; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763374	甲氧萘丙酸:物质的量浓度:时间点:XXX:定量型	4182948
40763375	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Level; Misc; Miscellaneous; Nicoderm; Nictoine; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763375	Nicotine Spec-sCnc	4180186
40763375	烟碱:物质的量浓度:时间点:XXX:定量型	4182948
40763377	Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763377	Norclomipramine Spec-sCnc	4180186
40763377	去甲基氯米帕明:物质的量浓度:时间点:XXX:定量型	4182948
40763378	Nordoxepin Spec-sCnc	4180186
40763378	Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Doxepin metabolite; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; N-desmethyldoxepin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763378	去甲基多虑平:物质的量浓度:时间点:XXX:定量型	4182948
40763379	Nortrip Spec-sCnc	4180186
40763379	Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Nortrip; Nortriptylene; Nortriptyln; Other; Pamelor; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763379	去甲阿米替林:物质的量浓度:时间点:XXX:定量型	4182948
40763380	DRUG/TOXICOLOGY; Drugs; Lanzek; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Zypadhera; Zyprexa	4180186
40763380	OLANZapine Spec-sCnc	4180186
40763380	奥氮平:物质的量浓度:时间点:XXX:定量型	4182948
40763381	OXcarbazepine Spec-sCnc	4180186
40763381	DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; OXC; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Trileptal; Unspecified	4180186
40763381	奥卡西平:物质的量浓度:时间点:XXX:定量型	4182948
40763385	Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Napsalgesic; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763385	Propoxyph Spec-sCnc	4180186
40763385	丙氧氨酚:物质的量浓度:时间点:XXX:定量型	4182948
40763386	DRUG/TOXICOLOGY; Drugs; Inderal; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763386	Propranolol Spec-sCnc	4180186
40763386	普萘洛尔:物质的量浓度:时间点:XXX:定量型	4182948
40763387	DRUG/TOXICOLOGY; Drugs; Ketipinor; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Seroquel; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Xeroquel	4180186
40763387	QUEtiapine Spec-sCnc	4180186
40763387	喹硫平:物质的量浓度:时间点:XXX:定量型	4182948
40763390	traZODone Spec-sCnc	4180186
40763390	Desyrel; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Trazon; Trialodine; Unspecified	4180186
40763390	曲唑酮:物质的量浓度:时间点:XXX:定量型	4182948
40763391	Addiction; Cotrimazine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; Surmontil; TMP; To be specified in another part of the message; Unspecified	4180186
40763391	Trimipramine Spec-sCnc	4180186
40763391	三甲丙咪嗪:物质的量浓度:时间点:XXX:定量型	4182948
40763393	4-Hydroxycoumarin; Coumadin; Coumarin; Coumarins; DRUG/TOXICOLOGY; Drugs; Level; Misc; Miscellaneous; Other; Panwarfin; Point in time; QNT; Quan; Quant; Quantitative; Random; Sofarin; Spec; Substance Concentration; To be specified in another part of the message; Unspecified	4180186
40763393	Warfarin Spec-sCnc	4180186
40763393	丙酮苄羟香豆素:物质的量浓度:时间点:XXX:定量型	4182948
40763394	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Imovane; Level; Misc; Miscellaneous; Other; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Concentration; To be specified in another part of the message; Unspecified; Zopliclone	4180186
40763394	Zopiclone Spec-sCnc	4180186
40763394	佐匹克隆:物质的量浓度:时间点:XXX:定量型	4182948
40763395	AM; Amorph; Amorph Cry; Amorphic; Crys; Cryst; Crystal; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
40763395	Amorph Cry UrnS Ql Micro	4180186
40763395	结晶.无定形:存在情况或阈值:时间点:尿沉渣:序数型:显微镜检查.光学	4182948
40763397	伯氏疏螺旋体抗体.IgG 条带组套:-:时间点:血清:-:免疫印迹法	4182948
40763397	B burg; B burgdor; B burgdor IgG bands pnl; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40763397	B burgdor IgG bands pnl Ser IB	4180186
40763398	伯氏疏螺旋体抗体.IgM 条带组套:-:时间点:血清:-:免疫印迹法	4182948
40763398	B burg; B burgdor; B burgdor IgM bands pnl; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40763398	B burgdor IgM bands pnl Ser IB	4180186
40763400	Viable CD34 cells NFr Fld	4180186
40763400	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; CELL MARKERS; Cellularity; Fl; Fld; FLU; Fluid; Gated cells; gp105-120; Hematopoietic stem cell; HSC; My10; My-10; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
40763400	活细胞.CD34/100 个细胞:计数型分数:时间点:体液:定量型	4182948
40763404	Apple IgG-mCnc	4180186
40763404	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Apple; Autoantibodies; Autoantibody; f049; f49; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Pyrus malus; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763404	苹果 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763407	Banana IgG-mCnc	4180186
40763407	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Banana; f092; f92; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Musa sp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763407	芭蕉属多个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763409	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beans; f287; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Phaseolus vulgaris; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Kidney Bean; Rf287; Serum; SR	4180186
40763409	Red Kidney Bean IgG-mCnc	4180186
40763409	红芸豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763413	Cabbage IgG-mCnc	4180186
40763413	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica aleraceae; Brassica oleracea capitata; Cabbage; f216; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763413	卷心菜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763417	Asparagus IgG-mCnc	4180186
40763417	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asparagus; Autoantibodies; Autoantibody; f261; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf261; Serum; SR	4180186
40763417	药用芦笋 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763418	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celery; f085; f85; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763418	Celery IgG-mCnc	4180186
40763418	芹菜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763423	Clam IgG-mCnc	4180186
40763423	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Clam; f207; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mollusc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763423	蛤蜊科多个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763430	Ginger IgG-mCnc	4180186
40763430	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f270; Ginger; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf270; Serum; SR	4180186
40763430	姜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763431	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f259; Grape; Grapes; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763431	Grape IgG-mCnc	4180186
40763431	葡萄 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763433	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f042; f42; Haddock; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763433	Haddock IgG-mCnc	4180186
40763433	黑线鳕 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763436	Lemon IgG-mCnc	4180186
40763436	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f208; Immune globulin G; Immunoglobulin G; Lemon; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763436	柠檬 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763437	Lime IgG-mCnc	4180186
40763437	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f306; Immune globulin G; Immunoglobulin G; Level; Lime; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf306; Serum; SR	4180186
40763437	来檬 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763438	Lobster IgG-mCnc	4180186
40763438	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f080; f80; Immune globulin G; Immunoglobulin G; Level; Lobster; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763438	大螯虾 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763444	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f012; f12; Green pea; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pea; peas; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763444	Pea IgG-mCnc	4180186
40763444	豌豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763447	Black Pepper IgG-mCnc	4180186
40763447	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black pepper; f280; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763447	黑胡椒 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763449	Pineapple IgG-mCnc	4180186
40763449	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f210; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pineapple; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763449	凤梨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763455	Salmon IgG-mCnc	4180186
40763455	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Atlantic salmon; Autoantibodies; Autoantibody; f041; f41; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salmon; Serum; SR	4180186
40763455	大西洋鲑 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763456	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f053; f338; f53; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf338; Scallop; Serum; SR	4180186
40763456	Scallop IgG-mCnc	4180186
40763456	扇贝多个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763464	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f204; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salmo gairdnieri; Serum; SR; Trout	4180186
40763464	Trout IgG-mCnc	4180186
40763464	虹鳟 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763466	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Meleagis gallopavo; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763466	Turkey IgG-mCnc	4180186
40763466	吐绶鸡 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763468	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brewer's yeast; f155; Immune globulin G; Immunoglobulin G; Level; Mass concentration; MNSs Blood Group System; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Saccharomyces carlsbergensis; Sacchromyces sp; Serum; SR	4180186
40763468	Brewer's yeast IgG-mCnc	4180186
40763468	啤酒酵母 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763469	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f118; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763469	Zucchini IgG-mCnc	4180186
40763469	绿皮密生西葫芦 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763471	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763471	HPIV3 RNA Islt Ql NAA+probe	4180186
40763471	副流感病毒 3 型 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763472	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763472	HPIV2 RNA Islt Ql NAA+probe	4180186
40763472	副流感病毒 2 型 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763474	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Dengue type III; Denv; DENV3; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763474	DENV3 RNA Ser Ql NAA+probe	4180186
40763474	登革热病毒 3 型 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
40763479	Antigen; Antigens; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Para; Parainflu; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763479	HPIV4 Ag Spec Ql	4180186
40763479	副流感病毒 4 型 抗原:存在情况或阈值:时间点:XXX:序数型	4182948
40763481	SARS-CoV Ab Titr Ser	4180186
40763481	SARS 冠状病毒 抗体:滴定度:时间点:血清:定量型	4182948
40763481	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; Serum; Severe Acute Respiratory Syndrome; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40763484	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV 71; EV71; EV-PCR; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40763484	EV 71 RNA Islt Ql NAA+probe	4180186
40763484	肠道病毒 71 RNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40763485	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
40763485	HEV Gentyp Bld NAA+probe	4180186
40763485	戊型肝炎病毒 基因型:存在与否或特征标识:时间点:全血:名义型:探针法.基因扩增.靶向	4182948
40763486	Date previous bx	4180186
40763486	Bx; Date previous bx; H+P; H+P.HX; P prime; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random	4180186
40763486	上次活组织检查日期:日期:时间点:^患者:定量型	4182948
40763488	?Tm; Addis count; Count/time; Kidney; Leuc; Leuk; Leukocyte; Lkcs; LM; Micro; Micros; Microscopic; Nephrology; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells	4180186
40763488	WBC ?Tm UrnS Micro-nRate	4180186
40763488	白细胞:计数型速率:XXX:尿沉渣:定量型:显微镜检查.光学	4182948
40763491	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD25+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HD-37; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Leu12; Leu-12; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Tac antigen; WB; Whole blood	4180186
40763491	CD19+CD25+ cells # Bld	4180186
40763491	细胞.CD19+CD25+:计数型浓度:时间点:全血:定量型	4182948
40763493	Amine oxidase; Arbitrary concentration; Chemistry; DAO; Diaminobenzidine Oxidase; Histaminase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763493	Diamine oxidase SerPl-aCnc	4180186
40763493	二胺氧化酶:任意型浓度:时间点:血清/血浆:定量型	4182948
40763494	100WBC; Blood; CELL MARKERS; Dynamic; FC; Leuc; Leuk; Leukocyte; Lg Gran Lymphs; LGL; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40763494	Lg Gran Lymphs/leuk NFr Bld FC	4180186
40763494	淋巴细胞.大颗粒型/100 个白细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
40763495	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tamiflu	4180186
40763495	Oseltamivir Islt Genotyp	4180186
40763495	奥司他韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
40763496	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Relenza; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tamiflu	4180186
40763496	Oseltamivir+Zanamivir Islt Genotyp	4180186
40763496	奥司他韦+扎那米韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
40763502	HEDIS 2011-12 CDC-K; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
40763502	HEDIS 2011-12 CDC-K	4180186
40763502	用于标识肾病证据的 HEDIS 2011-2013 代码 (CDC-K):-:时间点:^患者:-	4182948
40763507	HEDIS 2011-12 PPC-C Toxo; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Toxo; Toxoplasmosis	4180186
40763507	HEDIS 2011-12 PPC-C Toxo	4180186
40763507	HEDIS 2011-2013 早期产前护理当中所使用的试验 - 弓形体 (PPC-C):-:时间点:^患者:-	4182948
40763511	CD3+CD8+CD57+ Cells NFr Bld	4180186
40763511	Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD57+ Cells; CD3-CD8-CD57+; CD8 T cells; Cell; CELL MARKERS; Cellularity; Gated cells; HNK1; Leu2; Leu-2; Leu4; Leu-4; Leu7; Leu-7; Lyme disease; Natural killer cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
40763511	细胞.CD3+CD8+CD57+/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40763513	Blood; Coll; Collect; Collect Tme; Collected; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; sp6; Spec; Time stamp; Timestamp; WB; Whole blood	4180186
40763513	Collect Tme sp6 Bld	4180186
40763513	采集时间^第6个标本:时间戳:时间点:全血:定量型	4182948
40763514	C6.functional SerPl-aCnc	4180186
40763514	Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763514	补体 C6.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
40763516	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
40763516	HSV2 DNA # Spec NAA+probe	4180186
40763516	单纯疱疹病毒 2 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
40763520	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N men serogroup; N men sg Y; N men sg Y Ab; N men sg Y IgG; N menigitidis; N meningitidis; Neisseria meningitidis group Y; Neisseria meningitidis type Y; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
40763520	N men sg Y IgG Ser IA-mCnc	4180186
40763520	脑膜炎奈瑟菌 Y 血清群 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
40763522	Phenobarb SerPl Cfm-mCnc	4180186
40763522	Barbiturate; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763522	苯巴比妥:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
40763524	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; T canis; Visceral larva migrans	4180186
40763524	T canis Ab Fld-aCnc	4180186
40763524	犬弓首线虫 抗体:任意型浓度:时间点:体液:定量型	4182948
40763526	Arbitrary concentration; Beta 1 F-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763526	C5.functional SerPl-aCnc	4180186
40763526	补体 C5.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
40763528	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number concentration; Number Concentration (count/vol); Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; WB; Whole blood	4180186
40763528	Retics # Auto	4180186
40763528	网织红细胞:计数型浓度:时间点:全血:定量型:自动化计数方法	4182948
40763530	ID; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Typ	4180186
40763530	Stage Tick	4180186
40763530	分期:类型:时间点:^蜱:名义型	4182948
40763531	adj; Fetal; Gyn; Gynecology; MoM; Multiple of the median; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Wt; wt adj	4180186
40763531	Fet Nuchal fold MoM Thickness wt adj	4180186
40763531	厚度^^经过针对母亲体重而调整的:中位数的倍数:时间点:颈褶^胎儿:定量型	4182948
40763532	Gender; ID; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Typ	4180186
40763532	性别:类型:时间点:^蜱:名义型	4182948
40763534	Dextro; HEDIS 2010-11 CWP-D; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Strep; Strept	4180186
40763534	HEDIS 2010-11 CWP-D	4180186
40763534	用于标识 A 组链球菌试验的 HEDIS 2010-2011 代码 (CWP-D):-:时间点:^患者:-	4182948
40763535	HEDIS 2011-12 CDC-H	4180186
40763535	Asympt; Asymptomatic; HEDIS 2011-12 CDC-H; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
40763535	用于标识 LDLc 筛查的 HEDIS 2011-2013 代码 (CDC-H):-:时间点:^患者:-	4182948
40763536	DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; Epanutin; Fenantoin; HEDIS 2011-12 MPM-E Phenytoin; Lehydan; Pan; Panel; PANEL.HEDIS; Panl; Phenhydan; PHYT; Pnl; Point in time; Random; Ser; Sinergina; SR; Zentropil	4180186
40763536	HEDIS 2011-12 MPM-E Phenytoin	4180186
40763536	用于标识血清抗惊厥药物浓度监测试验的 HEDIS 2011-2013 代码 - 苯妥英 (MPM-E):-:时间点:^患者:-	4182948
40763537	HEDIS 2010 PPC-C Toxo; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Toxo; Toxoplasmosis	4180186
40763537	HEDIS 2010 PPC-C Toxo	4180186
40763537	HEDIS 2010 早期产前护理当中所使用的试验 - 弓形体 (PPC-C):-:时间点:^患者:-	4182948
40763539	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; G-INF; HEMATOLOGY/CELL COUNTS; IFN; IGNF; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763539	IGNF Fld-mCnc	4180186
40763539	干扰素.gamma:质量浓度:时间点:体液:定量型	4182948
40763540	ARC240; Blood; CAGH45; Document; FGS1; Finding; Findings; Genetics; Heredity; Heritable; HOPA; Inherited; KIAA0192; MED12S; Mediator complex subunit 12; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; OHDOX; OKS; OPA1; PCR; Point in time; Random; Tissue; Tissue, unspecified; TNRC11; TRAP230; WB; Whole blood; Whole blood or Tissue	4180186
40763540	MED12 gene Mut Anl Bld/T	4180186
40763540	MED12 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763542	Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nephrosis 2, idiopathic, steroid-resistant (podocin); PCR; PDCN; Point in time; Random; SRN1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763542	NPHS2 gene Mut Anl Bld/T	4180186
40763542	NPHS2 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763547	25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D metabolites; 25-hydroxyvitamin D2 + D3; 25-hydroxyvitamin D3; Activated ergosterol; C28H43OH; Calciderol; Calcidiol & Calciferol; Calcifediol; Chemistry; Ercalciol; Ergocalciferol; Level; Pl; Plasma; Plsm; Point in time; Pro vitamin D; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Viosterol; Vit D 1 25 hydroxy; Vit D2; Vitamin D 25 hydroxy; Vitamin D2	4180186
40763547	Calcidiol+Calciferol SerPl-sCnc	4180186
40763547	钙二醇+钙化醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
40763548	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009; FLUAV H1 2009 pand; FLUAV swine; FLUV; Fowl plague; H1N1; H1N1v; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; Interp; Interpretation; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Pig; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; S-OIV; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763548	FLUAV H1 2009 RNA Spec NAA+probe-Imp	4180186
40763548	流感病毒 A 型血凝素 H1 型 2009 大流行与流感病毒 A 型猪源性 RNA:印象:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40763549	Blood; CFC3; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; MAPKK1; MEK1; Mitogen-Activated Protein Kinase Kinase 1; MKK1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; PRKMK1; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763549	MAP2K1 gene Mut Anl Bld/T	4180186
40763549	MAP2K1 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763551	Blood; CDSP; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; OCTN2; OCTN2VT; PCR; Point in time; Random; solute carrier family 22 (organic cation/carnitine transporter), member 5; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763551	SLC22A5 gene Mut Anl Bld/T	4180186
40763551	SLC22A5 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763552	Cancer ID section; North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763552	Cancer ID section NAACCR v.12	4180186
40763552	癌症鉴定小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763555	Follow-up/Recur/Death sec; North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763555	Follow-up/Recur/Death sec NAACCR v.12	4180186
40763555	随访和或复发和或死亡小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763556	Hosp; Hosp-confidential section; North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763556	Hosp-confidential section NAACCR v.12	4180186
40763556	医院-保密小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763558	North American Association of Central Cancer Registries; Oncology; Othr; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763558	Other-confidential sec NAACCR v.12	4180186
40763558	其他-保密小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763559	North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763559	Patient-confidential section NAACCR v.12	4180186
40763559	患者-保密小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763560	Identifier; Intradermal; North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR)	4180186
40763560	Record ID section NAACCR v.12	4180186
40763560	记录标识符小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763562	North American Association of Central Cancer Registries; Oncology; Point in time; Random; Stage/prognost fact section; TUMOR REGISTRY(NAACCR)	4180186
40763562	Stage/prognost fact section NAACCR v.12	4180186
40763562	分期和或预后因素小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763563	Dx; North American Association of Central Cancer Registries; Oncology; Point in time; Random; Text-Dx section; TUMOR REGISTRY(NAACCR)	4180186
40763563	Text-Dx section NAACCR v.12	4180186
40763563	文本-诊断小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763565	North American Association of Central Cancer Registries; Oncology; Point in time; Random; Text-Tx section; TUMOR REGISTRY(NAACCR); Tx	4180186
40763565	Text-Tx section NAACCR v.12	4180186
40763565	文本-治疗小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763566	First; North American Association of Central Cancer Registries; Oncology; Point in time; Random; TUMOR REGISTRY(NAACCR); Tx; Tx-1st course section	4180186
40763566	Tx-1st course section NAACCR v.12	4180186
40763566	治疗-第一疗程小节:-:时间点:^患者:集合型:NAACCR v.12	4182948
40763568	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40763568	6-Acetylcodeine Ur Cfm-mCnc	4180186
40763568	6-乙酰可待因:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40763569	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Colonography; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; LGI; Pelvic; Point in time; Rad; RADIOLOGY; Random; Rectal; Rectum+colon; Virtual colonoscopy; W Air contr PR	4180186
40763569	CT Colon+Rect W Air contr PR	4180186
40763569	多层^采用经直肠给予空气对比剂:发现:时间点:腹部+盆腔>结肠+直肠:文档型:CT	4182948
40763573	Acd; Acid; Chemistry; Ester; FAEE; Fatty acid; Lipid; Mec; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40763573	Fatty acids.ethyl esters Mec-sCnt	4180186
40763573	脂肪酸类.乙酯类:物质的量含量:时间点:胎便:定量型	4182948
40763574	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Eos; Eosin; Eosino; Eosinophil; Eosins; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763574	Eosinophil Fld Ql Micro	4180186
40763574	嗜酸性粒细胞:存在情况或阈值:时间点:体液:序数型:显微镜检查.光学	4182948
40763575	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B microti; B microti Ab.IgG+IgM; Babesiosis; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Piroplasmosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40763575	B microti IgG+IgM Ser Ql	4180186
40763575	鼠源巴贝斯虫 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型	4182948
40763576	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B hermsii; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Relapsing fever; Screen; Serum; SR	4180186
40763576	B hermsii IgG+IgM Ser Ql	4180186
40763576	赫姆斯疏螺旋体 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型	4182948
40763578	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; C pylori; Campylobacter pylori; Gastro; Gastroenterology; GI; H pyl; H pylori; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40763578	H pylori IgG Ser Ql IB	4180186
40763578	幽门螺杆菌 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫印迹法	4182948
40763579	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Parecho virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; LV; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; PeV; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763579	PeV RNA Spec Ql NAA+probe	4180186
40763579	副肠孤病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40763580	Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40763580	Pseudo Pelger Huet cells Bld Ql Smear	4180186
40763580	假 Pelger Huet 细胞:存在情况或阈值:时间点:全血:序数型:显微镜检查.光学	4182948
40763581	123I; Document; Films; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; RAI; Random; Scan; Thy; View; VWS	4180186
40763581	NM Thyroid Views+views uptake W I-123 PO	4180186
40763581	多重视图+多重视图 摄取^采用口服 I-123:发现:时间点:颈部>甲状腺:文档型:NM	4182948
40763586	JEV IgM Titr CSF	4180186
40763586	日本脑炎病毒 抗体.IgM:滴定度:时间点:脑脊液:定量型	4182948
40763586	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; Flavivirus; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
40763587	M pneumo Ab Titr Ser LA	4180186
40763587	肺炎支原体 抗体:滴定度:时间点:血清:定量型:胶乳凝集试验法	4182948
40763587	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40763591	Blood; Chloride channel 5; chloride channel, voltage-sensitive 5; CLC5; ClC-5; CLCK2; DENTS; Document; Finding; Findings; Genetics; hCIC-K2; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NPHL1; NPHL2; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; XLRH; XRN	4180186
40763591	CLCN5 gene Mut Anl Bld/T	4180186
40763591	CLCN5 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763592	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1+H3+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763592	FLUAV H1+H3+FLUBV RNA Spec Ql NAA+probe	4180186
40763592	流感病毒 A 型血凝素 H1+H3+B 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40763593	Tryptase.beta SerPl-mCnc	4180186
40763593	B; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763593	类胰蛋白酶.beta:质量浓度:时间点:血清/血浆:定量型	4182948
40763594	alpha-2 globin; Blood; Document; Finding; Findings; Genetics; HBA-T2; HBH; Hemoglobin, alpha 2; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763594	HBA2 gene Mut Anl Bld/T	4180186
40763594	HBA2 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763595	Antigen; Antigens; CMV; CMV EA; Cytomegalo virus; Cytomgal; EA; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763595	CMV EA Ag Spec Ql	4180186
40763595	巨细胞病毒早期 抗原:存在情况或阈值:时间点:XXX:序数型	4182948
40763598	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Beaver fever; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; G duodenalis; G intestinalis; G lamblia; Giardiasis; ID; Infectious Disease; InfectiousDisease; Lamblia intestinalis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763598	G lamblia DNA Spec Ql NAA+probe	4180186
40763598	蓝氏贾第鞭毛虫 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40763599	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Crypt; Crypto; Cryptosporidiosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40763599	Cryptosp DNA Spec Ql NAA+probe	4180186
40763599	隐孢子虫属单个未知种 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40763600	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Poliovirus; PV; Random; Spec; Typ	4180186
40763600	PV Islt Cult	4180186
40763600	脊髓灰质炎病毒 已鉴定的:类型:时间点:分离株:名义型:微生物特异性培养	4182948
40763601	11oxoAndrost/Creat Ur	4180186
40763601	11oxoAndrost; Androster; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40763601	11-氧代-雄酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40763607	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; Donr; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
40763607	T cruzi Ab Ser Donr Ql	4180186
40763607	克氏锥虫 抗体:存在情况或阈值:时间点:血清^供体:序数型	4182948
40763613	FDA insert Components	4180186
40763613	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40763613	组成部分:-:-:^FDA 包装说明书:叙述型	4182948
40763614	DOCUMENT.REF; FDA insert; Intended use of device; Narrative; Report; SPL; Structured Product Labelling	4180186
40763614	FDA insert Intended use of device	4180186
40763614	装置的预期用途:-:-:^FDA 包装说明书:叙述型	4182948
40763617	DOCUMENT.REGULATORY; FDA insert; Narrative; Report; SPL; Structured Product Labelling; Summ of safety/effect	4180186
40763617	FDA insert Summ of safety/effect	4180186
40763617	安全与效果摘要:-:-:^FDA 包装说明书:叙述型	4182948
40763619	4 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40763619	Amikacin 4 ug/mL Islt SlowMyco	4180186
40763619	丁胺卡那霉素 4.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40763623	Path Report addendum.synoptic Doc	4180186
40763623	Document; Finding; Findings; Path; Pathology; Point in time; Random; Rprt addend.synop	4180186
40763623	报告附录.提纲:发现:时间点:^患者:文档型:病理学	4182948
40763624	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Point in time; Random; Visit note	4180186
40763624	会诊记录:发现:时间点:{环境}:文档型:病理学	4182948
40763625	Consult note; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Pathology; Point in time; Random; Visit note	4180186
40763625	会诊记录.提纲:发现:时间点:{环境}:文档型:病理学	4182948
40763626	DOC.MISC; Ident; Identifier; Intradermal; MISC; Nominal; Point in time; Random	4180186
40763626	报告模板标识符:标识符:时间点:报告:名义型	4182948
40763629	Arbitrary; B-cell Clonality; BM; BON; Bone marrow; Chains; Chn; Clonality; Genetics; HC gene Rear; Heredity; Heritable; IgH; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Inherited; Leukemia; Lymphoma; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen	4180186
40763629	HC gene Rear Mar Ql	4180186
40763629	免疫球蛋白重链基因重排:任意型:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
40763630	Arbitrary; B-cell leukemia/lymphoma 2; B-cell NHL; B-cell non-hodgkin lymphoma; BCL-2; breakpoint; Cerebral spinal fluid; Cerebrospinal Fl; DNA; Follicular B cell lymphoma; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Mbr; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Neuro; Neurology; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; RNA; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T prime; t(14,18)(IGH,BCL2) gene translocation; t(14,18)(IGH,BCL2) gene translocation major break points; t(14;18)(IGH,BCL2); translocation	4180186
40763630	t(14;18)(IGH,BCL2) Major CSF Ql	4180186
40763630	t(14;18)(q32;q21.3)(IGH,BCL2) 融合转录物主要断裂点:任意型:时间点:脑脊液:序数型:分子遗传学类实验室方法	4182948
40763632	Arbitrary; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Clonality; Fl; Fld; FLU; Fluid; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; T-cell rearranging gene gamma; TRG	4180186
40763632	TCRG gene Rear Fld Ql	4180186
40763632	TCRG 基因重排:任意型:时间点:体液:序数型:分子遗传学类实验室方法	4182948
40763636	Arbitrary; Cerebral spinal fluid; Cerebrospinal Fl; Clonality; Genetics; Heredity; Heritable; Inherited; Leukemia; Lymphoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Neuro; Neurology; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T cell receptor beta chain	4180186
40763636	TCRB gene Rear CSF Ql	4180186
40763636	TCRB 基因重排:任意型:时间点:脑脊液:序数型:分子遗传学类实验室方法	4182948
40763642	Acute promyelocytic leukemia; APL; Arbitrary; Blood; breakpoint cluster region 2; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Myelogenous; MYL; NR1B1; Ordinal; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; Promyelocytic leukemia; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; Screen; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(PML,RARA) gene translocation breakpoint cluster region 2; t(15,17)(q22,q11.2-q12); t(15;17) BCR2; t(15;17)(PML,RARA); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
40763642	t(15;17) BCR2 Bld/T Ql	4180186
40763642	t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 融合转录物:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40763646	DOC.EPSOS; Document; Finding; Findings; Point in time; Random	4180186
40763646	Patient summary.unexpected contact Doc	4180186
40763646	患者摘要.意外接触:发现:时间点:^患者:文档型	4182948
40763651	Cranial; Cranium; Dental; Dentistry; Head; Length Ratio; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Up; Xray; X-ray	4180186
40763651	Face upper/Face all Skull XR	4180186
40763651	面部上部/整个面部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763652	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763652	Face all Skull XR	4180186
40763652	整个面部:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763653	Cranial; Cranium; Dental; Dentistry; Face L1 to chin; Head; Length; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763653	Face L1 to chin Skull XR	4180186
40763653	面部 下切牙至颏部:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763655	1L-APG; Cranial; Cranium; Dental; Dentistry; Head; Length; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; Xray; X-ray	4180186
40763655	1L-APg Skull XR	4180186
40763655	下切牙至上齿槽座点-颏前点连线:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763656	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; U6_PTV; Up; Xray; X-ray	4180186
40763656	U6_PTV Skull XR	4180186
40763656	上颌磨牙位置:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763660	Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; IMPA; IMPA (1L-GoMe); Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763660	IMPA (1L-GOME) Skull XR	4180186
40763660	采用颏下点的切牙下颌平面角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763663	1U-NA; Cranial; Cranium; Dental; Dentistry; Head; NA; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; Up; Xray; X-ray	4180186
40763663	1U-Na Angle Skull XR	4180186
40763663	上切牙至鼻根点-上齿槽座点连线:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763669	CD-ANS; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SL; Xray; X-ray	4180186
40763669	Cd-ANS Skull XR	4180186
40763669	髁顶点至前鼻棘:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763677	Cranial; Cranium; Dental; Dentistry; Head; LNT-SN-LS; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763677	Lnt-Sn-Ls Skull XR	4180186
40763677	鼻唇角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763678	Cranial; Cranium; Dental; Dentistry; Head; NA'-PG'-LS; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763678	Na'-Pg'-Ls Skull XR	4180186
40763678	Holdaway 角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763679	Cranial; Cranium; Dental; Dentistry; FH; Head; Length; Na-FH; N-FH; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763679	Na-FH Skull XR	4180186
40763679	鼻根点至眼耳平面:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763680	BANA-CC; Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763680	BaNa-CC Skull XR	4180186
40763680	面轴:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763681	BANA-CC; BaNa-CC (constructed); Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763681	BaNa-CC (constructed) Skull XR	4180186
40763681	采用已构建颌下点的面轴:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763682	Cranial; Cranium; Dental; Dentistry; FH; FH-SEGN; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763682	FH-SeGn Skull XR	4180186
40763682	Y 轴至眼耳平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763684	Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Se-Na; SENA-SEGN; S-N; Xray; X-ray	4180186
40763684	SeNa-SeGn Skull XR	4180186
40763684	Y 轴至蝶鞍点-鼻根点平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763688	ANS-ME; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SL; Xray; X-ray	4180186
40763688	ANS-Me Skull XR	4180186
40763688	前鼻嵴至颏下点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763689	AR-GO-ME; Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763689	Ar-Go-Me Skull XR	4180186
40763689	下颌角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763690	AR-GO-ME; Ar-Go-Me (constructed); Cranial; Cranium; Dental; Dentistry; Head; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763690	Ar-Go-Me (constructed) Skull XR	4180186
40763690	采用已构建下颌角点的下颌角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763692	CF-GO; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SE-GO; Xray; X-ray	4180186
40763692	CF-Go Skull XR	4180186
40763692	采用 CF 点的后面高度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763693	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-ME'; Xray; X-ray	4180186
40763693	Sn-Me' Skull XR	4180186
40763693	面部下部:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763699	Cranial; Cranium; Dental; Dentistry; Head; Length; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-LI; Xray; X-ray	4180186
40763699	Sn-Li Skull XR	4180186
40763699	鼻中隔下点至下唇:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763701	ANS-PG; Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SL; Xray; X-ray	4180186
40763701	ANS-Pg Skull XR	4180186
40763701	前鼻嵴至颏前点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763702	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763702	Adenoid Skull XR	4180186
40763702	腺样体宽度:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763707	Cranial; Cranium; Dental; Dentistry; Head; Length; LI-ME'; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763707	Li-Me' Skull XR	4180186
40763707	下唇至颏下点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763708	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SE-AR; Xray; X-ray	4180186
40763708	Se-Ar Skull XR	4180186
40763708	后颅底:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763711	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-LS; Up; Xray; X-ray	4180186
40763711	Sn-Ls Skull XR	4180186
40763711	鼻中隔下点至上唇:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763712	Cranial; Cranium; Dental; Dentistry; Face L1 to chin; Head; Length Ratio; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SN-ME'; Xray; X-ray	4180186
40763712	Face L1 to chin/Face low Skull XR	4180186
40763712	面部 下切牙至颏部/面部下部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763714	Cranial; Cranium; Dental; Dentistry; Face L1 to chin; Head; Length Ratio; Low; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763714	Face L1 to chin/Face all Skull XR	4180186
40763714	面部 下切牙至颏部/整个面部:长度比率:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763715	ANSPNS-GoMe; Cranial; Cranium; Dental; Dentistry; Head; Mand; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763715	ANSPNS-GoMe Skull XR	4180186
40763715	采用颏下点的上下颌平面角:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763717	Cranial; Cranium; Dental; Dentistry; Go-Gn; gonion to gnathion; Head; Mand; Me-Goi; menton to reconstructed gonion; MP; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Se-Na; SENA-GOME; S-N; Xray; X-ray	4180186
40763717	SENA-GoMe Angle Skull XR	4180186
40763717	采用颏下点的蝶鞍点-鼻根点平面至下颌平面:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763719	Cranial; Cranium; Dental; Dentistry; Gl'-Sn; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763719	Gl'-Sn Skull XR	4180186
40763719	面部中部:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763725	Cranial; Cranium; Dental; Dentistry; Head; NP; NPg; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Se-Na; SENA-NAPG; S-N; Xray; X-ray	4180186
40763725	SeNa-NaPg Angle Skull XR	4180186
40763725	蝶鞍点-鼻根点平面至鼻根点-颏前点连线:角度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763728	Cranial; Cranium; Dental; Dentistry; Head; Length; NA-A; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; SS; Subspinale; Xray; X-ray	4180186
40763728	Na-A Skull XR	4180186
40763728	鼻根点至上齿槽座点:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763730	Ethyl sulfate Ur-mCnc	4180186
40763730	DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
40763730	硫酸乙酯:质量浓度:时间点:尿液:定量型	4182948
40763733	17-Hydroxycorticosterone; 30M p ACTH; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis F; Cortrosyn; F; FR; hydrocortisone; Level; Mass concentration; Non-protein bound; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40763733	Cortis F 30M p ACTH SerPl-mCnc	4180186
40763733	皮质醇.游离型^在给予剂量促肾上腺皮质激素之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
40763734	Cortis F 1h p ACTH SerPl-mCnc	4180186
40763734	1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis F; Cortrosyn; F; FR; hydrocortisone; Level; Mass concentration; Non-protein bound; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
40763734	皮质醇.游离型^在给予剂量促肾上腺皮质激素之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
40763736	FDA label Plasma derivative	4180186
40763736	DOCUMENT.REF; FDA label; Narrative; Report	4180186
40763736	血浆衍生物:-:-:^FDA 产品标签:叙述型	4182948
40763739	Cranial; Cranium; Dental; Dentistry; Head; Length; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; Random; Xray; X-ray	4180186
40763739	Overbite Skull XR	4180186
40763739	覆咬合:长度:时间点:颅骨:定量型:X射线摄影术.测量法	4182948
40763743	Pan; Panel; PANEL.TIMP; Panl; Pnl; Point in time; Random; Test of Infant Motor Performance	4180186
40763744	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763746	Finding; Findings; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763748	Finding; Findings; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763749	Bil; Bilat; Both; Finding; Findings; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763753	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763754	Finding; Findings; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance; Upper extremity	4180186
40763755	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763757	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763758	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763760	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763761	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763762	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Test of Infant Motor Performance	4180186
40763763	Finding; Findings; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763764	Finding; Findings; Head in midline W/O visual stimulation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Stim; Test of Infant Motor Performance	4180186
40763770	Finding; Findings; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763773	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; Rolling- elicited from the arms (right); RT; Screen; Test of Infant Motor Performance	4180186
40763777	Finding; Findings; Lat; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; React; Rxn; Screen; Test of Infant Motor Performance	4180186
40763780	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763783	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763784	Finding; Findings; Lat; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Test of Infant Motor Performance	4180186
40763788	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Test of Infant Motor Performance; Tot; Totl	4180186
40763789	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763791	Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Calc; Calculation; Chemistry; ctO2; Lung; O2; O2 Ct; O2CT; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Venous; Volfr; Volume fraction	4180186
40763791	O2 Ct VFr BldV Calc	4180186
40763791	氧含量:体积分数:时间点:静脉全血:定量型:计算法	4182948
40763792	Dynamic; Flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
40763794	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40763794	7Aminoclonazepam Ur Ql	4180186
40763794	7-氨基氯硝安定:存在情况或阈值:时间点:尿液:序数型	4182948
40763795	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763795	7Aminoclonazepam Spec Ql	4180186
40763795	7-氨基氯硝安定:存在情况或阈值:时间点:XXX:序数型	4182948
40763797	7-amino flunitrazepam; 7Aminoflunitrazepam; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40763797	7Aminoflunitrazepam Ur Ql	4180186
40763797	7-氨基氟硝安定:存在情况或阈值:时间点:尿液:序数型	4182948
40763798	7Aminoflunitrazepam Spec Ql	4180186
40763798	7-amino flunitrazepam; 7Aminoflunitrazepam; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763798	7-氨基氟硝安定:存在情况或阈值:时间点:XXX:序数型	4182948
40763799	A-OH Alpraz SerPl Ql	4180186
40763799	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; OH-Alpraz; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763799	Alpha-羟基阿普唑仑:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40763800	A-OH Alpraz Ur Ql	4180186
40763800	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; OH-Alpraz; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40763800	Alpha-羟基阿普唑仑:存在情况或阈值:时间点:尿液:序数型	4182948
40763801	A-OH Alpraz Spec Ql	4180186
40763801	Alfa; Alpha hydroxy alprazolam; Alprozolam metabolite; A-OH Alpraz; DRUG/TOXICOLOGY; Drugs; Hydroxy alprazolam; Hydroxyalpraz; Misc; Miscellaneous; OH-Alpraz; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763801	Alpha-羟基阿普唑仑:存在情况或阈值:时间点:XXX:序数型	4182948
40763802	DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Niravam; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Xanax	4180186
40763802	Alpraz Spec Ql	4180186
40763802	阿普唑仑:存在情况或阈值:时间点:XXX:序数型	4182948
40763805	Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Misc; Miscellaneous; norfludiazepam; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763805	Desalkylfluraz Spec Ql	4180186
40763805	N-去烷基氟胺安定:存在情况或阈值:时间点:XXX:序数型	4182948
40763809	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; MDA; Methylenedioxymethamphetamine metabolite; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763809	MDA SerPl Ql	4180186
40763809	亚甲基二氧苯丙胺:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40763815	Nordiazepam Spec Ql	4180186
40763815	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Madar; Misc; Miscellaneous; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Ordinal; Other; Point in time; PR; Praxadium; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Spec; Stilny; To be specified in another part of the message; Tranxilium N; Unspecified; Vegesan	4180186
40763815	去甲基安定:存在情况或阈值:时间点:XXX:序数型	4182948
40763816	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763816	Norfentanyl SerPl Ql	4180186
40763816	去甲基芬太尼:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40763817	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; Illicit; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763817	Norfentanyl Spec Ql	4180186
40763817	去甲基芬太尼:存在情况或阈值:时间点:XXX:序数型	4182948
40763819	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Serax; Spec; Temazepam metabolite; To be specified in another part of the message; Unspecified	4180186
40763819	Oxazepam Spec Ql	4180186
40763819	去甲羟安定:存在情况或阈值:时间点:XXX:序数型	4182948
40763821	Cenafed; DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Spec; Sudafed; To be specified in another part of the message; Unspecified	4180186
40763821	Pseudoephedrine Spec Ql	4180186
40763821	伪麻黄碱:存在情况或阈值:时间点:XXX:序数型	4182948
40763822	Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; II; Methylphenidate metabolite; Ordinal; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Point in time; PPAA; PR; QL; Qual; Qualitative; Random; Ritalinate; Ritalinic acid; Screen; UA; UR; Urn	4180186
40763822	PPAA Ur Ql	4180186
40763822	Alpha-苯基-2-乙酸哌啶:存在情况或阈值:时间点:尿液:序数型	4182948
40763827	11-nor-9-carboxy-delta-9-THC; 11-nor-9-carboxy-THC; 11-nor-delta-9-THC-9-COOH; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; Addiction; Carboxytetrahydrocannabinol; CarboxyTHC; Carboxy-THC-delta-9; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Misc; Miscellaneous; Nabilone; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spec; THC; THCA; THCC; THCCOOH; THC-COOH; To be specified in another part of the message; Unspecified	4180186
40763827	CarboxyTHC Spec Ql	4180186
40763827	羧基四氢大麻酚:存在情况或阈值:时间点:XXX:序数型	4182948
40763828	Triazolam SerPl Ql	4180186
40763828	APO-TRIAZO; DRUG/TOXICOLOGY; Drugs; Halcion; Novo-triolam; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763828	三唑苯二氮:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40763829	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; LSD; Lysergic acid; Lysergic acid diethylamide; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40763829	LSD Spec Ql	4180186
40763829	麦角二乙胺:存在情况或阈值:时间点:XXX:序数型	4182948
40763831	Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Spec; To be specified in another part of the message; Unspecified	4180186
40763831	Barbiturates Spec Ql Scn	4180186
40763831	巴比妥类药物:存在情况或阈值:时间点:XXX:序数型:毒理学筛查试验	4182948
40763832	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763832	7Aminoclonazepam Gast Ql	4180186
40763832	7-氨基氯硝安定:存在情况或阈值:时间点:胃液:序数型	4182948
40763836	Addiction; c311; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spec; Stesolid; To be specified in another part of the message; Unspecified; Valium	4180186
40763836	diazePAM Spec Ql	4180186
40763836	安定:存在情况或阈值:时间点:XXX:序数型	4182948
40763838	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GAST; Gastric contents; Gastric fluid; i; II; III; Illicit; Methadone metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763838	EDDP Gast Ql	4180186
40763838	2-亚乙基-1,5-二甲基-3,3-四氢吡咯:存在情况或阈值:时间点:胃液:序数型	4182948
40763843	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ketalar; Ketaset; Ketavet; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763843	Ketamine Gast Ql	4180186
40763843	氯胺酮:存在情况或阈值:时间点:胃液:序数型	4182948
40763844	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; MDEA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763844	MDEA Gast Ql	4180186
40763844	亚甲基二乙氧基苯丙胺:存在情况或阈值:时间点:胃液:序数型	4182948
40763847	Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Madar; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Ordinal; Point in time; PR; Praxadium; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Stilny; Tranxilium N; Vegesan	4180186
40763847	Nordiazepam Gast Ql	4180186
40763847	去甲基安定:存在情况或阈值:时间点:胃液:序数型	4182948
40763850	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Serax; Temazepam metabolite	4180186
40763850	Oxazepam Gast Ql	4180186
40763850	去甲羟安定:存在情况或阈值:时间点:胃液:序数型	4182948
40763851	Pseudoephedrine Gast Ql	4180186
40763851	Cenafed; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Sudafed	4180186
40763851	伪麻黄碱:存在情况或阈值:时间点:胃液:序数型	4182948
40763852	Acetic acid; Alfa; Alpha-phenyl-2-piperidine acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; GAST; Gastric contents; Gastric fluid; II; Methylphenidate metabolite; Ordinal; Phenylpiperidine acetate; Phenylpiperidine acetic acid; Point in time; PPAA; PR; QL; Qual; Qualitative; Random; Ritalinate; Ritalinic acid; Screen	4180186
40763852	PPAA Gast Ql	4180186
40763852	Alpha-苯基-2-乙酸哌啶:存在情况或阈值:时间点:胃液:序数型	4182948
40763853	Temazepam Gast Ql	4180186
40763853	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Normison; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Restoril; Screen	4180186
40763853	羟基安定:存在情况或阈值:时间点:胃液:序数型	4182948
40763856	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; LSD; Lysergic acid; Lysergic acid diethylamide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763856	LSD Gast Ql	4180186
40763856	麦角二乙胺:存在情况或阈值:时间点:胃液:序数型	4182948
40763860	Collect Date sp3 Stl	4180186
40763860	Bowel movement; Coll; Collect; Collect Date; Collected; Date and time; Faecal; Faeces; Fecal; Feces; Point in time; QNT; Quan; Quant; Quantitative; Random; sp3; Spec; Stl; Stool = Fecal; Time stamp; Timestamp	4180186
40763860	采集日期^第3个标本:时间戳:时间点:大便:定量型	4182948
40763863	A,B; ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; Identity or presence; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
40763863	FLUAV + FLUBV Ag Spec IF	4180186
40763863	流感病毒 A 型与 B 型 抗原:存在与否或特征标识:时间点:XXX:名义型:免疫荧光法	4182948
40763864	Prochlorperazine Ur-sCnc	4180186
40763864	Buccastem; Compazine; DRUG/TOXICOLOGY; Drugs; Level; Phenotil; Point in time; Prochlorper; Proclorperazine; QNT; Quan; Quant; Quantitative; Random; Stemetil; Stemzine; Substance concentration; UA; UR; Urn	4180186
40763864	普鲁氯嗪:物质的量浓度:时间点:尿液:定量型	4182948
40763866	Buccastem; Compazine; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Phenotil; Point in time; Prochlorper; Proclorperazine; QNT; Quan; Quant; Quantitative; Random; Stemetil; Stemzine; Substance concentration	4180186
40763866	Prochlorperazine Gast-sCnc	4180186
40763866	普鲁氯嗪:物质的量浓度:时间点:胃液:定量型	4182948
40763867	Amplification; Blood; Chromosom; Chromosomes; Cyto loc; Del; Del+Dup; Deletions; Dp; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763867	16p11.2 chrom Del+Dup Bld/T	4180186
40763867	16p11.2 染色体区域 缺失+重复:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40763868	ARALAR2; Blood; CITRIN; CTLN2; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; PCR; Point in time; Random; solute carrier family 25 (aspartate/glutamate carrier), member 13; solute carrier family 25, member 13; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763868	SLC25A13 gene Mut Anl Bld/T	4180186
40763868	SLC25A13 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763869	Blood; Compx; Deoxyribonucleic acid; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Mito; Mitochon; Mitochond; Mitochondrial; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; mtDNA; mtDNA I; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763869	mtDNA I Mut Anl Bld/T	4180186
40763869	线粒体 DNA 复合体 I 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763871	ACS4; Acyl-CoA synthetase long-chain family member 4; Blood; Document; FACL4; Finding; Findings; Genetics; Heredity; Heritable; Inherited; LACS4; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRX63; MRX68; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763871	ACSL4 gene Mut Anl Bld/T	4180186
40763871	ACSL4 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763874	Blood; Finding; Findings; Genetics; Heredity; Heritable; Ig gene Rear; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; PCR; Point in time; Random; Rearr; Rearrangement; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763874	Ig gene Rear Bld/T	4180186
40763874	免疫球蛋白基因:发现:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
40763875	3; Blood; Compx; Deoxyribonucleic acid; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Mito; Mitochon; Mitochond; Mitochondrial; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; mtDNA; mtDNA III; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40763875	mtDNA III Mut Anl Bld/T	4180186
40763875	线粒体 DNA 复合体 III 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
40763884	Lymphocytes/leuk NFr Spec FC	4180186
40763884	100WBC; CELL MARKERS; Dynamic; FC; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; WBC; WBCs; White blood cell; White blood cells	4180186
40763884	淋巴细胞/100 个白细胞:计数型分数:时间点:XXX:定量型:流式细胞测量术	4182948
40763885	Granulocytes/leuk NFr Spec FC	4180186
40763885	100WBC; CELL MARKERS; Dynamic; FC; Gran; Grans; Granulocyte; Granulocytes; Leuc; Leuk; Leukocyte; Lkcs; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; WBC; WBCs; White blood cell; White blood cells	4180186
40763885	粒细胞/100 个白细胞:计数型分数:时间点:XXX:定量型:流式细胞测量术	4182948
40763886	Monocytes/leuk NFr Spec FC	4180186
40763886	100WBC; CELL MARKERS; Dynamic; FC; Leuc; Leuk; Leukocyte; Lkcs; Misc; Miscellaneous; Mono; Monocyte; Monos; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; WBC; WBCs; White blood cell; White blood cells	4180186
40763886	单核细胞/100 个白细胞:计数型分数:时间点:XXX:定量型:流式细胞测量术	4182948
40763887	Blasts NFr Spec FC	4180186
40763887	Blast; Cell; CELL MARKERS; Cellularity; Dynamic; FC; Gated cells; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40763887	幼稚细胞/100 个细胞:计数型分数:时间点:XXX:定量型:流式细胞测量术	4182948
40763889	DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40763889	Cotinine SerPl Ql	4180186
40763889	可铁宁:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40763890	Demographic; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40763890	Domain - Demographics	4180186
40763890	PhenX 领域 - 人口统计学信息:-:时间点:^患者:-:PhenX	4182948
40763893	Point in time; QNT; Quan; Quant; Quantitative; Random; Test of Infant Motor Performance; TIMP	4180186
40763894	Imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Test of Infant Motor Performance	4180186
40763895	Finding; Findings; Nominal; Pan; Panel; PANEL.TIMP; Panl; Pnl; Point in time; Random; Test of Infant Motor Performance	4180186
40763897	Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Test of Infant Motor Performance; Time stamp; Timestamp; TIMP	4180186
40763900	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Isocyanate TDI; k75; Level; Mass concentration; Methylbenzene; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763900	Isocyanate TDI IgG-mCnc	4180186
40763900	甲苯二异氰酸酯 (TDI) 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763902	Isocyanate HDI IgG-mCnc	4180186
40763902	1,6-diisocyanatohexane; 1,6-hexamethylene diisocyanate; 1,6-hexanediol diisocyanate; 1,6-hexylene diisocyanate; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HDI; Hexane 1,6-diisocyanate; HMDI; Immune globulin G; Immunoglobulin G; Isocyanate HDI; k77; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40763902	六亚甲基二异氰酸酯 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40763904	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
40763904	摘要:发现:时间点:{环境}:文档型:护士	4182948
40763906	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40763906	Deprecated Plan of care Doc	4180186
40763907	Goals	4180186
40763907	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40763907	目标:发现:时间点:^患者:叙述型	4182948
40763908	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40763908	Expected outcomes	4180186
40763908	预期结局:发现:时间点:^患者:叙述型	4182948
40763910	Objective	4180186
40763910	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40763910	客观:发现:时间点:^患者:叙述型	4182948
40763911	DOC.MISC; Finding; Findings; MISC; Narrative; Point in time; Random; Report	4180186
40763911	Subjective	4180186
40763911	主观:发现:时间点:^患者:叙述型	4182948
40763914	BS; CHEMISTRY.CHALLENGE TESTING; Diaf; DiafP; Dialysate; Dialysis fluid; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40763914	Glucose BS DiafP-mCnc	4180186
40763914	葡萄糖^基线:质量浓度:时间点:腹膜透析液:定量型	4182948
40763915	ANTIBIOTIC SUSCEPTIBILITIES; Codon 180; Genotype; Genotypic; HBV; HBV L180M; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763915	HBV L180M Islt Ql Genotyp	4180186
40763915	乙型肝炎病毒 密码子 L180M:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763916	ANTIBIOTIC SUSCEPTIBILITIES; Codon 80; Genotype; Genotypic; HBV; HBV L80V; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763916	HBV L80V Islt Ql Genotyp	4180186
40763916	乙型肝炎病毒 密码子 L80V:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763918	ANTIBIOTIC SUSCEPTIBILITIES; Codon 204; Genotype; Genotypic; HBV; HBV M204V; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763918	HBV M204V Islt Ql Genotyp	4180186
40763918	乙型肝炎病毒 密码子 M204V:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763919	ANTIBIOTIC SUSCEPTIBILITIES; Codon 204; Genotype; Genotypic; HBV; HBV M204I; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763919	HBV M204I Islt Ql Genotyp	4180186
40763919	乙型肝炎病毒 密码子 M204I:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763920	ANTIBIOTIC SUSCEPTIBILITIES; Codon 204; Genotype; Genotypic; HBV; HBV M204S; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763920	HBV M204S Islt Ql Genotyp	4180186
40763920	乙型肝炎病毒 密码子 M204S:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763922	ANTIBIOTIC SUSCEPTIBILITIES; Codon 181; Genotype; Genotypic; HBV; HBV A181T; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763922	HBV A181T Islt Ql Genotyp	4180186
40763922	乙型肝炎病毒 密码子 A181T:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763926	ANTIBIOTIC SUSCEPTIBILITIES; Codon 184; Genotype; Genotypic; HBV; HBV T184I; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763926	HBV T184I Islt Ql Genotyp	4180186
40763926	乙型肝炎病毒 密码子 T184I:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763930	ANTIBIOTIC SUSCEPTIBILITIES; Codon 233; Genotype; Genotypic; HBV; HBV I233V; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763930	HBV I233V Islt Ql Genotyp	4180186
40763930	乙型肝炎病毒 密码子 I233V:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763934	ANTIBIOTIC SUSCEPTIBILITIES; Codon 80; Genotype; Genotypic; HBV; HBV L80I; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Liver; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
40763934	HBV L80I Islt Ql Genotyp	4180186
40763934	乙型肝炎病毒 密码子 L80I:存在情况或阈值:时间点:分离株:序数型:基因分型	4182948
40763936	PCB Aroclor1242 SerPl-mCnc	4180186
40763936	1,1'-Biphenyl; Bibenzene; Biphenyls; Diphenyl; DRUG/TOXICOLOGY; Drugs; Lemonene; Level; Mass concentration; PCB; PCB Aroclor1242; PCBs; Phenylbenzene; Pl; Plasma; Plsm; Point in time; Polychlorinated biphenyls; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrosin LY	4180186
40763936	多氯代联苯.氯化三联苯 1242:质量浓度:时间点:血清/血浆:定量型	4182948
40763937	PCB Aroclor1248 SerPl-mCnc	4180186
40763937	1,1'-Biphenyl; Bibenzene; Biphenyls; Diphenyl; DRUG/TOXICOLOGY; Drugs; Lemonene; Level; Mass concentration; PCB; PCB Aroclor1248; PCBs; Phenylbenzene; Pl; Plasma; Plsm; Point in time; Polychlorinated biphenyls; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrosin LY	4180186
40763937	多氯代联苯.氯化三联苯 1248:质量浓度:时间点:血清/血浆:定量型	4182948
40763938	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Oncology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40763938	Paraneoplastic Ab Ser Ql IF	4180186
40763938	副肿瘤型 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40763941	Blood; Fetal; Gyn; Gynecology; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763941	Hgb Bld Fetus-mCnc	4180186
40763941	血红蛋白:质量浓度:时间点:全血^胎儿:定量型	4182948
40763944	Myeloperoxidase Cells NFr Bld	4180186
40763944	Blood; Cell; CELL MARKERS; Cellularity; Gated cells; MPO; Myeloperoxidase Cells; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40763944	细胞.髓过氧化物酶/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40763947	Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm thin midpiece; URO; Urology	4180186
40763947	Sperm thin midpiece NFr Smn	4180186
40763947	精子.薄中片/100 个精子:计数型分数:时间点:精液:定量型	4182948
40763948	Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm bent midpiece; URO; Urology	4180186
40763948	Sperm bent midpiece NFr Smn	4180186
40763948	精子.弯曲的中片/100 个精子:计数型分数:时间点:精液:定量型	4182948
40763953	Appearance; Colour; Fetal; Gyn; Gynecology; Nominal; OB; ObGyn; Obstetrics; Pleural; Pleural fluid; Point in time; Random; SPEC; thoracentesis fluid; Typ	4180186
40763953	Color Plr Fetus	4180186
40763953	颜色:类型:时间点:胸膜液^胎儿:名义型	4182948
40763954	Fetal; Gyn; Gynecology; Nominal; OB; ObGyn; Obstetrics; Pleural; Pleural fluid; Point in time; Random; SPEC; thoracentesis fluid; Typ	4180186
40763954	Clarity Plr Fetus	4180186
40763954	透明度:类型:时间点:胸膜液^胎儿:名义型	4182948
40763958	14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Lortab; Numorphan; Numorphone; Opana; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Vicodin	4180186
40763958	oxyCODONE+oxyMORphone Ur Ql Cfm	4180186
40763958	羟考酮+羟吗啡酮:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40763959	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Isentress; Islt; Isol; MK-0518; Pheno; Phenotype; Phenotypic; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Virtual Phenotype	4180186
40763959	Raltegravir Islt Phenotyp	4180186
40763959	雷特拉韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型	4182948
40763960	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; HIV type 1; HIV type I; HIV1; HIV1 integrase; HIV1 integrase gene; HIV1 IntInh; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; IntInh; Islt; Isol; Mut; Mut Det; Mutation; Muts; Nominal; Point in time; Random	4180186
40763960	HIV1 integrase gene Mut Det Islt	4180186
40763960	HIV 1 型整合酶基因 已检出的突变:存在与否或特征标识:时间点:分离株:名义型	4182948
40763961	CTFV IgG Titr Ser IF	4180186
40763961	科洛拉多蜱传热病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40763961	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CTFV; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40763963	%; A artemisiifolia; A elatior; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Ambrosia artemisiifolia; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Buckhorn plantain; Common ragweed; Engl plantain; English plantain; Goosefoot; IgE total; Immune globulin E; Immunoglobulin E; Lamb's quarter; Lambs quarters; Lamb's quarters; Mugwort; Plantain Buckhorn; Point in time; QNT; Quan; Quant; Quantitative; Quinoa; Random; Ribwort; Russian thistle; Salosola kali; Salsola pestifer; Saltwort; Saltwort (prickly); Serum; Short ragweed; SR; Tot; Total IgE; Totl; w001; w006; w009; w010; w011; w1; w10; w11; w6; w9; Weed Allerg Mix1; Weed mix; wx1	4180186
40763963	Weed Allerg Mix1 IgE/IgE total %	4180186
40763963	(豚草+北艾+灰藜+长叶车前+猪毛菜) 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型:Multidisk 法	4182948
40763966	Coastal Maple IgE/IgE total %	4180186
40763966	%; A macrophylium; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bigleaf Maple; Coastal maple; IgE total; Immune globulin E; Immunoglobulin E; Oregon Maple; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763966	海岸槭 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763967	Boxelder IgE/IgE total %	4180186
40763967	%; A negundo; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Box elder; Boxelder; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t001; t1; Tot; Total IgE; Totl	4180186
40763967	羽叶槭 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763969	Aedes mosquito IgE/IgE total %	4180186
40763969	%; ABS; Aby; Aedes mosquito; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i071; i71; IgE total; Immune globulin E; Immunoglobulin E; Mosquito; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763969	普通伊蚊 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763970	Mushroom IgE/IgE total %	4180186
40763970	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Champignon; f212; IgE total; Immune globulin E; Immunoglobulin E; Mushroom; Mushrooms; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf212; Serum; SR; Tot; Total IgE; Totl	4180186
40763970	香蕈 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763973	Grey Alder IgE/IgE total %	4180186
40763973	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European alder; Gray alder; Grey alder; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Speckled alder; SR; t2; Tot; Total IgE; Totl	4180186
40763973	灰桤木 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763977	Pineapple IgE/IgE total %	4180186
40763977	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f210; IgE total; Immune globulin E; Immunoglobulin E; Pineapple; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763977	凤梨 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763978	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g001; g1; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sw Vernal grass; Sweet vernal grass; Tot; Total IgE; Totl	4180186
40763978	Sw Vernal grass IgE/IgE total %	4180186
40763978	黄花茅 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763979	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celery; f085; f85; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763979	Celery IgE/IgE total %	4180186
40763979	芹菜 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763980	Peanut IgE/IgE total %	4180186
40763980	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; IgE total; Immune globulin E; Immunoglobulin E; Peanut; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763980	落花生 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763981	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; p1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; Tot; Total IgE; Totl	4180186
40763981	Ascaris IgE/IgE total %	4180186
40763981	蛔线虫属单个未知种 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763982	A niger IgE/IgE total %	4180186
40763982	%; A niger; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; IgE total; Immune globulin E; Immunoglobulin E; m207; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763982	黑曲霉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763984	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Crawfish; Crayfish; f320; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf320; Serum; SR; Tot; Total IgE; Totl	4180186
40763984	Crawfish IgE/IgE total %	4180186
40763984	正螯虾 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763986	%; A pullulans; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Aureobasidm; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; m12; P aureobasidium; P pullulans; Point in time; Pullaria aureobasidium; Pullulan; Pullularia; Pullularia pullulans; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763986	A pullulans IgE/IgE total %	4180186
40763986	出芽短梗霉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763989	Silver Birch IgE/IgE total %	4180186
40763989	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common silver birch; IFR; IgE total; Immune globulin E; Immunoglobulin E; Isoflavone reductase; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Silver Birch; SR; t3; Tot; Total IgE; Totl	4180186
40763989	白桦树 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763990	Silver Birch (rBet v) 1 IgE/IgE total %	4180186
40763990	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common silver birch; i; IFR; IgE total; Immune globulin E; Immunoglobulin E; Isoflavone reductase; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt215; Serum; Silver Birch; Silver Birch (rBet v) 1; SR; t215; t3; Tot; Total IgE; Totl	4180186
40763990	白桦树 重组 (rBet v) 1 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763991	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B germanica; Cockroach; German cockroach; i006; i6; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Serum; SR; Tot; Total IgE; Totl	4180186
40763991	Roach IgE/IgE total %	4180186
40763991	德国小蠊 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763993	Cauliflower IgE/IgE total %	4180186
40763993	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cauliflower; f291; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf291; Serum; SR; Tot; Total IgE; Totl	4180186
40763993	花椰菜 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763995	Broccoli IgE/IgE total %	4180186
40763995	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brassica oleracea cymosa; Brassica oleracea var italics; Broccoli; f260; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763995	花茎甘蓝 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763997	Budgie Drop IgE/IgE total %	4180186
40763997	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie Drop; e77; Feces; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; stool; Tot; Total IgE; Totl	4180186
40763997	虎皮鹦鹉粪便 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40763998	Budgie Feather IgE/IgE total %	4180186
40763998	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie Feather; e78; Feathers; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40763998	虎皮鹦鹉羽毛 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764003	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C globosum; IgE total; Immune globulin E; Immunoglobulin E; m208; Point in time; QNT; Quan; Quant; Quantitative; Random; Rm208; Serum; SR; Tot; Total IgE; Totl	4180186
40764003	C globosum IgE/IgE total %	4180186
40764003	球毛壳菌 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764004	Goosefoot IgE/IgE total %	4180186
40764004	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Goosefoot; IgE total; Immune globulin E; Immunoglobulin E; Lamb's quarter; Lambs quarters; Lamb's quarters; Point in time; QNT; Quan; Quant; Quantitative; Quinoa; Random; Serum; SR; Tot; Total IgE; Totl; w010; w10	4180186
40764004	藜 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764009	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f033; f33; IgE total; Immune globulin E; Immunoglobulin E; Orange; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764009	Orange IgE/IgE total %	4180186
40764009	甜橙 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764010	C herbarum IgE/IgE total %	4180186
40764010	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C herbarum; Hormodendrum; IgE total; Immune globulin E; Immunoglobulin E; m002; m2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764010	多主枝孢 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764015	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Funeral cypress; IgE total; Immune globulin E; Immunoglobulin E; Italian cypress; Mediterranean cypress; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t023; t23; Tot; Total IgE; Totl	4180186
40764015	Italian Cypress IgE/IgE total %	4180186
40764015	地中海柏树 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764019	D pteronyss IgE/IgE total %	4180186
40764019	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D pteronyss; D pteronyssinus; d001; d1; European house dust mite; HDM; House dust mite; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764019	屋尘螨 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764020	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bald-faced hornet; i002; i2; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl; Wasp; White faced hornet; Whitefaced Hornet	4180186
40764020	Whitefaced Hornet IgE/IgE total %	4180186
40764020	白脸大黄蜂 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764022	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Eucalyptus; Gum-tree; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t018; t18; Tot; Total IgE; Totl	4180186
40764022	Gum-Tree IgE/IgE total %	4180186
40764022	按树属多个未知种 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764024	美国水青冈 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764024	Amer Beech IgE/IgE total %	4180186
40764024	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amer Beech; American beech; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t005; t5; Tot; Total IgE; Totl	4180186
40764026	Fennel Seed IgE/IgE total %	4180186
40764026	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f219; Fennel; Fennel Seed; Finocchio; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf219; Seeds; Serum; SR; Tot; Total IgE; Totl	4180186
40764026	茴香籽 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764029	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cod; Codfish; f003; f3; Fish; IgE total; Immune globulin E; Immune globulin G; Immunoglobulin E; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrod; Serum; SR; Tot; Total IgE; Totl	4180186
40764029	Codfish IgG/IgE total %	4180186
40764029	鳕鱼 抗体.IgG/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764030	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c13; c74; f340; gelatine; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764030	Gelatin IgE/IgE total %	4180186
40764030	动物胶 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764032	Soybean IgE/IgE total %	4180186
40764032	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f014; f14; Gly; IgE total; Immune globulin E; Immunoglobulin E; Largest; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; SR; Tot; Total IgE; Totl	4180186
40764032	大豆 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764035	House Dust Greer IgE/IgE total %	4180186
40764035	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; h001; h1; Housedust; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764035	室内灰尘 Greer 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764036	Hop IgE/IgE total %	4180186
40764036	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f324; Fruit cone; Hop; Hops; Hops oil; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf324; Serum; SR; Tot; Total IgE; Totl	4180186
40764036	啤酒花 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764037	Insulin Porcine IgE/IgE total %	4180186
40764037	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c070; c70; HUM; Humulin; IgE total; IH7; Immune globulin E; Immunoglobulin E; Insul; Lente; NPH; Point in time; Pork; QNT; Quan; Quant; Quantitative; Random; Semilente; Serum; Sliding; SR; Swine; Tot; Total IgE; Totl; Ultralente	4180186
40764037	猪胰岛素 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764038	Isocyanate HDI IgE/IgE total %	4180186
40764038	%; 1,6-diisocyanatohexane; 1,6-hexamethylene diisocyanate; 1,6-hexanediol diisocyanate; 1,6-hexylene diisocyanate; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HDI; Hexane 1,6-diisocyanate; HMDI; IgE total; Immune globulin E; Immunoglobulin E; Isocyanate HDI; k77; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764038	六亚甲基二异氰酸酯 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764039	Isocyanate TDI IgE/IgE total %	4180186
40764039	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Isocyanate TDI; k75; Methylbenzene; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764039	甲苯二异氰酸酯 (TDI) 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764042	Squid IgE/IgE total %	4180186
40764042	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cuttlefish; f258; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf258; Serum; species; spp; Squid; SR; Tot; Total IgE; Totl	4180186
40764042	乌贼单个未知种 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764043	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g005; g5; IgE total; Immune globulin E; Immunoglobulin E; Italian Ryegrass; Per rye grass; Perennial ryegrass; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye grass; Ryegrass; Serum; SR; Tot; Total IgE; Totl	4180186
40764043	Per rye grass IgE/IgE total %	4180186
40764043	多年生黑麦草 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764045	Cajeput tree IgE/IgE total %	4180186
40764045	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cajeput tree; IgE total; Immune globulin E; Immunoglobulin E; Point in time; Punk tree; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t021; t21; Tot; Total IgE; Totl	4180186
40764045	白千层 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764048	Banana IgE/IgE total %	4180186
40764048	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Banana; f092; f92; IgE total; Immune globulin E; Immunoglobulin E; Musa sp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764048	芭蕉属多个未知种 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764051	Oregano IgE/IgE total %	4180186
40764051	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f283; IgE total; Immune globulin E; Immunoglobulin E; Oregano; Oreganum; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf283; Serum; SR; Tot; Total IgE; Totl	4180186
40764051	牛至 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764052	Rice IgE/IgE total %	4180186
40764052	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f009; f9; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rice; Serum; SR; Tot; Total IgE; Totl	4180186
40764052	水稻 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764053	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f290; IgE total; Immune globulin E; Immunoglobulin E; Oyster; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764053	Oyster IgE/IgE total %	4180186
40764053	牡蛎 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764055	Avocado IgE/IgE total %	4180186
40764055	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alligator pear; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avocado; f096; f96; IgE total; Immune globulin E; Immunoglobulin E; Point in time; Prickly pear; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764055	美国鳄梨 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764057	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g006; g6; IgE total; Immune globulin E; Immunoglobulin E; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Timothy; Timothy grass; Tot; Total IgE; Totl	4180186
40764057	Timothy IgE/IgE total %	4180186
40764057	梯牧草 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764059	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Norway spruce; Picea abies; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt201; Serum; Spruce; SR; t201; Tot; Total IgE; Totl	4180186
40764059	Spruce IgE/IgE total %	4180186
40764059	云杉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764061	Pea IgE/IgE total %	4180186
40764061	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f012; f12; Green pea; IgE total; Immune globulin E; Immunoglobulin E; Pea; peas; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764061	豌豆 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764062	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Buckhorn plantain; Engl plantain; English plantain; IgE total; Immune globulin E; Immunoglobulin E; Plantain Buckhorn; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribwort; Serum; SR; Tot; Total IgE; Totl; w009; w9	4180186
40764062	Engl plantain IgE/IgE total %	4180186
40764062	长叶车前 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764064	Kent blue grass IgE/IgE total %	4180186
40764064	肯塔基蓝草 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764064	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g008; g8; IgE total; Immune globulin E; Immunoglobulin E; June blue grass; June grass; June Kentucky blue grass; Junegrass; Kent blue grass; Kentucky blue grass; Kentucky bluegrass; Meadow grass; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764065	Cottonwood IgE/IgE total %	4180186
40764065	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cottonwood; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t014; t14; Tot; Total IgE; Totl	4180186
40764065	三角叶杨 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764066	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey locust; IgE total; Immune globulin E; Immunoglobulin E; Mesquite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t020; t20; Tot; Total IgE; Totl	4180186
40764066	Mesquite IgE/IgE total %	4180186
40764066	柔黄花牡豆树 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764067	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bing cherry; Cherry; f242; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764067	Cherry IgE/IgE total %	4180186
40764067	甜樱桃 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764068	Pear IgE/IgE total %	4180186
40764068	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f094; f94; IgE total; Immune globulin E; Immunoglobulin E; Pear; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764068	西洋梨 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764069	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; m11; Point in time; QNT; Quan; Quant; Quantitative; R nigricans; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764069	R nigricans IgE/IgE total %	4180186
40764069	黑根霉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764070	Sheep Sorrel IgE/IgE total %	4180186
40764070	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sheep Sorrel; SR; Tot; Total IgE; Totl; w018; w18	4180186
40764070	小酸模 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764073	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f005; f5; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye; Serum; SR; Tot; Total IgE; Totl	4180186
40764073	Rye IgE/IgE total %	4180186
40764073	黑麦 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764075	Sheep Wool IgE/IgE total %	4180186
40764075	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; k21; Ovine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764075	绵羊毛 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764076	Red Imp Fire Ant IgE/IgE total %	4180186
40764076	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Fire ant; i070; i70; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Imp Fire Ant; Red imported fire ant; Serum; SR; Tot; Total IgE; Totl	4180186
40764076	入侵红火蚁 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764077	Goldenrod IgE/IgE total %	4180186
40764077	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Golden rod; Goldenrod; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl; w012; w12	4180186
40764077	毛果一枝黄花 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764078	Spinach IgE/IgE total %	4180186
40764078	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f214; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinach; SR; Tot; Total IgE; Totl	4180186
40764078	菠菜 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764080	Cocoa IgE/IgE total %	4180186
40764080	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cacao; Cocoa; f93; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764080	可可豆 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764082	TMA IgE/IgE total %	4180186
40764082	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Anhydrid; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE total; Immune globulin E; Immunoglobulin E; k86; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; TMA; Tot; Total IgE; Totl; Trimelllitic anhydride	4180186
40764082	偏苯三酸酐 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764084	Cranberry IgE/IgE total %	4180186
40764084	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cranberry; f177; f341; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf341; Serum; SR; Tot; Total IgE; Totl; Vaccinium oxycoccus	4180186
40764084	酸果蔓 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764086	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European hornet; i75; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764086	European Hornet IgE/IgE total %	4180186
40764086	胡蜂 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764087	Cocklebur IgE/IgE total %	4180186
40764087	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cocklebur; Common cocklebur; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl; w013; w13	4180186
40764087	苍耳 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764088	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corn; f008; f141; f74; f8; IgE total; Immune globulin E; Immunoglobulin E; Maize; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764088	Corn IgE/IgE total %	4180186
40764088	玉蜀黍 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764090	Cucumber IgE/IgE total %	4180186
40764090	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cucumber; f244; Gherkin; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764090	黄瓜 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764092	Beef IgE/IgE total %	4180186
40764092	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bos spp; f027; f27; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764092	牛肉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764093	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f002; f2; f43; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764093	Cow Milk IgE/IgE total %	4180186
40764093	牛奶 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764095	Dog Epith IgE/IgE total %	4180186
40764095	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; e002; e2; Epithelia; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764095	狗上皮细胞 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764100	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f075; f75; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764100	Egg Yolk IgE/IgE total %	4180186
40764100	卵黄 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764101	Cottonseed IgE/IgE total %	4180186
40764101	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cottonseed oil; f109; Gossypium hirsutum; Gossypium spp; IgE total; Immune globulin E; Immunoglobulin E; k83; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764101	棉籽 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764102	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e209; Epithelia; Gerbill; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Re209; Serum; SR; Tot; Total IgE; Totl	4180186
40764102	Gerbil Epith IgE/IgE total %	4180186
40764102	沙鼠上皮细胞 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764104	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e217; Epithelia; IgE total; Immune globulin E; Immunoglobulin E; Point in time; Putorius putorius; QNT; Quan; Quant; Quantitative; Random; Re217; Serum; SR; Tot; Total IgE; Totl	4180186
40764104	Ferret Epith IgE/IgE total %	4180186
40764104	白鼬上皮细胞 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764106	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f147; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764106	Flounder IgE/IgE total %	4180186
40764106	鲆 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764108	Pork IgE/IgE total %	4180186
40764108	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f026; f26; IgE total; Immune globulin E; Immunoglobulin E; Pig; Point in time; Porcine; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sus spp; Swine; Tot; Total IgE; Totl	4180186
40764108	猪肉 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764110	Cockatiel Feather IgE/IgE total %	4180186
40764110	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Feathers; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl	4180186
40764110	孔雀羽毛 抗体.IgE/IgE.总计:任意型分数:时间点:血清:定量型	4182948
40764112	Blood; LPA; LPT; LPT 0.6 ug PW; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40764112	LPT 0.6 ug PW Bld	4180186
40764112	淋巴细胞增殖. 0.60 ug 美洲商陆丝裂原刺激:相对比率:时间点:全血:定量型	4182948
40764114	Blood; LPA; LPT; LPT 10 ug PHA; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; mcg; PHA; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serology; Stim; WB; Whole blood	4180186
40764114	LPT 10 ug PHA Bld	4180186
40764114	淋巴细胞增殖. 10 ug 植物血凝素刺激:相对比率:时间点:全血:定量型	4182948
40764116	5 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Ogostal; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
40764116	Capreomycin 5 ug/mL Islt SlowMyco	4180186
40764116	卷曲霉素 5.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
40764118	DOC.MISC; Document; Finding; Findings; Medication pharm advice.brief; MISC; Point in time; Random	4180186
40764118	Medication pharm advice.brief Doc	4180186
40764118	药物药剂学建议.简要:发现:时间点:^患者:文档型	4182948
40764121	3 Self-Sustaining Sequence Replication; 3SR SR; A baumannii; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764121	A baumannii DNA Spec Ql NAA+probe	4180186
40764121	鲍曼不动杆菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764123	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E faecalis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764123	E faecalis DNA Spec Ql NAA+probe	4180186
40764123	粪肠球菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764126	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764126	HPIV RNA Spec Ql NAA+probe	4180186
40764126	副流感病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764128	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C diff; C difficile; Clostridium difficile; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; UniversalLabOrders; Unspecified	4180186
40764128	C diff DNA Spec Ql NAA+probe	4180186
40764128	艰难梭菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764129	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C jejuni; Campy; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764129	C jejuni DNA Spec Ql NAA+probe	4180186
40764129	空肠弯曲菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764130	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L monocytog; L monocytogenes; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Listeriosis; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764130	L monocytog DNA Spec Ql NAA+probe	4180186
40764130	单核细胞增生李斯特菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764134	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV18; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764134	HPV18 DNA Spec Ql NAA+probe	4180186
40764134	人乳头瘤病毒 18 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764136	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV31; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764136	HPV31 DNA Spec Ql NAA+probe	4180186
40764136	人乳头瘤病毒 31 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764137	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV33; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus intermediate risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764137	HPV33 DNA Spec Ql NAA+probe	4180186
40764137	人乳头瘤病毒 33 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764138	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV35; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764138	HPV35 DNA Spec Ql NAA+probe	4180186
40764138	人乳头瘤病毒 35 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764141	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV45; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus intermediate risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764141	HPV45 DNA Spec Ql NAA+probe	4180186
40764141	人乳头瘤病毒 45 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764144	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV53; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764144	HPV53 DNA Spec Ql NAA+probe	4180186
40764144	人乳头瘤病毒 53 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764145	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV58; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764145	HPV58 DNA Spec Ql NAA+probe	4180186
40764145	人乳头瘤病毒 58 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764146	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV59; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764146	HPV59 DNA Spec Ql NAA+probe	4180186
40764146	人乳头瘤病毒 59 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764147	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV66; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764147	HPV66 DNA Spec Ql NAA+probe	4180186
40764147	人乳头瘤病毒 66 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764151	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV70; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764151	HPV70 DNA Spec Ql NAA+probe	4180186
40764151	人乳头瘤病毒 70 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764156	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV42; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764156	HPV42 DNA Spec Ql NAA+probe	4180186
40764156	人乳头瘤病毒 42 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764158	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E faecium; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764158	E faecium DNA Spec Ql NAA+probe	4180186
40764158	屎肠球菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764161	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; P mirabilis; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764161	P mirabilis DNA Spec Ql NAA+probe	4180186
40764161	奇异变形杆菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764162	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; P aeruginosa; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764162	P aeruginosa DNA Spec Ql NAA+probe	4180186
40764162	铜绿假单胞菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764163	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S marcescens; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40764163	S marcescens DNA Spec Ql NAA+probe	4180186
40764163	粘质沙雷氏菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40764167	XXX blood group Ab Titr SerPl	4180186
40764167	XXX 血型 抗体:滴定度:时间点:血清/血浆:定量型	4182948
40764167	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
40764170	Cyclobenzaprine Ur Ql Cfm	4180186
40764170	Amrix; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flexaril; Flexeril; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40764170	环苯扎林:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40764172	CR; Crea; Creat; Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipramine metabolite; Mass concentration ratio; Mass ratio; MCRto; Norpramin; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40764172	Desipramine/Creat Ur	4180186
40764172	去甲丙咪嗪/肌酐:质量比率:时间点:尿液:定量型	4182948
40764178	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Imipra; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tofranil; UA; UCr; UR; Urn	4180186
40764178	Imipramine/Creat Ur	4180186
40764178	丙咪嗪/肌酐:质量比率:时间点:尿液:定量型	4182948
40764179	Imipramine Ur Ql Cfm	4180186
40764179	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Imipra; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tofranil; UA; UR; Urn	4180186
40764179	丙咪嗪:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40764180	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Imipra; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tofranil; UA; UR; Urn	4180186
40764180	Imipramine Ur Cfm-mCnc	4180186
40764180	丙咪嗪:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40764181	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Hydrocodone metabolite; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40764181	Norhydrocodone/Creat Ur	4180186
40764181	去甲基氢可酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40764182	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydrocodone metabolite; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40764182	Norhydrocodone Ur Ql Cfm	4180186
40764182	去甲基氢可酮:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40764186	Noroxycodone Ur Cfm-mCnc	4180186
40764186	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40764186	去甲基羟考酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40764188	Amitriptyline metabolite; Aventyl; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
40764188	Nortrip Ur Ql Cfm	4180186
40764188	去甲阿米替林:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40764190	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Nucynta; Palexia; Point in time; QNT; Quan; Quant; Quantitative; Random; Tapal; UA; UCr; UR; Urn	4180186
40764190	Tapentadol/Creat Ur	4180186
40764190	他喷他多/肌酐:质量比率:时间点:尿液:定量型	4182948
40764191	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Arbitrary Concentration; Autoantibodies; Autoantibody; Devic's disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; UniversalLabOrders; Water channel aquaporin-4	4180186
40764191	AQP4 H2O channel Ab SerPl IA-aCnc	4180186
40764191	水通道蛋白 4 受体 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40764192	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40764193	Age fed other than breastmlk PhenX	4180186
40764193	Age fed other than breastmlk; f43; Othr; Persons; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40764193	样本人员在其首次接受除母乳和水以外的某种食物时的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40764196	Ca; Cal; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40764196	Deprecated Calcium Intake (Da	4180186
40764200	Cold cereal in 30D PhenX	4180186
40764200	Cold cereal in 30D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764200	在过去的那30天当中,您多久吃一次冷麦片:发现:30天:^患者:序数型:PhenX	4182948
40764201	Finding; Findings; How much cold cereal past 30D; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764201	Deprecated When you ate cold cereal, how	4180186
40764202	Cheese in 30D PhenX	4180186
40764202	Cheese in 30D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764202	在过去的那30天当中,您多久吃一次奶酪:发现:30天:^患者:序数型:PhenX	4182948
40764203	Finding; Findings; How much cheese in 30D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764203	How much cheese in 30D PhenX	4180186
40764203	在过去的那30天当中,每次当您吃奶酪（干酪、芝士）的时候,您通常都吃掉了多少:发现:30天:^患者:序数型:PhenX	4182948
40764206	Macaroni cheese in 30D PhenX	4180186
40764206	Finding; Findings; Last; Macaroni cheese in 30D; Ordinal; QL; Qual; Qualitative; Screen	4180186
40764206	在过去的30天当中,您多久吃一次通心面和奶酪:发现:30天:^患者:序数型:PhenX	4182948
40764208	Arterial Stenosis; Finding; Findings; Last; Mexican foods in 30D; Ordinal; QL; Qual; Qualitative; Screen	4180186
40764208	Mexican foods in 30D PhenX	4180186
40764208	在过去的30天当中,您多久吃一次墨西哥玉米薄饼卷、脆玉米饼、玉米煎饼、墨西哥玉米面团包馅卷、法式达、墨西哥卷肉玉米面饼、墨西哥玉米面饼者辣肉馅玉米煎饼:发现:30天:^患者:序数型:PhenX	4182948
40764210	Milk in 30D PhenX	4180186
40764210	Arterial Stenosis; f43; Finding; Findings; Last; Milk in 30D; Ordinal; QL; Qual; Qualitative; Screen	4180186
40764210	在过去的30天当中,您多久喝一次作为饮料的牛奶:发现:30天:^患者:序数型:PhenX	4182948
40764212	f43; Finding; Findings; Kind of milk drink in the past 30D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764212	Kind of milk drink in the past 30D PhenX	4180186
40764212	在过去的那30天当中,您通常喝什么种类的奶:发现:30天:^患者:序数型:PhenX	4182948
40764214	100 % OJ in 30D PhenX	4180186
40764214	100 % OJ in 30D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764214	在过去的30天当中,您多久喝一次百分之百的果汁:发现:30天:^患者:序数型:PhenX	4182948
40764215	Consumed; Drink; Finding; Findings; How much orange juice in 30D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764215	How much orange juice in 30D PhenX	4180186
40764215	在过去的那30天当中,每次当您喝橙汁的时候,您通常都喝掉了多少:发现:30天:^患者:序数型:PhenX	4182948
40764216	Pizza in 30D PhenX	4180186
40764216	Finding; Findings; Last; Ordinal; Pizza in 30D; Ql; Qual; Qualitative; Screen	4180186
40764216	在过去30天当中,您多长时间吃一次比萨饼:发现:30天:^患者:序数型:PhenX	4182948
40764218	Yogurt in 30D PhenX	4180186
40764218	f360; Finding; Findings; Joghurt; Last; Ordinal; Ql; Qual; Qualitative; Screen; Yoghurt; Yogurt in 30D	4180186
40764218	在过去的30天当中,您多久吃一次酸奶:发现:30天:^患者:序数型:PhenX	4182948
40764219	Ca; Cal; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40764221	Finding; Findings; Hot cold cereals in 30D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764221	Hot cold cereals in 30D PhenX	4180186
40764221	在过去的30天当中,您多久吃一次冷麦片:发现:30天:^患者:序数型:PhenX	4182948
40764222	Kinds of cereal usu eat in 30D; Last; Nominal; Point in time; Random; Typ	4180186
40764222	Deprecated When you ate cereal,	4180186
40764223	Any cheese in 30D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764223	Any cheese in 30D PhenX	4180186
40764223	在过去的30天当中,您多久吃一次奶酪:发现:30天:^患者:序数型:PhenX	4182948
40764224	Cookies cake pie in 30D PhenX	4180186
40764224	Cookies cake pie in 30D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764224	在过去的30天当中,您多久吃一次小甜饼、蛋糕、馅饼或果仁巧克力饼干:发现:30天:^患者:序数型:PhenX	4182948
40764225	Doughnut poptart in 30D; Finding; Findings; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764225	Deprecated How often did you eat DOUGHNU	4180186
40764226	Fries hash browns in 30D PhenX	4180186
40764226	Finding; Findings; Fries hash browns in 30D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764226	在过去的30天当中,您多久吃一次炸薯条、自制炸薯条或者脆炸土豆饼:发现:30天:^患者:序数型:PhenX	4182948
40764227	Deprecated How often did you drink FRUIT	4180186
40764227	Arterial Stenosis; Finding; Findings; How oft fruit flav w sugar in 30D; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764228	Deprecated How often did you eat FRUIT i	4180186
40764228	Finding; Findings; Fruit in 30D; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764231	Finding; Findings; How often other vegetables in 30D; Last; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764231	Deprecated Not counting lettuce salads,	4180186
40764234	Carb soda w sugar in 30D; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764234	Carb soda w sugar in 30D PhenX	4180186
40764234	在过去的30天当中,您多久喝一次普通碳酸苏打水或者含糖的软饮料:发现:30天:^患者:序数型:PhenX	4182948
40764236	Finding; Findings; Last; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; White potatoes in 30D	4180186
40764236	Deprecated How often did you eat other W	4180186
40764241	Brewed coffee not decaf PhenX	4180186
40764241	Brewed coffee not decaf; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764241	您多久喝一次新鲜调制的咖啡,但并非无咖啡因的咖啡:发现:时间点:^患者:序数型:PhenX	4182948
40764243	Drink decaf coffee; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764243	Drink decaf coffee PhenX	4180186
40764243	您多久喝一次无咖啡因的咖啡（速溶型和新鲜调制的）:发现:时间点:^患者:序数型:PhenX	4182948
40764244	Size for decaf coffee PhenX	4180186
40764244	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Size for decaf coffee	4180186
40764244	您的无咖啡因的咖啡（速溶型和新鲜调制的）的分量大小是多少:发现:时间点:^患者:序数型:PhenX	4182948
40764246	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Size decaf espresso	4180186
40764246	Size decaf espresso PhenX	4180186
40764246	您的无咖啡因的浓咖啡及浓咖啡饮料的分量大小是多少:发现:时间点:^患者:序数型:PhenX	4182948
40764247	Herbal decaf tea PhenX	4180186
40764247	Finding; Findings; Herbal decaf tea; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764247	您多久喝一次凉茶或无咖啡因的茶（速溶型、瓶装和新鲜调制的）:发现:时间点:^患者:序数型:PhenX	4182948
40764249	Diet cola no caffeine PhenX	4180186
40764249	CAFFN; Diet cola no caffeine; Finding; Findings; FR; Non-protein bound; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764249	您多久喝一次低糖可乐和低糖菜根汽水（无咖啡因）:发现:时间点:^患者:序数型:PhenX	4182948
40764250	Size diet colas caffeine free PhenX	4180186
40764250	CAFFN; Finding; Findings; FR; Non-protein bound; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Size diet colas caffeine free	4180186
40764250	您的低糖可乐和低糖菜根汽水（无咖啡因）的分量大小是多少:发现:时间点:^患者:序数型:PhenX	4182948
40764255	Green tea PhenX	4180186
40764255	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764255	您多久喝一次绿茶:发现:时间点:^患者:序数型:PhenX	4182948
40764260	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Size instant coffee not decaf	4180186
40764260	Size instant coffee not decaf PhenX	4180186
40764260	您的速溶咖啡的分量大小是多少,但并非无咖啡因（包括各种调味类型）:发现:时间点:^患者:序数型:PhenX	4182948
40764261	Reg cola caffeine free PhenX	4180186
40764261	CAFFN; Finding; Findings; FR; Non-protein bound; Ordinal; Point in time; QL; Qual; Qualitative; Random; Reg cola caffeine free; Screen	4180186
40764261	您多久喝一次普通可乐和菜根汽水（无咖啡因,但并非低糖）:发现:时间点:^患者:序数型:PhenX	4182948
40764268	Finding; Findings; How often other vegetables in 30D; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen	4180186
40764268	How often other vegetables in 30D PhenX	4180186
40764268	不计莴苣沙拉、白马铃薯和熟干豆,并且不计大米,在过去的30天当中,您多久吃一次其他蔬菜:发现:30天:^患者:序数型:PhenX	4182948
40764269	Deprecated How often did you have MILK,	4180186
40764269	f43; Finding; Findings; Have milk drink or cereal in 30D; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764270	Measure - DS; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40764275	DS in 12Mo once W; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764275	DS in 12Mo once W PhenX	4180186
40764275	在过去的那一年当中您是否服用过任何的膳食补充剂,至少每星期一次:发现:1年:^患者:序数型:PhenX	4182948
40764280	Arterial Stenosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Years garlic pill capsule	4180186
40764280	Years garlic pill capsule PhenX	4180186
40764280	您当时服用了多少年时间的丸剂、片剂或胶囊剂型的大蒜:时间:时间点:^患者:定量型:PhenX	4182948
40764281	Glucosamine PhenX	4180186
40764281	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764281	采取单独服用或者与别的某种东西组合服用的方式,您当时多长时间服用一次氨基葡萄糖:发现:时间点:^患者:序数型:PhenX	4182948
40764282	Point in time; QNT; Quan; Quant; Quantitative; Random; Years glucosamine	4180186
40764282	Years glucosamine PhenX	4180186
40764282	采取单独服用或者与别的某种东西组合服用的方式,您当时服用了多少年时间的氨基葡萄糖:时间:时间点:^患者:定量型:PhenX	4182948
40764283	Iron PhenX	4180186
40764283	Fe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764283	您当时多久服用一次铁剂:发现:时间点:^患者:序数型:PhenX	4182948
40764284	Fe; Point in time; QNT; Quan; Quant; Quantitative; Random; Years iron	4180186
40764284	Years iron PhenX	4180186
40764284	您当时服用了多少年时间的铁剂:时间:时间点:^患者:定量型:PhenX	4182948
40764289	Coenzyme Q10; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764289	Coenzyme Q10 PhenX	4180186
40764289	您当时多久服用一次辅酶 Q 10:发现:时间点:^患者:序数型:PhenX	4182948
40764290	Years coenzyme Q10 PhenX	4180186
40764290	Point in time; QNT; Quan; Quant; Quantitative; Random; Years coenzyme Q10	4180186
40764290	您当时服用了多少年时间的辅酶 Q 10:时间:时间点:^患者:定量型:PhenX	4182948
40764297	Vit B6 PhenX	4180186
40764297	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vit B6	4180186
40764297	您当时多久服用一次维生素 B 6:发现:时间点:^患者:序数型:PhenX	4182948
40764299	Vit C PhenX	4180186
40764299	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vit C	4180186
40764299	您当时多久服用一次维生素 C:发现:时间点:^患者:序数型:PhenX	4182948
40764306	Point in time; QNT; Quan; Quant; Quantitative; Random; Years vit E	4180186
40764306	Years vit E PhenX	4180186
40764306	您当时服用了多少年时间的维生素 E:时间:时间点:^患者:定量型:PhenX	4182948
40764307	Years folic acid folate PhenX	4180186
40764307	Acd; Acids; Folat; Folic acid; Point in time; Pteroylglutamate; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Random; Vit M; Vitamin M; Years folic acid folate	4180186
40764307	您当时服用了多少年时间的叶酸:时间:时间点:^患者:定量型:PhenX	4182948
40764308	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Zn	4180186
40764308	Zinc PhenX	4180186
40764308	您当时多久服用一次锌剂:发现:时间点:^患者:序数型:PhenX	4182948
40764312	Finding; Findings; Fruit in 30D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764312	Fruit in 30D PhenX	4180186
40764312	在过去的30天当中,您多久吃一次水果:发现:30天:^患者:序数型:PhenX	4182948
40764313	Did you eat a green leafy or lettuce SALAD, W or W/O other vegetables, in past 30D; Finding; Findings; Green salad in 30D; Last; Ordinal; Othr; QL; Qual; Qualitative; Screen	4180186
40764313	Green salad in 30D PhenX	4180186
40764313	在过去的30天当中,您多久吃一次配有或不配有其他蔬菜的绿叶或生菜色拉:发现:30天:^患者:序数型:PhenX	4182948
40764316	Deprecated	4180186
40764316	Cookies cake pie in 30D; Finding; Findings; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40764318	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40764319	1 year; 12Mos; Cold cereal in 12Mo; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764319	Cold cereal in 12Mo PhenX	4180186
40764319	在过去的12个月当中,您多久吃一次冷麦片:发现:12个月:^患者:序数型:PhenX	4182948
40764320	在过去12个月当中,您大约多长时间喝一次脱脂牛奶（配合麦片或单独饮用）:发现:12个月:^患者:序数型:PhenX	4182948
40764320	How often skim milk in 12Mo PhenX	4180186
40764320	1 year; 12Mos; f43; Finding; Findings; How often skim milk in 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764323	在过去12个月当中,您大约多长时间吃一次涂抹在面包、面包卷或薄煎饼上的人造黄油或黄油:发现:12个月:^患者:序数型:PhenX	4182948
40764323	1 year; 12Mos; Finding; Findings; How often butter on bread in 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764323	How often butter on bread in 12Mo PhenX	4180186
40764325	在过去12个月当中,您大约多长时间吃一次水果（并非果汁）:发现:12个月:^患者:序数型:PhenX	4182948
40764325	How often fruit not juice in 12Mo PhenX	4180186
40764325	1 year; 12Mos; Finding; Findings; How often fruit not juice in 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764326	在过去12个月当中,您大约多长时间吃一次普通脂肪含量的牛肉或猪肉热狗:发现:12个月:^患者:序数型:PhenX	4182948
40764326	1 year; 12Mos; Bos spp; f026; f027; f26; f27; Finding; Findings; Freq beef pork hot dog in 12Mo; Last; Ordinal; Pig; Porcine; QL; Qual; Qualitative; Screen; Sus spp; Swine	4180186
40764326	Freq beef pork hot dog in 12Mo PhenX	4180186
40764328	在过去12个月当中,您大约多长时间吃一次炸薯条、自制薯条或脆炸土豆饼:发现:12个月:^患者:序数型:PhenX	4182948
40764328	How often fries hash brown in 12Mo PhenX	4180186
40764328	1 year; 12Mos; Finding; Findings; How often fries hash brown in 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764329	在过去12个月当中,您大约多长时间吃一次拌在蔬菜（包括土豆）上的人造黄油或黄油:发现:12个月:^患者:序数型:PhenX	4182948
40764329	How often butter on veg in 12Mo PhenX	4180186
40764329	1 year; 12Mos; Finding; Findings; How often butter on veg in 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764333	在过去12个月当中,您大约多长时间吃一次拌在米饭或通心粉上的人造黄油或黄油:发现:12个月:^患者:序数型:PhenX	4182948
40764333	1 year; 12Mos; Finding; Findings; Freq butter w rice pasta in 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764333	Freq butter w rice pasta in 12Mo PhenX	4180186
40764334	1 year; 12Mos; Finding; Findings; Freq reduced fat margarine 12Mo; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40764334	Freq reduced fat margarine 12Mo PhenX	4180186
40764334	在过去12个月当中,当您采用人造黄油烹制食物或者食用人造黄油时候,您多久使用一次减脂人造黄油:发现:12个月:^患者:序数型:PhenX	4182948
40764337	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764338	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
40764339	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764340	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764341	Emotional stability; Finding; Findings; In general how would you rate your mental health, including your mood and your ability to think; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764346	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764352	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764356	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764360	Activity; EXCZ; Exercise; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764364	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764368	Control; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764372	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upper extremity	4180186
40764377	Activity; EXCZ; Exercise; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764379	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764383	2; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764385	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764386	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764388	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764391	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764392	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764394	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764398	bod; Bodies; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764400	Finding; Findings; Job; Occupation; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764402	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764403	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764404	2; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764408	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764410	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764411	Exchange; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.PROMIS	4180186
40764412	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764413	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764414	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764415	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764418	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764420	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764421	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764424	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upper extremity joint	4180186
40764425	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764427	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764428	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764429	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764430	Exchange; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.PROMIS	4180186
40764432	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764433	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764434	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764438	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764439	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764442	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764445	FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764447	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764448	Finding; Findings; Limit climbing sev flights stairs; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764449	120 min; 120 minutes; 120min; 2 hours; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764453	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764454	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764459	Finding; Findings; Limit climbing 1 flight stairs; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764462	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764464	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764465	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764466	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764467	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764468	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764470	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764471	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764472	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764473	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
40764474	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764476	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764479	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764482	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764483	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764484	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764485	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764487	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764488	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764493	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764495	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764496	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764497	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764500	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764501	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764503	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764505	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764506	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764508	bod; Bodies; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764509	bod; Bodies; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764510	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764511	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764512	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764513	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764516	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764517	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764520	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764521	Emotionally tense from pain past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764523	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764525	Finding; Findings; Last; Ordinal; Pain make feel depressed in past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764526	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764527	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764528	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764529	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764530	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764531	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764534	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764535	Finding; Findings; Last; Ordinal; Pain make feel discouraged in past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764537	120 min; 120 minutes; 120min; 2 hours; Finding; Findings; How much did pain interfere with your ability to make trips from home that kept you gone for more than 2 hours in past 7D; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764539	Finding; Findings; Last; Ordinal; Pain make feel anxious in past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764540	Avoid social activities make hurt more past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764544	Finding; Findings; Last; Ordinal; Pain make difficult plan social activities past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764545	Finding; Findings; Last; Ordinal; Pain prevent standing 30 minutes past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764546	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764547	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764549	Finding; Findings; Last; Ordinal; Pain prevent sitting 10 minutes past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764550	Finding; Findings; Hard to plan social activities due to pain past 7D; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; T prime	4180186
40764551	Finding; Findings; Last; Ordinal; Pain restrict social life to home past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764552	Finding; Findings; Last; Ordinal; Pain keep from standing position in past 7D; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764554	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764555	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764557	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764558	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764560	Fatigue interfere with social activity past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764563	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764565	Fatigue make difficult to start anything new ipast 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Started; Survey; SURVEY.PROMIS	4180186
40764566	Fatigue make more forgetful in past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764572	Finding; Findings; Have to limit social activities due to fatigue in past 7D; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764573	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Too tired for household chores in past 7D	4180186
40764575	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Too tired to take bath or shower in past 7D	4180186
40764577	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Trouble starting things due to fatigue past 7D	4180186
40764578	Effort to conversation due to fatigue past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764582	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764584	Fatigue limit you at work past 7D; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764585	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764586	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764588	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764590	Activity; Enough energy exercise strenuously past 7D; EXCZ; Exercise; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764591	Finding; Findings; Last; Less effective at home due to fatigue past 7D; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764592	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764594	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764595	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764597	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764598	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764600	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764602	Finding; Findings; Have to force to get up due to fatigue past 7D; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764604	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764608	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; T prime	4180186
40764610	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764613	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764614	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764615	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764616	Enough energy to enjoy things for fun past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764618	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764619	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764620	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764622	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764624	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764626	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764627	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764628	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764630	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764633	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Think about fatigue past 7D	4180186
40764639	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764640	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764641	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764644	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764645	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764646	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764647	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764649	Activ; Actvty; Finding; Findings; Last; Movements; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764650	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764651	Able to do usual activities in past 7D; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764653	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764654	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764658	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764659	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764660	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764661	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Tx	4180186
40764662	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764663	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764676	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764677	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764682	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764683	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764684	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764687	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764688	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764689	Emotional stability; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764690	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764691	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764693	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764695	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764696	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764697	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764698	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764699	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764700	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764702	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764703	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764706	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764708	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764709	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764712	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764713	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764714	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764717	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764721	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764722	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764725	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764726	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764727	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764728	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764730	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764732	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764734	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764735	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764736	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764738	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764740	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764742	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764743	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764744	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764746	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764747	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764748	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764751	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764753	Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen; Trouble staying asleep past 7D	4180186
40764753	Trouble staying asleep past 7D	4180186
40764753	在过去的7天当中,在保持睡着状态方面存在麻烦:发现:7天:^患者:序数型	4182948
40764755	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764756	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764757	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764758	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764759	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764760	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764761	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764764	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764766	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764767	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764768	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764769	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764770	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764773	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764774	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764780	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764783	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764787	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764788	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764789	Activ; Actvty; Finding; Findings; Last; Levels; Levl; LV; LVL; Movements; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764791	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764793	Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764794	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764795	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764798	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764800	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764802	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764803	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764804	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764805	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764806	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764807	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764808	Arterial Stenosis; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764810	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764811	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764815	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764816	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764819	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764823	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764824	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764826	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764830	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764834	Activity; EXCZ; Exercise; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764835	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764836	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764837	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764838	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764840	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764841	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764842	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764843	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764845	bod; Bodies; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764847	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764848	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; T prime	4180186
40764850	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764851	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764852	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764854	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS; T prime	4180186
40764855	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764856	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764860	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764864	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764865	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764866	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764868	Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764869	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764870	EXCZ; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764878	FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764880	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764885	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764886	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764888	Finding; Findings; I could walk up stairs W/O holding on to anything in past 7D; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764894	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764901	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764904	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764905	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764906	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764911	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764914	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764915	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764916	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764918	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764919	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764920	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764923	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764925	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764929	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764934	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764935	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764939	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764940	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764944	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764949	1 week; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764950	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764951	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764953	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764954	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764955	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764958	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764959	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764960	FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764961	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764966	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764969	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764970	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764971	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40764976	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764980	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764984	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764987	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764989	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764991	Finding; Findings; Last; Mice; Murine; Mus musculus; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764992	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40764995	Alb; Chemistry; Hepatology; Kidney; Level; Liver; Nephrology; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
40764995	Albumin SerPl BCP-sCnc	4180186
40764995	白蛋白:物质的量浓度:时间点:血清/血浆:定量型:溴甲酚紫染料结合法	4182948
40764997	Pyridoxal Phos SerPl-sCnc	4180186
40764997	C8H10NO6P; C8H9NO3; Chemistry; Codecarboxylase; i Phos; Inorganic phosphate; Level; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; PLP; Plsm; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride	4180186
40764997	磷酸吡哆醛:物质的量浓度:时间点:血清/血浆:定量型	4182948
40764999	Blood; BSA.pred; Chemistry; EGFR; Estimated GFR; GFR; GFR/1.73 sq M; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; Pred GFR; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
40764999	GFR/BSA.pred SerPlBld CKD-EPI-ArVRat	4180186
40764999	肾小球滤过率/1.73 平方米.预测型:单位面积体积速率:时间点:血清/血浆/全血:定量型:基于肌酐的公式 (CKD-EPI)	4182948
40765001	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; WB; Whole blood	4180186
40765001	RBC # Bld Fetus Auto	4180186
40765001	红细胞:计数型浓度:时间点:全血^胎儿:定量型:自动化计数方法	4182948
40765008	Auto; Automated detection; Blood; Discocyte; Elec; Elect; Electr; Erc; Erythrocyte morphology index; Erythrocytes; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RCMI; RDW; RDW-CV; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WB; Whole blood	4180186
40765008	RDW Bld Fetus Auto-Rto	4180186
40765008	红细胞分布宽度:比率:时间点:全血^胎儿:定量型:自动化计数方法	4182948
40765010	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fetal; Gyn; Gynecology; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; Retic; Retics; Reticulocyte; WB; Whole blood	4180186
40765010	Retics # Fetus Auto	4180186
40765010	网织红细胞:计数型浓度:时间点:全血^胎儿:定量型:自动化计数方法	4182948
40765012	#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40765012	WBC # Plr Fetus Auto	4180186
40765012	白细胞:计数型浓度:时间点:胸膜液^胎儿:定量型:自动化计数方法	4182948
40765013	Blood; CD79 cells; Cell; CELL MARKERS; Cellularity; Gated cells; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40765013	CD79 cells NFr Bld	4180186
40765013	细胞.CD79/100 个细胞:计数型分数:时间点:全血:定量型	4182948
40765014	Alfa; Chemistry; Entitic length; HDL; High density lipoproteins; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40765014	HDL SerPl Qn	4180186
40765014	脂蛋白.Alpha:实体长度:时间点:血清/血浆:定量型	4182948
40765015	B; Before; Chemistry; Entitic length; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Very low density lipoproteins; VLDL	4180186
40765015	VLDL SerPl Qn	4180186
40765015	脂蛋白.前 Beta:实体长度:时间点:血清/血浆:定量型	4182948
40765019	ANTIBIOTIC SUSCEPTIBILITIES; Bact; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Methylase; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Sobelin; Spec; Topical	4180186
40765019	ermA+ermC Islt/Spm Ql	4180186
40765019	细菌红霉素+氯洁霉素耐药 ermA+ermC 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
40765020	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Arbitrary Concentration; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Spec; Staficyn; Staphicillin; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765020	Deprecated Methicillin resis XXX Ql PCR	4180186
40765026	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SE	4180186
40765027	PhenX - breastfeeding protocol	4180186
40765027	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765027	PhenX - 母乳喂养方案 050101:-:时间点:^患者:-:PhenX	4182948
40765028	CAFFN; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765028	PhenX - caffeine protocol	4180186
40765028	PhenX - 咖啡因方案 050301:-:时间点:^患者:-:PhenX	4182948
40765031	Fibers; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765031	PhenX - fiber protocol	4180186
40765031	PhenX - 膳食纤维方案 050601:-:时间点:^患者:-:PhenX	4182948
40765033	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765033	PhenX - energy from fat protocol	4180186
40765033	PhenX - 脂肪来源能量方案 050801:-:时间点:^患者:-:PhenX	4182948
40765036	Dextro; Osteoporosis; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Rickets; Vitamin D deficiency	4180186
40765036	PhenX - vitamin D protocol	4180186
40765036	PhenX - 维生素 D 方案 051101:-:时间点:^患者:-:PhenX	4182948
40765037	PhenX - calcium intake - adult protocol	4180186
40765037	Ca; Cal; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765037	PhenX - 钙摄入 - 成年人方案 050202:-:时间点:^患者:-:PhenX	4182948
40765039	1,25(OH)2D2; Chemistry; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40765039	1,25(OH)2D2 SerPl-mCnc	4180186
40765039	1,25-二羟维生素 D2:质量浓度:时间点:血清/血浆:定量型	4182948
40765040	25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol; Chemistry; Ercalcidiol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders; Vitamin D 25 hydroxy	4180186
40765040	25(OH)D3+25(OH)D2 SerPl-mCnc	4180186
40765040	钙二醇+羟基钙二醇:质量浓度:时间点:血清/血浆:定量型	4182948
40765041	Current age proto	4180186
40765041	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765041	PhenX - 当前年龄方案 010101:-:时间点:^患者:-:PhenX	4182948
40765042	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765042	PhenX - standing height	4180186
40765042	PhenX - 直立身高方案 020703:-:时间点:^患者:-:PhenX	4182948
40765043	Recumbent length proto	4180186
40765043	Len; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765043	PhenX - 平卧身长方案 020702:-:时间点:^患者:-:PhenX	4182948
40765044	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765044	Self reported height proto	4180186
40765044	PhenX - 自报身高方案 020704:-:时间点:^患者:-:PhenX	4182948
40765045	Measured weight proto	4180186
40765045	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Wt	4180186
40765045	PhenX - 体重 - 实测体重方案 021501:-:时间点:^患者:-:PhenX	4182948
40765046	Self reported weight proto	4180186
40765046	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Wt	4180186
40765046	PhenX - 体重 - 自报体重方案 021502:-:时间点:^患者:-:PhenX	4182948
40765051	Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; LSD; LSD NBS comment; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40765051	LSD NBS comment	4180186
40765051	溶酶体贮积症 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40765054	Alpha-galactosidase A deficiency; Anderson-Fabry disease; Angiokeratoma corporis diffusum; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dis; Diseases; Dried blood spot; Dz; Fabry disease NBS comment; Filter paper; FP; GLA; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40765054	Fabry disease NBS comment	4180186
40765054	法布里病 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40765055	Asympt; Asymptomatic; Blood; Chemistry; DBS; Dis; Diseases; Dried blood spot; Dz; Filter paper; FP; Galactocerebrosidase deficiency; GALC; Globoid Cell Leukodystrophy; Gyn; Gynecology; Krabbe disease NBS pnl; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood	4180186
40765055	Krabbe disease NBS pnl DBS	4180186
40765055	遗传性脑白质萎缩新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40765056	Krabbe disease DBS-Imp	4180186
40765056	Blood; Chemistry; DBS; Dis; Diseases; Dried blood spot; Dz; Filter paper; FP; Galactocerebrosidase deficiency; GALC; Globoid Cell Leukodystrophy; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood	4180186
40765056	遗传性脑白质萎缩:印象:时间点:全血.斑点:名义型	4182948
40765067	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blood; Chemistry; Cnt; Count; Count/volume; CT; DBS; DNA NUCLEIC ACID PROBE; DNA probe; Dried blood spot; Filter paper; FP; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; SDA; Strand Displacement Amplification; T cell; T prime; TMA; Transcription mediated amplification; TREC; UCHL-1; Viral load; WB; Whole blood	4180186
40765067	TREC # DBS NAA+probe	4180186
40765067	T-细胞受体重排删除环:计数型浓度:时间点:全血.斑点:定量型:探针法.基因扩增.靶向	4182948
40765069	SCID NBS comment	4180186
40765069	Alymphocytosis; Asympt; Asymptomatic; Blood; Bubble Boy Syndrome; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; Glanzmann-Riniker syndrome; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; SCID; SCID NBS comment; Scn; Severe mixed immunodeficiency syndrome; Text; Thymic alymphoplasia; WB; Whole blood	4180186
40765069	严重联合免疫缺陷 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40765070	ADMIN; Birth hospital ID; Hosp; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40765070	Birth hospital ID	4180186
40765070	出生医院设施标识符:标识符:时间点:设施:名义型	4182948
40765072	Address; ADMIN; Birth hospital address; Hosp; Nominal; Point in time; Random	4180186
40765072	Birth hospital address	4180186
40765072	出生医院设施地址:地址:时间点:设施:名义型	4182948
40765074	Alymphocytosis; Asympt; Asymptomatic; Blood; Bubble Boy Syndrome; Chemistry; DBS; Dried blood spot; Filter paper; FP; Glanzmann-Riniker syndrome; NB Screen Pnl; NBS; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; SCID; SCID NBS pnl; Scn; Severe mixed immunodeficiency syndrome; Thymic alymphoplasia; WB; Whole blood	4180186
40765074	SCID NBS pnl DBS	4180186
40765074	严重联合免疫缺陷 (SCID) 新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40765075	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
40765076	PhenX - knee height protocol	4180186
40765076	Lower extremity joint; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765076	PhenX - 膝关节高度方案 020701:-:时间点:^患者:-:PhenX	4182948
40765077	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; Prof; promise; Random; Survey; SURVEY.PROMIS	4180186
40765078	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; Prof; promise; Random; Survey; SURVEY.PROMIS	4180186
40765079	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; Prof; promise; Random; Survey; SURVEY.PROMIS	4180186
40765080	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40765081	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
40765083	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Blt; Burgdorf; ID; IgG+IgM; IMMUNE BLOT; Immune globulin G; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Lyme; Lyme disease; Lymes; Microbiology; Nominal; Point in time; Random; RIBA; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
40765083	B burgdor IgG+IgM Ser IB-Imp	4180186
40765083	伯氏疏螺旋体 抗体.IgG 与 IgM:印象:时间点:血清:名义型:免疫印迹法	4182948
40765086	Blood; Chrom analy; Chrom analy interphase; Chrom analy interphase pnl; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
40765086	Chrom analy interphase pnl Bld FISH	4180186
40765086	染色体分析.分裂间期组套:-:时间点:全血:-:FISH	4182948
40765087	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chrom analy; Chrom analy interphase; Chrom analy interphase pnl; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Gyn; Gynecology; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; OB; ObGyn; Obstetrics; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random	4180186
40765087	Chrom analy interphase pnl Amn FISH	4180186
40765087	染色体分析.分裂间期组套:-:时间点:羊水:-:FISH	4182948
40765090	Blood; Chrom analy; Chrom analy pnl; Chromosom; Chromosomes; Cytogenetics; Fetal; Genetics; Gyn; Gynecology; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; OB; ObGyn; Obstetrics; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
40765090	Chrom analy pnl Bld Fetus G-banded	4180186
40765090	染色体分析组套:-:时间点:全血^胎儿:-:G 显带法	4182948
40765091	Chorionic villi; Chorionic villus sample; Chrom analy; Chrom analy pnl; Chromosom; Chromosomes; Cytogenetics; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random	4180186
40765091	Chrom analy pnl CVS G-banded	4180186
40765091	染色体分析组套:-:时间点:绒毛膜绒毛样本:-:G 显带法	4182948
40765093	Chrom analy; Chrom analy pnl; Chromosom; Chromosomes; Cytogenetics; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Products of Conception; Random	4180186
40765093	Chrom analy pnl POC G-banded	4180186
40765093	染色体分析组套:-:时间点:怀孕产物:-:G 显带法	4182948
40765096	Blood; Chrom analy; Chrom analy pnl; Chromosom; Chromosomes; Cytogenetics; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765096	Chrom analy pnl Banding	4180186
40765096	染色体分析组套:-:时间点:全血/组织:-:显带技术	4182948
40765097	Chrom analy result (ISCN)	4180186
40765097	Blood; Chrom analy; Chrom analy result (ISCN); Chromosom; Chromosomes; Cytogenetics; Finding; Findings; HL7.CYTOGEN; Karyotype; Molecular genetics; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765097	采用ISCN表达的染色体分析结果:发现:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765099	ISCN band level Ql	4180186
40765099	Bands; Blood; bnd; Cnt; Count; HL7.CYTOGEN; Levels; Levl; LV; LVL; Molecular genetics; Number; Ordinal; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765099	ISCN 条带水平:数量(计数):时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40765101	Cells analyzed	4180186
40765101	Blood; Cell; Cellularity; Cnt; Count; HL7.CYTOGEN; Molecular genetics; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765101	已分析的细胞:数量(计数):时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
40765104	Blood; Finding; Findings; HL7.CYTOGEN; Molecular genetics; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765104	发现镶嵌性:发现:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765107	Recom F/U Patient	4180186
40765107	HL7.CYTOGEN; Identity or presence; Nominal; Pap Smear; Pap Stain; Papinacolou Smear; Point in time; Random; Recom F/U	4180186
40765107	推荐随访:存在与否或特征标识:时间点:^患者:名义型	4182948
40765108	Blood; Chrom analy; Chrom analy pnl; Chromosom; Chromosomes; Cytogenetics; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765108	Chrom analy pnl FISH	4180186
40765108	染色体分析组套:-:时间点:全血/组织:-:FISH	4182948
40765110	FISH probe name pnl; Genetics; Heredity; Heritable; HL7.CYTOGEN; HumanName; Inherited; Lab Device; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random	4180186
40765110	FISH probe name pnl Lab Device	4180186
40765110	FISH 探针名称组套:-:时间点:实验室仪器设备:-	4182948
40765111	Genetics; Heredity; Heritable; Ident; Identifier; Inherited; Lab Device; Molecular pathology; MOLPATH; Nominal; Point in time; Random	4180186
40765111	FISH probe gene name Lab Device	4180186
40765111	FISH 探针基因名称:标识符:时间点:实验室仪器设备:名义型	4182948
40765113	Genetics; Heredity; Heritable; Ident; Identifier; Inherited; Lab Device; Molecular pathology; MOLPATH; Nominal; Point in time; Random	4180186
40765113	FISH probe vendor Lab Device	4180186
40765113	FISH 探针厂商:标识符:时间点:实验室仪器设备:名义型	4182948
40765118	Blood; Chrom copy # change; Chrom copy # change pnl; Chromosom; Chromosomes; Exchange; HL7.CYTOGEN; Molecular genetics; No; Num; Pan; PANEL.HL7.CYTOGEN; Panl; PCR; Pnl; Point in time; Random; Replace; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765118	Chrom copy # change pnl	4180186
40765118	染色体拷贝数变化组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40765119	Chrom copy # change	4180186
40765119	Blood; Chrom copy # change; Chromosom; Chromosomes; Exchange; HL7.CYTOGEN; Molecular genetics; No; Nominal; Num; PCR; Point in time; Random; Replace; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
40765119	染色体拷贝数变化:类型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765120	Bands; Blood; bnd; Chrom band involved start; Chromosom; Chromosomes; Finding; Findings; HL7.CYTOGEN; Molecular genetics; Nominal; PCR; Point in time; Random; Started; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765120	Chrom band involved start	4180186
40765120	所涉及染色体区带起点:发现:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765121	Chrom band involved end	4180186
40765121	Bands; Blood; bnd; Chrom band involved end; Chromosom; Chromosomes; Finding; Findings; HL7.CYTOGEN; Molecular genetics; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765121	所涉及染色体区带终点:发现:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765122	Blood; Cnt; Count; HL7.CYTOGEN; Molecular genetics; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765122	Base pair start coordinate	4180186
40765122	碱基对起始坐标:数量(计数):时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
40765124	Flanking norm reg before start	4180186
40765124	Blood; Control; Finding; Findings; Flanking norm reg before start; HL7.CYTOGEN; Molecular genetics; Nominal; PCR; Point in time; Random; Started; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765124	起始之前的侧翼正常区域:发现:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765125	Blood; Control; Finding; Findings; Flanking norm reg after end; HL7.CYTOGEN; Molecular genetics; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765125	Flanking norm reg after end	4180186
40765125	终止之后的侧翼正常区域:发现:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40765126	Recommendation Patient Doc-Imp	4180186
40765126	Document; HL7.CYTOGEN; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Point in time; Random	4180186
40765126	建议:印象:时间点:^患者:文档型	4182948
40765127	Blood; Chrom analy; Chrom anl summary pnl; Chromosom; Chromosomes; Cytogenetics; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Molecular genetics; Pan; PANEL.HL7.CYTOGEN; Panl; PCR; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765127	Chrom anl summary pnl	4180186
40765127	染色体分析摘要组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
40765129	Blood; Chemistry; Endocrine; Endocrinology; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; Japanese Diabetes Society/Japanese Society for Clinical Chemistry; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
40765129	HbA1c MFr Bld JDS/JSCC	4180186
40765129	血红蛋白 A1c/血红蛋白.总计:质量分数:时间点:全血:定量型:JDS/JSCC	4182948
40765130	Blood; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Genetics; Heredity; Heritable; HL7.CYTOGEN; Inherited; Karyotype; Pan; PANEL.HL7.CYTOGEN; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40765130	染色体分析主组套:-:时间点:全血/组织:-	4182948
40765132	Lipid profile proto	4180186
40765132	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Prof; Random	4180186
40765132	PhenX - 血脂谱方案 040201:-:时间点:^患者:-:PhenX	4182948
40765133	BP; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765133	Blood pressure proto	4180186
40765133	PhenX - 血压方案 040301:-:时间点:^患者:-:PhenX	4182948
40765134	Preg high blood pressure proto	4180186
40765134	BP; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765134	PhenX - 妊娠期高血压方案 040401:-:时间点:^患者:-:PhenX	4182948
40765137	Sudden cardiac arrest proto	4180186
40765137	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765137	PhenX - 突发心脏停搏方案 040701:-:时间点:^患者:-:PhenX	4182948
40765138	Myocardial infarct proto	4180186
40765138	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765138	PhenX - 心肌梗死方案 040801:-:时间点:^患者:-:PhenX	4182948
40765139	Periph arterial disease proto	4180186
40765139	Dis; Diseases; Dz; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765139	PhenX - 外周动脉疾病方案 040901:-:时间点:^患者:-:PhenX	4182948
40765142	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765142	Deep venous thrombosis proto	4180186
40765142	PhenX - 深静脉血栓形成方案 041201:-:时间点:^患者:-:PhenX	4182948
40765144	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765144	Rheumatic fever proto	4180186
40765144	PhenX - 风湿热方案 041401:-:时间点:^患者:-:PhenX	4182948
40765145	PhenX - arm span protocol	4180186
40765145	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Upper extremity	4180186
40765145	PhenX - 臂展方案 020101:-:时间点:^患者:-:PhenX	4182948
40765148	PhenX - hip circumference protocol	4180186
40765148	Girth; Lower extremity joint; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765148	PhenX - 臀围方案 020801:-:时间点:^患者:-:PhenX	4182948
40765149	PhenX - max adult ht protocol	4180186
40765149	Largest; Maximal; Maximum; Pan; Panel; PANEL.PHENX; Panl; Peak; Pnl; Point in time; Random	4180186
40765149	PhenX - 最大成年身高方案 020901:-:时间点:^患者:-:PhenX	4182948
40765150	Largest; Maximal; Maximum; Pan; Panel; PANEL.PHENX; Panl; Peak; Pnl; Point in time; Random	4180186
40765150	Max adult wt proto	4180186
40765150	PhenX - 最大成年体重方案 021001:-:时间点:^患者:-:PhenX	4182948
40765151	PhenX - upper arm circ protocol	4180186
40765151	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Up; Upper extremity	4180186
40765151	PhenX - 上臂围方案 021101:-:时间点:^患者:-:PhenX	4182948
40765152	Neck circumference proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765152	Neck circumference proto	4180186
40765152	PhenX - 颈围方案 021201:-:时间点:^患者:-:PhenX	4182948
40765153	Pregnancy wt gain proto	4180186
40765153	Gestation; Gestations; Gravida; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Pregnancies; Random	4180186
40765153	PhenX - 妊娠期体重增加方案 021301:-:时间点:^患者:-:PhenX	4182948
40765154	PhenX - wt loss - gain protocol	4180186
40765154	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765154	PhenX - 体重增加或减轻方案 021401:-:时间点:^患者:-:PhenX	4182948
40765155	Chemistry; G/I; Glu; Gluc; Glucoseur; HUM; Humulin; IH7; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
40765155	Glucose/Insulin SerPl-Rto	4180186
40765155	葡萄糖/胰岛素:比率:时间点:血清/血浆:定量型	4182948
40765157	Acd; Acid; After; Aliphatic carboxylate C10-C26; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; Fatty acid; FFA; Free Fatty Acids; Level; Lipid; NEFA; p fast; PC; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p fast; Spec; SR; Substance concentration	4180186
40765157	NEFA sp8 p fast SerPl-sCnc	4180186
40765157	脂肪酸类.非酯化型^在热量型禁食之后的第8个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40765160	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765160	HCoV HKU1 RNA Spec Ql NAA+probe	4180186
40765160	人类冠状病毒 HKU1 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765165	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765165	Bordetella DNA Spec NAA+probe	4180186
40765165	博德特菌属单个未知种 DNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40765166	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EEE virus; EEEV; Enc; Enceph; Encephalomyelitis; Equin; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Togavirus; TRF	4180186
40765166	EEEV IgM Fld Ql IF	4180186
40765166	东方马脑炎病毒 抗体.IgM:存在情况或阈值:时间点:体液:序数型:免疫荧光法	4182948
40765168	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EEE virus; EEEV; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; Fl; Fld; FLU; Fluid; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; Togavirus	4180186
40765168	EEEV IgG Fld Ql IA	4180186
40765168	东方马脑炎病毒 抗体.IgG:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40765169	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; California Encephalitis Virus; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS	4180186
40765169	LACV IgM Fld Ql IA	4180186
40765169	拉克罗斯病毒 抗体.IgM:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40765171	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Enc; Enceph; Encephalomyelitis; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SLE virus; SLEV; St Louis; Time Resolved Fluorescence; TRF	4180186
40765171	SLEV IgM Fld Ql IF	4180186
40765171	圣路易型脑炎病毒 抗体.IgM:存在情况或阈值:时间点:体液:序数型:免疫荧光法	4182948
40765173	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; WNV	4180186
40765173	WNV IgM Fld Ql IA	4180186
40765173	西尼罗河病毒 抗体.IgM:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40765176	nRBC # Fld Auto	4180186
40765176	#; ABS; absolute; absolutes; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Normoblasts; nRBC; nRBCs; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
40765176	红细胞.有核:计数型浓度:时间点:体液:定量型:自动化计数方法	4182948
40765178	nRBC/100 WBC CSF Auto-Rto	4180186
40765178	100WBC; Auto; Automated detection; Cerebral spinal fluid; Cerebrospinal Fl; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythroblasts; Erythrocyte; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Normoblasts; nRBC; nRBCs; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells	4180186
40765178	红细胞.有核/100 个白细胞:比率:时间点:脑脊液:定量型:自动化计数方法	4182948
40765180	1V; Dental; Dentistry; Document; Film; Finding; Findings; Plain Films; Point in time; Random; Single View; VW; Xray; X-ray	4180186
40765180	1V Teeth Doc XR	4180186
40765180	视图:发现:时间点:牙齿类:文档型:X射线摄影术	4182948
40765183	Abd; Abdo; Abdomen+; Abdominal; Art; Arteriogram; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Kidney; L; LT; Point in time; Rad; RADIOLOGY; Random; Renal a-L; RFA; View; VWS; W contr IA; WC	4180186
40765183	RFA Renal a-L Views W contr IA	4180186
40765183	多重视图^采用动脉注射对比剂:发现:时间点:腹部>肾动脉.左侧:文档型:放射荧光透视法.血管造影术	4182948
40765185	Art; Arteriogram; Brain; c; Cardio; Cardiology; Contr; Contra; Contrst; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Head a+Neck a-L; Heart Disease; Imaging; Intracranial; L; LT; Neuro; Neurology; Point in time; Rad; RADIOLOGY; Random; RFA; Skull; View; VWS; W contr IA; WC	4180186
40765185	RFA Head a+Neck a-L Views W contr IA	4180186
40765185	多重视图^采用动脉注射对比剂:发现:时间点:头部>头部动脉.左侧 & 颈部>颈部动脉.左侧:文档型:放射荧光透视法.血管造影术	4182948
40765186	Art; Arteriogram; Brain; c; Cardio; Cardiology; Contr; Contra; Contrst; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Head a+Neck a-L-R; Heart Disease; Imaging; Intracranial; Neuro; Neurology; Point in time; R; Rad; RADIOLOGY; Random; RFA; RT; Skull; View; VWS; W contr IA; WC	4180186
40765186	RFA Head a+Neck a-L-R Views W contr IA	4180186
40765186	多重视图^采用动脉注射对比剂:发现:时间点:头部>头部动脉.右侧 & 颈部>颈部动脉.右侧:文档型:放射荧光透视法.血管造影术	4182948
40765189	Document; Echography; EXT; Extr-R; Finding; Findings; Imaging; LMTED; LTD; Point in time; R; Radiology; Random; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
40765189	US Extr-R Ltd	4180186
40765189	局部多层:发现:时间点:肢体.右侧:文档型:超声	4182948
40765190	Fatty acids.ethyl esters Hair-sCnt	4180186
40765190	Acd; Acid; Chemistry; Ester; FAEE; Fatty acid; Har; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content	4180186
40765190	脂肪酸类.乙酯类:物质的量含量:时间点:毛发:定量型	4182948
40765192	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C immitis F; Coccidiodes; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Serum; species; spp; SR; Valley fever	4180186
40765192	C immitis F Ab Ser Ql ID	4180186
40765192	球孢子菌属 F 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40765198	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
40765198	T vaginalis DNA Vag Ql NAA+probe	4180186
40765198	阴道毛滴虫 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
40765199	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765199	FLUAV+FLUBV RNA Spec Ql NAA+probe	4180186
40765199	流感病毒 A+B 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765200	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40765200	EV RNA # CSF NAA+probe	4180186
40765200	肠道病毒 RNA:计数型浓度:时间点:脑脊液:定量型:探针法.基因扩增.靶向	4182948
40765201	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40765201	EV RNA # SerPl NAA+probe	4180186
40765201	肠道病毒 RNA:计数型浓度:时间点:血清/血浆:定量型:探针法.基因扩增.靶向	4182948
40765202	T gondii DNA # CSF NAA+probe	4180186
40765202	刚地弓形虫 DNA:计数型浓度:时间点:脑脊液:定量型:探针法.基因扩增.靶向	4182948
40765202	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; T gondii; T gondii DNA; TMA; Toxo; Toxoplasmosis; Transcription mediated amplification; Viral load	4180186
40765208	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Viral load	4180186
40765208	HSV1 DNA # Tiss NAA+probe	4180186
40765208	单纯疱疹病毒 1 型 DNA:计数型浓度:时间点:组织与涂片:定量型:探针法.基因扩增.靶向	4182948
40765209	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40765209	HSV1 DNA # Amn NAA+probe	4180186
40765209	单纯疱疹病毒 1 型 DNA:计数型浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
40765210	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40765210	HSV1 DNA # BAL NAA+probe	4180186
40765210	单纯疱疹病毒 1 型 DNA:计数型浓度:时间点:支气管肺泡灌洗液:定量型:探针法.基因扩增.靶向	4182948
40765211	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40765211	HSV2 DNA # Mar NAA+probe	4180186
40765211	单纯疱疹病毒 2 型 DNA:计数型浓度:时间点:骨髓:定量型:探针法.基因扩增.靶向	4182948
40765214	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
40765214	HSV2 DNA # BAL NAA+probe	4180186
40765214	单纯疱疹病毒 2 型 DNA:计数型浓度:时间点:支气管肺泡灌洗液:定量型:探针法.基因扩增.靶向	4182948
40765215	3 Self-Sustaining Sequence Replication; 3SR SR; A fumigatus; Amplif; Amplification; Amplified; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Farmers lung; Fum; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m003; m3; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765215	A fumigatus DNA Spec Ql NAA+probe	4180186
40765215	烟曲霉 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765216	3 Self-Sustaining Sequence Replication; 3SR SR; A terreus; Amplif; Amplification; Amplified; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Farmers lung; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m309; m36; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765216	A terreus DNA Spec Ql NAA+probe	4180186
40765216	土曲霉 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765218	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV 6A; Human herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40765218	HHV 6A DNA CSF Ql NAA+probe	4180186
40765218	疱疹病毒 6A 型 DNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
40765219	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV 6B; Human herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40765219	HHV 6B DNA CSF Ql NAA+probe	4180186
40765219	疱疹病毒 6B 型 DNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
40765220	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV 6A; Human herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40765220	HHV 6A DNA SerPl Ql NAA+probe	4180186
40765220	疱疹病毒 6A 型 DNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40765221	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV 6B; Human herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40765221	HHV 6B DNA SerPl Ql NAA+probe	4180186
40765221	疱疹病毒 6B 型 DNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
40765222	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV 6A; Human herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765222	HHV 6A DNA Spec Ql NAA+probe	4180186
40765222	疱疹病毒 6A 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765224	Auto; Automated detection; Dip stick; Dipstick; Elec; Elect; Electr; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UBG; UR; URINALYSIS; Urn; Urobili; Urobilngn	4180186
40765224	Urobilinogen Ur Ql Strip.auto	4180186
40765224	尿胆素原:存在情况或阈值:时间点:尿液:序数型:试纸条.自动化法	4182948
40765226	Inorg Sulfate 24h Ur-sRate	4180186
40765226	1 day; 24 hours; 24HR; Chemistry; Inorg Sulfate; QNT; Quan; Quant; Quantitative; SO4; SO4-2; sRate; Substance Rate; Sulf; UA; UR; Urn	4180186
40765226	硫酸盐.无机:物质的量速率:24小时:尿液:定量型	4182948
40765228	Abd; Abd+Pelvis; Abdo; Abdominal; Art; Arteriogram; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Iliac a-R; Imaging; Pelvic; Pelvic artery; Point in time; Prosth place; R; Rad; Radiology; Random; RFA; RT; W contr IA; WC	4180186
40765228	RFA Guided Iliac a-R Prosth pl--W cont IA	4180186
40765228	旨在置入假体的引导^采用动脉注射对比剂:发现:时间点:腹部+盆腔>髂动脉.右侧:文档型:放射荧光透视法.血管造影术	4182948
40765229	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; Haemoph; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S agalactiae; S pn + HFLU + S agal; S pn + HFLU + S agal DNA; S pneumo; S pneumoniae; S pneumoniase DNA; SDA; Spec; Spn; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; To be specified in another part of the message; Transcription mediated amplification;...	4180186
40765229	S pn+HFLU+S agal DNA XXX NAA+pr	4180186
40765229	肺炎链球菌 DNA 与流感嗜血杆菌 DNA 与无乳链球菌 DNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
40765231	Tobac age init use adult proto	4180186
40765231	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tobac age init use adult proto	4180186
40765231	PhenX - 烟草 - 开始使用年龄 - 成年人方案 030702:-:时间点:^患者:-:PhenX	4182948
40765234	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tobacco 30D quant freq adult proto	4180186
40765234	Tobacco 30D quant freq adult proto	4180186
40765234	PhenX - 烟草 - 30 天数量与频率 - 成年人方案 030802:-:时间点:^患者:-:PhenX	4182948
40765235	Measure - tobac age offset use; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765237	Tobac age offset adult proto	4180186
40765237	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tobac age offset adult proto	4180186
40765237	PhenX - 烟草 - 停止使用年龄 - 成年人方案 030902:-:时间点:^患者:-:PhenX	4182948
40765238	Habitrol; Measure - tobac nicotine depend; Nicoderm; Nictoine; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765240	Measure - subst lifetime use; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Subs	4180186
40765250	Environ exp current residence proto; Housing; Living Arrangement; Living Arrangements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765250	Environ exp current residence proto	4180186
40765250	PhenX - 环境暴露 - 当前住宅特点方案 060101:-:时间点:^患者:-:PhenX	4182948
40765251	Measure - envir water source; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Srce	4180186
40765255	Exp; Job; Measure - envir exp work daily life; Occupation; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765258	Environ exp occupation hx proto; Hx; Job; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Work	4180186
40765258	Environ exp occupation hx proto	4180186
40765258	PhenX - 环境暴露 - 职业 - 职业史方案 060501:-:时间点:^患者:-:PhenX	4182948
40765259	Measure - envir exp hobbies; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765260	Environ exp hobbies proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765260	Environ exp hobbies proto	4180186
40765260	PhenX - 环境暴露 - 业余爱好暴露方案 060601:-:时间点:^患者:-:PhenX	4182948
40765263	Measure - envir sibship; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765264	Environ exp sibship birth order proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765264	Environ exp sibship birth order proto	4180186
40765264	PhenX - 环境暴露 - 血缘关系 - 出生次序方案 060801:-:时间点:^患者:-:PhenX	4182948
40765265	Before; Measure - envir day care preschool; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765267	H/O; Hx; Measure - envir hx breast fed; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765269	Measure - envir air contam; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765270	Environ exp air contaminants proto	4180186
40765270	Environ exp air contaminants proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765270	PhenX - 环境暴露 - 家庭环境之中的空气污染物方案 061101:-:时间点:^患者:-:PhenX	4182948
40765271	Coll; Collect; Collected; Measure - envir dust vacuum; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765279	Alcohol lifetime use proto	4180186
40765279	Alc; Alcohol lifetime use proto; alcoholic; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765279	PhenX - 酒精 - 终生饮用方案 030101:-:时间点:^患者:-:PhenX	4182948
40765280	Alc; alcoholic; Measure - alcohol age of first use; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765281	Alcohol age first use proto	4180186
40765281	Alc; Alcohol age first use proto; alcoholic; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765281	PhenX - 酒精 - 首次饮用年龄方案 030201:-:时间点:^患者:-:PhenX	4182948
40765283	Alcohol 30D quantity frequency proto	4180186
40765283	Alc; Alcohol 30D quantity frequency proto; alcoholic; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765283	PhenX - 酒精 - 30天数量 - 频率方案 030301:-:时间点:^患者:-:PhenX	4182948
40765284	Alc; alcoholic; Measure - alcohol max drinks in 24h; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765286	Alc; alcoholic; Measure alcohol life abuse depend; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765290	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tobac smok status adult proto; Tobac smoke stat	4180186
40765290	Tobac smok status adult proto	4180186
40765290	PhenX - 烟草 - 吸烟状况 - 成年人方案 030602:-:时间点:^患者:-:PhenX	4182948
40765291	Measure - tobac age initiation use; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765292	Tobac age init use adoles proto	4180186
40765292	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tobac age init use adoles proto	4180186
40765292	PhenX - 烟草 - 开始使用年龄 - 青少年方案 030701:-:时间点:^患者:-:PhenX	4182948
40765294	Alc; alcoholic; Exp; Measure cumul life alcohol exp; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765297	Activ; Activity; Actvty; Exercise; Lifetime phys act proto; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765297	Lifetime phys act proto	4180186
40765297	PhenX - 终生体力活动方案 070201:-:时间点:^患者:-:PhenX	4182948
40765301	Exogenous female hormone proto; Horm; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765301	Exogenous female hormone proto	4180186
40765301	PhenX - 外源性雌性激素使用方案 070401:-:时间点:^患者:-:PhenX	4182948
40765302	Hx; Measure - ovulation hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765303	Ovulation hx proto	4180186
40765303	Hx; Ovulation hx proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765303	PhenX - 排卵史方案 070501:-:时间点:^患者:-:PhenX	4182948
40765305	Cancer pers family hx proto	4180186
40765305	Cancer pers family hx proto; Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765305	PhenX - 癌症 - 个人与家族史方案 070601:-:时间点:^患者:-:PhenX	4182948
40765306	Measure - knowl smok cancer risk; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765307	Knowl smok cancer risk proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765307	Knowl smok cancer risk proto	4180186
40765307	PhenX - 吸烟相关癌症风险了解方案 070701:-:时间点:^患者:-:PhenX	4182948
40765310	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765311	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765311	Cancer screenings proto	4180186
40765311	PhenX - 癌症筛查方案 070901:-:时间点:^患者:-:PhenX	4182948
40765312	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765312	Domain - Oral health	4180186
40765312	PhenX 领域 - 口腔健康:-:时间点:^患者:-:PhenX	4182948
40765314	Oral breast bottle feeding proto	4180186
40765314	Oral breast bottle feeding proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765314	PhenX - 口腔健康 - 母乳喂养或奶瓶喂养模式方案 080101:-:时间点:^患者:-:PhenX	4182948
40765319	Measure - oral dry mouth; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765321	Measure - oral cleft lip or palate; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765322	Oral cleft lip or palate proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765322	Oral cleft lip or palate proto	4180186
40765322	PhenX - 口腔健康 - 存在唇裂或颚裂方案 080501:-:时间点:^患者:-:PhenX	4182948
40765323	Fl; Measure - oral fluoride use; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765325	Measure - oral malocclusion; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765327	Measure - oral num natural teeth; No; Num; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765333	Dis; Diseases; Dz; Measure - oral periodontal dis; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765334	Oral periodontal dis proto	4180186
40765334	Dis; Diseases; Dz; Oral periodontal dis proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765334	PhenX - 口腔健康 - 牙周病 - 流行程度方案 081101:-:时间点:^患者:-:PhenX	4182948
40765337	Measure - oral profess dental care; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765340	Oral tobac non-cigarette proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Smoke; Smokes; Smoking; Tobacco	4180186
40765340	Oral tobac non-cigarette proto	4180186
40765340	PhenX - 口腔健康 - 非香烟烟草制品使用方案 081401:-:时间点:^患者:-:PhenX	4182948
40765341	Measure - oral tooth orofacial pain; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765342	Oral toothache orofacial pain proto	4180186
40765342	Oral toothache orofacial pain proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765342	PhenX - 口腔健康 - 牙痛与颜面部疼痛方案 081501:-:时间点:^患者:-:PhenX	4182948
40765343	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765344	Smoking quit attempts proto	4180186
40765344	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765344	PhenX - 戒烟尝试方案 071001:-:时间点:^患者:-:PhenX	4182948
40765347	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765347	Domain - Respiratory	4180186
40765347	PhenX 领域 - 呼吸系统:-:时间点:^患者:-:PhenX	4182948
40765351	Resp bronchodil respons proto	4180186
40765351	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp bronchodil respons proto	4180186
40765351	PhenX - 呼吸系统 - 支气管扩张剂响应性方案 090301:-:时间点:^患者:-:PhenX	4182948
40765352	Measure - resp chest CT; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765353	Resp chest CT proto	4180186
40765353	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp chest CT proto	4180186
40765353	PhenX - 呼吸系统 - 胸部计算机断层扫描方案 090401:-:时间点:^患者:-:PhenX	4182948
40765355	Activity; EXCZ; Exercise; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp exercise 6M walk proto	4180186
40765355	Resp exercise 6M walk proto	4180186
40765355	PhenX - 呼吸系统 - 运动能力 - 6 分钟行走试验方案 090601:-:时间点:^患者:-:PhenX	4182948
40765356	Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Measure - resp immunoglobulin E; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Spec; Tot; Totl	4180186
40765357	Resp immunoglobulin E proto	4180186
40765357	Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp immunoglobulin E proto; Spec; Tot; Totl	4180186
40765357	PhenX - 呼吸系统 - 免疫球蛋白 E - 总计与特异性方案 090701:-:时间点:^患者:-:PhenX	4182948
40765358	Dynamic; Measure - resp peak expiratory flow; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765360	Measure - resp fam hx resp sympts; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sx; Symp + dis	4180186
40765362	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp fam hx resp sympt child proto; Sx; Symp + dis	4180186
40765362	Resp fam hx resp sympt child proto	4180186
40765362	PhenX - 呼吸系统 - 个人 - 呼吸系统症状与疾病家族史 - 儿童方案 090902:-:时间点:^患者:-:PhenX	4182948
40765363	EXCZ; Measure - resp pulse ox exercise; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765364	Activity; EXCZ; Exercise; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp pulse ox exercise proto	4180186
40765364	Resp pulse ox exercise proto	4180186
40765364	PhenX - 呼吸系统 - 脉搏血氧定量法 - 运动方案 091001:-:时间点:^患者:-:PhenX	4182948
40765368	Resp rate infant proto	4180186
40765368	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp rate infant proto	4180186
40765368	PhenX - 呼吸系统 - 呼吸速率 - 婴幼儿方案 091401:-:时间点:^患者:-:PhenX	4182948
40765372	Resp sleep apnea adult proto	4180186
40765372	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Resp sleep apnea adult proto	4180186
40765372	PhenX - 呼吸系统 - 睡眠呼吸暂停 - 成年人方案 091501:-:时间点:^患者:-:PhenX	4182948
40765374	Measure - resp spirometry; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765379	Measure - assess pubertal development; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765380	Assess pubertal dev female proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765380	Assess pubertal dev female proto	4180186
40765380	PhenX - 青春期发育评估 - 女性方案 100101:-:时间点:^患者:-:PhenX	4182948
40765381	Assess pubertal dev male proto	4180186
40765381	Assess pubertal dev male proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765381	PhenX - 青春期发育评估 - 男性方案 100102:-:时间点:^患者:-:PhenX	4182948
40765383	Cause treat infertility male proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tx; Txs	4180186
40765383	Cause treat infertility male proto	4180186
40765383	PhenX - 已知不育症的原因与治疗 - 男性方案 100201:-:时间点:^患者:-:PhenX	4182948
40765384	Cause treat infertility female proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tx; Txs	4180186
40765384	Cause treat infertility female proto	4180186
40765384	PhenX - 已知不育症的原因与治疗 - 女性方案 100202:-:时间点:^患者:-:PhenX	4182948
40765385	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765388	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765389	Difficulty conceiving proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765389	Difficulty conceiving proto	4180186
40765389	PhenX - 受孕难度方案 100401:-:时间点:^患者:-:PhenX	4182948
40765390	Measure - fem reprod surg proced; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Surg; Surg proc	4180186
40765400	Male reproductive birth defects proto	4180186
40765400	Male reproductive birth defects proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765400	PhenX - 男性生殖道出生缺陷方案 100901:-:时间点:^患者:-:PhenX	4182948
40765401	FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765402	FCN; Func; Funct; Male sexual func proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765402	Male sexual func proto	4180186
40765402	PhenX - 男性性功能方案 101001:-:时间点:^患者:-:PhenX	4182948
40765405	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765408	Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Reproductive history female proto	4180186
40765408	Reproductive history female proto	4180186
40765408	PhenX - 生育史 - 女性方案 101301:-:时间点:^患者:-:PhenX	4182948
40765410	Sexual history proto	4180186
40765410	Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765410	PhenX - 性史方案 101401:-:时间点:^患者:-:PhenX	4182948
40765413	Domain - Ocular	4180186
40765413	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765413	PhenX 领域 - 眼睛:-:时间点:^患者:-:PhenX	4182948
40765414	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765415	Contact biometry proto	4180186
40765415	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765415	PhenX - 接触式生物测量法方案 110101:-:时间点:^患者:-:PhenX	4182948
40765416	Appearance; Colour; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765418	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765421	Eye diseases young children proto	4180186
40765421	Eye diseases young children proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tx	4180186
40765421	PhenX - 眼病 - 幼小儿童治疗方案 110401:-:时间点:^患者:-:PhenX	4182948
40765424	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765426	IOP; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765427	Intraocular pressure proto	4180186
40765427	IOP; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765427	PhenX - 眼压方案 110701:-:时间点:^患者:-:PhenX	4182948
40765428	Exp; Measure - ocular exposure to UV light; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765429	Ocular exposure UV light protocol	4180186
40765429	Exp; Ocular exposure UV light protocol; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765429	PhenX - 眼睛紫外线暴露方案 110801:-:时间点:^患者:-:PhenX	4182948
40765431	H/O; Hx; Measure fam hx strabismus; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765436	Visual function proto	4180186
40765436	FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765436	PhenX - 视觉功能方案 111201:-:时间点:^患者:-:PhenX	4182948
40765438	Contact lens use adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765438	Contact lens use adult proto	4180186
40765438	PhenX - 隐形眼镜使用 - 成年人方案 111301:-:时间点:^患者:-:PhenX	4182948
40765445	Domain - Psychiatric	4180186
40765445	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765445	PhenX 领域 - 精神病学:-:时间点:^患者:-:PhenX	4182948
40765446	Measure - general psych assessment; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765448	Gen psych assess child protocol; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765448	Gen psych assess child protocol	4180186
40765448	PhenX - 通用精神病学评估 - 儿童方案 120102:-:时间点:^患者:-:PhenX	4182948
40765449	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765451	Anx disorders screener adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765451	Anx disorders screener adult proto	4180186
40765451	PhenX - 焦虑症筛查工具 - 成年人方案 120202:-:时间点:^患者:-:PhenX	4182948
40765452	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765455	Hypomania mania sympts child proto	4180186
40765455	Hypomania mania sympts child proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sx	4180186
40765455	PhenX - 轻躁狂 - 躁狂症症状 - 儿童方案 120401:-:时间点:^患者:-:PhenX	4182948
40765457	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765458	Depression child proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765458	Depression child proto	4180186
40765458	PhenX - 抑郁 - 儿童方案 120501:-:时间点:^患者:-:PhenX	4182948
40765459	Depression adult proto	4180186
40765459	Depression adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765459	PhenX - 抑郁 - 成年人方案 120502:-:时间点:^患者:-:PhenX	4182948
40765460	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765461	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765461	Eating disorders screener proto	4180186
40765461	PhenX - 进食障碍筛查工具方案 120601:-:时间点:^患者:-:PhenX	4182948
40765463	Glasses contact lenses child proto	4180186
40765463	Arterial Stenosis; Glasses contact lenses child proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765463	PhenX - 使用眼镜及隐形眼镜 - 儿童方案 111302:-:时间点:^患者:-:PhenX	4182948
40765465	Meds pain statins steroids proto	4180186
40765465	Meds pain statins steroids proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Ste; Steriods; Steroid	4180186
40765465	PhenX - 药物 - 止疼药物、他汀类药物、类固醇类药物方案 071201:-:时间点:^患者:-:PhenX	4182948
40765467	Measure - resp pulse ox rest; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765469	Measure - autism disorders; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sx	4180186
40765474	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765474	Sleep disorders screener proto	4180186
40765474	PhenX - 睡眠障碍筛查工具方案 121001:-:时间点:^患者:-:PhenX	4182948
40765477	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765480	Posttraumatic stress disorder proto	4180186
40765480	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Posttraumatic stress disorder proto; Random	4180186
40765480	PhenX - 创伤后应激障碍方案 121401:-:时间点:^患者:-:PhenX	4182948
40765484	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765485	Psychopathy proto	4180186
40765485	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765485	PhenX - 精神病方案 121601:-:时间点:^患者:-:PhenX	4182948
40765487	Domain - Neurology	4180186
40765487	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765487	PhenX 领域 - 神经病学:-:时间点:^患者:-:PhenX	4182948
40765491	Clinical neuropathy proto	4180186
40765491	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765491	PhenX - 临床神经病方案 130201:-:时间点:^患者:-:PhenX	4182948
40765495	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765495	Epilepsy screener proto	4180186
40765495	PhenX - 癫痫筛查工具方案 130401:-:时间点:^患者:-:PhenX	4182948
40765498	H/O; Hx; Measure - hx of head truama; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765499	Head trauma proto	4180186
40765499	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765499	PhenX - 头部创伤方案 130601:-:时间点:^患者:-:PhenX	4182948
40765500	Measure - glob mental stat screener; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765501	Global mental status adult proto	4180186
40765501	Global mental status adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765501	PhenX - 总体心理状况 - 成年人方案 130701:-:时间点:^患者:-:PhenX	4182948
40765502	Global mental status child proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765502	Global mental status child proto	4180186
40765502	PhenX - 总体心理状况 - 儿童方案 130702:-:时间点:^患者:-:PhenX	4182948
40765503	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765505	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765506	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765506	Visual memory proto	4180186
40765506	PhenX - 视觉记忆方案 130901:-:时间点:^患者:-:PhenX	4182948
40765507	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765512	FCN; Func; Funct; Gross motor func 2-4Y proto; II; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765512	Gross motor func 2-4Y proto	4180186
40765512	PhenX - 粗大运动功能 - 2-4 岁方案 131201:-:时间点:^患者:-:PhenX	4182948
40765513	Gross motor func 4-6Y proto	4180186
40765513	FCN; Func; Funct; Gross motor func 4-6Y proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765513	PhenX - 粗大运动功能 - 4-6 岁方案 131202:-:时间点:^患者:-:PhenX	4182948
40765514	FCN; Func; Funct; Gross motor func 6-12Y proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765514	Gross motor func 6-12Y proto	4180186
40765514	PhenX - 粗大运动功能 - 6-12 岁方案 131203:-:时间点:^患者:-:PhenX	4182948
40765516	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765516	Signs of essential tremor proto	4180186
40765516	PhenX - 特发性震颤体征方案 131301:-:时间点:^患者:-:PhenX	4182948
40765517	Measure - restless legs syndrome; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sx	4180186
40765519	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765519	Domain - Diabetes	4180186
40765519	PhenX 领域 - 糖尿病:-:时间点:^患者:-:PhenX	4182948
40765521	Autoimmune dis type 1 diabetes proto	4180186
40765521	Autoimmune dis type 1 diabetes proto; i; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765521	PhenX - I 型糖尿病相关自身免疫性疾病方案:-:时间点:^患者:-:PhenX	4182948
40765522	Family hx diabetes; H/O; Hx; Measure - fam hx of diabetes; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765523	Fam hx diabetes proto; Family hx diabetes; H/O; Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765523	Fam hx diabetes proto	4180186
40765523	PhenX - 糖尿病家族史方案 140201:-:时间点:^患者:-:PhenX	4182948
40765524	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765528	H/O; Hx; i; II; Measure - hx type 1-2 diabetes; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765531	Pers hx kidney failure proto	4180186
40765531	H/O; Hx; Pan; Panel; PANEL.PHENX; Panl; Pers hx kidney failure proto; Pnl; Point in time; Random	4180186
40765531	PhenX - 肾功能衰竭个人史方案 140601:-:时间点:^患者:-:PhenX	4182948
40765532	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765533	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765533	Diabetic retinopathy proto	4180186
40765533	PhenX - 糖尿病视网膜病变方案 140701:-:时间点:^患者:-:PhenX	4182948
40765534	B; C peptide; Connecting peptide of insulin; FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pept; Pnl; Point in time; Pro-insulin c peptide; Random	4180186
40765535	B; C peptide; Connecting peptide of insulin; Fasting C-peptide proto; FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pept; Pnl; Point in time; Pro-insulin c peptide; Random	4180186
40765535	Fasting C-peptide proto	4180186
40765535	PhenX - 残余 beta 细胞功能空腹 C-肽检测方案 141201:-:时间点:^患者:-:PhenX	4182948
40765537	HUM; Humulin; IH7; Insul; Lente; NPH; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Semilente; Ser; Sliding; SR; Ultralente	4180186
40765537	Fasting serum insulin proto	4180186
40765537	PhenX - 空腹血清胰岛素方案 141301:-:时间点:^患者:-:PhenX	4182948
40765538	CR; Crea; Creat; FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Ser; SR	4180186
40765541	FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Urinary microalbumin assay proto	4180186
40765541	Urinary microalbumin assay proto	4180186
40765541	PhenX - 肾功能尿液微量白蛋白检测方案 141501:-:时间点:^患者:-:PhenX	4182948
40765542	CR; Crea; Creat; FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765544	Activ; Activity; Actvty; Domain Physical act physical fit; Exercise; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765544	Domain Physical act physical fit	4180186
40765544	PhenX 领域 - 体力活动与身体健康:-:时间点:^患者:-:PhenX	4182948
40765545	EXCZ; Measure - cardiorespiratory exercise; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765546	Cardioresp fitness 1 mi walk proto; i; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765546	Cardioresp fitness 1 mi walk proto	4180186
40765546	PhenX - 心脏和呼吸系统健康状况 - 1 英里行走方案 150101:-:时间点:^患者:-:PhenX	4182948
40765547	Cardioresp fitness treadmill proto	4180186
40765547	Cardioresp fitness treadmill proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765547	PhenX - 心脏和呼吸系统健康状况 - 踏车方案 150102:-:时间点:^患者:-:PhenX	4182948
40765549	Integrated fitness adult proto	4180186
40765549	Integrated fitness adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765549	PhenX - 综合体质 - 成年人方案 150201:-:时间点:^患者:-:PhenX	4182948
40765550	Integrated fitness older adult proto	4180186
40765550	Integrated fitness older adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765550	PhenX - 综合体质 - 老年成人方案 150202:-:时间点:^患者:-:PhenX	4182948
40765551	Integrated fitness child proto	4180186
40765551	Integrated fitness child proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765551	PhenX - 综合体质 - 儿童方案 150203:-:时间点:^患者:-:PhenX	4182948
40765554	Activ; Actvty; Measure - phys act readiness; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765555	Activ; Activity; Actvty; Exercise; Movements; Pan; Panel; PANEL.PHENX; Panl; Phys act readiness proto; Pnl; Point in time; Random	4180186
40765555	Phys act readiness proto	4180186
40765555	PhenX - 体力活动 - 就绪状态方案 150401:-:时间点:^患者:-:PhenX	4182948
40765556	Measure - phys func objective; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765559	Sit sedentary behav adult proto	4180186
40765559	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sit sedentary behav adult proto	4180186
40765559	PhenX - 坐姿 - 久坐行为 - 成年人方案 150601:-:时间点:^患者:-:PhenX	4182948
40765560	Sit sedentary behav adoles proto	4180186
40765560	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Sit sedentary behav adoles proto	4180186
40765560	PhenX - 坐姿 - 久坐行为 - 青少年方案 150602:-:时间点:^患者:-:PhenX	4182948
40765563	Activ; Activity; Actvty; Exercise; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tot; Tot phys act comp adult proto; Totl	4180186
40765563	Tot phys act comp adult proto	4180186
40765563	PhenX - 全部体力活动 - 综合 - 成年人方案 150702:-:时间点:^患者:-:PhenX	4182948
40765564	Activ; Activity; Actvty; Exercise; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tot; Tot phys activity comp old adult proto; Totl	4180186
40765564	Tot phys activity comp old adult proto	4180186
40765564	PhenX - 全部体力活动 - 综合 - 老年人方案 150703:-:时间点:^患者:-:PhenX	4182948
40765566	Activ; Activity; Actvty; Exercise; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tot; Total phys activity objective proto; Totl	4180186
40765566	Total phys activity objective proto	4180186
40765566	PhenX - 全部体力活动 - 客观方案 150801:-:时间点:^患者:-:PhenX	4182948
40765567	Activ; Actvty; Measure - total phys act screener; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Tot; Totl	4180186
40765570	Walking ambulation objective proto	4180186
40765570	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Walking ambulation objective proto	4180186
40765570	PhenX - 行走 - 下床活动 客观方案 151001:-:时间点:^患者:-:PhenX	4182948
40765571	Measure - phys func subjective; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765573	Activ; Actvty; Measure - phys act neighbor environ; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765574	Activ; Activity; Actvty; Exercise; Movements; Pan; Panel; PANEL.PHENX; Panl; Phys act neighbor environ proto; Pnl; Point in time; Random	4180186
40765574	Phys act neighbor environ proto	4180186
40765574	PhenX - 体力活动 - 临近街坊环境方案 151201:-:时间点:^患者:-:PhenX	4182948
40765575	Activ; Actvty; Measure - phys act self efficacy; Movements; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765579	Activity; Cardioresp non-exercise proto; EXCZ; Exercise; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765579	Cardioresp non-exercise proto	4180186
40765579	PhenX - 心脏和呼吸系统健康状况 - 非运动方案 151401:-:时间点:^患者:-:PhenX	4182948
40765581	文拉法辛+O-去甲基文拉法辛:质量浓度:时间点:血清/血浆:定量型	4182948
40765581	Vnlfxn+ODV SerPl-mCnc	4180186
40765581	Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Efexor; Effexor; Level; Mass concentration; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Pl; Plasma; Plsm; Point in time; Pristiq; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Venlafaxin; Venlafaxine metabolite; Vnlfxn+ODV	4180186
40765582	Asympt; Asymptomatic; Glu; Gluc; Glucoseur; Measure - fast plas gluc bld draw; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Scn	4180186
40765584	Fast plasma gluc glucometer proto	4180186
40765584	Asympt; Asymptomatic; Fast plasma gluc glucometer proto; Glu; Gluc; Glucoseur; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Scn	4180186
40765584	PhenX - 糖尿病筛查空腹血浆葡萄糖 - 血糖测定仪方案 140802:-:时间点:^患者:-:PhenX	4182948
40765585	Glu; Gluc; Glucoseur; Haemoglobin; Hb; Hgb; Measure - glycosylated hem assay; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765587	Glu; Glu tol; Gluc; Glucoseur; GTT; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765588	Glu; Glu tol; Gluc; Glucoseur; GTT; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765588	Oral glucose tolerance test proto	4180186
40765588	PhenX - 口服葡萄糖耐量试验方案 141001:-:时间点:^患者:-:PhenX	4182948
40765590	Micromegakaryocytes/leuk NFr Bld Manual	4180186
40765590	100WBC; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Megakaryocyte hypoploidy; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
40765590	小巨核细胞/100 个白细胞:计数型分数:时间点:全血:定量型:手工计数方法	4182948
40765591	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765591	RV RNA Spec Ql NAA+probe	4180186
40765591	轮状病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765593	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV 71; EV71; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40765593	EV 71 RNA Spec Ql NAA+probe	4180186
40765593	肠道病毒 71 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40765596	Chlam; Chlamid; Measure - chlamydia gonorrhea; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765600	Hep; Hepatis; Hepatit; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765601	Hep; Hepatis; Hepatit; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765601	Assay for hepatitis C proto	4180186
40765601	PhenX - 丙型肝炎分析方案 160301:-:时间点:^患者:-:PhenX	4182948
40765603	Assay for hepatitis B proto	4180186
40765603	Hep; Hepatis; Hepatit; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765603	PhenX - 乙型肝炎分析方案 160401:-:时间点:^患者:-:PhenX	4182948
40765604	Herp splx; HSV; i; II; Measure - assay herpes simplex 1-2; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765610	Imm; Imun; Imune; Measure - immune response screener; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765611	Imm; Immune response - adult proto; Imun; Imune; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765611	Immune response - adult proto	4180186
40765611	PhenX - 与免疫应答相关的健康状况 - 筛查工具 - 成年人方案 160801:-:时间点:^患者:-:PhenX	4182948
40765612	Immune response - child proto	4180186
40765612	Imm; Immune response - child proto; Imun; Imune; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765612	PhenX - 与免疫应答相关的健康状况 - 筛查工具 - 儿童方案 160802:-:时间点:^患者:-:PhenX	4182948
40765613	AIDS; Human immunodeficiency virus; Measure - HIV; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765614	HIV proto	4180186
40765614	AIDS; HIV proto; Human immunodeficiency virus; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765614	PhenX - 人类免疫缺陷病毒方案 160901:-:时间点:^患者:-:PhenX	4182948
40765615	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765620	Hx; International travel hx proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765620	International travel hx proto	4180186
40765620	PhenX - 国际旅行史方案 161201:-:时间点:^患者:-:PhenX	4182948
40765622	Medical history proto	4180186
40765622	Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765622	PhenX - 病史方案 161301:-:时间点:^患者:-:PhenX	4182948
40765625	Allergies Hx; H/O; Hx; Measure - med hx allerg inf dis immun; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765626	Allergies Hx; H/O; Hx; Hx allerg infect immun child proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765626	Hx allerg infect immun child proto	4180186
40765626	PhenX - 变态反应、传染病及疫苗接种方面的个人病史 - 儿童方案 161601:-:时间点:^患者:-:PhenX	4182948
40765627	Allergies Hx; H/O; Hx; Hx allerg infect immun adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765627	Hx allerg infect immun adult proto	4180186
40765627	PhenX - 变态反应、传染病及疫苗接种方面的个人病史 - 成年人方案 161602:-:时间点:^患者:-:PhenX	4182948
40765628	Integument; Musc; Muscl; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765628	Domain - Skin, bone, muscle and joint	4180186
40765628	PhenX 领域 - 皮肤、骨骼、肌肉及关节:-:时间点:^患者:-:PhenX	4182948
40765629	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; Pan; Panel; PANEL.PHENX; Panl; Phos; Phosphtase; Pnl; Point in time; Random	4180186
40765630	Alkaline phosphatase proto	4180186
40765630	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; Pan; Panel; PANEL.PHENX; Panl; Phos; Phosphtase; Pnl; Point in time; Random	4180186
40765630	PhenX - 碱性磷酸酶方案 170101:-:时间点:^患者:-:PhenX	4182948
40765631	Arth; Measure - arthritis osteoarthritis; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765634	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765634	Eczema proto	4180186
40765634	PhenX - 湿疹方案 170301:-:时间点:^患者:-:PhenX	4182948
40765635	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765637	H/O; Hx; Measure - personal family hx psoriasis; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765640	Integument; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765640	Skin cancer proto	4180186
40765640	PhenX - 皮肤癌方案 170601:-:时间点:^患者:-:PhenX	4182948
40765642	BMD; Den; DEX; DEXA; Lower extremity; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Spine - femur bone density DXA proto	4180186
40765642	Spine - femur bone density DXA proto	4180186
40765642	PhenX - 双能X线吸收法脊椎 - 股骨密度方案 170701:-:时间点:^患者:-:PhenX	4182948
40765643	Domain - Psychosocial	4180186
40765643	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765643	PhenX 领域 - 心理社会学:-:时间点:^患者:-:PhenX	4182948
40765649	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765651	Measure - disinhibit behav - impuls; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765653	Disinhibit behav/impuls -child UPPS-R-C	4180186
40765653	Disinhibit behav/impuls -child; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; R prime; Random; Right; UPPS-P Impulsive Behavior Scale for Children; Urgency,Perseverance,Premeditation,Sensation Seeking-Impulsive Behavior Scale	4180186
40765653	PhenX - 去抑制行为 - 冲动性 - 儿童方案 180402:-:时间点:^患者:-:UPPS-R-C 法	4182948
40765654	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765658	Gen self-efficacy - adult proto	4180186
40765658	Gen self-efficacy - adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765658	PhenX - 总体自我效能 - 成年人方案 180601:-:时间点:^患者:-:PhenX	4182948
40765661	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765661	Social support - conflict proto	4180186
40765661	PhenX - 所感知到的社会支持 - 冲突方案 180701:-:时间点:^患者:-:PhenX	4182948
40765662	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765665	Isol; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765665	Social isolation proto	4180186
40765665	PhenX - 社会隔离方案 181001:-:时间点:^患者:-:PhenX	4182948
40765668	Temperament - early child proto	4180186
40765668	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765668	PhenX - 性情 - 儿童早期方案 181102:-:时间点:^患者:-:PhenX	4182948
40765670	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765672	Crime delinquency adult proto	4180186
40765672	Crime delinquency adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765672	PhenX - 犯罪行为及青少年犯罪行为 - 成年人方案 181202:-:时间点:^患者:-:PhenX	4182948
40765673	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765675	Measure - exp to violence; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765676	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765676	Exposures to violence - adult proto	4180186
40765676	PhenX - 暴力暴露 - 成年人方案 181401:-:时间点:^患者:-:PhenX	4182948
40765677	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765677	Exposures to violence - child proto	4180186
40765677	PhenX - 暴力暴露 - 儿童方案 181402:-:时间点:^患者:-:PhenX	4182948
40765678	JCV IgM Titr Fld IF	4180186
40765678	詹姆斯敦峡谷病毒 抗体.IgM:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40765678	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; JCV; Microbiology; Point in time; Random; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40765679	Arbitrary; Blood; CD110; C-MPL; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MPL p.W515L+W515K; MPL p.W515L+W515K+S505N; MPL proto-oncogene, thrombopoietin receptor; MPLV; MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; Ordinal; P prime; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Ser505Asn; THCYT2; thrombopoietin receptor mutations; Tissue; Tissue, unspecified; TPOR; Trp515Leu; Trp515Lys; WB; Whole blood; Whole blood or Tissue	4180186
40765679	MPL p.W515L+W515K+S505N Bld/T Ql	4180186
40765679	MPL 基因.p.W515L+W515K+S505N:任意型:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40765682	GI; Measure - assess func GI disorders; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765686	Dis; Diseases; Dz; Measure - assess gallbladder disease; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765689	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765689	Celiac sprue assay proto	4180186
40765689	PhenX - 脂肪便症检测方案 190301:-:时间点:^患者:-:PhenX	4182948
40765691	Colorectal procedure outcomes proto	4180186
40765691	Colorectal procedure outcomes proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765691	PhenX - 结直肠操作与结局方案 190401:-:时间点:^患者:-:PhenX	4182948
40765693	CTabdominal organs proto	4180186
40765693	Abd; Abdo; Abdomen; CTabdominal organs proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765693	PhenX - 腹部器官计算机断层扫描方案 190501:-:时间点:^患者:-:PhenX	4182948
40765695	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765695	Emotional distress proto	4180186
40765695	PhenX - 负性情绪方案 190601:-:时间点:^患者:-:PhenX	4182948
40765696	Dis; Diseases; Dz; IBD; Measure - impact of inflamm bowel; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765698	FCN; Func; Funct; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765699	Liver func assay proto	4180186
40765699	FCN; Func; Funct; Liver func assay proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765699	PhenX - 肝功能检测方案 190801:-:时间点:^患者:-:PhenX	4182948
40765701	Pain abd - type intensity proto	4180186
40765701	Abd; Abdo; Abdomen; Pain abd - type intensity proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765701	PhenX - 腹痛 - 类型与强度方案 190901:-:时间点:^患者:-:PhenX	4182948
40765703	Pers hx GI conditions proto	4180186
40765703	GI; H/O; Hx; Pan; Panel; PANEL.PHENX; Panl; Pers hx GI conditions proto; Pnl; Point in time; Random	4180186
40765703	PhenX - 胃肠道疾病个人史方案 191001:-:时间点:^患者:-:PhenX	4182948
40765706	Emotional stability; Measure mntl hlth funct SF-36v2; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765707	Phys soc mntl hlth func SF-36v2 proto	4180186
40765707	Emotional stability; Pan; Panel; PANEL.PHENX; Panl; Phys soc mntl hlth func SF-36v2 proto; Pnl; Point in time; Random	4180186
40765707	PhenX - 身体、社会及心理健康功能发挥情况 - SF-36v2 方案 191201:-:时间点:^患者:-:PhenX	4182948
40765708	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765711	Ear infections - otitis media proto	4180186
40765711	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765711	PhenX - 耳部感染 - 中耳炎方案 200201:-:时间点:^患者:-:PhenX	4182948
40765712	Measure - childhood speech lang assess; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765713	Child speech age stages proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765713	Child speech age stages proto	4180186
40765713	PhenX - 早期儿童言语与语言评估方案 - 年龄 - 阶段问卷 200301:-:时间点:^患者:-:PhenX	4182948
40765716	Fam hx speech lang impair proto	4180186
40765716	Fam hx speech lang impair proto; H/O; Hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765716	PhenX - 言语和语言障碍家族史方案 200401:-:时间点:^患者:-:PhenX	4182948
40765717	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765719	Grammat impairment proto	4180186
40765719	Grammat impairment proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765719	PhenX - 语法障碍 - 早期语法障碍试验方案 200502:-:时间点:^患者:-:PhenX	4182948
40765726	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765726	Reading comprehension proto	4180186
40765726	PhenX - 阅读理解方案 200801:-:时间点:^患者:-:PhenX	4182948
40765727	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765728	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765728	Stuttering proto	4180186
40765728	PhenX - 口吃方案 200901:-:时间点:^患者:-:PhenX	4182948
40765731	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765734	Vocabulary assessment proto	4180186
40765734	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765734	PhenX - 词汇评估方案 201201:-:时间点:^患者:-:PhenX	4182948
40765737	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765738	Word decoding proto	4180186
40765738	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765738	PhenX - 单词拆解拼读方案 201401:-:时间点:^患者:-:PhenX	4182948
40765739	H/O; Hx; Measure fam hx hearing loss; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765749	Fam conflict intimate-relat proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765749	Fam conflict intimate-relat proto	4180186
40765749	PhenX - 家庭冲突 - 亲密关系方案 210401:-:时间点:^患者:-:PhenX	4182948
40765753	Measure - fam interpersonal relat; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765754	Fam interpersonal relat proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765754	Fam interpersonal relat proto	4180186
40765754	PhenX - 家庭人际关系方案 210601:-:时间点:^患者:-:PhenX	4182948
40765757	Measure - neighbor comm cohesion; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765758	Neighborhood - comm cohesion proto	4180186
40765758	Neighborhood - comm cohesion proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765758	PhenX - 临近街坊集体效能 - 社区凝聚力与非正式社会控制方案 210801:-:时间点:^患者:-:PhenX	4182948
40765759	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765760	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765760	Neighborhood safety proto	4180186
40765760	PhenX - 临近街坊安全方案 210901:-:时间点:^患者:-:PhenX	4182948
40765761	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765762	School social environ proto	4180186
40765762	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; School social environ proto	4180186
40765762	PhenX - 学校社会环境方案 211001:-:时间点:^患者:-:PhenX	4182948
40765764	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; SDOH	4180186
40765764	Social networks proto	4180186
40765764	PhenX - 社交网络方案 211101:-:时间点:^患者:-:PhenX	4182948
40765767	Measure - neighborhood disadvantage; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765770	Race - ethnic resid segregation proto	4180186
40765770	Ethnicity; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Race - ethnic resid segregation proto; Random	4180186
40765770	PhenX - 种族 - 种族居住隔离方案 211401:-:时间点:^患者:-:PhenX	4182948
40765771	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765774	17OHP/Creat Ur	4180186
40765774	17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; Chemistry; CR; Crea; Creat; Hydroxyproges; Hydroxyprogstron; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40765774	17-羟孕酮/肌酐:质量比率:时间点:尿液:定量型	4182948
40765777	Pan; Panel; PANEL.PHENX; Panl; Place of Birth; Pnl; Point in time; Random; Where were you born	4180186
40765778	Birthplace proto	4180186
40765778	Pan; Panel; PANEL.PHENX; Panl; Place of Birth; Pnl; Point in time; Random; Where were you born	4180186
40765778	PhenX - 出生地方案 010201:-:时间点:^患者:-:PhenX	4182948
40765780	Birthplace of parents proto	4180186
40765780	Pan; Panel; PANEL.PHENX; Panl; Place of Birth; Pnl; Point in time; Random; Where were you born	4180186
40765780	PhenX - 父母出生地方案 010301:-:时间点:^患者:-:PhenX	4182948
40765781	Measure - birthplace grandparents; Pan; Panel; PANEL.PHENX; Panl; Place of Birth; Pnl; Point in time; Random; Where were you born	4180186
40765788	Current educ attainment proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765788	Current educ attainment proto	4180186
40765788	PhenX - 当前教育程度方案 011001:-:时间点:^患者:-:PhenX	4182948
40765790	Annual family income proto	4180186
40765790	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765790	PhenX - 家庭年收入方案 011101:-:时间点:^患者:-:PhenX	4182948
40765792	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; S prime; Years in US proto	4180186
40765792	Years in US proto	4180186
40765792	PhenX - 在美国居住年数方案 011201:-:时间点:^患者:-:PhenX	4182948
40765793	Job; Occupation; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Work	4180186
40765794	Current employment proto; Job; Occupation; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Work	4180186
40765794	Current employment proto	4180186
40765794	PhenX - 当前就业状况方案 011301:-:时间点:^患者:-:PhenX	4182948
40765795	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765796	Household relat proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765796	Household relat proto	4180186
40765796	PhenX - 家庭花名册-关系方案 011401:-:时间点:^患者:-:PhenX	4182948
40765797	Measure - health ins coverage; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765799	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40765799	Domain - Speech and hearing	4180186
40765799	PhenX 领域 - 言语与听力:-:时间点:^患者:-:PhenX	4182948
40765800	CEP17; Chr 17 copy num; Chromosom; Chromosome 17 centromere; Chromosome Enumeration Probe 17; Chromosomes; DNA topoisomerase II, 170 kD; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; No; Num; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; TOP2; TOP22; TOP2A copy num; topoisomerase (DNA) II alpha 170kDa; TP2A	4180186
40765800	TOP2A copy num/Chr 17 copy num Tiss FISH	4180186
40765800	TOP2A 基因拷贝数/染色体 17 拷贝数:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
40765801	DNA topoisomerase II, 170 kD; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; TOP2; TOP22; Topoisomerase (DNA) II alpha 170kDa; TP2A	4180186
40765801	TOP2A gene Tiss-Imp	4180186
40765801	TOP2A 基因:印象:时间点:组织与涂片:叙述型	4182948
40765802	Amplification; Del; Del+Dup; Deletions; DNA topoisomerase II, 170 kD; Dp; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; TOP2; TOP22; TOP2A 17q21-22; TOP2A gene 17q21-22 del/dup; topoisomerase (DNA) II alpha 170kDa; TP2A	4180186
40765802	TOP2A 17q21-22 Del+Dup Tiss Ql FISH	4180186
40765802	TOP2A 基因 17q21-22 缺失+重复:存在情况或阈值:时间点:组织与涂片:序数型:FISH	4182948
40765807	D farinae IgG-mCnc	4180186
40765807	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American house dust mite; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D farinae; d002; d2; Dermatophagoides farianae; Gd2; HDM; House dust mite; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765807	粉尘螨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765808	Cat Dander IgG-mCnc	4180186
40765808	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cat epithelium; Cat hair; e1; Feline; Felis domesticus; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765808	猫毛屑 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765809	Dog Dander IgG-mCnc	4180186
40765809	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; Dog hair; e005; e5; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765809	狗毛屑 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765816	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coconut; f036; f36; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765816	Coconut IgG-mCnc	4180186
40765816	椰子 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765822	ABS; Aby; Agf77; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B; B-Lactoglob; B-Lactoglob IgG; f077; f77; Immune globulin G; Immunoglobulin G; Level; Mass concentration; nBos d 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765822	B-Lactoglob IgG-mCnc	4180186
40765822	Beta 乳球蛋白 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765826	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f086; f86; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Parsley; Petrosilenum crispum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765826	Parsley IgG-mCnc	4180186
40765826	皱叶欧芹 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765832	Black-eye Pea IgG-mCnc	4180186
40765832	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black-eye bean; Blackeye pea; Black-eye Pea; Black-eyed bean; Cowpea; f127; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; V senensis; Vigna bean	4180186
40765832	豇豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765833	Duck Meat IgG-mCnc	4180186
40765833	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f157; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765833	鸭肉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765836	Cranberry IgG-mCnc	4180186
40765836	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cranberry; f177; f341; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf341; Serum; SR; Vaccinium oxycoccus	4180186
40765836	酸果蔓 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765837	Rhubarb IgG-mCnc	4180186
40765837	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f178; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rhubarb; Serum; SR	4180186
40765837	大黄属多个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765838	Lima Bean IgG-mCnc	4180186
40765838	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f182; Immune globulin G; Immunoglobulin G; Level; Lima bean; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765838	利马豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765839	Flax IgG-mCnc	4180186
40765839	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f198; f333; Flax; Flaxseed; Immune globulin G; Immunoglobulin G; Level; Linseed; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf333; Serum; SR	4180186
40765839	亚麻 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765841	Cashew nut IgG-mCnc	4180186
40765841	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cashew; Cashew nut; f202; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765841	腰果 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765842	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f203; Green almond; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pistachio; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765842	Pistachio IgG-mCnc	4180186
40765842	阿月浑子 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765845	Rabbit IgG-mCnc	4180186
40765845	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f213; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Oryctalagus spp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765845	家兔 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765848	Pumpkin IgG-mCnc	4180186
40765848	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C. maxima; C. mixta; C. moschata; Cucumis pepo; f225; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Pumpkin; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765848	西葫芦 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765849	Safflower IgG-mCnc	4180186
40765849	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f229; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Safflower; Serum; SR	4180186
40765849	红花 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765850	Lentils IgG-mCnc	4180186
40765850	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f235; Immune globulin G; Immunoglobulin G; Lentil; Lentils; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765850	兵豆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765855	Cumin IgG-mCnc	4180186
40765855	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cumin; Cummin; f265; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765855	莳萝 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765856	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basil; f269; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf269; Serum; SR	4180186
40765856	Basil IgG-mCnc	4180186
40765856	罗勒 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765860	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bay leaf; Bay sweet; Bayleaf; f278; Immune globulin G; Immunoglobulin G; Laurel; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf278; Serum; SR	4180186
40765860	Bayleaf IgG-mCnc	4180186
40765860	月桂树 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765862	Dates IgG-mCnc	4180186
40765862	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Date; Dates; f289; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf289; Serum; SR	4180186
40765862	海枣 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765863	Papaya IgG-mCnc	4180186
40765863	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f293; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Papaw; Papaya; Paw Paw; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf293; Serum; SR; Tree Melon	4180186
40765863	番木瓜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765864	Chestnut IgG-mCnc	4180186
40765864	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chestnut; European chestnut; f299; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet chestnut	4180186
40765864	欧洲板栗 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765865	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f300; f409; f43; Goat's milk; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf300; Serum; SR	4180186
40765865	Goat Milk IgG-mCnc	4180186
40765865	山羊奶 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765866	Sardine (pilchard) IgG-mCnc	4180186
40765866	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f308; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf308; Sardine; Sardine (pilchard); Sardine pilchard; Serum; SR	4180186
40765866	沙丁鱼 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765868	Allspice IgG-mCnc	4180186
40765868	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allspice; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Clove pepper; f310; f339; Immune globulin G; Immunoglobulin G; Jamaica pepper; Level; Mass concentration; P dioica; P officinalis; Pimenta officinalis; Pimento; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf339; Serum; SR	4180186
40765868	多香果树 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765870	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f324; Fruit cone; Hop; Hops; Hops oil; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf324; Serum; SR	4180186
40765870	Hop IgG-mCnc	4180186
40765870	啤酒花 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765872	Gelatin IgG-mCnc	4180186
40765872	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c13; c74; f340; gelatine; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765872	动物胶 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765873	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f360; Immune globulin G; Immunoglobulin G; Joghurt; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Yoghurt	4180186
40765873	Yogurt IgG-mCnc	4180186
40765873	酸乳酪 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765877	ABS; Aby; Acacia gum; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f297; f373; Gum acacia; Gum senegal; Gum sudan; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf297; Senegal gum; Serum; SR; Sudan gum	4180186
40765877	Gum Arabic IgG-mCnc	4180186
40765877	阿拉伯树胶 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765878	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f374; Immune globulin G; Immunoglobulin G; Indian tragacanth; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765878	Karaya Gum IgG-mCnc	4180186
40765878	刺梧桐树胶 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765880	Maple Syrup IgG-mCnc	4180186
40765880	ABS; Aby; Acer; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f377; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765880	槭糖浆 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765882	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f380; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Parsnip; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765882	Parsnip IgG-mCnc	4180186
40765882	美国防风 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765883	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carya pecan; Cashew; Cashew nut; Chestnut; European chestnut; f202; f203; f256; f299; Food Allerg Mix46; fx46; Green almond; Hickory; Immune globulin G; Immunoglobulin G; Juglans sp; Level; Mass concentration; Pecan; Pecan/Hick; Pistachio; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet chestnut; Walnut; Walnuts	4180186
40765883	Food Allerg Mix46 IgG-mCnc	4180186
40765883	(腰果+美洲山核桃+欧洲板栗+胡桃+阿月浑子) 抗体.IgG:质量浓度:时间点:血清:定量型:Multidisk 法	4182948
40765886	Cultivated Rye IgG-mCnc	4180186
40765886	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cultivated rye; Cultivated rye grass; f005; f5; g012; g12; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye; Serum; SR	4180186
40765886	黑麦花粉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765889	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; h001; h1; Housedust; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765889	House Dust Greer IgG-mCnc	4180186
40765889	室内灰尘 Greer 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765893	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hevea braziliensis; Immune globulin G; Immunoglobulin G; k082; k82; Level; Ltx; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765893	Ltx IgG-mCnc	4180186
40765893	乳胶 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765894	C lunata IgG-mCnc	4180186
40765894	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C lunata; Culvularia lunata; Immune globulin G; Immunoglobulin G; Level; m16; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765894	新月弯孢菌 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765895	Paecilomyces IgG-mCnc	4180186
40765895	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; m24; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR	4180186
40765895	拟青霉属单个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765900	A amstelodami IgG-mCnc	4180186
40765900	A amstelodami; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; m40; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765900	阿姆斯特丹曲霉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765903	N sitophila IgG-mCnc	4180186
40765903	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; N sitophila; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765903	好食脉孢菌 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765905	M perniciosa IgG-mCnc	4180186
40765905	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; M perniciosa; m67; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765905	菌盖疣孢霉 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765908	Algae IgG-mCnc	4180186
40765908	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; m075; m75; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765908	藻类 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765909	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cephalosporium; Immune globulin G; Immunoglobulin G; Level; m202; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR	4180186
40765909	Acremonium IgG-mCnc	4180186
40765909	枝顶孢属单个未知种 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765915	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cottonwood; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t014; t14	4180186
40765915	Cottonwood IgG-mCnc	4180186
40765915	三角叶杨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765919	Saltwort IgG-mCnc	4180186
40765919	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Russian thistle; Salosola kali; Salsola pestifer; Saltwort; Saltwort (prickly); Serum; SR; w011; w11	4180186
40765919	猪毛菜 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765920	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cocklebur; Common cocklebur; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w013; w13	4180186
40765920	Cocklebur IgG-mCnc	4180186
40765920	苍耳 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765921	Rough Pigweed IgG-mCnc	4180186
40765921	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amaranth; Amaranthus retroflexus; Amaranthus sp; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rough Pigweed; Serum; SR	4180186
40765921	西风古 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765922	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Marsh Elder; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rough marsh elder; Rough marshelder; Serum; SR; w016; w16	4180186
40765922	Marsh Elder IgG-mCnc	4180186
40765922	沼泽地松 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765924	Yellow Dock IgG-mCnc	4180186
40765924	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w23; Yellow dock; Yellow dockweed	4180186
40765924	皱叶酸模 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765925	Sagbrsh IgG-mCnc	4180186
40765925	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common sagebrush; Great basin sagebrush; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sagbrsh; Sagebrush; Serum; SR; w43	4180186
40765925	三齿蒿 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765926	Alfalfa IgG-mCnc	4180186
40765926	ABS; Aby; Alfalfa; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Lucerne; M sativa; Mass concentration; Medicago sative; Medick; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w45	4180186
40765926	紫花苜蓿 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765927	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rw204; Serum; SR; Sunflower; Sunflower Poln; w204	4180186
40765927	Sunflower Poln IgG-mCnc	4180186
40765927	向日葵 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765928	A alternata+D farinae IgG-mCnc	4180186
40765928	A alternata; A alternata+D farinae; A tenuis; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Alternaria tenuis; American house dust mite; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D farinae; d002; d2; Dermatophagoides farianae; Gd2; Gm6; HDM; House dust mite; Immune globulin G; Immunoglobulin G; Level; m006; m6; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765928	(链格孢+粉尘螨) 抗体.IgG:质量浓度:时间点:血清:定量型:Multidisk 法	4182948
40765931	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Carya pecan; Cashew; Cashew nut; Chestnut; European chestnut; f202; f203; f256; f299; Food Allerg Mix46; fx46; Green almond; Hickory; Immune globulin E; Immunoglobulin E; Juglans sp; Pecan; Pecan/Hick; Pistachio; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sweet chestnut; Walnut; Walnuts	4180186
40765931	Food Allerg Mix46 IgE Qn	4180186
40765931	(腰果+美洲山核桃+欧洲板栗+胡桃+阿月浑子) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
40765932	Goldenrod IgG-mCnc	4180186
40765932	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Golden rod; Goldenrod; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w012; w12	4180186
40765932	毛果一枝黄花 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765934	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mulberry; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t070; t70; White mulberry	4180186
40765934	White mulberry IgG-mCnc	4180186
40765934	白桑树 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765935	Smooth Alder IgG-mCnc	4180186
40765935	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alnus incana ssp. Rugosa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Smooth Alder; SR; t202; Tag alder	4180186
40765935	北美灌木杨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765936	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Privet; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t210	4180186
40765936	Privet IgG-mCnc	4180186
40765936	欧洲女贞 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765937	Aspen IgG-mCnc	4180186
40765937	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Aspen; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; P tremula; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40765937	白杨 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765940	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mugwort; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w006; w6	4180186
40765940	Mugwort IgG-mCnc	4180186
40765940	北艾 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40765942	ABS; Aby; Antby; Anti; Antibodies; Antibody; ASMA; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F-actin; Hepatology; IAA; Liver; MEIA; Musc; Muscl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SM; SMA; SR; SUDS	4180186
40765942	SMA Ab Ser Ql IA	4180186
40765942	肌动蛋白.平滑肌 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765943	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ASMA; Autoantibodies; Autoantibody; FA; F-actin; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Musc; Muscl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SM; SMA; SR; Time Resolved Fluorescence; TRF	4180186
40765943	SMA Ab Ser Ql IF	4180186
40765943	肌动蛋白.平滑肌 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40765944	GM1 Asialo IgG Ser Ql IA	4180186
40765944	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asialo Gm1; AsialoGM1; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside asialo; GM1 Asialo; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monoasialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765944	无唾液酸基神经节苷脂 Gm1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765945	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; BPI; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40765945	BPI Ab Ser IA-aCnc	4180186
40765945	杀菌/通透性增加蛋白 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40765947	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40765947	Cathepsin G Ab Ser IA-aCnc	4180186
40765947	组织蛋白酶 G 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40765948	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; CRMP5; CRMP-5; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Point in time; POP66; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; ULIP	4180186
40765948	CV2 Ab CSF Ql IF	4180186
40765948	CV2 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40765952	dsDNA Ab Titr CSF IF	4180186
40765952	双链 DNA 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40765952	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; Dilution factor; Dilution Factor (Titer); DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Native DNA; N-DNA; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40765955	dsDNA Ab Titr Plr IF	4180186
40765955	双链 DNA 抗体:滴定度:时间点:胸膜液:定量型:免疫荧光法	4182948
40765955	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Deoxyribonucleic acid; Dilution factor; Dilution Factor (Titer); DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Lung; Native DNA; N-DNA; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Serology; SmQn; Stranded; Strnd; thoracentesis fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40765958	dsDNA IgG Fld IA-aCnc	4180186
40765958	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; Immune globulin G; Immunoglobulin G; MEIA; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Stranded; Strnd; SUDS	4180186
40765958	双链 DNA 抗体.IgG:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40765959	dsDNA IgG Titr Fld IF	4180186
40765959	双链 DNA 抗体.IgG:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40765959	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; Dilution factor; Dilution Factor (Titer); DNA binding ab; ds; dsDNA; dsnda; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Native DNA; N-DNA; Point in time; Random; Serology; SmQn; Stranded; Strnd; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40765961	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Native DNA; N-DNA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; SUDS	4180186
40765961	dsDNA IgG CSF IA-aCnc	4180186
40765961	双链 DNA 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40765962	dsDNA IgG Titr CSF IF	4180186
40765962	双链 DNA 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40765962	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; Dilution factor; Dilution Factor (Titer); DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Native DNA; N-DNA; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40765966	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Native DNA; N-DNA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; SUDS	4180186
40765966	dsDNA IgM CSF IA-aCnc	4180186
40765966	双链 DNA 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40765968	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Native DNA; N-DNA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stranded; Strnd; Time Resolved Fluorescence; TRF	4180186
40765968	dsDNA IgM Ser Ql IF	4180186
40765968	双链 DNA 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40765970	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40765970	ENA Ab Fld Ql IA	4180186
40765970	可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40765972	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD3 Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765972	GD3 Gangl IgG+IgM Ser Ql IA	4180186
40765972	神经节苷脂 GD3 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765975	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside monosialo; GM1 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765975	GM1 Gangl IgG Ser Ql IA	4180186
40765975	神经节苷脂 GM1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765979	GM1 Gangl IgM Ser Ql IA	4180186
40765979	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside monosialo; GM1 Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765979	神经节苷脂 GM1 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765981	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765981	GM2 Gangl IgG+IgM Ser Ql IA	4180186
40765981	神经节苷脂 GM2 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765983	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765983	GM3 IgG Ser Ql IA	4180186
40765983	神经节苷脂 GM3 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765984	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40765984	GM3 IgG+IgM Ser Ql IA	4180186
40765984	神经节苷脂 GM3 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765986	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Tetrasialylganglioside	4180186
40765986	GQ1b Gangl IgG Ser Ql IA	4180186
40765986	神经节苷脂 GQ1b 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765987	GQ1b Gangl IgM Ser Ql IA	4180186
40765987	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin M; Immunoglobulin M; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Tetrasialylganglioside	4180186
40765987	神经节苷脂 GQ1b 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765988	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1a Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40765988	GT1a Gangl IgG+IgM Ser Ql IA	4180186
40765988	神经节苷脂 GT1a 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765989	GT1b Ganlg IgG Ser Ql IA	4180186
40765989	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1b Ganlg; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40765989	神经节苷脂 GT1b 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765991	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GT1b Ganlg; IAA; Immune globulin M; Immunoglobulin M; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Trisialoganglioside	4180186
40765991	GT1b Ganlg IgM Ser Ql IA	4180186
40765991	神经节苷脂 GT1b 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765993	Gliadin IgG Titr CSF IA	4180186
40765993	麦醇溶蛋白 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫测定法	4182948
40765993	ABS; Aby; Agf98; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celiac disease; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; F98; Gliadine; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Titer; Titered; Titre; Ttr	4180186
40765994	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basem; Basemt; BM; EIA; ELFA; ELISA; Enzyme immunoassay; GBM; Glom; Goodpastures; IAA; Kidney; MEIA; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Serology; Serum; SR; SUDS	4180186
40765994	GBM Ab Ser Ql IA	4180186
40765994	肾小球基底膜 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40765995	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40765995	Histone Ab Fld Ql IA	4180186
40765995	组蛋白 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40765997	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; ENA; ENA Jo1; Fl; Fld; FLU; Fluid; Histidyl-tRNA synthease; i; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology	4180186
40765997	ENA Jo1 Ab Fld Ql ID	4180186
40765997	Jo-1 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫扩散法	4182948
40765998	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA Jo1; Enzyme immunoassay; Fl; Fld; FLU; Fluid; Histidyl-tRNA synthease; i; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40765998	ENA Jo1 Ab Fld Ql IA	4180186
40765998	Jo-1 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766001	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40766001	Ku Ab Fld Ql IA	4180186
40766001	Ku 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766003	LKM-1 Ab Titr Fld IF	4180186
40766003	肝肾微粒体 1 抗体:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40766003	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; Hepatology; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Liver kidney microsome; LKM; LKM1; LKM-1; Microsm; Microsom; Point in time; Random; Serology; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766005	LKM-1 Ab Titr CSF IF	4180186
40766005	肝肾微粒体 1 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40766005	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver kidney microsome; LKM; LKM1; LKM-1; Microsm; Microsom; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766007	LKM-2 Ab Titr Ser IF	4180186
40766007	肝肾微粒体 2 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40766007	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Liver kidney microsome; LKM; LKM2; LKM-2; Microsm; Microsom; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766008	MI2 Ab Fld Ql IA	4180186
40766008	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CHD2; Chromodomain-helicase-DNA-binding protein 2; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; II; MEIA; MI2; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40766008	Mi-2 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766010	Mitochondria Ab Titr Fld IF	4180186
40766010	线粒体 抗体:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40766010	ABS; Aby; ACIF; AMA; Antby; Anti; Antibodies; Antibodies to Microtubule Associated Protein 2; Antibody; Anticomplement Immunofluorescence; Antimitochondrial antibodies; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; M2; MA; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial Ab; PBC; Point in time; Primary Biliary Cirrhosis; Random; S; Serology; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766012	Mitochondria Ab Titr CSF IF	4180186
40766012	线粒体 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40766012	ABS; Aby; ACIF; AMA; Antby; Anti; Antibodies; Antibodies to Microtubule Associated Protein 2; Antibody; Anticomplement Immunofluorescence; Antimitochondrial antibodies; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; M2; MA; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial Ab; Neuro; Neurology; PBC; Point in time; Primary Biliary Cirrhosis; Random; S; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766013	ABS; Aby; AMA-M2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; Hepatology; IAA; Liver; MEIA; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Ordinal; Point in time; PR; Pyruvate dehydrogenase ab; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40766013	Mitochondria M2 Ab Fld Ql IA	4180186
40766013	线粒体 M2 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766014	ABS; Aby; AMA-M2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microtubule Associated Protein 2; Mito; Mitochon; Mitochond; Mitochondrial; Mitochondrial m2; Neuro; Neurology; Ordinal; Point in time; PR; Pyruvate dehydrogenase ab; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766014	Mitochondria M2 Ab CSF Ql IA	4180186
40766014	线粒体 M2 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766017	Mitochondria M5 Ab Titr Ser IF	4180186
40766017	线粒体 M5 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40766017	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Mito; Mitochon; Mitochond; Mitochondrial; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766018	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Time Resolved Fluorescence; TRF	4180186
40766018	Myelin Ab Fld Ql IF	4180186
40766018	髓磷脂 抗体:存在情况或阈值:时间点:体液:序数型:免疫荧光法	4182948
40766019	Myelin Ab CSF Ql IF	4180186
40766019	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
40766019	髓磷脂 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40766020	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; gG; Glycoprot; Glycoproteins; GP; IAA; MAG; MEIA; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40766020	MAG Ab Fld Ql IA	4180186
40766020	髓磷脂相关糖蛋白 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766021	MAG Ab Fld IA-aCnc	4180186
40766021	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Assoc; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; gG; Glycoprot; Glycoproteins; GP; IAA; MAG; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SUDS	4180186
40766021	髓磷脂相关糖蛋白 抗体:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40766023	ABS; Aby; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; Hu; Hu2; IAA; II; MEIA; Neuro; Neurology; Neuronal nuclear type II; Nuc; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RI; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766023	Hu2 Ab CSF Ql IA	4180186
40766023	神经元细胞核 2 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766024	ANCA Ab Titr Fld IF	4180186
40766024	嗜中性粒细胞细胞浆 抗体:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40766024	ABS; Aby; ACIF; ACNA; ACPA; ANCA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neut; Neutr; Neutrophils; PMN; PNM; Point in time; Random; Serology; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vasculitis	4180186
40766027	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
40766027	ANA CSF Ql HEp2 subst	4180186
40766027	细胞核 抗体:存在情况或阈值:时间点:脑脊液:序数型:Hep2 细胞底物法	4182948
40766028	ANA Titr CSF IF	4180186
40766028	细胞核 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40766028	ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Neuro; Neurology; Nuc; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766034	PTH Ab Titr Ser IF	4180186
40766034	甲状旁腺素 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40766034	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Parathormone; Parathyroid hormone; Point in time; PTH; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766035	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; GAST; Gastric contents; Gastric fluid; Gastro; Gastroenterology; GI; Hematology; Heme; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; PCA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Time Resolved Fluorescence; TRF	4180186
40766035	PCA Ab Gast Ql IF	4180186
40766035	壁细胞 抗体:存在情况或阈值:时间点:胃液:序数型:免疫荧光法	4182948
40766040	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; ENA; ENA PM/SCL; Enzyme immunoassay; Evening; IAA; MEIA; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766040	ENA PM/SCL Ab CSF Ql IA	4180186
40766040	PM-SCL 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766042	Proteinase3 Ab Ser Ql IA	4180186
40766042	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; III; MEIA; Ordinal; Point in time; PR; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; QL; Qual; Qualitative; Random; Screen; Serine protease 3; Serology; Serum; SR; SUDS; Vasculitis	4180186
40766042	蛋白酶 3 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40766044	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Neuro; Neurology; Ordinal; Paraneoplastic syndrome; PCA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Yo autoantibody	4180186
40766044	Purkinje Cells Ab CSF Ql IA	4180186
40766044	浦肯雅细胞 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766046	Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Fl; Fld; FLU; Fluid; IAA; Immune globulin A; Immunoglobulin A; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; RF; RF IgA; Serology; SUDS	4180186
40766046	RF IgA Fld IA-aCnc	4180186
40766046	类风湿因子.IgA:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40766050	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA RNP; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; SUDS	4180186
40766050	ENA RNP Ab Fld Ql IA	4180186
40766050	核糖核酸蛋白可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766052	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Time Resolved Fluorescence; TRF	4180186
40766052	Ribosomal Ab Fld Ql IF	4180186
40766052	核糖体 抗体:存在情况或阈值:时间点:体液:序数型:免疫荧光法	4182948
40766053	Ribosomal Ab Titr Fld IF	4180186
40766053	核糖体 抗体:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40766053	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766054	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
40766054	Ribosomal Ab CSF Ql IF	4180186
40766054	核糖体 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40766055	Ribosomal Ab Titr CSF IF	4180186
40766055	核糖体 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40766055	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766057	Ribosomal IgG Titr Ser IA	4180186
40766057	核糖体 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
40766057	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; Random; Serology; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr	4180186
40766060	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Ordinal; Point in time; Pol III; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RNAp III; Screen; Serology; Serum; SR; SUDS	4180186
40766060	RNAp III Ab Ser Ql IA	4180186
40766060	RNA 聚合酶 III 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40766063	Baker's yeast IgA Ql IF	4180186
40766063	ABS; Aby; ACIF; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ASCA; Autoantibodies; Autoantibody; Bakers yeast; Baker's yeast; f045; f403; f45; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SCA; Screen; Serum; SR; Time Resolved Fluorescence; TRF; Yeast	4180186
40766063	酿酒酵母 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40766064	Baker's yeast IgG Fld Qn IA	4180186
40766064	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; ASCA; Autoantibodies; Autoantibody; B/F; Bakers yeast; Baker's yeast; BF; bod; Bodies; Body fluid; Body fluid, unsp; Crohn disease; EIA; ELFA; ELISA; Enzyme immunoassay; f045; f403; f45; Fl; Fld; FLU; Fluid; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; SCA; SUDS; Yeast	4180186
40766064	酿酒酵母 抗体.IgG:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40766065	Baker's yeast IgG Ql IF	4180186
40766065	ABS; Aby; ACIF; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ASCA; Autoantibodies; Autoantibody; Bakers yeast; Baker's yeast; Crohn disease; f045; f403; f45; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SCA; Screen; Serum; SR; Time Resolved Fluorescence; TRF; Yeast	4180186
40766065	酿酒酵母 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40766067	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DNA-Topoisomerase I; EIA; ELFA; ELISA; ENA; ENA Scl70; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; SUDS; Topo I; Topoisomerase I	4180186
40766067	ENA Scl70 Ab Fld Ql IA	4180186
40766067	SCL-70 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766068	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DNA-Topoisomerase I; EIA; ELFA; ELISA; ENA; ENA Scl70; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Scleroderma ab; Serology; SUDS; Topo I; Topoisomerase I	4180186
40766068	ENA Scl70 Ab Fld IA-aCnc	4180186
40766068	SCL-70 可提取性核 抗体:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40766069	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; DNA-Topoisomerase I; EIA; ELFA; ELISA; ENA; ENA Scl70; Enzyme immunoassay; IAA; MEIA; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Topo I; Topoisomerase I	4180186
40766069	ENA Scl70 Ab CSF Ql IA	4180186
40766069	SCL-70 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766070	ENA Scl70 Ab Titr Ser IA	4180186
40766070	SCL-70 可提取性核 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
40766070	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); DNA-Topoisomerase I; EIA; ELFA; ELISA; ENA; ENA Scl70; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Point in time; Random; Scleroderma; Scleroderma ab; Serology; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Topo I; Topoisomerase I; Ttr	4180186
40766072	ENA SS-A 52kD Ab Titr Fld IA	4180186
40766072	Sjogrens 综合征-a 可提取性核 52kD 抗体:滴定度:时间点:体液:定量型:免疫测定法	4182948
40766072	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-A 52kD; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; Nuc; Point in time; Random; Ro; Ro AB; Serology; Sjogren; SmQn; SS; SSA; SS-A; SUDS; Titer; Titered; Titre; Ttr	4180186
40766073	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-A 52kD; Enzyme immunoassay; IAA; MEIA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Sjogren; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SS; SSA; SS-A; SUDS	4180186
40766073	ENA SS-A 52kD Ab CSF Ql IA	4180186
40766073	Sjogrens 综合征-a 可提取性核 52kD 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766075	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-a 60kD; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Sjogren; SS; SSA; SS-A; SUDS	4180186
40766075	ENA SS-a 60kD Ab Fld Ql IA	4180186
40766075	Sjogrens 综合征-a 可提取性核 60kD 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766079	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA SS-A; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Sjogren; SS; SSA; SS-A; SUDS	4180186
40766079	ENA SS-A Ab Fld Ql IA	4180186
40766079	Sjogrens 综合征-a 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766080	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA SS-A; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Sjogren; SS; SSA; SS-A; SUDS	4180186
40766080	ENA SS-A Ab Fld IA-aCnc	4180186
40766080	Sjogrens 综合征-a 可提取性核 抗体:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40766082	ENA SS-B Ab Fld Ql IA	4180186
40766082	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA SS-B; Enzyme immunoassay; Fl; Fld; FLU; Fluid; HA; Ha AB; IAA; La AB; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Sjogren; SS; SSB; SS-B; SUDS	4180186
40766082	Sjogrens 综合征-b 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766084	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; ENA; ENA SM; Fl; Fld; FLU; Fluid; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SM	4180186
40766084	ENA SM Ab Fld Ql ID	4180186
40766084	Smith 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫扩散法	4182948
40766085	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA SM; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SM; SUDS	4180186
40766085	ENA SM Ab Fld Ql IA	4180186
40766085	Smith 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766088	Smooth muscle Ab Titr Fld IF	4180186
40766088	平滑肌 抗体:滴定度:时间点:体液:定量型:免疫荧光法	4182948
40766088	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ASMA; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Musc; Muscl; Point in time; Random; Serology; SM; SMA; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766095	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Blood; Endocrine; Endocrinology; Fetal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Thyroid stimulating hormone; Thyroid stimulating hormone receptor antibody; Thyrotropic hormone; TRAb; TSH; TSH Recep; WB; Whole blood	4180186
40766095	TSH Recep Ab Bld Fetus-aCnc	4180186
40766095	促甲状腺激素受体 抗体:任意型浓度:时间点:全血^胎儿:定量型	4182948
40766096	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Blood - (umbilical) cord; Cord (umbilical) blood; Cord bld; Cord blood; Endocrine; Endocrinology; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Thyroid stimulating hormone; Thyroid stimulating hormone receptor antibody; Thyrotropic hormone; TRAb; TSH; TSH Recep	4180186
40766096	TSH Recep Ab BldCo-aCnc	4180186
40766096	促甲状腺激素受体 抗体:任意型浓度:时间点:脐带全血:定量型	4182948
40766097	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Endocrine; Endocrinology; Fl; Fld; FLU; Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Thyroid stimulating hormone; Thyroid stimulating hormone receptor antibody; Thyrotropic hormone; TRAb; TSH; TSH Recep	4180186
40766097	TSH Recep Ab Fld-aCnc	4180186
40766097	促甲状腺激素受体 抗体:任意型浓度:时间点:体液:定量型	4182948
40766101	Arbitrary concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
40766101	Chronic urticaria index Ser-aCnc	4180186
40766101	慢性荨麻疹指数:任意型浓度:时间点:血清:定量型	4182948
40766102	Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit E; Vitamin E	4180186
40766102	Gamma tocopherol SerPl-mCnc	4180186
40766102	Gamma 生育酚:质量浓度:时间点:血清/血浆:定量型	4182948
40766103	酮体^在剂量葡萄糖之后1小时:存在情况或阈值:时间点:尿液:序数型:试纸条	4182948
40766103	Ketones 1h p Glc Ur Strip	4180186
40766103	1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; Acetest; Acetoacetate; Acetoacetates; Acetone bodies; After; CHEMISTRY.CHALLENGE TESTING; Dip stick; Dipstick; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Ketone; Ketone bodies; p dose; p Glc; Point in time; PR; PST; Random; SmQn; UA; UR; Urn	4180186
40766104	酮体^在剂量葡萄糖之后3小时:存在情况或阈值:时间点:尿液:序数型:试纸条	4182948
40766104	3h p Glc; Acetest; Acetoacetate; Acetoacetates; Acetone bodies; After; CHEMISTRY.CHALLENGE TESTING; Dip stick; Dipstick; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Ketone; Ketone bodies; p dose; p Glc; Point in time; PR; PST; Random; SmQn; UA; UR; Urn	4180186
40766104	Ketones 3h p Glc Ur Strip	4180186
40766106	F roseum IgE Qn	4180186
40766106	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; F roseum; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40766106	粉红镰孢菌 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40766107	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; cCP; CCP3; Cyclic Citrulinated Peptide; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Ordinal; Pept; Point in time; PR; QL; Qual; Qualitative; Random; Rheum; Rheumatoid arthritis; Rheumatology; Screen; Serology; Serum; SR	4180186
40766107	cCP IgA+IgG Ser Ql	4180186
40766107	环瓜氨酸肽 抗体.IgA+IgG:存在情况或阈值:时间点:血清:序数型	4182948
40766108	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Lf; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
40766108	Lactoferrin Stl Ql	4180186
40766108	乳铁蛋白:存在情况或阈值:时间点:大便:序数型	4182948
40766111	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Met; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40766111	Methionine DBS Ql	4180186
40766111	蛋氨酸:存在情况或阈值:时间点:全血.斑点:序数型	4182948
40766112	dsDNA IgG Titr Ser	4180186
40766112	双链 DNA 抗体.IgG:滴定度:时间点:血清:定量型	4182948
40766112	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Deoxyribonucleic acid; Dilution factor; Dilution Factor (Titer); DNA binding ab; ds; dsDNA; dsnda; Immune globulin G; Immunoglobulin G; Native DNA; N-DNA; Point in time; Random; Serology; Serum; SmQn; SR; Stranded; Strnd; Titer; Titered; Titre; Ttr	4180186
40766113	Glucose p fast Ur-mCnc	4180186
40766113	After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Fast; Fasting; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p fast; PC; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40766113	葡萄糖^在热量型禁食之后:质量浓度:时间点:尿液:定量型	4182948
40766116	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Dynamic; FC; Fl; Fld; FLU; Fluid; Immune globulin G; Immunoglobulin G; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Stranded; Strnd	4180186
40766116	dsDNA IgG Fld FC-aCnc	4180186
40766116	双链 DNA 抗体.IgG:任意型浓度:时间点:体液:定量型:流式细胞测量术	4182948
40766117	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Dynamic; FC; Immune globulin G; Immunoglobulin G; Lung; Native DNA; N-DNA; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Serology; Stranded; Strnd; thoracentesis fluid	4180186
40766117	dsDNA IgG Plr FC-aCnc	4180186
40766117	双链 DNA 抗体.IgG:任意型浓度:时间点:胸膜液:定量型:流式细胞测量术	4182948
40766118	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40766118	Elastase Ab Fld Ql IA	4180186
40766118	弹性蛋白酶 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766121	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
40766121	ENA Ab Ser Ql ID	4180186
40766121	可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40766122	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
40766122	ENA Ab Ser Ql IA	4180186
40766122	可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40766125	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; ENA; ENA Jo1; Enzyme immunoassay; Histidyl-tRNA synthease; i; IAA; MEIA; NA; Neuro; Neurology; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766125	ENA Jo1 Ab CSF IA-aCnc	4180186
40766125	Jo-1 可提取性核 抗体:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766126	Liver Cytosol Ab Titr Ser IF	4180186
40766126	肝脏细胞溶质 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
40766126	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hepatology; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Liver; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766128	Myeloperoxidase Ab Fld Ql IA	4180186
40766128	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; MPO; MPO - ANCA; Myeloperoxidase ANCA; Ordinal; p-ANCA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS; Vasculitis	4180186
40766128	髓过氧化物酶 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766132	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; ENA; ENA SS-A; Enzyme immunoassay; IAA; MEIA; NA; Neuro; Neurology; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Sjogren; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SS; SSA; SS-A; SUDS	4180186
40766132	ENA SS-A Ab CSF IA-aCnc	4180186
40766132	Sjogrens 综合征-a 可提取性核 抗体:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766133	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; ENA; ENA SS-A; Enzyme immunoassay; IAA; MEIA; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Sjogren; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SS; SSA; SS-A; SUDS	4180186
40766133	ENA SS-A Ab CSF Ql IA	4180186
40766133	Sjogrens 综合征-a 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766136	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; ENA; ENA SM; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SM; SUDS	4180186
40766136	ENA SM Ab Fld IA-aCnc	4180186
40766136	Smith 可提取性核 抗体:任意型浓度:时间点:体液:定量型:免疫测定法	4182948
40766138	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40766138	Thyroid Colloidal Ab Ser Ql IF	4180186
40766138	甲状腺胶质 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40766139	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Native DNA; N-DNA; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; SUDS	4180186
40766139	dsDNA Ab CSF Ql IA	4180186
40766139	双链 DNA 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766140	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Native DNA; N-DNA; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; Time Resolved Fluorescence; TRF	4180186
40766140	dsDNA Ab CSF Ql IF	4180186
40766140	双链 DNA 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40766141	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Native DNA; N-DNA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stranded; Strnd; SUDS	4180186
40766141	dsDNA Ab CSF IA-aCnc	4180186
40766141	双链 DNA 抗体:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766142	ENA SS-a 60kD Ab Ser Ql IA	4180186
40766142	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA SS-A; ENA SS-a 60kD; Enzyme immunoassay; IAA; MEIA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Serum; Sjogren; SR; SS; SSA; SS-A; SUDS	4180186
40766142	Sjogrens 综合征-a 可提取性核 60kD 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40766143	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
40766143	Thyroid Colloidal Ab CSF Ql IF	4180186
40766143	甲状腺胶质 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
40766145	Pompe disease NBS pnl DBS	4180186
40766145	Acid alpha-glucosidase deficiency; Acid maltase deficiency; Asympt; Asymptomatic; Blood; Chemistry; DBS; Dis; Diseases; Dried blood spot; Dz; Filter paper; FP; GAA; Glycogen storage disease type II; GSD-II; Lysosomal alpha Glucosidase; NB Screen Pnl; NBS; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Pompe disease NBS pnl; Random; Scn; WB; Whole blood	4180186
40766145	庞贝病新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40766147	Acid alpha-glucosidase deficiency; Acid maltase deficiency; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dis; Diseases; Dried blood spot; Dz; Filter paper; FP; GAA; Glycogen storage disease type II; GSD-II; Lysosomal alpha Glucosidase; Narrative; NBS comment; New born; Point in time; Pompe disease NBS comment; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
40766147	Pompe disease NBS comment	4180186
40766147	庞贝病 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
40766149	a163; ABS; Aby; Agf76; A-Lactalb; A-Lactalb IgG; Alfa; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f076; f76; Immune globulin G; Immunoglobulin G; Level; Mass concentration; nBos d 4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40766149	A-Lactalb IgG-mCnc	4180186
40766149	乳白蛋白 alpha 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
40766150	Blood; CLOVE; CWS5; E542K; E545D; E545K; Gene mut tested; Genetics; H1047R; Heredity; Heritable; Identity or presence; Inherited; MCAP; MCM; MCMTC; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; p110-alpha; P13K; PCR; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; PI3K; PIK3CA Oncogene; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40766150	PIK3CA gene Mut Tested Bld/T	4180186
40766150	PIK3CA 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40766151	ABS; Aby; Agf98; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Celiac; Celiac disease; Deamidated gliadin peptide; Deaminated gliadin; DGP; EIA; ELFA; ELISA; Enzyme immunoassay; F98; Fibrin stabilizing factor; Gastro; Gastroenterology; GI; Gliadin peptide+tTG; Gliadine; IAA; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; MEIA; Ordinal; Pept; Point in time; PR; Protein-glutamine gamma glutamyltransferase; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; TG2; tTG; tTG antibodies; tTg/DGP	4180186
40766151	Gliadin peptide+tTG IgA+IgG Ser Ql IA	4180186
40766151	麦醇溶蛋白肽+组织谷氨酰胺转移酶 抗体.IgA+IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40766152	Blood; Erythrocytosis; Genetics; Heredity; Heritable; Identity or presence; Inherited; JAK2 exon 12; Janus kinase 2; Janus kinase 2 gene; JTK10; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Polycythemia vera; PV; Random; THCYT3; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40766152	JAK2 exon 12 Mut Tested Bld/T	4180186
40766152	JAK2 基因外显子 12 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40766154	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E. coli attaching-effacing gene; EC eaeA gene; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40766154	EC eaeA gene Spec Ql NAA+probe	4180186
40766154	大肠埃希菌 eaeA 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40766157	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bact; DNA NUCLEIC ACID PROBE; DNA probe; Etx; Heat-stable enterotoxin gene; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40766157	ST Spec Ql NAA+probe	4180186
40766157	细菌耐热性肠毒素 ST 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40766159	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli Shiga-like toxin gene; EC stx2 gene; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shiga Like Toxin II; Shiga-Like Toxins; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
40766159	EC stx2 Spec QI NAA+probe	4180186
40766159	大肠埃希菌 Stx2 毒素 stx2 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
40766164	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Microbiology; Nominal; Point in time; Random; Rheum; Rheumatology; SF; SNV; St; Stains; Stn; Syn; Syn fl; Synov; Synovial fluid; ZN Stn	4180186
40766164	ZN Stn Snv	4180186
40766164	显微镜观察:存在与否或特征标识:时间点:滑液:名义型:抗酸染色法.Ziehl-Neelsen	4182948
40766167	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dextro; i004; i210; i4; Immune globulin E; Immunoglobulin E; Paper wasp; Paper wasp (rPol d) 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40766167	Paper wasp (rPol d) 5 IgE Qn	4180186
40766167	马蜂属 重组 (rPol d) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40766168	B abortus Ab Titr Ser AHG	4180186
40766168	牛种布鲁氏菌 抗体:滴定度:时间点:血清:定量型:抗人球蛋白试验法	4182948
40766168	Abort; ABS; Aby; AHG; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B abortus; Bangs disease; Bovine brucellosis; Bruc; Brucellosis; Contagious abortion; Coomb; Coombs; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Undulant fever	4180186
40766169	Blood; DDPAC; Disinhibition-dementia-Parkinsonism-amyotrophy complex; FLJ31424; FTDP-17; G protein beta1/gamma2 subunit-interacting factor 1; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; MAPTL; Microtubule-associated protein tau; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MSTD; MTBT1; MTBT2; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; PPND; PPP1R103; Random; TAU; TAU gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40766169	MAPT gene Mut Tested Bld/T	4180186
40766169	MAPT 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40766170	AQP4 H2O channel IgG SerPl Ql IF	4180186
40766170	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Devic's disease; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF; Water channel aquaporin-4	4180186
40766170	水通道蛋白 4 受体 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
40766173	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; F hepatica; Hemagglutination; ID; IHA; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40766173	F hepatica Ab Ser Ql HA	4180186
40766173	肝片吸虫 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集试验法	4182948
40766174	7h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40766174	GH 7h p chal SerPl-mCnc	4180186
40766174	生长激素^在XXX刺激之后7小时:质量浓度:时间点:血清/血浆:定量型	4182948
40766178	CD3+CD5+ cells NFr CSF	4180186
40766178	CD3 Cells; CD3+CD5- cells; CD3+CD5+ cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Gated cells; Leu1; Leu-1; Leu4; Leu-4; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T1; T3; Tp67	4180186
40766178	细胞.CD3+CD5+/100 个细胞:计数型分数:时间点:脑脊液:定量型	4182948
40766181	CD3+CD8+ Cells # CSF	4180186
40766181	#; ABS; absolute; absolutes; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Leu2; Leu-2; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor	4180186
40766181	细胞.CD3+CD8+:计数型浓度:时间点:脑脊液:定量型	4182948
40766183	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celiac disease; Deamidated gliadin peptide; Deaminated gliadin; DGP; EIA; ELFA; ELISA; Enzyme immunoassay; F98; Gastro; Gastroenterology; GI; Gliadine; IAA; Immune globulin A; Immunoglobulin A; MEIA; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
40766183	Gliadin peptide IgA Ser IA-aCnc	4180186
40766183	麦醇溶蛋白肽 抗体.IgA:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
40766184	Blood; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; thiopurine S-methyltransferase; Thiopurine S-methyltransferase gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40766184	TPMT gene Mut Tested Bld/T	4180186
40766184	TPMT 基因 已测试的突变:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40766185	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnet Ph1; C burnetii; Coxiella burnetii phase I; Coxiella burnettii; FA; Fluorescent antibody; Fluoresent; i; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Q fev; Q fever; Qfever; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40766185	C burnet Ph1 IgM Ser Ql IF	4180186
40766185	贝氏柯克斯体 1 相 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
40766188	Mugwort (nArt v) 1 IgE Qn	4180186
40766188	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; Immune globulin E; Immunoglobulin E; Mugwort; Mugwort (nArt v) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w006; w231; w6	4180186
40766188	北艾 原生 (nArt v) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40766192	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Congenital rubella syndrome; German measles; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RUBV; Screen; Serum; SR	4180186
40766192	RUBV IgG Ser Ql LA	4180186
40766192	风疹病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:胶乳凝集试验法	4182948
40766195	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bruc; Brucellosis; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40766195	Brucella DNA CSF Ql NAA+probe	4180186
40766195	布鲁氏菌属单个未知种 DNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
40766196	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766196	GM3 IgG CSF IA-aCnc	4180186
40766196	神经节苷脂 GM3 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766197	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766197	GM3 IgM CSF IA-aCnc	4180186
40766197	神经节苷脂 GM3 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766199	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; GT1b Ganlg; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Trisialoganglioside	4180186
40766199	GT1b Ganlg IgG CSF IA-aCnc	4180186
40766199	神经节苷脂 GT1b 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766200	GM4 IgG CSF IA-aCnc	4180186
40766200	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766200	神经节苷脂 GM4 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766202	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD3 Gangl; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766202	GD3 Gangl IgG CSF IA-aCnc	4180186
40766202	神经节苷脂 GD3 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
40766204	18 hours; 18HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn	4180186
40766204	Microalbumin 18h Ur-mRate	4180186
40766204	白蛋白:质量速率:18小时:尿液:定量型:检测极限 <= 20 mg/L	4182948
40766205	BKV; Blood; Deoxyribonucleic acid; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
40766205	BKV DNA Bld Ql	4180186
40766205	BK 病毒 DNA:存在情况或阈值:时间点:全血:序数型	4182948
40766206	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f014; f14; f353; Gly; Immune globulin E; Immunoglobulin E; Largest; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; Soybean (rGly m) 4; SR	4180186
40766206	Soybean (rGly m) 4 IgE Qn	4180186
40766206	大豆 重组 (rGly m) 4 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40766207	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f013; f13; f352; Immune globulin E; Immunoglobulin E; NR1B1; Peanut; Peanut (rAra h) 8; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
40766207	Peanut (rAra h) 8 IgE Qn	4180186
40766207	落花生 重组 (rAra h) 8 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40766208	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; IAA; MEIA; Ordinal; Pl; Plat Gp; Plat Gp Ib/Ix; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
40766208	Plat Gp Ib/Ix Ab Bld Ql IA	4180186
40766208	血小板糖蛋白 Ib-IX 抗体:存在情况或阈值:时间点:全血:序数型:免疫测定法	4182948
40766211	Urea 24h Ur-mCnc	4180186
40766211	1 day; 24 hours; 24HR; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
40766211	尿素:质量浓度:24小时:尿液:定量型	4182948
40766213	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; m001; m1; Microbiology; Ordinal; P chrysogenum; P notatum; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
40766213	P notatum Ab Ser Ql ID	4180186
40766213	特异青霉 抗体:存在情况或阈值:时间点:血清:序数型:免疫扩散法	4182948
40766214	F-actin Ab SerPl Ql IF	4180186
40766214	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; F-actin; Filament; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
40766214	纤丝状肌动蛋白 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
40766215	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
40766215	Computer generated recommendation Doc	4180186
40766215	计算机生成型建议:发现:时间点:^患者:文档型	4182948
40766216	Allergen; Allergens; ALLERGY TESTING; Alrgen; Nut allergen pnl; Nuts; Pan; PANEL.ALLERGY; Panl; Pnl; Point in time; Random; Serum; SR; UniversalLabOrders	4180186
40766216	Nut allergen pnl Ser	4180186
40766216	坚果类变应原组套:-:时间点:血清:-	4182948
40766222	Finding; Findings; Maternal grandfather birthplace; Nominal; Point in time; Random; S prime	4180186
40766222	Maternal grandfather birthplace	4180186
40766222	您的外祖父出生在何地:发现:时间点:^患者:名义型:PhenX	4182948
40766225	Current street number	4180186
40766225	Location; No; Nominal; Num; Point in time; Random	4180186
40766225	当前街道号码:位置:时间点:^患者:名义型:PhenX	4182948
40766227	Location; No; Nominal; Num; Point in time; Random	4180186
40766227	Current apartment number	4180186
40766227	当前公寓号码:位置:时间点:^患者:名义型:PhenX	4182948
40766228	Location; Nominal; Point in time; Random	4180186
40766228	Current city	4180186
40766228	当前城市:位置:时间点:^患者:名义型:PhenX	4182948
40766230	Location; Nominal; Point in time; Random	4180186
40766230	Deprecated Zip code	4180186
40766231	Current marital status [NHANES]	4180186
40766231	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40766231	婚姻状况:发现:时间点:^患者:名义型:NHANES	4182948
40766232	Current educ attainment; Finding; Findings; Levels; Levl; LV; LVL; Nominal; PhenX; Point in time; Random; SDOH	4180186
40766232	Current educational attainment	4180186
40766232	您在学校已经完成的最高年级或等级是什么,或者您已经获得的最高学历是什么:发现:时间点:^患者:名义型:NHANES	4182948
40766233	Annual family income 50K; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Tot; Totl	4180186
40766233	Annual family income 50K	4180186
40766233	您所有来源的家庭总收入究竟是低于50,000美元还是不低于50,000美元:发现:时间点:^患者:序数型:PhenX	4182948
40766234	Annual family income 35K; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Tot; Totl	4180186
40766234	Annual family income 35K	4180186
40766234	您所有来源的家庭总收入究竟是低于35,000美元还是不低于35,000美元:发现:时间点:^患者:序数型:PhenX	4182948
40766235	Annual income poverty; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Tot; Totl	4180186
40766235	Annual family income poverty threshold	4180186
40766235	您所有来源的家庭总收入究竟是低于还是不低于贫困线:发现:时间点:^患者:序数型:PhenX	4182948
40766237	Annual family income 75K; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Tot; Totl	4180186
40766237	Annual family income 75K	4180186
40766237	您所有来源的家庭总收入究竟是低于75,000美元还是不低于75,000美元:发现:时间点:^患者:序数型:PhenX	4182948
40766238	Current employment status; Finding; Findings; Job; Nominal; Occupation; Point in time; Random	4180186
40766238	Current employment status	4180186
40766238	您现在有工作,正在找工作,已经退休,负责看房子,是位学生,或者是别的什么:发现:时间点:^患者:名义型:PhenX	4182948
40766239	Cnt; Count; No. people this address; Number; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766239	No people this address	4180186
40766239	当前有多少人正在这个地址生活或逗留:数量(计数):时间点:^患者:定量型	4182948
40766240	Health insurance coverage	4180186
40766240	Finding; Findings; Health insurance coverage; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766240	您是否参加了健康保险或者某种其他种类的医疗保健计划:发现:时间点:^患者:序数型:PhenX	4182948
40766241	Health insurance coverage type	4180186
40766241	Finding; Findings; Health insurance coverage type; Nominal; Point in time; Random	4180186
40766241	您拥有什么种类的健康保险或者健康保健保险范围:发现:时间点:^患者:名义型:PhenX	4182948
40766242	Finding; Findings; Mother birthplace; Nominal; Point in time; Random	4180186
40766242	Mother birthplace PhenX	4180186
40766242	您的亲生母亲出生在何地:发现:时间点:^患者:名义型:PhenX	4182948
40766247	DXA proto	4180186
40766247	bod; Bodies; Compn; DEX; DEXA; DXA proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40766247	PhenX - 双能X线吸收法体成分方案 020301:-:时间点:^患者:-:PhenX	4182948
40766248	bod; Bodies; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40766249	bod; Bodies; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40766249	Body image proto	4180186
40766249	PhenX - 体像方案 020401:-:时间点:^患者:-:PhenX	4182948
40766250	COHgb MFr BldCoA	4180186
40766250	Bld cord; Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Cord arterial blood; Cord BldA; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
40766250	碳氧血红蛋白/血红蛋白.总计:质量分数:时间点:脐带动脉全血:定量型	4182948
40766253	Centromere Ab Fld Ql IA	4180186
40766253	ABS; Aby; ACA; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cen; CRST syndrome; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS	4180186
40766253	着丝点 抗体:存在情况或阈值:时间点:体液:序数型:免疫测定法	4182948
40766254	Centromere Ab Fld Ql IF	4180186
40766254	ABS; Aby; ACA; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cen; CRST syndrome; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Time Resolved Fluorescence; TRF	4180186
40766254	着丝点 抗体:存在情况或阈值:时间点:体液:序数型:免疫荧光法	4182948
40766257	Centromere Ab Titr CSF IF	4180186
40766257	着丝点 抗体:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
40766257	ABS; Aby; ACA; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cen; Cerebral spinal fluid; Cerebrospinal Fl; CRST syndrome; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
40766262	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; ENA; ENA Jo1; Fl; Fld; FLU; Fluid; Histidyl-tRNA synthease; i; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology	4180186
40766262	ENA Jo1 Ab Fld Ql	4180186
40766262	Jo-1 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型	4182948
40766263	MuSK IgG Ser IA-mCnc	4180186
40766263	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; Level; Mass concentration; MEIA; Musc; Muscl; MuSK; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; Spec; SR; SUDS; Tyr	4180186
40766263	肌肉特异性受体酪氨酸激酶 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
40766264	Myeloperoxidase Ab Fld-aCnc	4180186
40766264	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; MPO; MPO - ANCA; Myeloperoxidase ANCA; p-ANCA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Vasculitis	4180186
40766264	髓过氧化物酶 抗体:任意型浓度:时间点:体液:定量型	4182948
40766265	Proteinase3 Ab Fld-aCnc	4180186
40766265	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; III; Point in time; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; QNT; Quan; Quant; Quantitative; Random; Serine protease 3; Serology; Vasculitis	4180186
40766265	蛋白酶 3 抗体:任意型浓度:时间点:体液:定量型	4182948
40766268	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DNA-Topoisomerase I; ENA; ENA Scl70; Fl; Fld; FLU; Fluid; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scleroderma; Scleroderma ab; Screen; Serology; Topo I; Topoisomerase I	4180186
40766268	ENA Scl70 Ab Fld Ql	4180186
40766268	SCL-70 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型	4182948
40766271	ENA SS-B Ab Fld Ql	4180186
40766271	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; ENA; ENA SS-B; Fl; Fld; FLU; Fluid; HA; Ha AB; La AB; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Sjogren; SS; SSB; SS-B	4180186
40766271	Sjogrens 综合征-b 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型	4182948
40766273	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; ENA; ENA RNP; ENA SM; ENA SM+RNP; Fl; Fld; FLU; Fluid; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; SM	4180186
40766273	ENA SM+RNP Ab Fld Ql	4180186
40766273	Smith 可提取性核抗体+核糖核蛋白可提取性核 抗体:存在情况或阈值:时间点:体液:序数型	4182948
40766276	Ca; Cal; Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; i Phos; Inorganic phosphate; Kidney; MAG; Magnes; Mass fraction; Mg; Nephrology; Percent; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Stn; Stone; Stones; Tot; Totl; Whitlockite	4180186
40766276	Calcium magnesium phosphate MFr Stone	4180186
40766276	钙镁磷/总计:质量分数:时间点:结石:定量型	4182948
40766278	Macrophages NFr Mar Manual	4180186
40766278	BM; BON; Bone marrow; Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; Macrop; Macrophage; Macros; Macrphg; Manl; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766278	巨噬细胞/100 个细胞:计数型分数:时间点:骨髓:定量型:手工计数方法	4182948
40766279	Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SAICAR; Screen; UA; UR; Urn	4180186
40766279	SAICAR Ur Ql	4180186
40766279	琥珀酰氨基咪唑氨甲酰核苷:存在情况或阈值:时间点:尿液:序数型	4182948
40766280	1 day; 24 hours; 24HR; Addis count; Count/time; Kidney; Leuc; Leuk; Leukocyte; Lkcs; Micro; Micros; Microscopic; Nephrology; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBCs; White blood cell; White blood cells	4180186
40766280	WBC 24h UrnS Micro-nRate	4180186
40766280	白细胞:计数型速率:24小时:尿沉渣:定量型:显微镜检查类实验室方法	4182948
40766282	Fat Stl-mCnt	4180186
40766282	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
40766282	脂肪:质量含量:时间点:大便:定量型	4182948
40766283	Antigen; Antigens; Arbitrary concentration; Australia antigen; EIA; ELFA; ELISA; Enzyme immunoassay; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; IAA; ID; Infectious Disease; InfectiousDisease; Liver; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Surf	4180186
40766283	HBV surface Ag SerPl IA-aCnc	4180186
40766283	乙型肝炎病毒表面 抗原:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
40766284	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40766284	HLA-DQB1*06:02 Ql	4180186
40766284	HLA-DQB1*06:02:存在情况或阈值:时间点:全血/组织:序数型	4182948
40766285	SRP Ab SerPl Ql IB	4180186
40766285	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SRP; WB; WBLOT; West blot; West blt; Western blot	4180186
40766285	信号识别颗粒 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫印迹法	4182948
40766286	8.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
40766286	GH 8.5h p chal SerPl-mCnc	4180186
40766286	生长激素^在XXX刺激之后8.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
40766287	Act/Nor; Activated partial thromboplastin time; aPTT; Clot; Clottable; Coag; Coagulation assay; Control; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; RlTm; Surf; Tilt tube	4180186
40766287	aPTT Act/Nor PPP	4180186
40766287	表面诱导型凝血过程 实际的/正常的:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
40766288	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
40766288	JEV IgM Ser Ql IA	4180186
40766288	日本脑炎病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
40766289	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
40766289	JEV IgM CSF Ql IA	4180186
40766289	日本脑炎病毒 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
40766292	BM Ab pattern Ser IF-Imp	4180186
40766292	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Basem; Basemt; BM; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40766292	基底膜 抗体模式:印象:时间点:血清:名义型:免疫荧光法	4182948
40766294	ABS; Aby; ACIF; ACNA; ACPA; ANCA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA Pat; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Neuro; Neurology; Neut; Neutr; Neutrophils; Nominal; PMN; PNM; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Vasculitis	4180186
40766294	ANCA Ab pattern CSF IF-Imp	4180186
40766294	嗜中性粒细胞细胞浆 抗体模式:印象:时间点:脑脊液:名义型:免疫荧光法	4182948
40766295	ANA Pat CSF IF-Imp	4180186
40766295	ABS; Aby; ACIF; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; NA; Nominal; Nuc; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
40766295	细胞核 抗体模式:印象:时间点:脑脊液:名义型:免疫荧光法	4182948
40766297	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Endocrine; Endocrinology; FA; Fluorescent antibody; Fluoresent; ICA; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Panc Islet Cell; Pancr; Pancreatc; Point in time; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
40766297	Panc Islet Cell Ab pattern Ser IF-Imp	4180186
40766297	胰岛细胞 抗体模式:印象:时间点:血清:名义型:免疫荧光法	4182948
40766299	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Coag neg Staph; CoNS; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; NEG; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
40766299	Coag neg Staph DNA Islt Ql NAA+probe	4180186
40766299	葡萄球菌.凝固酶阴性 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
40766303	2; Alc; alcoholic; Cnt; Count; Largest drinking 24h; No; Num; Number; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766303	Largest drinking 24h SSAGA II	4180186
40766303	在您一生当中,您曾经在24小时内饮酒的最多杯数是多少,包括所有类型的酒精饮料:数量(计数):时间点:^患者:定量型:SSAGA II	4182948
40766305	Cigarette smoking; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke; Smokes; Smoking; Tobacco	4180186
40766305	Cigarette smoking PhenX	4180186
40766305	您是否曾经部分地或完整地抽过一支香烟:发现:时间点:^患者:序数型:PhenX	4182948
40766306	Smoked 100 Cigs entire life	4180186
40766306	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Smoked 100 Cigs entire life	4180186
40766306	一生中至少抽过100支香烟:发现:时间点:^患者:序数型	4182948
40766307	Cigarette smoking current; Dextro; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766307	Cigarette smoking current PhenX	4180186
40766307	您现在是每天抽烟、有些天抽烟还是根本不抽烟:发现:时间点:^患者:序数型:PhenX	4182948
40766308	Cigarette everday 30D PhenX	4180186
40766308	Cigarette everday 30D; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766308	在您的一生当中,是否曾经存在过一段时期您每天都抽若干支香烟并持续了至少30天时间:发现:时间点:^患者:序数型:PhenX	4182948
40766310	Years living in US PhenX	4180186
40766310	Point in time; QNT; Quan; Quant; Quantitative; Random; Years living in US	4180186
40766310	您在美国大约有多长时间了:时间:时间点:^患者:定量型:PhenX	4182948
40766311	Annual family income; Count/time; Gross income; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; SDOH; Tot; Totl	4180186
40766311	Annual family income nRate PhenX	4180186
40766311	对于去年所有家庭成员所有来源的税前总收入,您的最佳估计是多少:计数型速率:1年:^患者:定量型:PhenX	4182948
40766312	Whole body scan image name PhenX	4180186
40766312	bod; Bodies; Finding; Findings; Nominal; Point in time; Random; WB	4180186
40766312	全身扫描图像名称:发现:时间点:^患者:名义型:PhenX	4182948
40766315	bod; Bodies; Choose picture body shape; Finding; Findings; Nominal; Point in time; Random	4180186
40766315	Choose picture body shape PhenX	4180186
40766315	请选择最酷似您的体型或您孩子的体型的那张图片:发现:时间点:^患者:名义型:PhenX	4182948
40766317	Alc half increase same effect SSAGA II	4180186
40766317	2; Alc; Alc half increase same effect; alcoholic; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766317	您对酒精的耐受能力当时是否增加了50%或者更多:发现:时间点:^患者:序数型:SSAGA II	4182948
40766318	Alcohol half increase drunk SSAGA II	4180186
40766318	2; Alcohol half increase drunk; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766318	在您喝醉之前要喝很多酒的需要是否增加了50%或者更多:发现:时间点:^患者:序数型:SSAGA II	4182948
40766319	2; Finding; Findings; III; Not stop cut down 3X; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766319	Not stop cut down 3X SSAGA II	4180186
40766319	您无法停止饮酒或者减少饮酒量,这种情况是否曾经发生过3次或更多的次数:发现:时间点:^患者:序数型:SSAGA II	4182948
40766321	2; Alcohol interfere activity 3X; Finding; Findings; III; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766321	Alcohol interfere activity 3X SSAGA II	4180186
40766321	饮酒时放弃或大幅度减少重要活动的情况是否发生过3次或更多的次数,或者持续了一个月或更长的时间:发现:时间点:^患者:序数型:SSAGA II	4182948
40766322	Alcohol 30D freq; Count/time; Dextro; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40766322	Alcohol 30D freq PhenX	4180186
40766322	在过去的那30天当中,有多少天您曾经喝掉过一杯或更多杯酒精饮料:计数型速率:30天:^患者:定量型:PhenX	4182948
40766324	2; Alc; Alcohol tolerant; alcoholic; Consumed; Drink; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766324	Alcohol tolerant SSAGA II	4180186
40766324	您是否曾经变得耐受酒精,也就是说,为了达到某种效果,您要喝得多得多,或者发现按照自己过去所习惯喝的量,无法再达到兴奋的状态:发现:时间点:^患者:序数型:SSAGA II	4182948
40766328	2; Alc; Alcohol interfere life 3X; alcoholic; Finding; Findings; III; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766328	Alcohol interfere life 3X SSAGA II	4180186
40766328	花费那么多的时间饮酒或从酒精的影响当中恢复,以致于您几乎没有做任何其他事情的时候,这样的情况是否发生过3次或更多的次数,或者持续了一个月或更长的时间:发现:时间点:^患者:序数型:SSAGA II	4182948
40766329	2; Finding; Findings; Health prob long drinking; Nominal; PhenX; Point in time; Random	4180186
40766329	Health prob long drinking SSAGA II	4180186
40766329	长期饮酒所导致的健康问题:发现:时间点:^患者:名义型:SSAGA II	4182948
40766335	30Dcigarette smoking; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Smoke; Smokes; Smoking; Tobacco	4180186
40766335	30Dcigarette smoking PhenX	4180186
40766335	在过去的那30天当中,每支香烟您抽掉的是一部分还是全部:发现:30天:^患者:序数型:PhenX	4182948
40766336	Count/time; Dextro; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Smoke; Smoke 30D freq; Smokes; Smoking; Tobacco	4180186
40766336	Smoke 30D freq nRate PhenX	4180186
40766336	在过去的那30天当中,有多少天您曾经抽掉每支香烟的一部分或全部:计数型速率:30天:^患者:定量型:PhenX	4182948
40766337	30D freq estimate; Count/time; Dextro; Last; No; nRate; Num; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Smoke; Smokes; Smoking; Tobacco	4180186
40766337	30D freq estimate nRate PhenX	4180186
40766337	在过去的那30天当中,您对自己抽部分或完整一支香烟的天数的最佳估计是多少:计数型速率:30天:^患者:定量型:PhenX	4182948
40766338	2; Alcohol more get drunk; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766338	Alcohol more get drunk SSAGA II	4180186
40766338	您是否曾经发现自己在喝醉之前能够喝得多很多:发现:时间点:^患者:序数型:SSAGA II	4182948
40766340	Alcohol cessation SSAGA II	4180186
40766340	2; Alcohol cessation; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766340	您是否曾经试图停止饮酒或减少饮酒量:发现:时间点:^患者:序数型:SSAGA II	4182948
40766341	Alc withdraw failure times SSAGA II	4180186
40766341	2; Alc withdraw failure times; Cnt; Count; Number; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766341	有多少次您曾经无法停止饮酒或者减少饮酒量:数量(计数):时间点:^患者:定量型:SSAGA II	4182948
40766342	2; Drunk not intended; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40766342	Drunk not intended SSAGA II	4180186
40766342	您是否曾经开始饮酒并且在自己并不想醉酒的情况下醉酒:发现:时间点:^患者:序数型:SSAGA II	4182948
40766343	2; Drinking other health probs; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766343	Drinking other health probs SSAGA II	4180186
40766343	饮酒是否曾经造成过您碰到任何其他的身体健康问题:发现:时间点:^患者:序数型:SSAGA II	4182948
40766344	Alc continue health problems SSAGA II	4180186
40766344	2; Alc continue health problems; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766344	在您知道饮酒造成了您出现健康问题的情况下您当时还继续饮酒吗:发现:时间点:^患者:序数型:SSAGA II	4182948
40766346	2; Alc continue use emot problems; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766346	Alc continue use emot problems SSAGA II	4180186
40766346	在您知道饮酒造成了您出现任何这些情绪上或心理上的问题之后您当时还继续饮酒吗:发现:时间点:^患者:序数型:SSAGA II	4182948
40766351	Alcohol withdraw problems SSAGA II	4180186
40766351	2; Alcohol withdraw problems; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766351	当您停止饮酒、削减酒量或者说不饮酒的时候,您是否曾经在白天的大多数时间里经历过这种问题,并且持续了2天或更长的时间:发现:时间点:^患者:序数型:SSAGA II	4182948
40766352	Alc withdraw problem type SSAGA II	4180186
40766352	2; Alc withdraw problem type; Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40766352	削减酒量或戒酒之后的问题:发现:时间点:^患者:名义型:SSAGA II	4182948
40766354	Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Smoke; Smokes; Smoking; Smoking cessation time; Tobacco	4180186
40766354	Smoking cessation time PhenX	4180186
40766354	自从您最后一次抽一整支或不到一支香烟以来,已经有多长时间:时间:时间点:^患者:定量型:PhenX	4182948
40766358	Alc first use age PhenX	4180186
40766358	Alc; Alc first use age; alcoholic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766358	您在首次开始饮酒（不包括品尝或啜饮酒精饮料）时大约是多大年龄:时间:时间点:^患者:定量型:PhenX	4182948
40766360	First smoke time FTND	4180186
40766360	Finding; Findings; First smoke time; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke; Smokes; Smoking; Tobacco	4180186
40766360	现在或过去,在您醒来之后,多久才抽第一支香烟:发现:时间点:^患者:序数型:FTND	4182948
40766363	Smoke first give up FTND	4180186
40766363	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke; Smoke first give up; Smokes; Smoking; Tobacco	4180186
40766363	哪支香烟是您会或曾经最恨不得放弃的:发现:时间点:^患者:序数型:FTND	4182948
40766364	现在或过去,您每天抽多少支香烟:发现:时间点:^患者:名义型	4182948
40766364	Smoke quant 1D	4180186
40766364	Finding; Findings; Nominal; PhenX; Point in time; Random; Smoke quant 1D	4180186
40766365	Smoke more 1st Hs FTND	4180186
40766365	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke more 1st Hs	4180186
40766365	现在或过去,与一天的其余时间相比,在醒来后的前几个小时当中,您是否抽烟更加频繁:发现:时间点:^患者:序数型:FTND	4182948
40766366	Smoke during illness FTND	4180186
40766366	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke during illness	4180186
40766366	现在或过去,如果您病得如此严重,以致于一天当中大多数时间里都得卧床,您是否还抽烟:发现:时间点:^患者:序数型:FTND	4182948
40766369	Drug first use age; Drugs; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766369	Drug first use age AUDADIS-IV	4180186
40766369	您首次使用这种药品时的年龄是多大:时间:时间点:^患者:定量型:AUDADIS-IV	4182948
40766373	2; Finding; Findings; Nominal; PhenX; Point in time; Problem marijuana &gt; 24h; Random	4180186
40766373	Problem marijuana > 24h SSAGA II	4180186
40766373	发生时间上已经超过24小时,以致于其干扰了您的职责行使或人际关系的,与使用大麻相关的问题:发现:时间点:^患者:名义型:SSAGA II	4182948
40766374	Continue marijuana depressed SSAGA II	4180186
40766374	2; Continue marijuana depressed; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766374	在您知道大麻造成了您出现任何这些情绪上或心理上的问题之后您当时还继续使用大麻吗:发现:时间点:^患者:序数型:SSAGA II	4182948
40766375	Marijuana want stop SSAGA II	4180186
40766375	2; Finding; Findings; Marijuana want stop; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766375	您是否常常希望停止吸食大麻或减少大麻的吸食量:发现:时间点:^患者:序数型:SSAGA II	4182948
40766376	2; Finding; Findings; Marijuana could not stop; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40766376	Marijuana could not stop SSAGA II	4180186
40766376	您是否曾经试图停止吸食大麻或减少大麻吸食量,但却发现自己并没有能够做到:发现:时间点:^患者:序数型:SSAGA II	4182948
40766382	2; Finding; Findings; III; Marijuana prevent withdrawal 3X; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766382	Marijuana prevent withdrawal 3X SSAGA II	4180186
40766382	为了摆脱任何这些问题的困扰而使用大麻,这种情况是否发生过3次或更多的次数:发现:时间点:^患者:序数型:SSAGA II	4182948
40766385	Medicine drug lifetime use SSAGA II	4180186
40766385	2; Drugs; Finding; Findings; Medicine drug lifetime use; Nominal; PhenX; Point in time; Random	4180186
40766385	用于感觉良好或极度兴奋或者感觉更加活跃或警觉的药物或毒品:发现:时间点:^患者:名义型:SSAGA II	4182948
40766386	Meds drugs feel high PhenX	4180186
40766386	Drug; Finding; Findings; Meds drugs ever; Meds drugs feel high; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rx; Screen	4180186
40766386	为了感觉良好或兴奋,或者为了感觉上更加积极活跃或警觉,您是否曾经使用过任何这些药物 - 或者,您是否曾经使用过任何并非处方开出的处方药,或者使用的量比处方规定的多:发现:时间点:^患者:序数型:PhenX	4182948
40766387	2; Cnt; Count; Drug lifetime times used; Drugs; Number; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766387	Drug lifetime times used SSAGA II	4180186
40766387	在一生当中,您曾经有多少次使用过这种药物:数量(计数):时间点:^患者:定量型:SSAGA II	4182948
40766388	Drug 30D use get over SSAGA II	4180186
40766388	2; Drug 30D use get over; Drugs; Finding; Findings; month; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766388	是否曾经存在过一段为期1个月或更长的时期,您的大量时间都花费在从这种毒品或者其影响当中恢复过来之上:发现:时间点:^患者:序数型:SSAGA II	4182948
40766392	Drug need more for effect SSAGA II	4180186
40766392	2; Drug need more for effect; Drugs; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766392	为了达到某种效果,您是否曾经需要过更大量的这种毒品,或者发现按照自己过去所习惯使用的量,无法再达到兴奋的状态:发现:时间点:^患者:序数型:SSAGA II	4182948
40766395	Reduced activity 3X SSAGA II	4180186
40766395	2; Drugs; Finding; Findings; III; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Reduc; Reduced activity 3X; Screen	4180186
40766395	使用这种毒品时放弃或大幅度减少重要活动的情况是否发生过3次或更多的次数,或者持续了一个月或更长的时间:发现:时间点:^患者:序数型:SSAGA II	4182948
40766398	2; Drug; Drug withdraw prob experience; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766398	Drug withdraw prob experience SSAGA II	4180186
40766398	当您在稳定使用毒品之后停止使用毒品、削减其用量或者说不使用毒品的时候,您是否曾经经历过这种问题:发现:时间点:^患者:序数型:SSAGA II	4182948
40766401	2; Drugs; Finding; Findings; III; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Use ease withdrawal 3X	4180186
40766401	Use ease withdrawal 3X SSAGA II	4180186
40766401	您不得不使用这种毒品来让问题消失掉,这种情况是否曾经发生过3次或更多的次数:发现:时间点:^患者:序数型:SSAGA II	4182948
40766402	2; Drug use overdose; Drugs; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
40766402	Drug use overdose SSAGA II	4180186
40766402	这种毒品的使用是否造成过您出现任何的其他问题,比如需要医学处理的使用过量:发现:时间点:^患者:序数型:SSAGA II	4182948
40766404	Drug use hepatitis SSAGA II	4180186
40766404	2; Drug use hepatitis; Drugs; Finding; Findings; Hep; Hepatis; Hepatit; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766404	这种毒品的使用是否造成过您出现任何的其他问题,比如肝炎:发现:时间点:^患者:序数型:SSAGA II	4182948
40766405	Drug continue cause hepatitis SSAGA II	4180186
40766405	2; Drug continue cause hepatitis; Drugs; Finding; Findings; Hep; Hepatis; Hepatit; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766405	在您知道这种毒品造成了肝炎的情况下您当时还继续使用这种毒品吗:发现:时间点:^患者:序数型:SSAGA II	4182948
40766406	Drug use other health probs SSAGA II	4180186
40766406	2; Drug use other health probs; Drugs; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766406	这种毒品的使用是否造成过您出现任何严重的健康问题:发现:时间点:^患者:序数型:SSAGA II	4182948
40766407	Drug use serious hlth probs SSAGA II	4180186
40766407	2; Drug use serious hlth probs; Drugs; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766407	在您知道这种毒品造成了其他严重的健康问题的情况下您当时还继续使用这种毒品吗:发现:时间点:^患者:序数型:SSAGA II	4182948
40766408	Drug emot_psych probs > 24h SSAGA II	4180186
40766408	2; Drug emot_psych probs &gt; 24h; Drugs; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766408	使用这种毒品是否已经造成您的这种情绪或心理问题并在时间上已经超过24小时,以致于其干扰了您的职责行使或人际关系:发现:时间点:^患者:序数型:SSAGA II	4182948
40766414	2; Finding; Findings; Marijuana withdraw problem; Nominal; PhenX; Point in time; Random	4180186
40766414	Marijuana withdraw problem SSAGA II	4180186
40766414	停止使用大麻、削减其用量或者说不使用大麻2天或更长时间时的问题:发现:时间点:^患者:名义型:SSAGA II	4182948
40766415	Dwelling type; ICAS; Nominal; PhenX; Point in time; Random; Typ	4180186
40766415	Dwelling type ICAS	4180186
40766415	住宅是什么类型:类型:时间点:^患者:名义型:内城区哮喘调查	4182948
40766416	Dwelling type other; ICAS; Nominal; Othr; PhenX; Point in time; Random; Typ	4180186
40766416	Dwelling type other ICAS	4180186
40766416	存在其他情况时的住宅类型:类型:时间点:^患者:名义型:内城区哮喘调查	4182948
40766418	Building age; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766418	Building age MESA	4180186
40766418	您的建筑物的大致年龄是多少:时间:时间点:^患者:定量型:MESA 空气污染	4182948
40766419	What Y was building built LIBCSP	4180186
40766419	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766419	该建筑物是哪一年建造的:日期:时间点:^患者:定量型:LIBCSP	4182948
40766423	Residence move Mo NHEXAS	4180186
40766423	Finding; Findings; month; Nominal; PhenX; Point in time; Random; Residence move Mo	4180186
40766423	您是何月从那里迁走的:发现:时间点:^患者:名义型:NHEXAS	4182948
40766424	Residence move Y NHEXAS	4180186
40766424	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Residence move Y	4180186
40766424	您是何年从那里迁走的:日期:时间点:^患者:定量型:NHEXAS	4182948
40766426	Ys at address NHEXAS	4180186
40766426	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Ys at address	4180186
40766426	您已经或曾经在那里生活了多少年时间:时间:时间点:^患者:定量型:NHEXAS	4182948
40766428	Garage vehicle parked NHEXAS	4180186
40766428	Finding; Findings; Garage vehicle parked; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766428	在这个车库之中停泊有任何的汽车、面包车或其他机动车辆吗:发现:时间点:^患者:序数型:NHEXAS	4182948
40766429	Gas powered device storage NHEXAS	4180186
40766429	Basem; Basemt; Finding; Findings; Gas powered device storage; Gases; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766429	在这所房子或公寓的任何房间、地下室或附属车库之中存储有任何的燃气装置或设备吗:发现:时间点:^患者:序数型:NHEXAS	4182948
40766430	1 year; 12Mos; Finding; Findings; House water dampness; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766430	House water dampness NSLAH	4180186
40766430	在过去的那12个月当中,您的家中是否因为管道破裂、漏水、大雨或洪水而存在积水或潮气:发现:12个月:^患者:序数型:NSLAH	4182948
40766432	Finding; Findings; House air conditioning; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766432	House air conditioning NHEXAS	4180186
40766432	空调设备、制冷设备是否用于为这所房子或公寓降温:发现:时间点:^患者:序数型:NHEXAS	4182948
40766433	House air conditioning type; Nominal; PhenX; Point in time; Random; Typ	4180186
40766433	House air conditioning type NHEXAS	4180186
40766433	您使用的是哪些类型的空调设备:类型:时间点:^患者:名义型:NHEXAS	4182948
40766438	Finding; Findings; House heating start month; month; Nominal; PhenX; Point in time; Random; Started	4180186
40766438	House heating start month NHEXAS	4180186
40766438	您通常在哪个月份开始使用加热装置:发现:时间点:^患者:名义型:NHEXAS	4182948
40766440	1 year; 12Mos; Arterial Stenosis; f213; Finding; Findings; House pet; Ordinal; Oryctalagus spp; Othr; Past; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766440	House pet NHANES	4180186
40766440	在过去的那12个月当中,任何的狗、猫或其他的小型毛皮动物在您家中生活过或者说呆过一段时间,如家兔、豚鼠或仓鼠:发现:12个月:^患者:序数型:NHANES	4182948
40766444	Dpth; Finding; Findings; Next-of-kin Questionnaire; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Well depth	4180186
40766444	Well depth Next-of-kin	4180186
40766444	私有水井的深度当时是多少:发现:时间点:^患者:序数型:最近亲属	4182948
40766445	Finding; Findings; Next-of-kin Questionnaire; Nominal; PhenX; Point in time; Random	4180186
40766445	Well cased Next-of-kin	4180186
40766445	对该私有水井当时是否进行了拦护:发现:时间点:^患者:名义型:最近亲属	4182948
40766446	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx; Water treatment usage	4180186
40766446	Water treatment usage PhenX	4180186
40766446	在这所房子或公寓的任何房间、地下室或附属车库之中存储有任何的水处理装置或设备吗:发现:时间点:^患者:序数型:PhenX	4182948
40766448	Residence PEG	4180186
40766448	Finding; Findings; Housing; Living Arrangement; Living Arrangements; Nominal; PhenX; Point in time; Polyethylene Glycol; Random	4180186
40766448	居住:发现:时间点:^患者:名义型:聚乙二醇研究	4182948
40766449	ADMIN; ADMIN.PATIENT; Housing; Living Arrangement; Living Arrangements; Point in time; QNT; Quan; Quant; Quantitative; Random; Residence date lived from	4180186
40766449	Residence date lived from	4180186
40766449	您最初开始居住在该居住地的日期:日期:时间点:^患者:定量型	4182948
40766450	Resid date lived to	4180186
40766450	ADMIN; ADMIN.PATIENT; Housing; Living Arrangement; Living Arrangements; Point in time; QNT; Quan; Quant; Quantitative; Random; Resid date lived to	4180186
40766450	您当时在该居住地居住到的日期:日期:时间点:^患者:定量型	4182948
40766451	Residence address PEG	4180186
40766451	Finding; Findings; Housing; Living Arrangement; Living Arrangements; Nominal; PhenX; Point in time; Polyethylene Glycol; Random	4180186
40766451	居住者的地址是什么,街道 - 十字街口、城市、州或地标:发现:时间点:^患者:名义型:聚乙二醇研究	4182948
40766452	Was this on a farm PEG	4180186
40766452	Finding; Findings; Nominal; PhenX; Point in time; Polyethylene Glycol; Random	4180186
40766452	这是否在农场:发现:时间点:^患者:名义型:聚乙二醇研究	4182948
40766456	Finding; Findings; Nominal; PhenX; Point in time; Polyethylene Glycol; Random; Residence near town	4180186
40766456	Residence near town PEG	4180186
40766456	您当时是否生活在靠近城镇中心或边缘的地方:发现:时间点:^患者:名义型:聚乙二醇研究	4182948
40766457	Finding; Findings; Ordinal; PhenX; Point in time; Polyethylene Glycol; QL; Qual; Qualitative; Random; Screen	4180186
40766457	Geocoordinates verified PEG	4180186
40766457	地理坐标是否得到了核对:发现:时间点:^患者:序数型:聚乙二醇研究	4182948
40766458	Finding; Findings; Nominal; PhenX; Point in time; Polyethylene Glycol; Random; Resid geocoord verified how	4180186
40766458	Resid geocoord verified how PEG	4180186
40766458	当时是如何核对地理坐标的:发现:时间点:^患者:名义型:聚乙二醇研究	4182948
40766459	2; ACSCP-II; Exposure to materials; Finding; Findings; Job; Nominal; Occupation; PhenX; Point in time; Random	4180186
40766459	Exposure to materials ACSCP-II	4180186
40766459	您在自己的工作或者日常生活当中所暴露于的物质:发现:时间点:^患者:名义型:ACSCP 研究项目 II	4182948
40766460	2; ACSCP-II; Exposure work and life; Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766460	Exposure work and life ACSCP-II	4180186
40766460	在您的工作或日常生活当中,您是否规律地暴露于这种物质:发现:时间点:^患者:序数型:ACSCP 研究项目 II	4182948
40766461	2; ACSCP-II; Exposure Ys; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766461	Exposure Ys ACSCP-II	4180186
40766461	您当时定期暴露于这种材料有多少年时间:时间:时间点:^患者:定量型:ACSCP 研究项目 II	4182948
40766463	Finding; Findings; Job; Job 35h/W; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Tot; Totl	4180186
40766463	Job 35h/W NHANES	4180186
40766463	在全部的工作或业务上,您通常是否每星期工作35个小时或更长的时间:发现:时间点:^患者:序数型:NHANES	4182948
40766468	Finding; Findings; Job; Job shift schedule; Nominal; Occupation; PhenX; Point in time; Random; Work	4180186
40766468	Job shift schedule NHANES	4180186
40766468	下列哪一项能够最佳地描述您通常在自己的主要工作或者业务中工作的小时数:发现:时间点:^患者:名义型:NHANES	4182948
40766471	Finding; Findings; Job; Longest job industry; Nominal; Occupation; PhenX; Point in time; Random	4180186
40766471	Longest job industry NHANES	4180186
40766471	您工作时间最长的是什么种类的工作或者行业:发现:时间点:^患者:名义型:NHANES	4182948
40766472	Finding; Findings; Job duties; Longest job duties; Nominal; Occupation; PhenX; Point in time; Random; Work	4180186
40766472	Longest job duties NHANES	4180186
40766472	在这项工作或者业务中,您当时最为重要的活动是什么:发现:时间点:^患者:名义型:NHANES	4182948
40766473	Job; Longest job duration; Occupation; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Work	4180186
40766473	Longest job duration	4180186
40766473	您到底在这项工作或业务中工作了大约多长时间:时间:时间点:^患者:定量型	4182948
40766474	Finding; Findings; Job; Job hx since age 16; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766474	Job hx since age 16 NHANES	4180186
40766474	自从16岁以来,您是否曾经工作过6个月或者更长的时间:发现:时间点:^患者:序数型:NHANES	4182948
40766475	Finding; Findings; No; Nominal; Num; Occupation; PhenX; Point in time; Random; Work	4180186
40766475	Job number NHANES	4180186
40766475	工作编号:发现:时间点:^患者:名义型:NHANES	4182948
40766476	Job hx employer NHANES	4180186
40766476	Finding; Findings; Job hx employer; Nominal; PhenX; Point in time; Random	4180186
40766476	当时您首次或后续工作了6个月或者更长时间的那家公司的名称是什么:发现:时间点:^患者:名义型:NHANES	4182948
40766478	Job hx Y start; Occupation; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Work	4180186
40766478	Job hx Y start NHANES	4180186
40766478	您是哪一年开始干这份工作的:日期:时间点:^患者:定量型:NHANES	4182948
40766479	Job hx stop Y; Occupation; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Work	4180186
40766479	Job hx stop Y NHANES	4180186
40766479	您是哪一年停止干这份工作的:日期:时间点:^患者:定量型:NHANES	4182948
40766482	Finding; Findings; Job hx business industry; Job hx business industry verbatim; Nominal; PhenX; Point in time; Random	4180186
40766482	Job hx business industry NHANES	4180186
40766482	他们制造的是什么,或者他们提供的是什么服务 - 它是什么类型的工商企业:发现:时间点:^患者:名义型:NHANES	4182948
40766483	Finding; Findings; Job hx duties; Nominal; Occupation; PhenX; Point in time; Random; Work	4180186
40766483	Job hx duties NHANES	4180186
40766483	对于这项工作,您当时主要的活动或职责是什么:发现:时间点:^患者:名义型:NHANES	4182948
40766485	Job hx tool equipment NHANES	4180186
40766485	Finding; Findings; Job hx tool equipment; Nominal; PhenX; Point in time; Random	4180186
40766485	您当时使用的是什么种类的工具和装备:发现:时间点:^患者:名义型:NHANES	4182948
40766487	Finding; Findings; Hobby participated; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766487	Hobby participated LIBCSP	4180186
40766487	您参加这种业余爱好是否已有6个月或更长的时间:发现:时间点:^患者:序数型:LIBCSP	4182948
40766488	Hobby first Y LIBCSP	4180186
40766488	Hobby first Y; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766488	您是哪一年首次涉及这项业余爱好的:日期:时间点:^患者:定量型:LIBCSP	4182948
40766489	Hobby last Y; Past; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766489	Hobby last Y LIBCSP	4180186
40766489	您是哪一年最后一次涉及这项业余爱好的:日期:时间点:^患者:定量型:LIBCSP	4182948
40766490	Hobby total Ys LIBCSP	4180186
40766490	Hobby total Ys; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766490	总的来说,当时您参加这项业余爱好有多少年时间:时间:时间点:^患者:定量型:LIBCSP	4182948
40766492	Finding; Findings; Hobby chemicals specify; Nominal; Othr; PhenX; Point in time; Random	4180186
40766492	Hobby chemicals specify LIBCSP	4180186
40766492	涉及使用化学品的其他活动:发现:时间点:^患者:名义型:LIBCSP	4182948
40766493	Finding; Findings; Nominal; PhenX; Point in time; Random; Smoking at home; World Heatlth Organization	4180186
40766493	Smoking at home NHANES	4180186
40766493	住在这里的任何人是否在这个家里的任何地方抽香烟、雪茄或烟斗:发现:时间点:^患者:名义型:NHANES	4182948
40766495	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Smoking cigarette quantity	4180186
40766495	Smoking cigarette quantity nRate NHANES	4180186
40766495	您通常每天在家里的任何地方抽多少支香烟:计数型速率:时间点:^患者:定量型:NHANES	4182948
40766496	Dextro; Hs smell smoke at work; Job; Occupation; Othr; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Work	4180186
40766496	Hs smell smoke at work NHANES	4180186
40766496	在这项工作或业务中,也就是在您的雇主或单位那里,在您的职业当中,您每天有多少小时能够闻到他人抽吸香烟、雪茄或烟斗的烟味:时间:时间点:^患者:定量型:NHANES	4182948
40766498	CBCS; Cnt; Count; Number; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766498	Full sisters CBCS	4180186
40766498	您有多少位亲姐妹:数量(计数):时间点:^患者:定量型:卡罗来纳乳腺癌研究	4182948
40766500	Identical twin CBCS	4180186
40766500	CBCS; Finding; Findings; Identical twin; Nominal; PhenX; Point in time; Random	4180186
40766500	您与您的双胞胎兄弟（姐妹）是否完全相同:发现:时间点:^患者:名义型:卡罗来纳乳腺癌研究	4182948
40766505	Sibling age CBCS	4180186
40766505	CBCS; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Sibling age	4180186
40766505	这位兄弟或姐妹现在的年龄是多大或者这位兄弟或姐妹在其死亡时的年龄是多大:时间:时间点:^患者:定量型:卡罗来纳乳腺癌研究	4182948
40766506	Day care preschool; Finding; Findings; Nominal; Point in time; Random	4180186
40766506	Day care preschool PhenX	4180186
40766506	日托或学前班类别:发现:时间点:^患者:名义型:PhenX	4182948
40766507	Day care begin Mo; month; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766507	Day care begin Mo PhenX	4180186
40766507	孩子在何年何月开始参加首次或下次不在家里的日托或学前班:日期:时间点:^患者:定量型:PhenX	4182948
40766508	Day care end Mo PhenX	4180186
40766508	Day care end Mo; month; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766508	孩子在何年何月结束了参加首次或下次不在家里的日托或学前班:日期:时间点:^患者:定量型:PhenX	4182948
40766509	Day care Hs per W PhenX	4180186
40766509	Day care Hs per W; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766509	孩子每周参加大约多少小时不在家里的日托或学前班:时间:时间点:^患者:定量型:PhenX	4182948
40766511	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766511	Did your mother breastfeed you LIBCSP	4180186
40766511	您的母亲当时是对您进行母乳喂养吗:发现:时间点:^患者:序数型:LIBCSP	4182948
40766513	Renovation type RIOPA	4180186
40766513	Nominal; PhenX; Point in time; Random; Renovation type; Typ	4180186
40766513	什么类型的修缮:类型:时间点:^患者:名义型:RIOPA	4182948
40766517	When were they cleaned RIOPA	4180186
40766517	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40766517	何时对它们进行了清洁:发现:时间点:^患者:名义型:RIOPA	4182948
40766519	House apartment painted RIOPA	4180186
40766519	Finding; Findings; House apartment painted; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766519	在过去的那一年当中,这所房子或公寓内部是否刷过油漆:发现:1年:^患者:序数型:RIOPA	4182948
40766520	Finding; Findings; Nominal; Painting date; Past; PhenX; Point in time; Random	4180186
40766520	Painting date RIOPA	4180186
40766520	这所房子或公寓内部最后一次刷油漆的时间是什么时候:发现:时间点:^患者:名义型:RIOPA	4182948
40766522	1 week; Dry cleaner visit; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766522	Dry cleaner visit RIOPA	4180186
40766522	在过去的那个星期当中您是否曾经去过干洗店:发现:1星期:^患者:序数型:RIOPA	4182948
40766523	Dry-cleaned items past W RIOPA	4180186
40766523	1 week; Dry-cleaned items past W; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766523	在过去的那个星期当中您是否从洗衣店带回家中任何经过干洗的东西:发现:1星期:^患者:序数型:RIOPA	4182948
40766525	2 days; 2D; 48 hours; 48HR; Exposure; Finding; Findings; Ordinal; Past; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766525	Exposure RIOPA	4180186
40766525	在过去的那48小时当中,您或您身边的某个人是否使用过这种空气污染物:发现:48小时:^患者:序数型:RIOPA	4182948
40766530	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40766530	Which cleaning solutions RIOPA	4180186
40766530	哪些清洗液:发现:时间点:^患者:名义型:RIOPA	4182948
40766532	2 days; 2D; 48 hours; 48HR; Finding; Findings; Nominal; Othr; Past; PhenX; Start car garage carport; Started; Study report	4180186
40766532	Start car garage carport RIOPA	4180186
40766532	在过去的那48小时当中,即该次检查期间,您或其他任何人是否曾经在下列类型车库之一之中发动过一辆汽车或其他机动车:发现:48小时:^患者:名义型:RIOPA	4182948
40766533	2 days; 2D; 48 hours; 48HR; Finding; Findings; Ordinal; Park diesel vehicle; Past; PhenX; Ql; Qual; Qualitative; Screen; Study report	4180186
40766533	Park diesel vehicle RIOPA	4180186
40766533	在过去的那48小时当中,即该次检查期间,是否有任何的柴油车辆停泊在住宅周围:发现:48小时:^患者:序数型:RIOPA	4182948
40766534	Operate near diesel vehicle RIOPA	4180186
40766534	2 days; 2D; 48 hours; 48HR; Finding; Findings; Operate near diesel vehicle; Ordinal; Past; PhenX; Ql; Qual; Qualitative; Screen; Study report	4180186
40766534	在过去的那48小时当中,即该次检查期间,您是否操作过或靠近过柴油发动机,如公共汽车终点站、卡车服务站:发现:48小时:^患者:序数型:RIOPA	4182948
40766535	Vacuum bag emptied time Clock time PhenX	4180186
40766535	Clock time; Nominal; Point in time; Random; Vacuum bag emptied time	4180186
40766535	真空袋的清空时间:时钟时间:时间点:^患者:名义型:PhenX	4182948
40766539	Finding; Findings; Integument; Nominal; PhenX; Point in time; Random; Skin reaction	4180186
40766539	Skin reaction NHL	4180186
40766539	如果您在不用防晒霜的情况下在中午的太阳下待上一个小时的话,在下列这些反应当中,哪个或哪些能够最佳地描述您的皮肤所会发生的情况:发现:时间点:^患者:名义型:NHL	4182948
40766540	Finding; Findings; Job provided most responses; Nominal; PhenX; Point in time; Random; World Heatlth Organization	4180186
40766540	Job provided most responses NHANES	4180186
40766540	在这个部门当中,谁提供了大多数的响应:发现:时间点:^患者:名义型:NHANES	4182948
40766541	2; Drink allev withdraw SZ 3X; Finding; Findings; III; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766541	Drink allev withdraw SZ 3X SSAGA II	4180186
40766541	您是否曾经在3个或更多的不同场合当中,为了避免出现惊厥、发作或抽搐或者让它们消失掉而饮上一杯酒:发现:时间点:^患者:序数型:SSAGA II	4182948
40766544	2; Alc withdraw seizure; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766544	Alc withdraw seizure SSAGA II	4180186
40766544	当您停止饮酒、削减酒量或者说不饮酒的时候,您是否曾经出现过惊厥、癫痫发作或者抽搐,其中您丧失了意识,跌倒在地板上,并且在记住究竟发生过什么事情方面存在困难:发现:时间点:^患者:序数型:SSAGA II	4182948
40766548	Tanning booth ever NHL	4180186
40766548	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Tanning booth ever	4180186
40766548	您是否曾经使用过人工晒身箱（紫外线保健房、人工日光浴房）:发现:时间点:^患者:序数型:NHL	4182948
40766551	Weekday sun Hs nRate NHL	4180186
40766551	Count/time; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Weekday sun Hs	4180186
40766551	在一个普通的夏季工作日当中,您一般在正午的阳光下花费大约多少个小时:计数型速率:时间点:^患者:定量型:NHL	4182948
40766552	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Weekend day sun Hs	4180186
40766552	Weekend day sun Hs nRate NHL	4180186
40766552	在一个通常的夏季周末日子当中,您一般在正午的阳光下花费大约多少个小时:计数型速率:时间点:^患者:定量型:NHL	4182948
40766554	Finding; Findings; Nominal; PhenX; Point in time; Random; SDOH; The Finnish Environment and Asthma Study; Workspace floor material	4180186
40766554	Workspace floor material FEAS	4180186
40766554	您工作场所的地板是什么材料:发现:时间点:^患者:名义型:FEAS	4182948
40766555	Finding; Findings; Nominal; Othr; PhenX; Point in time; Random; SDOH; The Finnish Environment and Asthma Study; Workspace floor material other	4180186
40766555	Workspace floor material other FEAS	4180186
40766555	存在其他情况时您的工作场所当中的地板材料:发现:时间点:^患者:名义型:FEAS	4182948
40766558	Finding; Findings; Home renovation moisture; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; The Finnish Environment and Asthma Study	4180186
40766558	Home renovation moisture FEAS	4180186
40766558	您家中是否因为受潮进行过翻新或修缮:发现:时间点:^患者:序数型:FEAS	4182948
40766560	1 year; 12Mos; Finding; Findings; Home repairs enumerated; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen; SDOH; The Finnish Environment and Asthma Study	4180186
40766560	Home repairs enumerated FEAS	4180186
40766560	在过去的那12个月当中,在您的家中完成了下列哪一项维修:发现:12个月:^患者:序数型:FEAS	4182948
40766561	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; The Finnish Environment and Asthma Study; Wall to wall carpeting	4180186
40766561	Wall to wall carpeting FEAS	4180186
40766561	您家中是否有满铺地毯:发现:时间点:^患者:序数型:FEAS	4182948
40766562	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; The Finnish Environment and Asthma Study; Vinyl plastic floor	4180186
40766562	Vinyl plastic floor FEAS	4180186
40766562	您家中的地板材料是否为塑料的或乙烯基塑料的:发现:时间点:^患者:序数型:FEAS	4182948
40766563	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Textile wall material home; The Finnish Environment and Asthma Study	4180186
40766563	Textile wall material home FEAS	4180186
40766563	您家中的墙壁材料是否为纺织品、布料、黄麻等等:发现:时间点:^患者:序数型:FEAS	4182948
40766564	Finding; Findings; Ordinal; PhenX; Plastic wall material home; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; The Finnish Environment and Asthma Study	4180186
40766564	Plastic wall material home FEAS	4180186
40766564	您家中的墙壁材料是否为塑料的:发现:时间点:^患者:序数型:FEAS	4182948
40766566	Child attended preschool PhenX	4180186
40766566	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766566	孩子是否已经参加了学前班:发现:时间点:^患者:序数型:PhenX	4182948
40766567	Carpet rug installed; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766567	Carpet rug installed RIOPA	4180186
40766567	在过去的那一年当中,是否铺了新的地毯或者说毛毯:发现:1年:^患者:序数型:RIOPA	4182948
40766572	First exposure age exact NHL	4180186
40766572	Exp; First exposure age exact; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766572	您首次遭遇这种暴露时的年龄是多大:时间:时间点:^患者:定量型:NHL	4182948
40766573	First exposure age estimate NHL	4180186
40766573	Exp; First exposure age estimate; First exposure age exact; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766573	您在首次接受此暴露时大约是多大年龄:时间:时间点:^患者:定量型:NHL	4182948
40766574	Exp; Last exposure age exact; Past; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766574	Last exposure age exact NHL	4180186
40766574	您最后一次遭遇这种暴露时的年龄是多大:时间:时间点:^患者:定量型:NHL	4182948
40766575	Last exposure age estimate NHL	4180186
40766575	Exp; Last exposure age estimate; Last exposure age exact; Past; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766575	您在最后一次接受此暴露时大约是多大年龄:时间:时间点:^患者:定量型:NHL	4182948
40766578	Count/time; month; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Tan Mos	4180186
40766578	Tan Mos nRate NHL	4180186
40766578	通常您每年有多少个月皮肤是晒黑的:计数型速率:时间点:^患者:定量型:NHL	4182948
40766580	Drinking ever PhenX	4180186
40766580	Arterial Stenosis; Drank; Drink; Drinking ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766580	您是否曾经喝过啤酒、葡萄酒或烈性酒之类的酒精饮料,并每星期至少喝过一次且持续6个月或更长时间:发现:时间点:^患者:序数型:PhenX	4182948
40766581	Drinking weekly; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen	4180186
40766581	Drinking weekly PhenX	4180186
40766581	在这个年龄范围内,您是否饮用过酒精饮料,并每星期至少饮用一次且持续6个月或更长时间:发现:时间点:^患者:序数型:PhenX	4182948
40766585	Activity; CA; Calif; Count/time; CTS; EXCZ; Exercise; month; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge; Strenuous exercise Mo	4180186
40766585	Strenuous exercise Mo CTS	4180186
40766585	在这个年龄范围期间您参加剧烈锻炼活动或者数趟游泳、有氧健身运动、健美操、跑步、慢跑、篮球、山地骑行或短网拍墙球之类体育项目的每年月数:计数型速率:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766587	Activity; CA; Calif; Count/time; CTS; EXCZ; Exercise; Levels; Levl; LV; LVL; Moderate exercise Mo; month; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge	4180186
40766587	Moderate exercise Mo CTS	4180186
40766587	在这个年龄范围期间您参加适度锻炼活动或者快步走、高尔夫、排球、平坦街道自行车骑行、娱乐性网球或垒球之类体育项目的每年月数:计数型速率:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766590	Activ; Activity; Activity D per W; Actvty; CA; Calif; Count/time; CTS; Dextro; Exercise; Movements; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766590	Activity D per W CTS	4180186
40766590	您在进行这项活动上每星期所花费的平均天数:计数型速率:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766593	Dextro; Exposure smoke present_Hs; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766593	Exposure smoke present_Hs PhenX	4180186
40766593	目前,您每天有多少小时暴露在他人吸烟的烟雾当中:时间:时间点:^患者:定量型:PhenX	4182948
40766594	CA; Calif; CTS; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Ever estrogen; Exchange; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Sx	4180186
40766594	Ever estrogen CTS	4180186
40766594	您是否曾经针对绝经期（或者说更年期）症状或者出于其他的原因而服用雌激素（或者说雌性激素）:发现:时间点:^患者:序数型:加利福尼亚教师研究	4182948
40766595	Arterial Stenosis; CA; Calif; CTS; Ever premarin; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766595	Ever premarin CTS	4180186
40766595	您是否曾经口服普雷马林药片或药丸:发现:时间点:^患者:序数型:加利福尼亚教师研究	4182948
40766596	CA; Calif; CTS; PhenX; Point in time; Premarin age first; QNT; Quan; Quant; Quantitative; Random	4180186
40766596	Premarin age first CTS	4180186
40766596	您在多大年龄时首次服用普雷马林:时间:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766597	CA; Calif; CTS; Past; PhenX; Point in time; Premarin age last; QNT; Quan; Quant; Quantitative; Random	4180186
40766597	Premarin age last CTS	4180186
40766597	您在多大年龄时最后服用普雷马林:时间:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766601	CA; Calif; CTS; Estrogen age last; Othr; Past; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766601	Estrogen age last CTS	4180186
40766601	您在多大年龄时最后服用除普雷马林药片或药丸外的雌激素:时间:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766603	CA; Calif; CTS; Ever progesterone progestin; Finding; Findings; Nominal; P4; PhenX; Point in time; Prog; Proges; Progest; Progestin; Random	4180186
40766603	Ever progesterone progestin CTS	4180186
40766603	您是否曾经使用过孕酮（又称为孕激素、黄体酮、孕甾酮）:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766604	CA; Calif; CTS; P4; PhenX; Point in time; Prog; Proges; Progest; Progesterone age first; Progestin; QNT; Quan; Quant; Quantitative; Random	4180186
40766604	Progesterone age first CTS	4180186
40766604	您在多大年龄时首次服用孕酮或孕激素:时间:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766605	CA; Calif; CTS; P4; Past; PhenX; Point in time; Prog; Proges; Progest; Progesterone age last; Progestin; QNT; Quan; Quant; Quantitative; Random	4180186
40766605	Progesterone age last CTS	4180186
40766605	您在多大年龄时最后服用孕酮或孕激素:时间:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766606	Progestin Ys CTS	4180186
40766606	CA; Calif; CTS; P4; PhenX; Point in time; Prog; Proges; Progest; Progestin; Progestin Ys; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
40766606	您总共服用过多少年时间的孕酮或者说黄体酮 - 排除您暂时停用的任何时候:时间:时间点:^患者:定量型:加利福尼亚教师研究	4182948
40766607	Provera dose CTS	4180186
40766607	CA; Calif; CTS; Finding; Findings; Nominal; PhenX; Point in time; Provera dose; Random	4180186
40766607	如果您使用的是安宫黄体酮,当时您通常采用的剂量是多少:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766609	AOEObservation; Gyn; Gynecology; OB; ObGyn; Obstetrics; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766609	首次月经周期年龄:时间:时间点:^患者:定量型	4182948
40766610	Menstrual period in last year PhenX	4180186
40766610	Finding; Findings; Menstrual period in last year; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766610	在过去的那一年内您是否有过一次月经周期:发现:1年:^患者:序数型:PhenX	4182948
40766611	AOEObservation; Gyn; Gynecology; LMP; OB; ObGyn; Obstetrics; Past; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766611	末次月经周期年龄:时间:时间点:^患者:定量型	4182948
40766612	Finding; Findings; Nominal; Point in time; Random	4180186
40766612	Cause of menopause PhenX	4180186
40766612	绝经原因:发现:时间点:^患者:名义型:PhenX	4182948
40766613	Have you ever been pregnant PhenX	4180186
40766613	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766613	您是否曾经怀孕过:发现:时间点:^患者:序数型:PhenX	4182948
40766614	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Nominal; P prime; Point in time; Pregnancies; Random	4180186
40766614	妊娠结局:发现:时间点:^患者:名义型	4182948
40766617	Months of breast feeding PhenX	4180186
40766617	Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766617	母乳喂养月数:时间:时间点:^患者:定量型:PhenX	4182948
40766619	CA; Calif; CTS; Fam Mem; Gender; Nominal; PhenX; Point in time; Random; Rel; Typ	4180186
40766619	Deprecated Cancer relative gender	4180186
40766620	CA; Calif; CTS; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Rel; Screen	4180186
40766620	Relative alive CTS	4180186
40766620	亲戚当前是否还在世:发现:时间点:^患者:序数型:加利福尼亚教师研究	4182948
40766621	Current age or death age	4180186
40766621	Age @ Death; Current age or death age; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766621	当前年龄或死亡年龄:时间:时间点:^患者:定量型	4182948
40766622	Relative never had cancer CTS	4180186
40766622	CA; Calif; CTS; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Rel; Screen	4180186
40766622	亲戚从未患过癌症:发现:时间点:^患者:序数型:加利福尼亚教师研究	4182948
40766625	Second cancer diagnosis CTS	4180186
40766625	2nd; CA; Calif; CTS; Finding; Findings; Nominal; Othr; PhenX; Point in time; Random; Second cancer diagnosis	4180186
40766625	第二或其他癌症诊断:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766626	Finding; Findings; Lung cancer worry; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766626	Lung cancer worry PLCO	4180186
40766626	您多久出现一次担心患上肺癌的情况:发现:时间点:^患者:序数型:PLCO	4182948
40766628	Clinician-diagnosed illness PhenX	4180186
40766628	Finding; Findings; Nominal; Point in time; Random	4180186
40766628	临床医师诊断的疾病:发现:时间点:^患者:名义型:PhenX	4182948
40766629	Pre-existing condition hx PhenX	4180186
40766629	Finding; Findings; Ordinal; Point in time; Pre-existing condition hx; Ql; Qual; Qualitative; Random; Screen	4180186
40766629	您是否患有这种由临床医生所诊断的疾病:发现:时间点:^患者:序数型:PhenX	4182948
40766630	Dx; Point in time; Pre-existing condition Y; QNT; Quan; Quant; Quantitative; Random	4180186
40766630	Pre-existing condition Y PhenX	4180186
40766630	临床医师诊断的疾病的诊断年份:日期:时间点:^患者:定量型:PhenX	4182948
40766632	Fibrocystic by breast biopsy PhenX	4180186
40766632	Bx; Dis; Diseases; Dz; Fibrocystic by breast biopsy; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766632	乳腺活组织检查所确诊的乳腺纤维囊性病或者其他的良性乳腺疾病:发现:时间点:^患者:序数型:PhenX	4182948
40766634	Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40766634	Site of other cancer PhenX	4180186
40766634	其他癌症的部位:发现:时间点:^患者:名义型:PhenX	4182948
40766635	Gallstones symptoms PhenX	4180186
40766635	Finding; Findings; Gallstones symptoms; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
40766635	您是否有过胆石症状:发现:时间点:^患者:序数型:PhenX	4182948
40766637	Endometriosis by laparoscopy PhenX	4180186
40766637	Endometriosis by laparoscopy; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766637	子宫内膜异位症是否经过了腹腔镜检查确认:发现:时间点:^患者:序数型:PhenX	4182948
40766640	Asympt; Asymptomatic; Cancer screening test 3Y; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Scn; Screen	4180186
40766640	Cancer screening test 3Y 3Y PLCO	4180186
40766640	在过去的那3年当中,您是否接受过这项癌症筛查试验:发现:3年:^患者:序数型:PLCO	4182948
40766641	Asympt; Asymptomatic; Finding; Findings; Nominal; PhenX; Point in time; Random; Scn	4180186
40766641	Cancer screening PLCO	4180186
40766641	癌症筛查:发现:时间点:^患者:名义型:PLCO	4182948
40766642	Quit smoking consider PLCO	4180186
40766642	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Quit smoking consider; Random; Screen	4180186
40766642	您是否正在考虑在接下来的6个月当中戒烟:发现:时间点:^患者:序数型:PLCO	4182948
40766645	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Quit smoking age; Random	4180186
40766645	Quit smoking age PLCO	4180186
40766645	您最近一次戒烟时的年龄是多大:时间:时间点:^患者:定量型:PLCO	4182948
40766646	Quit smoking products PLCO	4180186
40766646	Finding; Findings; Nominal; PhenX; Point in time; Prods; Product; Quit smoking products; Random	4180186
40766646	请回想一下您最近一次戒烟,您是否使用过任何下列的产品:发现:时间点:^患者:名义型:PLCO	4182948
40766647	Quit smoking profess advise PLCO	4180186
40766647	1 year; 12Mos; Finding; Findings; Last; nursing; Ordinal; Othr; PhenX; Ql; Qual; Qualitative; Quit smoking profess advise; Screen	4180186
40766647	在过去的那12个月当中,是否有任何的医生、牙科医生、护士或者任何其他的健康专业人员建议过您戒烟:发现:12个月:^患者:序数型:PLCO	4182948
40766648	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766648	Have you ever had cancer PhenX	4180186
40766648	您是否患有癌症:发现:时间点:^患者:序数型:PhenX	4182948
40766651	Date of Dx	4180186
40766651	Date of Dx; Dx; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766651	诊断日期:日期:时间点:^患者:定量型	4182948
40766653	Finding; Findings; Nominal; Point in time; Random; Tx	4180186
40766653	Cancer treatment PhenX	4180186
40766653	癌症治疗:发现:时间点:^患者:名义型:PhenX	4182948
40766658	Chemo; Nominal; Point in time; Random; Typ	4180186
40766658	Type of chemotherapy PhenX	4180186
40766658	化学疗法类型:类型:时间点:^患者:名义型:PhenX	4182948
40766659	End date treatment or therapy	4180186
40766659	End date treatment or therapy; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Tx	4180186
40766659	处理或治疗结束日期:日期:时间点:^患者:定量型	4182948
40766661	Cancer other therapy PhenX	4180186
40766661	Cancer other therapy; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766661	您是否曾经接受过任何其他类型的治疗:发现:时间点:^患者:序数型:PhenX	4182948
40766662	Other cancer therapy PhenX	4180186
40766662	Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40766662	其他癌症疗法名称:发现:时间点:^患者:名义型:PhenX	4182948
40766663	Cancer recurrence PhenX	4180186
40766663	Cancer recurrence; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766663	您是否出现过此癌症的复发:发现:时间点:^患者:序数型:PhenX	4182948
40766664	Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766664	Date of cancer recurrence PhenX	4180186
40766664	癌症复发日期:日期:时间点:^患者:定量型:PhenX	4182948
40766667	CA; Calif; CTS; Finding; Findings; Ordinal; Pain-relieving med once a W; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766667	Pain-relieving med once a W CTS	4180186
40766667	您当前每星期至少服用一次这种疼痛缓解药物吗:发现:时间点:^患者:序数型:加利福尼亚教师研究	4182948
40766669	CA; Calif; CTS; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen; Stop regular use pain med past 3Y	4180186
40766669	Stop regular use pain med past 3Y 3Y CTS	4180186
40766669	在过去3年当中您是否停止了疼痛缓解药物的常规使用:发现:3年:^患者:序数型:加利福尼亚教师研究	4182948
40766670	CA; Calif; CTS; Finding; Findings; Nominal; PhenX; Point in time; Random; Stop reg use pain med past 3Y why	4180186
40766670	Stop reg use pain med past 3Y why CTS	4180186
40766670	当时您为何停止了疼痛缓解药物的常规使用:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766671	CA; Calif; Canef; CTS; Finding; Findings; Last; Lescol; Lipitor; Mevacor; Ordinal; PhenX; Pravachol; QL; Qual; Qualitative; Screen; Selektine; Statins past 3Y; Vastin; Zocor	4180186
40766671	Statins past 3Y 3Y CTS	4180186
40766671	在过去的那3年当中,您是否服用过他汀类药物,如洛伐他汀（美降脂）、阿托伐他汀（立普妥）、罗苏伐他汀（克来斯妥）、普伐他汀（普拉固）、辛伐他汀（舒降之）、氟伐他汀（来适可）:发现:3年:^患者:序数型:加利福尼亚教师研究	4182948
40766677	Premarin pill CTS	4180186
40766677	CA; Calif; CTS; Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40766677	普雷马林药片或药丸:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766678	CA; Calif; CTS; Finding; Findings; Ordinal; PhenX; Point in time; Premarin pill use; Ql; Qual; Qualitative; Random; Screen	4180186
40766678	Premarin pill use CTS	4180186
40766678	您是否曾经服用过这种普雷马林药片或药丸:发现:时间点:^患者:序数型:加利福尼亚教师研究	4182948
40766679	CA; Calif; CTS; Est; Estr; Estroge; Estrogen admin method; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Finding; Findings; Meth; Method of; Nominal; PhenX; Point in time; Random	4180186
40766679	Estrogen admin method CTS	4180186
40766679	雌激素施用方法:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766681	Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40766681	Cause of menopause if other PhenX	4180186
40766681	存在其他情况时的绝经原因:发现:时间点:^患者:名义型:PhenX	4182948
40766683	Gestation; Gestations; Gravida; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
40766683	Date of end of pregnancy PhenX	4180186
40766683	妊娠结束日期:日期:时间点:^患者:定量型:PhenX	4182948
40766684	CA; Calif; Cancer Dx; Cancer Dx other; CTS; Dx; Finding; Findings; Nominal; Othr; PhenX; Point in time; Random	4180186
40766684	Cancer Dx other CTS	4180186
40766684	存在其他情况时的癌症诊断:发现:时间点:^患者:名义型:加利福尼亚教师研究	4182948
40766685	Maj illness surgery date; Point in time; QNT; Quan; Quant; Quantitative; Random; Surg	4180186
40766685	Maj illness surgery date PhenX	4180186
40766685	重大疾病或外科手术日期:日期:时间点:^患者:定量型:PhenX	4182948
40766687	14 days; 2; 2 weeks; Finding; Findings; Give baby bottle past 2W; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766687	Give baby bottle past 2W IFPS-II	4180186
40766687	在过去的那2个星期当中,您是否曾经给过您的宝贝儿一个瓶子:发现:2星期:^患者:序数型:IFPS-II	4182948
40766688	14 days; 2; 2 weeks; f43; Finding; Findings; Freq add to bottle/milk in p 2W; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766688	Freq add to bottle/milk in p 2W IFPS-II	4180186
40766688	在过去2个星期当中,您多久在婴儿的奶瓶或母乳之中添加一次这种东西:发现:2星期:^患者:序数型:IFPS-II	4182948
40766693	Child beverage per D amount; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766693	Child beverage per D amount PhenX	4180186
40766693	您的孩子每天喝掉多少份这种饮料:计数型速率:时间点:^患者:定量型:PhenX	4182948
40766695	Beverage child consume at meals PhenX	4180186
40766695	Beverage child consume at meals; Finding; Findings; Nominal; Point in time; Random	4180186
40766695	正餐时您的孩子最常饮用的是什么饮料:发现:时间点:^患者:名义型:PhenX	4182948
40766696	Beverage most between meals; Finding; Findings; Nominal; Point in time; Random	4180186
40766696	Beverage most between meals PhenX	4180186
40766696	正餐之间您的孩子最常饮用的是什么饮料:发现:时间点:^患者:名义型:PhenX	4182948
40766697	Finding; Findings; Nominal; Point in time; Random; S prime	4180186
40766697	Nighttime feedings PhenX	4180186
40766697	下列哪一项陈述能够最佳地描述您孩子的夜间喂养情况:发现:时间点:^患者:名义型:PhenX	4182948
40766701	Finding; Findings; Liquids freq mouth moist; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766701	Liquids freq mouth moist PhenX	4180186
40766701	白天您是否频繁地呷吸饮料来保持自己口腔的湿润:发现:时间点:^患者:序数型:PhenX	4182948
40766702	Difficulties swallowing W/O fluids PhenX	4180186
40766702	Add; Deglutition; Difficulties swallowing W/O fluids; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766702	吃东西时如果没有额外的液体,您是否存在吞咽食物的困难:发现:时间点:^患者:序数型:PhenX	4182948
40766703	Diagnosed cleft lip palate PhenX	4180186
40766703	Diagnosed cleft lip palate; Finding; Findings; Nominal; Point in time; Random	4180186
40766703	您是否已经被诊断患有唇裂或颚裂:发现:时间点:^患者:名义型:PhenX	4182948
40766705	Code cleft lip palate defect PhenX	4180186
40766705	Code cleft lip palate defect; Finding; Findings; Nominal; Point in time; Random	4180186
40766705	唇裂或颚裂代码:发现:时间点:^患者:名义型:PhenX	4182948
40766707	Family use toothpaste fluoride PhenX	4180186
40766707	Family use toothpaste fluoride; Finding; Findings; Fl; Nominal; Point in time; Random; World Heatlth Organization	4180186
40766707	家庭里有谁使用含有氟化物的牙膏吗:发现:时间点:^患者:名义型:PhenX	4182948
40766711	Fixed braces on teeth duration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766711	Fixed braces on teeth duration PhenX	4180186
40766711	您的牙齿佩戴了多长时间的固定牙齿矫正器:时间:时间点:^患者:定量型:PhenX	4182948
40766712	Natural teeth amount PhenX	4180186
40766712	Cnt; Count; Natural teeth amount; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766712	您有多少颗天然牙:数量(计数):时间点:^患者:序数型:PhenX	4182948
40766718	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sores irritations &gt; 6Mo ago	4180186
40766718	Sores irritations > 6Mo ago PhenX	4180186
40766718	您首次出现疮肿溃疡或激惹现象是否已不止6个月的时间:发现:时间点:^患者:序数型:PhenX	4182948
40766722	Entire life tobacco type PhenX	4180186
40766722	Entire life tobacco type; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766722	在您整个的一生当中,您是否曾经抽过或使用过这种类型的烟草:发现:时间点:^患者:序数型:PhenX	4182948
40766724	Pain toothache >1 past 6Mo PhenX	4180186
40766724	Finding; Findings; Last; Ordinal; Pain toothache &gt;1 past 6Mo; Ql; Qual; Qualitative; Screen	4180186
40766724	在过去6个月当中您是否不止一次有过这种疼痛或牙痛:发现:6个月:^患者:序数型:PhenX	4182948
40766726	Pain come go contin uninterrupt PhenX	4180186
40766726	Finding; Findings; Nominal; Pain come go contin uninterrupt; Point in time; Random	4180186
40766726	当您有这种疼痛的时候,它究竟是霎来即去,还是持续不断:发现:时间点:^患者:名义型:PhenX	4182948
40766727	Housing; Latitude residence; Living Arrangement; Living Arrangements; PhenX; Point in time; Polyethylene Glycol; QNT; Quan; Quant; Quantitative; Random	4180186
40766727	Latitude residence PEG	4180186
40766727	居住地纬度:角度:时间点:^患者:定量型:聚乙二醇研究	4182948
40766729	Blood; C/EBP-alpha; CCAAT/enhancer binding protein (C/EBP), alpha; CEBP; Familial AML; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40766729	CEBPA gene Mut Anl Bld/T	4180186
40766729	CEBPA 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
40766731	2; Baby fed breast milk session len; Count/time; f43; Last; nRate; Number rate; Number Rate = Count/Time; Ordinal; Past; PhenX; Ql; Qual; Qualitative; Screen	4180186
40766731	Baby fed breast milk session len IFPS-II	4180186
40766731	如果在过去7天当中您的宝贝儿采取的是直接母乳喂养或者采用母乳来喂养的方式,那么每次母乳喂养平均持续大约多长时间:计数型速率:7天:^患者:序数型:IFPS-II	4182948
40766740	Nominal; Point in time; Random; Supported ventilation mode; Typ	4180186
40766740	Supported ventilation mode PhenX	4180186
40766740	所支持通气的方式:类型:时间点:^患者:名义型:PhenX	4182948
40766741	Spirometry contraindicated PhenX	4180186
40766741	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766741	肺活量测定属于禁忌:发现:时间点:^患者:序数型:PhenX	4182948
40766742	Reason contraindication PhenX	4180186
40766742	Finding; Findings; Nominal; Point in time; Random; Reason contraindication	4180186
40766742	关于禁忌证的原因:发现:时间点:^患者:名义型:PhenX	4182948
40766745	2nd; After; Finding; Findings; i; Nominal; Point in time; Post-bronch FEV1 attempt; PST; Random; Vol	4180186
40766745	Post-bronch FEV1 attempt PhenX	4180186
40766745	一秒钟尝试内支气管扩张剂施用后用力呼气体积:发现:时间点:^患者:名义型:PhenX	4182948
40766752	1 year; 12Mos; Finding; Findings; Home repairs enumerated other; Last; Nominal; Othr; PhenX; SDOH; The Finnish Environment and Asthma Study	4180186
40766752	Home repairs enumerated other FEAS	4180186
40766752	存在其他情况时在过去的那12个月当中您家中所完成的修理工作:发现:12个月:^患者:名义型:FEAS	4182948
40766754	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cod; Codfish; Codfish (rGad c) 1; f003; f3; f426; Fish; i; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Scrod; Serum; SR	4180186
40766754	鳕鱼 重组 (rGad c) 1 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
40766754	Deprecated Codfish (rGad c) 1 IgE RAST Ql	4180186
40766756	Decayed filled tooth; Finding; Findings; Nominal; Point in time; Random	4180186
40766756	Decayed filled tooth Tooth PhenX	4180186
40766756	龋变的牙齿表面 + 已充填的牙齿表面:发现:时间点:牙齿:名义型:PhenX	4182948
40766762	Tooth position - fluorosis Tooth PhenX	4180186
40766762	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766762	牙齿位置 - 氟牙症:发现:时间点:牙齿:序数型:PhenX	4182948
40766764	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Surf	4180186
40766764	TSIF Tooth.aspect PhenX	4180186
40766764	氟牙症牙面指数:发现:时间点:牙齿.外观:序数型:PhenX	4182948
40766765	Missing teeth Tooth PhenX	4180186
40766765	Finding; Findings; Nominal; Point in time; Random	4180186
40766765	缺失牙齿:发现:时间点:牙齿:名义型:PhenX	4182948
40766768	Breast lymph ves-R; Brst; Brst-R; Document; Films; Finding; Findings; Imaging; INTRALYMPHATIC; Point in time; R; Rad; RADIOLOGY; Random; RN; RNC; RT; Scan; Vesl; Vessels.XXX; View; VWS; W RNC Intra Lymph	4180186
40766768	NM Breast lymph ves-R Vs W RNC IL	4180186
40766768	多重视图^采用淋巴管内放射性核素:发现:时间点:乳腺.右侧>淋巴管类:文档型:NM	4182948
40766769	General medicine Hosp Admit eval note	4180186
40766769	Admit eval note; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Hosp; Inpatient; notes; Point in time; Random; Visit note	4180186
40766769	入院评价记录:发现:时间点:医院:文档型:普通内科学	4182948
40766770	Gen med MS Hosp Admit eval note	4180186
40766770	Admit eval note; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gen med MS; H&P; History and physical; Hosp; Inpatient; MS; notes; Point in time; Random; Visit note	4180186
40766770	入院评价记录:发现:时间点:医院:文档型:普通内科学.医学生	4182948
40766773	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
40766773	Surgery Hosp Prog note	4180186
40766773	病程记录:发现:时间点:医院:文档型:外科学	4182948
40766777	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
40766777	Cardiothor surg Hosp Prog note	4180186
40766777	病程记录:发现:时间点:医院:文档型:胸心外科学	4182948
40766779	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Lung; notes; Point in time; Prog note; Pulmonary; Pulmonology; Random; Respiratory; Respirology; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
40766779	Pulmonary disease Hosp Prog note	4180186
40766779	病程记录:发现:时间点:医院:文档型:肺病	4182948
40766783	Surg Med stdnt Hosp Prog note	4180186
40766783	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; MS; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Surg Med stdnt; Visit note	4180186
40766783	病程记录:发现:时间点:医院:文档型:外科学.医学生	4182948
40766784	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; MS; notes; Point in time; Random; Surg; Surg Med stdnt; Visit note	4180186
40766784	Surg Med stdnt Hosp Consult note	4180186
40766784	会诊记录:发现:时间点:医院:文档型:外科学.医学生	4182948
40766789	Cardio; Cardiology; Cardiothor surg; Cardiothor surg Attend; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Hosp; Inpatient; notes; Point in time; Random; Surg; Surg attend; Visit note	4180186
40766789	Cardiothor surg Attend Hosp Note	4180186
40766789	记录:发现:时间点:医院:文档型:胸心外科学.主治	4182948
40766790	Admit eval note; Assessment; Cardio; Cardiology; Cardiothor surg; Cardiothor surg MS; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; Heart Disease; History and physical; Hosp; Inpatient; MS; notes; Point in time; Random; Surg; Surg Med stdnt; Visit note	4180186
40766790	Cardiothor surg MS Hosp Admit eval note	4180186
40766790	入院评价记录:发现:时间点:医院:文档型:胸心外科学.医学生	4182948
40766791	Cardiothor surg MS Hosp Prog note	4180186
40766791	Cardio; Cardiology; Cardiothor surg; Cardiothor surg MS; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Hosp; Inpatient; MS; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Surg Med stdnt; Visit note	4180186
40766791	病程记录:发现:时间点:医院:文档型:胸心外科学.医学生	4182948
40766792	Cardio; Cardiology; Cardiothor surg; Cardiothor surg MS; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Hosp; Inpatient; MS; notes; Point in time; Random; Surg; Surg Med stdnt; Visit note	4180186
40766792	Cardiothor surg MS Hosp Consult note	4180186
40766792	会诊记录:发现:时间点:医院:文档型:胸心外科学.医学生	4182948
40766794	Admit eval note; Assessment; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Hosp; Inpatient; Lung; MS; notes; Point in time; Pulmonary; Pulmonary MS; Pulmonology; Random; Respiratory; Respirology; Visit note	4180186
40766794	Pulmonary MS Hosp Admit eval note	4180186
40766794	入院评价记录:发现:时间点:医院:文档型:肺病.医学生	4182948
40766796	Consult note; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Lung; MS; notes; Point in time; Pulmonary; Pulmonary MS; Pulmonology; Random; Respiratory; Respirology; Visit note	4180186
40766796	Pulmonary MS Hosp Consult note	4180186
40766796	会诊记录:发现:时间点:医院:文档型:肺病.医学生	4182948
40766797	Blood; Cell; Cellularity; FMRP cells; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; St; Stains; Stn; WB; Whole blood	4180186
40766797	FMRP cells/lymph NFr Bld ImStn	4180186
40766797	细胞.FMRP/100 个淋巴细胞:计数型分数:时间点:全血:定量型:免疫染色法	4182948
40766798	Bili; Bilirub Indirect; Bilirubin indirect; Bilirubin non-conjugated; Bilirubin primary; Bilirubin unconjugated; Bilirubins; Billirubin; Blood - (umbilical) cord; Bu; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TBIL	4180186
40766798	Bilirub Indirect BldCo-mCnc	4180186
40766798	胆红素.非葡糖醛酸化:质量浓度:时间点:脐带全血:定量型	4182948
40766805	Cell; Cellularity; Chorionic villi; Chorionic villus sample; Cnt; Count; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766805	Cells counted CVS	4180186
40766805	已计数的细胞:数量(计数):时间点:绒毛膜绒毛样本:定量型:分子遗传学类实验室方法	4182948
40766806	Chrom analy overall interp Spec-Imp	4180186
40766806	Chrom analy; Chrom analy overall interp; Chromosom; Chromosomes; Cytogenetics; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Karyotype; Misc; Miscellaneous; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; Other; PCR; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
40766806	染色体分析总体解释:印象:时间点:XXX:序数型:分子遗传学类实验室方法	4182948
40766808	Cells analyzed Amn	4180186
40766808	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Cell; Cellularity; Cnt; Count; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766808	已分析的细胞:数量(计数):时间点:羊水:定量型:分子遗传学类实验室方法	4182948
40766810	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chromosome analysis; Genetics; Genotype; Gyn; Gynecology; Heredity; Heritable; Identity or presence; Inherited; Karyogram; Molecular pathology; MOLPATH; Narrative; OB; ObGyn; Obstetrics; Point in time; Random; Report	4180186
40766810	Karyotyp Amn	4180186
40766810	核型:存在与否或特征标识:时间点:羊水:叙述型	4182948
40766812	Colonies counted Amn	4180186
40766812	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Cnt; Count; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766812	已计数的集落:数量(计数):时间点:羊水:定量型:分子遗传学类实验室方法	4182948
40766813	Fatigue post exercise	4180186
40766813	After; EXCZ; Finding; Findings; Ordinal; p Exc; PhenX; Point in time; PST; QL; Qual; Qualitative; Random; Screen	4180186
40766813	疲劳^在运动之后:发现:时间点:^患者:序数型	4182948
40766818	O2 therapy type PhenX	4180186
40766818	Nominal; O2; O2 therapy; O2 therapy type; Point in time; Random; tO2; Typ	4180186
40766818	步行试验过程中的氧疗法类型:类型:时间点:^患者:名义型:PhenX	4182948
40766819	Clock time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766819	基线时间:时钟时间:时间点:^患者:定量型	4182948
40766820	Stopped before 6M	4180186
40766820	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Stopped before 6M	4180186
40766820	6 分钟之前停止或者暂停:发现:时间点:^患者:序数型	4182948
40766822	Other sympts exercise end	4180186
40766822	EXCZ; Finding; Findings; Nominal; Other sympts exercise end; Othr; PhenX; Point in time; Random; Sx	4180186
40766822	运动结束时的其他症状:发现:时间点:^患者:名义型	4182948
40766824	Length; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766824	最终部分行程距离:长度:时间点:^患者:定量型	4182948
40766825	Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Nominal; PhenX; Point in time; Random	4180186
40766825	解释:印象:时间点:^患者:名义型	4182948
40766826	Blood draw time; Clock time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766826	Blood draw time Clock time	4180186
40766826	抽血时间:时钟时间:时间点:^患者:定量型	4182948
40766829	Test time end Clock time	4180186
40766829	Clock time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Test time end	4180186
40766829	测试结束时间:时钟时间:时间点:^患者:定量型	4182948
40766830	Asympt; Asymptomatic; Blood; DBS; Dried blood spot; Filter paper; FP; Haemoglobin; Hb; Hb observations NBS pnl; HEMATOLOGY/CELL COUNTS; Hgb; NB Screen Pnl; NBS; New born; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood	4180186
40766830	Hb observations NBS pnl DBS	4180186
40766830	血红蛋白观测新生儿筛查组套:-:时间点:全血.斑点:-	4182948
40766832	2nd; 2nd most predominant Hb; Blood; DBS; Dried blood spot; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Most predominant Hb; Nominal; Point in time; Random; WB; Whole blood	4180186
40766832	2nd most predominant Hb DBS	4180186
40766832	第2位最主要的血红蛋白:发现:时间点:全血.斑点:名义型	4182948
40766833	3rd most predominant Hb DBS	4180186
40766833	3rd; 3rd most predominant Hb; Blood; DBS; Dried blood spot; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Most predominant Hb; Nominal; Point in time; Random; WB; Whole blood	4180186
40766833	第3位最主要的血红蛋白:发现:时间点:全血.斑点:名义型	4182948
40766834	4th; 4th most predominant Hb; Blood; DBS; Dried blood spot; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Most predominant Hb; Nominal; Point in time; Random; WB; Whole blood	4180186
40766834	4th most predominant Hb DBS	4180186
40766834	第4位最主要的血红蛋白:发现:时间点:全血.斑点:名义型	4182948
40766835	5th; 5th most predominant Hb; Blood; DBS; Dried blood spot; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Most predominant Hb; Nominal; Point in time; Random; WB; Whole blood	4180186
40766835	5th most predominant Hb DBS	4180186
40766835	第5位最主要的血红蛋白:发现:时间点:全血.斑点:名义型	4182948
40766837	FDA insert Indexing - adverse rx	4180186
40766837	DOCUMENT.REF; FDA insert; Indexing - adverse rx; Narrative; React; Report; Rxn; SPL; Structured Product Labelling	4180186
40766837	索引 - 不良反应:-:-:^FDA 包装说明书:叙述型	4182948
40766838	FDA insert Indexing - substance	4180186
40766838	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling; Subs	4180186
40766838	索引 - 物质:-:-:^FDA 包装说明书:叙述型	4182948
40766839	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Lyrica; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
40766839	Pregabalin Ur Cfm-mCnc	4180186
40766839	普瑞巴林:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
40766840	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Drug; DRUG/TOXICOLOGY; Drugs; GCMS; Identity or presence; Isolated; Mec; Nominal; Point in time; Random	4180186
40766840	Drugs Mec Cfm	4180186
40766840	药物类 已鉴定的:存在与否或特征标识:时间点:胎便:名义型:毒理学确认试验	4182948
40766841	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; MDEA; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40766841	MDEA/Creat Ur	4180186
40766841	亚甲基二乙氧基苯丙胺/肌酐:质量比率:时间点:尿液:定量型	4182948
40766842	Amobarbital/Creat Ur	4180186
40766842	Amobarb; Amylobarbitone; Amytal; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40766842	异戊巴比妥/肌酐:质量比率:时间点:尿液:定量型	4182948
40766843	CR; Crea; Creat; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Mass concentration ratio; Mass ratio; MCRto; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40766843	Desalkylfluraz/Creat Ur	4180186
40766843	N-去烷基氟胺安定/肌酐:质量比率:时间点:尿液:定量型	4182948
40766845	CR; Crea; Creat; DF-118; DHC; DHCPlus; Drocode; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40766845	DHC/Creat Ur	4180186
40766845	二氢可待因/肌酐:质量比率:时间点:尿液:定量型	4182948
40766851	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lyrica; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
40766851	Pregabalin Ur Ql Scn	4180186
40766851	普瑞巴林:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
40766852	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; MDA; Methylenedioxymethamphetamine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40766852	MDA/Creat Ur	4180186
40766852	亚甲基二氧苯丙胺/肌酐:质量比率:时间点:尿液:定量型	4182948
40766854	Abd; Abdo; Abdomen+; Abdominal; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Kidney; L; LT; Point in time; Rad; RADIOLOGY; Random; Renal ves-L; RFA; Vesl; ves-L; Vessels.XXX; View; VWS; WC	4180186
40766854	RFA Renal ves-L Views W contr	4180186
40766854	多重视图^采用对比剂:发现:时间点:腹部>肾血管类.左侧:文档型:放射荧光透视法.血管造影术	4182948
40766861	Cough consecutive M; Finding; Findings; III; month; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766861	Cough consecutive M PhenX	4180186
40766861	在一年当中您是否在连续三个月的大多数日子里通常都像这样咳嗽:发现:时间点:^患者:序数型:PhenX	4182948
40766863	Phlegm hx PhenX	4180186
40766863	Finding; Findings; Ordinal; Phlegm hx; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766863	您通常是从胸部里面咳出痰液吗:发现:时间点:^患者:序数型:PhenX	4182948
40766864	Arterial Stenosis; Dextro; Finding; Findings; Ordinal; Phlegm frequently; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766864	Phlegm frequently PhenX	4180186
40766864	您通常咳痰的次数通常是每天两次,每星期4天或更多的天数:发现:时间点:^患者:序数型:PhenX	4182948
40766866	Dextro; Finding; Findings; Ordinal; Phlegm D night; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766866	Phlegm D night PhenX	4180186
40766866	在白天剩下的时间里或者夜间,您通常咳痰吗:发现:时间点:^患者:序数型:PhenX	4182948
40766870	Cough phlegm lasting time PhenX	4180186
40766870	Cough phlegm lasting time; i; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766870	您究竟有多长时间每年至少一次咳嗽与咳痰发作期:时间:时间点:^患者:定量型:PhenX	4182948
40766873	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Wheezying day/night	4180186
40766873	Wheezying day/night PhenX	4180186
40766873	大多数白天或晚上您的胸部是否曾经发出哮鸣音或者哨音:发现:时间点:^患者:序数型:PhenX	4182948
40766874	Point in time; QNT; Quan; Quant; Quantitative; Random; Wheezing Ys	4180186
40766874	Wheezing Ys PhenX	4180186
40766874	这种哮鸣已经存在了多少年时间:时间:时间点:^患者:定量型:PhenX	4182948
40766876	Wheezing first age PhenX	4180186
40766876	Point in time; QNT; Quan; Quant; Quantitative; Random; Wheezing first age	4180186
40766876	您首次哮喘发作让您呼吸困难时的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40766878	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx; Wheezing meds ever	4180186
40766878	Wheezing meds ever PhenX	4180186
40766878	您是否要求过针对这些哮喘发作的药物或治疗:发现:时间点:^患者:序数型:PhenX	4182948
40766881	Breath need walk slower; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766881	Breath need walk slower PhenX	4180186
40766881	您是否因为呼吸困难而比同龄人在平地上行走得慢:发现:时间点:^患者:序数型:PhenX	4182948
40766883	Breath stop 100 yards; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766883	Breath stop 100 yards PhenX	4180186
40766883	您是否曾经在平地上行走大约100码之后或者几分钟之后不得不停下了呼吸:发现:时间点:^患者:序数型:PhenX	4182948
40766886	Chest illness home bed; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40766886	Chest illness home bed 3Y PhenX	4180186
40766886	在过去的那3年当中,您是否患有任何的胸部疾病,使您一直没有上班、在家待在室内或者卧床不起:发现:3年:^患者:序数型:PhenX	4182948
40766887	Chest illness phlegm; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766887	Chest illness phlegm PhenX	4180186
40766887	您是否曾经因为任何这些胸部疾病而产生痰液:发现:时间点:^患者:序数型:PhenX	4182948
40766888	Chest illness phlegm > W 3Y nRate PhenX	4180186
40766888	Chest illness phlegm &gt; W; Count/time; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative	4180186
40766888	在过去的那3个月当中,您当时患有多少种持续1个星期或者更长时间且伴有痰液增多的此类疾病:计数型速率:3年:^患者:定量型:PhenX	4182948
40766896	Hay fever ever PhenX	4180186
40766896	Finding; Findings; Hay fever ever; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766896	您是否患有花粉症:发现:时间点:^患者:序数型:PhenX	4182948
40766897	Finding; Findings; Hay fever Dr confirmed; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766897	Hay fever Dr confirmed PhenX	4180186
40766897	发热是否经过了医生确认:发现:时间点:^患者:序数型:PhenX	4182948
40766899	Chronic bronch ever PhenX	4180186
40766899	Chronic bronch ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766899	您是否患有支气管炎:发现:时间点:^患者:序数型:PhenX	4182948
40766902	Chronic bronch start age PhenX	4180186
40766902	Chronic bronch start age; Point in time; QNT; Quan; Quant; Quantitative; Random; Started	4180186
40766902	慢性支气管炎开始于多大年龄:时间:时间点:^患者:定量型:PhenX	4182948
40766903	Emphysema ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766903	Emphysema ever PhenX	4180186
40766903	您是否患有肺气肿:发现:时间点:^患者:序数型:PhenX	4182948
40766907	Asthma ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766907	Asthma ever PhenX	4180186
40766907	您是否患有哮喘:发现:时间点:^患者:序数型:PhenX	4182948
40766908	Asthma still have PhenX	4180186
40766908	Asthma still have; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766908	您仍然患有哮喘吗:发现:时间点:^患者:序数型:PhenX	4182948
40766909	Asthma Dr confirmed PhenX	4180186
40766909	Asthma Dr confirmed; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766909	哮喘是否经过了医生确认:发现:时间点:^患者:序数型:PhenX	4182948
40766912	Finding; Findings; Ordinal; Other chest illness ever; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766912	Other chest illness ever PhenX	4180186
40766912	您是否曾经患有任何其他的胸部疾病:发现:时间点:^患者:序数型:PhenX	4182948
40766916	Finding; Findings; Heart trouble ever; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766916	Heart trouble ever PhenX	4180186
40766916	医生是否曾经告诉过您,您存在心脏问题:发现:时间点:^患者:序数型:PhenX	4182948
40766918	BP; Finding; Findings; High blood press tx ever; HTN; Last; Ordinal; Ql; Qual; Qualitative; Screen; Tx	4180186
40766918	High blood press tx ever PhenX	4180186
40766918	在过去的那10年当中,您是否接受过任何的高血压治疗:发现:10年:^患者:序数型:PhenX	4182948
40766921	Dusty job specify; Finding; Findings; Nominal; Occupation; Point in time; Random; Work	4180186
40766921	Dusty job specify PhenX	4180186
40766921	存在粉尘危害工作的岗位或行业:发现:时间点:^患者:名义型:PhenX	4182948
40766922	Dusty job exp degree; Exp; Finding; Findings; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Work	4180186
40766922	Dusty job exp degree PhenX	4180186
40766922	存在粉尘危害工作的岗位粉尘暴露程度:发现:时间点:^患者:序数型:PhenX	4182948
40766927	Smoke cigarettes ever PhenX	4180186
40766927	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke cigarettes ever	4180186
40766927	您是否曾经抽过香烟:发现:时间点:^患者:序数型:PhenX	4182948
40766929	现在您每天抽多少支香烟:计数型速率:时间点:^患者:定量型	4182948
40766929	Cigarettes quant D now; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40766929	Cigarettes quant D now nRate PhenX	4180186
40766931	Smoke cigarettes inhale PhenX	4180186
40766931	Finding; Findings; Nominal; Point in time; Random; Smoke; Smoke cigarettes inhale; Smokes; Smoking; Tobacco	4180186
40766931	您现在或过去是否吸入香烟烟气:发现:时间点:^患者:名义型:PhenX	4182948
40766932	Smoke pipe ever PhenX	4180186
40766932	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke pipe ever	4180186
40766932	您是否曾经规律地抽过烟斗:发现:时间点:^患者:序数型:PhenX	4182948
40766933	Smoke pipe first age PhenX	4180186
40766933	Point in time; QNT; Quan; Quant; Quantitative; Random; Smoke pipe first age	4180186
40766933	您开始规律地抽烟斗时的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40766938	Smoke cigars ever PhenX	4180186
40766938	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke cigars ever	4180186
40766938	您是否曾经规律地抽过雪茄:发现:时间点:^患者:序数型:PhenX	4182948
40766939	Point in time; QNT; Quan; Quant; Quantitative; Random; Smoke cigars first age	4180186
40766939	Smoke cigars first age PhenX	4180186
40766939	您开始规律地抽雪茄时的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40766940	Smoke cigars stop age PhenX	4180186
40766940	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Smoke cigars stop age	4180186
40766940	彻底停止抽雪茄时的年龄:时间:时间点:^患者:定量型	4182948
40766943	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Smoke; Smoke cigars inhale; Smokes; Smoking; Tobacco	4180186
40766943	Smoke cigars inhale PhenX	4180186
40766943	您现在或过去是否吸入雪茄烟烟气:发现:时间点:^患者:序数型:PhenX	4182948
40766945	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766945	现时吸烟者:发现:时间点:^患者:序数型	4182948
40766947	Chest operations ever PhenX	4180186
40766947	Chest operations ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766947	您是否曾接受过任何的胸部手术:发现:时间点:^患者:序数型:PhenX	4182948
40766948	Chest operations had PhenX	4180186
40766948	Chest operations had; Finding; Findings; Nominal; Point in time; Random	4180186
40766948	您所接受过的胸部手术:发现:时间点:^患者:名义型:PhenX	4182948
40766949	Finding; Findings; Nominal; Point in time; Random	4180186
40766949	Natural parent PhenX	4180186
40766949	亲生父亲或母亲:发现:时间点:^患者:名义型:PhenX	4182948
40766950	Hx parent chronic bronchitis PhenX	4180186
40766950	Finding; Findings; Hx parent chronic bronchitis; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766950	某位医生是否曾经告诉您的父母之一说,他或她患有慢性支气管炎:发现:时间点:^患者:序数型:PhenX	4182948
40766951	Finding; Findings; Hx parent emphysema; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766951	Hx parent emphysema PhenX	4180186
40766951	某位医生是否曾经告诉您的父母之一说,他或她患有肺气肿:发现:时间点:^患者:序数型:PhenX	4182948
40766954	Finding; Findings; Hx parent other chest conditions; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766954	Hx parent other chest conditions PhenX	4180186
40766954	某位医生是否曾经告诉您的父母之一说,他或她患有其他的胸部疾病:发现:时间点:^患者:序数型:PhenX	4182948
40766955	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Wheezing whistling chest ever	4180186
40766955	Wheezing whistling chest ever PhenX	4180186
40766955	您的胸部之中是否曾经有过哮鸣音或哨笛音:发现:时间点:^患者:序数型:PhenX	4182948
40766959	Hx wheezy whistling chest multiple PhenX	4180186
40766959	1 year; 12Mos; Finding; Findings; Hx wheezy whistling chest multiple; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766959	在过去的那12个月当中,您的胸部之中是否听起来每星期不止一次的哮鸣音或哨笛音:发现:12个月:^患者:序数型:PhenX	4182948
40766960	Hx wheezy whistling chest D night PhenX	4180186
40766960	1 year; 12Mos; Finding; Findings; Hx wheezy whistling chest D night; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766960	在过去的那12个月当中的大多数白天和夜晚,您的胸部之中是否听起来都有过哮鸣音或哨笛音:发现:12个月:^患者:序数型:PhenX	4182948
40766961	1 year; 12Mos; Assoc; Finding; Findings; Hx awake coughing; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766961	Hx awake coughing PhenX	4180186
40766961	在过去的那12个月当中,除与感冒或者胸腔感染相关的咳嗽之外,您是否因为咳嗽而从睡眠当中醒来:发现:12个月:^患者:序数型:PhenX	4182948
40766962	1 year; 12Mos; Finding; Findings; Hx awake breath chest tightness I; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766962	Hx awake breath chest tightness I PhenX	4180186
40766962	在过去的那12个月当中,您是否因为呼吸急促或者感觉自己胸部憋闷而从睡眠当中醒来:发现:12个月:^患者:序数型:PhenX	4182948
40766963	1 year; 12Mos; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Sneezing runny nose 12Mo 13	4180186
40766963	Sneezing runny nose 12Mo 13 PhenX	4180186
40766963	在过去的那12个月当中,一直困扰您的是不是,在并未患感冒或流感的情况下,在打喷嚏方面存在某种问题,或者流鼻涕或出现鼻塞:发现:12个月:^患者:序数型:PhenX	4182948
40766967	1 year; 12Mos; Count/time; Hx cough phlegm &gt; 1W; i; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40766967	How many times cough phlegm > 1W PhenX	4180186
40766967	在过去12个月当中,您曾经大约出现过多少次持续1周或更长时间的伴有痰液的咳嗽:计数型速率:12个月:^患者:定量型:PhenX	4182948
40766970	Hx antibiotics tx chest last Y PhenX	4180186
40766970	Finding; Findings; Hx antibiotics tx chest last Y; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40766970	在过去的那一年当中,您是否曾经因为某种胸部疾病接受过抗生素治疗:发现:1年:^患者:序数型:PhenX	4182948
40766975	Wheezing whistling chest last 12Mo PhenX	4180186
40766975	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Wheezing whistling chest last 12Mo	4180186
40766975	在过去的那12个月当中,您的胸部之中是否有过哮鸣音或哨笛音:发现:12个月:^患者:序数型:PhenX	4182948
40766976	1 year; 12Mos; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Past; QL; Qual; Qualitative; Screen; Wheezing times 12Mo	4180186
40766976	Wheezing times 12Mo PhenX	4180186
40766976	在过去的那12个月当中,您究竟哮喘发作了多少次:计数型速率:12个月:^患者:序数型:PhenX	4182948
40766979	Wheezy chest exercise 12Mo PhenX	4180186
40766979	1 year; 12Mos; EXCZ; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Wheezy chest exercise 12Mo	4180186
40766979	在过去的那12个月当中,在锻炼过程中或者之后,您的胸腔是否发出哮鸣音:发现:12个月:^患者:序数型:PhenX	4182948
40766981	Finding; Findings; Hx sneezing blocked runny nose; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766981	Hx sneezing blocked runny nose PhenX	4180186
40766981	您是否曾经在并未患感冒或流感的情况下在打喷嚏方面存在某种问题,或者流鼻涕或出现鼻塞:发现:时间点:^患者:序数型:PhenX	4182948
40766982	Hx sneezing runny blocked nose PhenX	4180186
40766982	1 year; 12Mos; Finding; Findings; Hx sneezing runny blocked nose; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40766982	在过去的那12个月当中,您是否曾经在并未患感冒或流感的情况下在打喷嚏方面存在某种问题,或者流鼻涕或出现鼻塞:发现:12个月:^患者:序数型:PhenX	4182948
40766983	1 year; 12Mos; Finding; Findings; Last; Nose itchy eyes 12Mo 13; Ordinal; QL; Qual; Qualitative; Screen	4180186
40766983	Nose itchy eyes 12Mo 13 PhenX	4180186
40766983	在过去的那12个月当中,这种鼻部问题是否伴有眼睛发痒或者爱流泪:发现:12个月:^患者:序数型:PhenX	4182948
40766986	Finding; Findings; Itchy rash ever; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40766986	Itchy rash ever PhenX	4180186
40766986	您是否曾经出现过发痒的皮疹且从出现到消失共持续了至少6个月:发现:时间点:^患者:序数型:PhenX	4182948
40766993	Child wheezing last 12Mo PhenX	4180186
40766993	1 year; 12Mos; Child wheezing last 12Mo; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766993	在过去的那12个月当中,您孩子的胸部之中是否有过哮鸣音或哨笛音:发现:12个月:^患者:序数型:PhenX	4182948
40766994	Child wheezing times 12Mo PhenX	4180186
40766994	1 year; 12Mos; Child wheezing times 12Mo; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40766994	在过去的那12个月当中,您的孩子究竟哮喘发作了多少次:发现:12个月:^患者:序数型:PhenX	4182948
40766996	Asympt; Asymptomatic; DOC.ONT; Document; Finding; Findings; Hx; Medical Hx screening form; Point in time; Random; Scn	4180186
40766996	Medical Hx screening form	4180186
40766996	病史筛查表单:发现:时间点:{环境}:文档型:患者	4182948
40766999	DOC.ONT; Document; Finding; Findings; Point in time; Random; Rx	4180186
40766999	眼镜处方:发现:时间点:{环境}:文档型:{角色}	4182948
40767002	DOC.ONT; Document; Finding; Findings; Health insu-related form; Point in time; Random	4180186
40767002	健康保险相关表格:发现:时间点:{环境}:文档型:患者	4182948
40767003	DOC.ONT; Document; Finding; Findings; Form; Point in time; Random	4180186
40767003	Release of information consent	4180186
40767003	信息发布同意书:发现:时间点:{环境}:文档型:患者	4182948
40767007	Auto; Automated detection; DOC.MISC; Document; Elec; Elect; Electr; Finding; Findings; MISC; PH monitoring report; Point in time; Random	4180186
40767007	PH monitoring report Auto	4180186
40767007	个人健康监测报告:发现:时间点:{环境}:文档型:自动化法	4182948
40767009	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
40767009	委任书:发现:时间点:{环境}:文档型:患者	4182948
40767011	Organ donation consent	4180186
40767011	DOC.ONT; Document; Finding; Findings; Form; Point in time; Random	4180186
40767011	器官捐献同意书:发现:时间点:{环境}:文档型:患者	4182948
40767012	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767014	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767015	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767016	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767018	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767021	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767022	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767023	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767024	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767025	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Social work; Survey	4180186
40767026	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767030	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767033	Cnt; Count; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767034	Admin; Dis; Diseases; Dz; End Stage Renal Disease (ESDR) pnl; End-stage renal disease; ESRD; ESRD CMS Form 2744; ESRD survey; Kidney; Nephrology; Pan; Panel; Panl; Pnl; Point in time; Random; Renal	4180186
40767036	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767040	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
40767041	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
40767042	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
40767044	Admitted; Cnt; Count; Dialy; ESRD; ESRD survey; Number; Othr; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
40767046	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
40767047	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767048	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767049	Cnt; Count; Dialy; ESRD; ESRD survey; FCN; Func; Funct; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767052	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767053	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Othr; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767060	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767061	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767063	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767064	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767066	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767070	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Tot; Totl	4180186
40767074	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767075	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767077	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767079	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Tot; Totl	4180186
40767080	Cnt; Count; Dialy; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767081	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767082	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767083	Cnt; Count; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx; Txs	4180186
40767084	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Othr; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx; Txs	4180186
40767086	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767088	Cnt; Count; ESRD; ESRD survey; Number; nursing; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40767089	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; World Heatlth Organization	4180186
40767090	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; World Heatlth Organization	4180186
40767091	Cnt; Count; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; World Heatlth Organization	4180186
40767093	Cnt; Count; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767094	Cnt; Count; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; World Heatlth Organization	4180186
40767095	Cnt; Count; ESRD; ESRD survey; Number; QNT; Quan; Quant; Quantitative; Report period; Survey; Tot; Totl; World Heatlth Organization	4180186
40767096	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; World Heatlth Organization	4180186
40767097	Cnt; Count; Dialy; ESRD; ESRD survey; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; World Heatlth Organization	4180186
40767100	Hx; Measure fracture hx; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40767102	LE; Measure lupus SLE; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40767104	Measure perceived stress; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40767107	Social capitol proto	4180186
40767107	Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random	4180186
40767107	PhenX - 社会资本方案 181501:-:时间点:^患者:-:PhenX	4182948
40767109	Child wheeze limit speech 12Mo PhenX	4180186
40767109	1 year; 12Mos; 2; Child wheeze limit speech 12Mo; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40767109	在过去的那12个月当中,气喘是否曾经严重得足以将您孩子的话语限制到在呼吸之间每次一两个词语:发现:12个月:^患者:序数型:PhenX	4182948
40767114	1 year; 12Mos; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Sneeze runny nose 12Mo 6	4180186
40767114	Sneeze runny nose 12Mo 6 PhenX	4180186
40767114	在过去的那12个月当中,您的孩子是否曾经在并未患感冒或流感的情况下,在打喷嚏方面存在某种问题,或者流鼻涕或出现鼻塞:发现:12个月:^患者:序数型:PhenX	4182948
40767115	1 year; 12Mos; Finding; Findings; Last; Nose itchy eyes 12Mo 6; Ordinal; QL; Qual; Qualitative; Screen	4180186
40767115	Nose itchy eyes 12Mo 6 PhenX	4180186
40767115	在过去的那12个月当中,这种鼻部问题是否伴有眼睛发痒、爱流泪:发现:12个月:^患者:序数型:PhenX	4182948
40767116	Nose interfere activities 12Mo 6 PhenX	4180186
40767116	1 year; 12Mos; Finding; Findings; Last; Nose interfere activities 12Mo 6; Ordinal; QL; Qual; Qualitative; Screen	4180186
40767116	在过去的那12个月当中,这种鼻部问题是否干扰过您孩子的日常活动:发现:12个月:^患者:序数型:PhenX	4182948
40767118	Finding; Findings; Itchy rash ever 6Mo; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767118	Itchy rash ever 6Mo PhenX	4180186
40767118	您的孩子是否曾经出现过发痒的皮疹且从出现到消失共持续了至少6个月:发现:时间点:^患者:序数型:PhenX	4182948
40767121	1 year; 12Mos; Count/time; Itchy rash awake 12Mo 6; nRate; Number rate; Number Rate = Count/Time; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40767121	Itchy rash awake 12Mo 6 PhenX	4180186
40767121	在过去的那12个月当中,平均来说,您的孩子在夜间因为这种发痒的皮疹而保持醒着的状态,这种情况的出现有多频繁:计数型速率:12个月:^患者:序数型:PhenX	4182948
40767125	KIR 2DL2 Bld/T Ql	4180186
40767125	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 2DL2; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767125	KIR 基因 等位基因 2DL2:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767126	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 2DL3; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767126	KIR 2DL3 Bld/T Ql	4180186
40767126	KIR 基因 等位基因 2DL3:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767127	KIR 2DL4 Bld/T Ql	4180186
40767127	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 2DL4; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767127	KIR 基因 等位基因 2DL4:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767129	Blood; KIR pnl; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767129	KIR pnl Bld/T	4180186
40767129	KIR 基因分型组套:-:时间点:全血/组织:-	4182948
40767131	KIR 2DS1 Bld/T Ql	4180186
40767131	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 2DS1; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767131	KIR 基因 等位基因 2DS1:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767132	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 2DS2; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767132	KIR 2DS2 Bld/T Ql	4180186
40767132	KIR 基因 等位基因 2DS2:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767134	Blood; KIR2DS4 full variant; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767134	KIR2DS4 full variant Bld/T Ql	4180186
40767134	KIR2DS4 基因完整变异:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767135	Blood; KIR2DS4 del variant; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767135	KIR2DS4 del variant Bld/T Ql	4180186
40767135	KIR2DS4 基因缺失变异:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767137	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 3DL1; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767137	KIR 3DL1 Bld/T Ql	4180186
40767137	KIR 基因 等位基因 3DL1:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767140	KIR 3DS1 Bld/T Ql	4180186
40767140	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 3DS1; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767140	KIR 基因 等位基因 3DS1:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767141	Blood; CD158E1; Killer cell Immunoglobulin-like Recptor; KIR; KIR 2DP1; KIR3DL1/S1; Molecular genetics; Molecular pathology; MOLPATH; NKAT3; NKAT-3; NKB1; NKB1B; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767141	KIR 2DP1 Bld/T Ql	4180186
40767141	KIR 基因 等位基因 2DP1:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767142	Blood; KIR3DP1 full variant; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
40767142	KIR3DP1 full variant Bld/T Ql	4180186
40767142	KIR3DP1 基因完整变异:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
40767144	Blood; Fragile X protein (FMRP) pnl; Pan; PANEL.PATH; Panl; Pathology; Pnl; Point in time; PR; Prot; Random; WB; Whole blood	4180186
40767144	Fragile X protein (FMRP) pnl Bld	4180186
40767144	脆性 X 蛋白 (FMRP) 组套:-:时间点:全血:-	4182948
40767145	Finding; Findings; Nominal; Point in time; Random	4180186
40767145	Medication oximetry	4180186
40767145	药物:发现:时间点:^患者:名义型:PhenX	4182948
40767146	Medication time date pre Exc PhenX	4180186
40767146	Before; Date and time; EXCZ; Medication time date; Point in time; pre Exc; Pre exercise; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767146	用药时间和日期^在运动之前:时间戳:时间点:^患者:定量型:PhenX	4182948
40767147	Finding; Findings; Nominal; Point in time; Random	4180186
40767147	Indication for test PhenX	4180186
40767147	试验的临床或研究适应症:发现:时间点:^患者:名义型:PhenX	4182948
40767148	Contraindications for test PhenX	4180186
40767148	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767148	试验禁忌证:发现:时间点:^患者:序数型:PhenX	4182948
40767149	Finding; Findings; Health self assess; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767149	Health self assess	4180186
40767149	您如何描述自己当前的健康状况:发现:时间点:^患者:序数型	4182948
40767151	Freq 3Mo phlegm - sputum PhenX	4180186
40767151	3 months; Finding; Findings; Freq 3Mo phlegm - sputum; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40767151	在过去的那3个月当中,我有过咯痰:发现:3个月:^患者:序数型:PhenX	4182948
40767155	Worst chest attack last PhenX	4180186
40767155	Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Worst chest attack last	4180186
40767155	胸部问题最严重的一次发作当时持续了多少时间:时间:时间点:^患者:定量型:PhenX	4182948
40767156	Good Ds in W PhenX	4180186
40767156	3 months; Count/time; Good Ds in W; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40767156	在过去的那3个月当中,在通常的一个星期当中,您很少有胸部问题的良好天数是多少:计数型速率:3个月:^患者:定量型:PhenX	4182948
40767157	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Wheeze worse in morning	4180186
40767157	Wheeze worse in morning PhenX	4180186
40767157	如果您存在气喘,早上是否更严重:发现:时间点:^患者:序数型:PhenX	4182948
40767158	Chest self assess PhenX	4180186
40767158	Chest self assess; Finding; Findings; Nominal; Point in time; Random	4180186
40767158	您会如何描述自己的胸部情况:发现:时间点:^患者:名义型:PhenX	4182948
40767163	Cough breathless bend over PhenX	4180186
40767163	Cough breathless bend over; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767163	我在弯腰时呼吸困难:发现:时间点:^患者:序数型:PhenX	4182948
40767164	Cough breathless disturb sleep PhenX	4180186
40767164	Cough breathless disturb sleep; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767164	我的咳嗽或呼吸干扰我的睡眠:发现:时间点:^患者:序数型:PhenX	4182948
40767166	Chest effect embarrassing PhenX	4180186
40767166	Chest effect embarrassing; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767166	在公共场合,我的咳嗽或呼吸让人尴尬:发现:时间点:^患者:序数型:PhenX	4182948
40767167	Chest effect nuisance PhenX	4180186
40767167	Chest effect nuisance; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767167	我的胸部问题对于我的家人、朋友或邻居们来说是一件令人讨厌的事情:发现:时间点:^患者:序数型:PhenX	4182948
40767168	Chest effect afraid panic PhenX	4180186
40767168	Chest effect afraid panic; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767168	当我无法喘口气的时候,我变得害怕或恐慌:发现:时间点:^患者:序数型:PhenX	4182948
40767169	Chest effect no control; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767169	Chest effect no control PhenX	4180186
40767169	我感到自己无法控制自己的胸部问题:发现:时间点:^患者:序数型:PhenX	4182948
40767170	Chest effect not get better PhenX	4180186
40767170	Chest effect not get better; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767170	我没有期望自己的胸部有任何的好转:发现:时间点:^患者:序数型:PhenX	4182948
40767172	Activity; EXCZ; Exercise; Exercise not safe; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767172	Exercise not safe PhenX	4180186
40767172	运动对我来说不安全:发现:时间点:^患者:序数型:PhenX	4182948
40767173	Chest effect everything effort; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767173	Chest effect everything effort PhenX	4180186
40767173	每件事情看上去过于费力:发现:时间点:^患者:序数型:PhenX	4182948
40767174	Medication not help PhenX	4180186
40767174	Finding; Findings; Medication not help; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767174	我的药物并没有为我带来很大的帮助:发现:时间点:^患者:序数型:PhenX	4182948
40767176	Finding; Findings; Medication unpleasant effects; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767176	Medication unpleasant effects PhenX	4180186
40767176	我存在自己的药物所造成的令人不快的副作用:发现:时间点:^患者:序数型:PhenX	4182948
40767179	Activities affect bath shower PhenX	4180186
40767179	Activities affect bath shower; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767179	我无法洗澡或淋浴,或者我需要较长的时间:发现:时间点:^患者:序数型:PhenX	4182948
40767180	Activities affect walk stop; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767180	Activities affect walk stop PhenX	4180186
40767180	我行走比他人慢,或者我停下了休息:发现:时间点:^患者:序数型:PhenX	4182948
40767182	Activities affect upstairs stop PhenX	4180186
40767182	Activities affect upstairs stop; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767182	如果我走上一段楼梯的台阶,我就不得不缓慢行进或者停下了:发现:时间点:^患者:序数型:PhenX	4182948
40767184	Arterial Stenosis; Breathing diff activ light; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767184	Breathing diff activ light PhenX	4180186
40767184	我的呼吸使我难以去做诸如步行攀登小山丘、搬运东西上楼梯、除草等轻度的园艺劳动、跳舞、打保龄球或者打高尔夫球之类的事情:发现:时间点:^患者:序数型:PhenX	4182948
40767191	Daily no move bed chair PhenX	4180186
40767191	Daily no move bed chair; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767191	我无法远离我的床铺或座椅:发现:时间点:^患者:序数型:PhenX	4182948
40767195	Do you snore PhenX	4180186
40767195	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767195	您打鼾吗:发现:时间点:^患者:序数型:PhenX	4182948
40767196	Your snoring is PhenX	4180186
40767196	Finding; Findings; Nominal; Point in time; Random	4180186
40767196	您的鼾声:发现:时间点:^患者:名义型:PhenX	4182948
40767198	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea snore bother other	4180186
40767198	Sleep apnea snore bother other PhenX	4180186
40767198	您的打鼾是否打扰了其他人:发现:时间点:^患者:序数型:PhenX	4182948
40767199	Sleep apnea quit breathing PhenX	4180186
40767199	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea quit breathing	4180186
40767199	是否有任何人注意到过您在睡眠过程中中断过呼吸:发现:时间点:^患者:序数型:PhenX	4182948
40767200	Sleep apnea tired fatigued waking PhenX	4180186
40767200	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea tired fatigued waking	4180186
40767200	您多久出现一次在睡觉之后感到疲乏的情况:发现:时间点:^患者:序数型:PhenX	4182948
40767201	Sleep apnea tired waking PhenX	4180186
40767201	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea tired waking	4180186
40767201	在您醒来的时间里,您是否感到疲惫、精疲力竭或者不如往常好:发现:时间点:^患者:序数型:PhenX	4182948
40767202	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea asleep driving	4180186
40767202	Sleep apnea asleep driving PhenX	4180186
40767202	您是否曾经驾车过程中打瞌睡或睡着过:发现:时间点:^患者:序数型:PhenX	4182948
40767203	Sleep apnea sleep drive freq PhenX	4180186
40767203	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea sleep drive freq	4180186
40767203	多久发生一次驾车时打盹或睡着的情况:发现:时间点:^患者:序数型:PhenX	4182948
40767204	BP; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep apnea high B/P	4180186
40767204	Sleep apnea high B/P PhenX	4180186
40767204	您是否患有高血压:发现:时间点:^患者:序数型:PhenX	4182948
40767208	Child snore ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767208	Child snore ever PhenX	4180186
40767208	在睡觉的时候,您的孩子是否打鼾:发现:时间点:^患者:序数型:PhenX	4182948
40767209	Child snore &gt; half time; Child snore ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767209	Child snore > half time PhenX	4180186
40767209	在睡觉的时候,您的孩子是否超过一半的时间打鼾:发现:时间点:^患者:序数型:PhenX	4182948
40767211	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767211	Child snore loudly PhenX	4180186
40767211	在睡觉的时候,您的孩子是否鼾声大:发现:时间点:^患者:序数型:PhenX	4182948
40767213	Child struggle breathing; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767213	Child struggle breathing PhenX	4180186
40767213	在睡觉的时候,您的孩子是否在呼吸方面存在困难或者说呼吸困难:发现:时间点:^患者:序数型:PhenX	4182948
40767216	Shake wake sleeping child PhenX	4180186
40767216	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Shake wake sleeping child	4180186
40767216	您是否曾经不得不摇晃您睡着的孩子,以便让其呼吸或者醒来并呼吸:发现:时间点:^患者:序数型:PhenX	4182948
40767217	Child wake snorting PhenX	4180186
40767217	Child wake snorting; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767217	您是否看到过您的孩子醒来时伴有喷鼻息的声音:发现:时间点:^患者:序数型:PhenX	4182948
40767218	Child restless sleep; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767218	Child restless sleep PhenX	4180186
40767218	您的孩子是否存在不安的睡眠:发现:时间点:^患者:序数型:PhenX	4182948
40767219	Child describe restless legs bed PhenX	4180186
40767219	Child describe restless legs bed; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767219	您的孩子是否描述在床上时腿部不安好动:发现:时间点:^患者:序数型:PhenX	4182948
40767221	Child growing pains worst bed PhenX	4180186
40767221	Child growing pains worst bed; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767221	您的孩子是否存在在床上时更糟糕的生长痛:发现:时间点:^患者:序数型:PhenX	4182948
40767222	Child legs brief kicks; Finding; Findings; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767222	Child legs brief kicks PhenX	4180186
40767222	当您的孩子睡觉的时候,您是否看见过快速踢一条腿或两条腿:发现:时间点:^患者:序数型:PhenX	4182948
40767226	Child night urinate PhenX	4180186
40767226	Child night urinate; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767226	夜里,您的孩子是不是通常会下床排尿:发现:时间点:^患者:序数型:PhenX	4182948
40767228	Child sleep mouth open; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767228	Child sleep mouth open PhenX	4180186
40767228	您的孩子是否通常张着嘴睡觉:发现:时间点:^患者:序数型:PhenX	4182948
40767230	Child allergy affect breathe nose; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767230	Child allergy affect breathe nose PhenX	4180186
40767230	有任何变态反应影响您的孩子通过鼻子呼吸的能力吗:发现:时间点:^患者:序数型:PhenX	4182948
40767238	Child sleep talking; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767238	Child sleep talking PhenX	4180186
40767238	您是否曾经听到过您的孩子在睡眠过程中讲话 - 说梦话:发现:时间点:^患者:序数型:PhenX	4182948
40767240	Child wake screaming night PhenX	4180186
40767240	Child wake screaming night; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767240	您的孩子是否曾经在夜间尖叫着醒来:发现:时间点:^患者:序数型:PhenX	4182948
40767241	Child neither awake asleep PhenX	4180186
40767241	Child neither awake asleep; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767241	您的孩子是否曾经以某种方式在夜间走动或移动过,或者有过举止表现,以致使您认为您的孩子当时既没有完全醒来,也没有睡着:发现:时间点:^患者:序数型:PhenX	4182948
40767244	Child difficult bed routines; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767244	Child difficult bed routines PhenX	4180186
40767244	在睡前,您的孩子是不是通常有困难的例行程序或仪式,争辩很多,或在其他方面表现得不好:发现:时间点:^患者:序数型:PhenX	4182948
40767246	Child wake multiple times PhenX	4180186
40767246	Child wake multiple times; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767246	平均来说,您的孩子是否每晚醒来不止两次:发现:时间点:^患者:序数型:PhenX	4182948
40767247	Child trouble back asleep PhenX	4180186
40767247	Child trouble back asleep; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767247	当夜间醒来时,您的孩子是否在重新入睡方面存在困难:发现:时间点:^患者:序数型:PhenX	4182948
40767248	Child trouble back sleep morn PhenX	4180186
40767248	Child trouble back sleep morn; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767248	您的孩子是否在早上醒来早时难于重新入睡:发现:时间点:^患者:序数型:PhenX	4182948
40767249	Child bedtime change a lot PhenX	4180186
40767249	Child bedtime change a lot; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen	4180186
40767249	您的孩子上床睡觉的时间是否每天有很大的变化:发现:时间点:^患者:序数型:PhenX	4182948
40767251	Clock time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time child bed weekday	4180186
40767251	Time child bed weekday Clock time PhenX	4180186
40767251	在一星期的工作日当中,您的孩子通常都在什么时间上床睡觉:时钟时间:时间点:^患者:定量型:PhenX	4182948
40767252	Time child bed weekend Clock time PhenX	4180186
40767252	Clock time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time child bed weekend	4180186
40767252	在周末或假日,您的孩子通常都在什么时间上床睡觉:时钟时间:时间点:^患者:定量型:PhenX	4182948
40767256	Child sleepy problem day PhenX	4180186
40767256	Child sleepy problem day; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767256	您的孩子是否存在白天瞌睡的问题:发现:时间点:^患者:序数型:PhenX	4182948
40767259	Child usually nap day PhenX	4180186
40767259	Child usually nap day; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767259	您的孩子是否白天通常小睡一下:发现:时间点:^患者:序数型:PhenX	4182948
40767262	Child headache once Mo; Finding; Findings; month; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767262	Child headache once Mo PhenX	4180186
40767262	平均起来,您的孩子是否每个月至少有一次头痛:发现:时间点:^患者:序数型:PhenX	4182948
40767264	Child tonsils removed; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767264	Child tonsils removed PhenX	4180186
40767264	您的孩子是否仍然具有扁桃体:发现:时间点:^患者:序数型:PhenX	4182948
40767266	Childs tonsils removed reason; Finding; Findings; Nominal; Point in time; Random	4180186
40767266	Childs tonsils removed reason PhenX	4180186
40767266	您孩子的扁桃体是为何被切除的:发现:时间点:^患者:名义型:PhenX	4182948
40767267	Child difficulty breathing ever PhenX	4180186
40767267	Child difficulty breathing ever; Condition difficulty breathing; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767267	您的孩子是否曾经患有某种造成呼吸困难的疾病:发现:时间点:^患者:序数型:PhenX	4182948
40767268	Child surgery ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Surg	4180186
40767268	Child surgery ever PhenX	4180186
40767268	您的孩子是否接受过外科手术:发现:时间点:^患者:序数型:PhenX	4182948
40767269	Child difficulty breathing surgery; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Surg	4180186
40767269	Child difficulty breathing surgery PhenX	4180186
40767269	在外科手术过程的前中后是否出现过任何的呼吸困难:发现:时间点:^患者:序数型:PhenX	4182948
40767270	Child sudden weak legs ever PhenX	4180186
40767270	Child sudden weak legs ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767270	在大笑或因某种事情而惊讶时,您孩子的腿部或任何其他部位是否曾经突然变得虚弱无力:发现:时间点:^患者:序数型:PhenX	4182948
40767272	Child irresistible urge nap; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767272	Child irresistible urge nap PhenX	4180186
40767272	您的孩子是否有时感到过某种不可抗拒的冲动要去小睡一下,并且为了睡觉而强迫自己停下所正在做的事情:发现:时间点:^患者:序数型:PhenX	4182948
40767274	Child caffeinated beverage; Dextro; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767274	Child caffeinated beverage PhenX	4180186
40767274	在典型的一天时间里您的孩子是否饮用含有咖啡因的饮料 - 可乐、茶水、咖啡:发现:时间点:^患者:序数型:PhenX	4182948
40767275	Child caffeinated beverage quant; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767275	Child caffeinated beverage quant PhenX	4180186
40767275	每天多少杯或罐咖啡因饮料:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767276	Child recreational drug PhenX	4180186
40767276	Child recreational drug; Drug; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767276	您的孩子是否使用消遣性毒品:发现:时间点:^患者:序数型:PhenX	4182948
40767280	Child cigarette tobacco freq; Child use cigarette tobacco; Count/time; nRate; Number rate; Number Rate = Count/Time; Othr; Point in time; Prods; Product; QNT; Quan; Quant; Quantitative; Random	4180186
40767280	Child cigarette tobacco freq nRate PhenX	4180186
40767280	您的孩子多久使用一次香烟、无烟烟草、鼻烟或其他的烟草制品:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767281	Child overweight PhenX	4180186
40767281	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767281	您的孩子是否体重超重:发现:时间点:^患者:序数型:PhenX	4182948
40767282	Child overweight first age; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767282	Child overweight first age PhenX	4180186
40767282	这首次发展于多大年龄:时间:时间点:^患者:定量型:PhenX	4182948
40767283	Child high-arched palate mouth; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767283	Child high-arched palate mouth PhenX	4180186
40767283	某位医生是否已经告诉您,您的孩子存在硬腭高拱（又称为高腭穹或上腭高尖）,即口腔上颚的高拱:发现:时间点:^患者:序数型:PhenX	4182948
40767284	Child Ritalin ever; Finding; Findings; Me-phenidate; Ordinal; Point in time; QL; Qual; Qualitative; Random; Ritalin; Screen	4180186
40767284	Child Ritalin ever PhenX	4180186
40767284	您的孩子是否曾经服用过利他林:发现:时间点:^患者:序数型:PhenX	4182948
40767287	Child long term medical problem PhenX	4180186
40767287	3; Child long term medical problem; Finding; Findings; Nominal; Point in time; Random	4180186
40767287	如果您的孩子存在长期的医学问题,请列出您认为最重要的三项:发现:时间点:^患者:名义型:PhenX	4182948
40767288	Child current medication dose; Finding; Findings; Nominal; Point in time; Random	4180186
40767288	Child current medication dose PhenX	4180186
40767288	请列出您的孩子当前所服用的每剂药物的大小、毫克数或者数量:发现:时间点:^患者:名义型:PhenX	4182948
40767294	Child sleep disorder still present PhenX	4180186
40767294	Child sleep disorder still present; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767294	当前是否仍然存在睡眠障碍:发现:时间点:^患者:序数型:PhenX	4182948
40767298	Data type PhenX	4180186
40767298	Finding; Findings; Nominal; Point in time; Random	4180186
40767298	数据类型:发现:时间点:^患者:名义型:PhenX	4182948
40767299	Breathing; Finding; Findings; FVCQA; Lungs; Nominal; Point in time; Random; RS	4180186
40767299	FVCQA Respiratory PhenX	4180186
40767299	FVC 质量属性:发现:时间点:呼吸系统:名义型:PhenX	4182948
40767300	FEV1QA Respiratory PhenX	4180186
40767300	Breathing; FEV1QA; Finding; Findings; Lungs; Nominal; Point in time; Random; RS	4180186
40767300	FEV1 质量属性:发现:时间点:呼吸系统:名义型:PhenX	4182948
40767302	Deleted maneuver PhenX	4180186
40767302	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767302	已删除的策略:发现:时间点:^患者:序数型:PhenX	4182948
40767303	Accept; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767303	Acceptable maneuver PhenX	4180186
40767303	可接受的策略:发现:时间点:^患者:序数型:PhenX	4182948
40767304	Technician quality control code PhenX	4180186
40767304	Ident; Identifier; Nominal; Point in time; Random	4180186
40767304	技师质量控制代码:标识符:时间点:^患者:名义型:PhenX	4182948
40767306	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767306	Plateau achieved PhenX	4180186
40767306	已达到稳定阶段:发现:时间点:^患者:序数型:PhenX	4182948
40767308	Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767308	Date of review PhenX	4180186
40767308	审核日期:日期:时间点:^患者:定量型:PhenX	4182948
40767310	ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
40767310	Technician ID	4180186
40767310	技师标识符:标识符:时间点:^患者:名义型	4182948
40767311	Finding; Findings; No; Nominal; Num; Point in time; Random	4180186
40767311	Maneuver number PhenX	4180186
40767311	策略编号:发现:时间点:^患者:名义型:PhenX	4182948
40767313	Ref values source PhenX	4180186
40767313	Finding; Findings; Nominal; Point in time; Random; Ref values source; Srce	4180186
40767313	参考值来源:发现:时间点:^患者:名义型:PhenX	4182948
40767315	Finding; Findings; Nominal; Point in time; Random	4180186
40767315	Current breast stage PhenX	4180186
40767315	当前乳腺发育阶段:发现:时间点:^患者:名义型:PhenX	4182948
40767318	Current stage of physical dev PhenX	4180186
40767318	Finding; Findings; Nominal; Point in time; Random	4180186
40767318	体格发育的当前阶段:发现:时间点:^患者:名义型:PhenX	4182948
40767321	Finding; Findings; Help have baby infertility male; Nominal; Point in time; Random	4180186
40767321	Help have baby infertility male PhenX	4180186
40767321	当您和您的伴侣为了共同生一个宝宝而去寻求医学帮助的时候,您是否曾经被告知,您存在任何下列的男性不育问题:发现:时间点:^患者:名义型:PhenX	4182948
40767322	Finding; Findings; Had uterus fibroid tumor; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767322	Had uterus fibroid tumor PhenX	4180186
40767322	某位医生或其他的医疗护理服务提供者是否曾经告诉过您,您的子宫当中存在纤维瘤或肌瘤:发现:时间点:^患者:序数型:PhenX	4182948
40767325	Other sterilization operation PhenX	4180186
40767325	Finding; Findings; Ordinal; Other sterilization operation; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767325	您是否接受过任何其他的手术,从而使您不可能生孩子:发现:时间点:^患者:序数型:PhenX	4182948
40767327	Vasectomy operation PhenX	4180186
40767327	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Vasectomy operation	4180186
40767327	您的丈夫或伴侣是否已经接受过输精管结扎术或任何其他手术使他将来不可能成为一个孩子的父亲:发现:时间点:^患者:序数型:PhenX	4182948
40767329	Arterial Stenosis; Completely sterile male; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767329	Completely sterile male PhenX	4180186
40767329	据您所知,他是否因此次手术而彻底绝育,也就是说,该手术使他将来不可能再以父亲的身份去生孩子:发现:时间点:^患者:序数型:PhenX	4182948
40767335	Contraception; Contraceptive Method; Current birth control list; Finding; Findings; Nominal; Point in time; Random	4180186
40767335	Current birth control list PhenX	4180186
40767335	标记出您当前所使用的节育方法:发现:时间点:^患者:名义型:PhenX	4182948
40767336	Prevent pregnancy STD method list PhenX	4180186
40767336	1 year; 12Mos; Finding; Findings; Gestation; Gestations; Gravida; Nominal; Past; Pregnancies; Prevent pregnancy STD method list	4180186
40767336	包括您可能已经告诉过我的任何方法以及那些您可能仅仅采用过一次的方法在内,在这些方法当中,您和她当时采用了哪些方法来避免怀孕或者预防性传播疾病:发现:12个月:^患者:名义型:PhenX	4182948
40767337	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Try pregnancy currently	4180186
40767337	Try pregnancy currently PhenX	4180186
40767337	您和您的伴侣当前正在努力怀孕吗:发现:时间点:^患者:序数型:PhenX	4182948
40767338	Try pregnancy Mos PhenX	4180186
40767338	month; Point in time; QNT; Quan; Quant; Quantitative; Random; Try pregnancy Mos	4180186
40767338	您和您的伴侣在尝试怀孕上花费了多长时间,多少个月:时间:时间点:^患者:定量型:PhenX	4182948
40767341	Full height age; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767341	Full height age PhenX	4180186
40767341	您大约在多大年龄时达到了自己的完整身高:时间:时间点:^患者:序数型:PhenX	4182948
40767342	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Voice changed peer comparison	4180186
40767342	Voice changed peer comparison PhenX	4180186
40767342	您的嗓音当时发生了变化。与您的朋友们相比,这项是:发现:时间点:^患者:序数型:PhenX	4182948
40767344	Penis size increase peer compar PhenX	4180186
40767344	Finding; Findings; Ordinal; Penis size increase peer compar; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767344	您的阴茎大小当时开始增长。与您的朋友们相比,这项是:发现:时间点:^患者:序数型:PhenX	4182948
40767345	Penis size increase age; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767345	Penis size increase age PhenX	4180186
40767345	您当时阴茎大小开始增长时是多大年龄:时间:时间点:^患者:定量型:PhenX	4182948
40767347	Pubic hair peer comparison PhenX	4180186
40767347	Finding; Findings; Ordinal; Point in time; Pubic hair peer comparison; Ql; Qual; Qualitative; Random; Screen	4180186
40767347	您长出了阴毛。与您的朋友们相比,这项是:发现:时间点:^患者:序数型:PhenX	4182948
40767349	Finding; Findings; Ordinal; Point in time; Puberty reach; Ql; Qual; Qualitative; Random; Screen	4180186
40767349	Puberty reach PhenX	4180186
40767349	您会说这些身体变化是:发现:时间点:^患者:序数型:PhenX	4182948
40767352	Evista used Mos; month; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767352	Evista used Mos PhenX	4180186
40767352	您已经使用了多少个月的雷洛昔芬:时间:时间点:^患者:定量型:PhenX	4182948
40767354	Evista Nolvadex currently; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767354	Evista Nolvadex currently PhenX	4180186
40767354	您当前正在使用雷洛昔芬或他莫昔芬（抑乳癌、三苯氧胺）吗:发现:时间点:^患者:序数型:PhenX	4182948
40767355	After; Finding; Findings; Herb natural soy ERT current; Horm; Ordinal; Point in time; PST; QL; Qual; Qualitative; Random; Screen; Sx	4180186
40767355	Herb natural soy ERT current PhenX	4180186
40767355	您当前正在为激素替代或者治疗绝经后症状而使用任何的非处方型草药、天然制剂或大豆制品:发现:时间点:^患者:序数型:PhenX	4182948
40767357	Female hormone prescript used; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rx; Screen	4180186
40767357	Female hormone prescript used PhenX	4180186
40767357	您是否使用过处方雌激素:发现:时间点:^患者:序数型:PhenX	4182948
40767358	Female hormone prescript Mos PhenX	4180186
40767358	Female hormone prescript Mos; month; Point in time; QNT; Quan; Quant; Quantitative; Random; Rx	4180186
40767358	当时您使用了多少个月的处方激素:时间:时间点:^患者:定量型:PhenX	4182948
40767359	Female hormone currently using PhenX	4180186
40767359	1 month; 1 month (30 days); 30 days; Female hormone currently using; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40767359	您当前正在使用它们吗 - 在上个月当中:发现:1个月:^患者:序数型:PhenX	4182948
40767362	Current use estrogen other; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40767362	Current use estrogen other PhenX	4180186
40767362	您当前正在服用的其他雌激素:发现:时间点:^患者:名义型:PhenX	4182948
40767364	Current other progesterone PhenX	4180186
40767364	Current other progesterone; Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40767364	您当前正在服用的其他孕酮:发现:时间点:^患者:名义型:PhenX	4182948
40767365	Current use hormones other PhenX	4180186
40767365	Arterial Stenosis; Current use hormones other; Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40767365	当前所使用的其他激素（如Tri-est）:发现:时间点:^患者:名义型:PhenX	4182948
40767369	HPV vaccination ever	4180186
40767369	Finding; Findings; HPV vaccination ever; Immunizations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vaccine	4180186
40767369	您是否曾经接受过人乳头状瘤病毒疫苗接种:发现:时间点:^患者:序数型	4182948
40767370	Age when received HPV vaccine	4180186
40767370	Age when received HPV vaccine; Immunizations; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccine	4180186
40767370	接受人乳头瘤病毒疫苗接种时的年龄:时间:时间点:^患者:定量型	4182948
40767372	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Undescended testicle born	4180186
40767372	Undescended testicle born PhenX	4180186
40767372	您出生时是否两个睾丸之一或二者均未下降（未完全下降到阴囊之中）:发现:时间点:^患者:序数型:PhenX	4182948
40767374	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Undescended testicle down itself	4180186
40767374	Undescended testicle down itself PhenX	4180186
40767374	该睾丸当时是否是自行下降到阴囊当中:发现:时间点:^患者:序数型:PhenX	4182948
40767375	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
40767375	Did you receive treatment PhenX	4180186
40767375	您是否曾经接受过治疗:发现:时间点:^患者:序数型:PhenX	4182948
40767376	Finding; Findings; Nominal; Point in time; Random; Tx	4180186
40767376	What treatment PhenX	4180186
40767376	什么治疗:发现:时间点:^患者:名义型:PhenX	4182948
40767378	Finding; Findings; Ordinal; Other penis testicles disease; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767378	Other penis testicles disease PhenX	4180186
40767378	您的医生或别的医疗保健服务提供者是否曾经告诉过您,您现在患有阴茎、睾丸、尿道或阴囊的其他疾病:发现:时间点:^患者:序数型:PhenX	4182948
40767380	Finding; Findings; Hypospadius ever; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767380	Hypospadius ever PhenX	4180186
40767380	您的医生或别的医疗保健服务提供者是否曾经告诉过您,您现在患有尿道下裂:发现:时间点:^患者:序数型:PhenX	4182948
40767381	Most treatment medication PhenX	4180186
40767381	Finding; Findings; Most treatment medication; Nominal; Point in time; Random; Tx	4180186
40767381	如果有的话,您最近一次的治疗或用药是什么:发现:时间点:^患者:名义型:PhenX	4182948
40767384	Difficult ejaculating early PhenX	4180186
40767384	Difficult ejaculating early; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767384	您多久出现一次早泄性的困难:发现:时间点:^患者:序数型:PhenX	4182948
40767388	4 weeks; Erections hard penetration; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Stim	4180186
40767388	Erections hard penetration PhenX	4180186
40767388	在过去的那4个星期当中,当你因为性刺激而勃起的时候,多久出现一次您的勃起足够坚挺而适合于插入的情况:发现:4星期:^患者:序数型:PhenX	4182948
40767390	Maintain erection after penetrate PhenX	4180186
40767390	4 weeks; Finding; Findings; Last; Maintain erection after penetrate; Nominal	4180186
40767390	在过去的那4个星期当中,在性交过程中,在您已经插入您伴侣体内之后,您多久一次能够保持勃起状态:发现:4星期:^患者:名义型:PhenX	4182948
40767391	4 weeks; Finding; Findings; Last; Maint erection complete penetrate; Nominal	4180186
40767391	Maint erection complete penetrate PhenX	4180186
40767391	在过去的那4个星期当中,在性交过程中,您保持勃起状态来完成性交的难度有多大:发现:4星期:^患者:名义型:PhenX	4182948
40767392	Attempt sexual intercourse times PhenX	4180186
40767392	4 weeks; Attempt sexual intercourse times; Count/time; Last; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Screen	4180186
40767392	在过去的那4个星期当中,您有多少次曾经尝试性交:计数型速率:4星期:^患者:序数型:PhenX	4182948
40767393	Attempt sex intercourse satisfac PhenX	4180186
40767393	4 weeks; Attempt sex intercourse satisfac; Finding; Findings; Last; Nominal	4180186
40767393	在过去的那4个星期当中,当您尝试性交的时候,多久出现一次您感到满意的情况:发现:4星期:^患者:名义型:PhenX	4182948
40767394	Enjoy sexual intercourse PhenX	4180186
40767394	4 weeks; Enjoy sexual intercourse; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40767394	在过去的那4个星期当中,您对性交的喜欢程度有多大:发现:4星期:^患者:序数型:PhenX	4182948
40767398	4 weeks; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Sexual desire level rate	4180186
40767398	Sexual desire level rate PhenX	4180186
40767398	在过去的那4个星期当中,您会如何评价自己的性欲水平:发现:4星期:^患者:序数型:PhenX	4182948
40767400	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Sexual relationship satisfac	4180186
40767400	Sexual relationship satisfac PhenX	4180186
40767400	在过去的那4个星期当中,您对您与自己伴侣之间的性关系的满意程度如何:发现:4星期:^患者:序数型:PhenX	4182948
40767401	Confidence get keep erection PhenX	4180186
40767401	4 weeks; Confidence get keep erection; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40767401	在过去的那4个星期当中,您如何评价您对于自己能够实现并保持勃起状态的信心:发现:4星期:^患者:序数型:PhenX	4182948
40767402	No menstrual period 3 or more Mos PhenX	4180186
40767402	Finding; Findings; III; month; No menstrual period 3 or more Mos; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767402	自从18岁以来,您是否曾经经历过长度为3个月或更长时间且没有一次月经周期的时间间隔:发现:时间点:^患者:序数型:PhenX	4182948
40767403	Finding; Findings; No menstrual period breastfeeding; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767403	No menstrual period breastfeeding PhenX	4180186
40767403	那时您是否正在进行母乳喂养:发现:时间点:^患者:序数型:PhenX	4182948
40767404	Finding; Findings; No period breastfeed preg always; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767404	No period breastfeed preg always PhenX	4180186
40767404	每次发生这种情况的时候,您是否都正在进行母乳喂养或者妊娠:发现:时间点:^患者:序数型:PhenX	4182948
40767405	Menstrual cycle pattern age 18-22 PhenX	4180186
40767405	Finding; Findings; Gestation; Gestations; Gravida; Menstrual cycle pattern age 18-22; Ordinal; Point in time; Pregnancy; QL; Qual; Qualitative; Random; Screen	4180186
40767405	在18到22岁期间,您的月经周期的模式是什么样的,排除妊娠附近的时间:发现:时间点:^患者:序数型:PhenX	4182948
40767408	Menstrual period stopped age PhenX	4180186
40767408	Menstrual period stopped age; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767408	您的月经周期停止时您的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40767411	Trouble starting urinate PhenX	4180186
40767411	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Trouble starting urinate	4180186
40767411	您通常是否在开始排尿上,即在开始小便或小解上存在困难:发现:时间点:^患者:序数型:PhenX	4182948
40767412	Urinary stream force decrease PhenX	4180186
40767412	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Urinary stream force decrease	4180186
40767412	多年来您所排出的尿流的力量是否已经减弱:发现:时间点:^患者:序数型:PhenX	4182948
40767414	Ab; Aborta; Cnt; Count; Gestation; Gestations; Gravida; Number; Number pregnancy; Othr; Point in time; Pregnancy; QNT; Quan; Quant; Quantitative; Random	4180186
40767414	Number pregnancy PhenX	4180186
40767414	包括活产、死胎、早产、自然流产、人工流产、输卵管妊娠以及其他的异位妊娠在内,您总共怀孕过多少次:数量(计数):时间点:^患者:定量型:PhenX	4182948
40767418	Gestation; Gestations; Gravida; Point in time; Pregnancies; Pregnancy end date; QNT; Quan; Quant; Quantitative; Random	4180186
40767418	Pregnancy end date PhenX	4180186
40767418	该次妊娠结束于什么日期:日期:时间点:^患者:定量型:PhenX	4182948
40767419	Frequent nausea vomiting Mos PhenX	4180186
40767419	Finding; Findings; Frequent nausea vomiting Mos; Gestation; Gestations; Gravida; Nominal; Point in time; Pregnancies; Random	4180186
40767419	在该次怀孕的哪些月份当中,您存在频繁的恶心或呕吐:发现:时间点:^患者:名义型:PhenX	4182948
40767420	Baby boy girl; Finding; Findings; Nominal; Point in time; Random	4180186
40767420	Baby boy girl PhenX	4180186
40767420	该婴儿是位男孩还是女孩:发现:时间点:^患者:名义型:PhenX	4182948
40767422	Alcohol last 3Mo pregnancy; Count/time; Gestation; Gestations; Gravida; nRate; Number rate; Number Rate = Count/Time; Past; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
40767422	Alcohol last 3Mo pregnancy PhenX	4180186
40767422	在您妊娠的过去的那三个月当中,您一般每星期喝掉多少杯酒精饮料:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767423	Heavy alc last 3Mo preg nRate PhenX	4180186
40767423	Count/time; Gestation; Gestations; Gravida; Heavy alc last 3Mo preg; nRate; Number rate; Number Rate = Count/Time; Past; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
40767423	在您妊娠的过去的那三个月当中,有多少次您曾经一下子喝掉4杯酒精饮料:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767424	Receive help alcohol drug prob PhenX	4180186
40767424	Alc; alcoholic; Drugs; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Receive help alcohol drug prob; Screen	4180186
40767424	在这次妊娠过程中,您是否曾经接受过针对某种酒精或毒品问题的帮助:发现:时间点:^患者:序数型:PhenX	4182948
40767427	Father pregnancy age; Gestation; Gestations; Gravida; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
40767427	Father pregnancy age PhenX	4180186
40767427	以父亲的身份经历此次怀孕时您的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40767428	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
40767428	Planned pregnancy PhenX	4180186
40767428	其是否为计划妊娠:发现:时间点:^患者:序数型:PhenX	4182948
40767431	Finding; Findings; Gestation; Gestations; Gravida; Nominal; Point in time; Pregnancies; Random; This pregnancy outcome	4180186
40767431	This pregnancy outcome PhenX	4180186
40767431	这次妊娠的结局是什么:发现:时间点:^患者:名义型:PhenX	4182948
40767432	Birth loss date PhenX	4180186
40767432	Birth loss date; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767432	出生或损失日期:时间戳:时间点:^患者:定量型:PhenX	4182948
40767433	Had vaginal intercourse PhenX	4180186
40767433	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767433	您是否曾经进行过阴道性交:发现:时间点:^患者:序数型:PhenX	4182948
40767434	Vaginal intercourse first age PhenX	4180186
40767434	Point in time; QNT; Quan; Quant; Quantitative; Random; Vaginal intercourse first age	4180186
40767434	您首次进行阴道性交时的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40767436	Vag intercrse partners 12Mo nRate PhenX	4180186
40767436	1 year; 12Mos; Count/time; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Vag intercrse partners 12Mo	4180186
40767436	在过去的那12个月当中,您与多少位不同的伴侣进行过阴道性交:计数型速率:12个月:^患者:定量型:PhenX	4182948
40767438	Condom use count 12Mo nRate PhenX	4180186
40767438	1 year; 12Mos; Condom use count 12Mo; Count/time; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40767438	在过去的那12个月当中,在这些场合里面,您或您的伴侣有多少次使用过避孕套:计数型速率:12个月:^患者:定量型:PhenX	4182948
40767441	Finding; Findings; Gender; Ordinal; Point in time; QL; Qual; Qualitative; Random; Same gender genital contact ever; Screen	4180186
40767441	Same gender genital contact ever PhenX	4180186
40767441	对于女性 - 您是否曾经与某位妇女进行过涉及生殖器区域或阴道接触的性交. 对于男性 - 您是否曾经与某位男子进行过涉及生殖器区域或阴茎接触的性交:发现:时间点:^患者:序数型:PhenX	4182948
40767442	Finding; Findings; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; Screen; When was last occasion	4180186
40767442	When was last occasion PhenX	4180186
40767442	最后的时机是何时:发现:时间点:^患者:序数型:PhenX	4182948
40767444	# of largest bead - L testis; Arterial Stenosis; Finding; Findings; L; LT; No; Nominal; Num; Point in time; Random; Testicle	4180186
40767444	# of largest bead - L testis PhenX	4180186
40767444	至少同左侧睾丸一样大的最大睾丸测量珠的数量:发现:时间点:^患者:名义型:PhenX	4182948
40767445	Eye Contact biometry instru mod PhenX	4180186
40767445	Contact biometry instru mod; Eyeball; Ident; Identifier; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual	4180186
40767445	接触式生物测量学设备型号:标识符:时间点:眼睛:名义型:PhenX	4182948
40767446	Eye PhenX	4180186
40767446	Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual	4180186
40767446	眼睛:发现:时间点:眼睛:名义型:PhenX	4182948
40767447	Eye; EYE.PX; Eyeball; Len; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Skyline; Tangential; Vision; Visual	4180186
40767447	R eye Axial length	4180186
40767447	轴长度:长度:时间点:眼睛.右侧:定量型	4182948
40767448	角膜厚度:长度:时间点:眼睛.右侧:定量型	4182948
40767448	Corneal; Eyeball; Length; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Thick; Vision; Visual	4180186
40767448	Cornea thickness R eye	4180186
40767451	Which eye PhenX	4180186
40767451	Finding; Findings; Nominal; Point in time; Random	4180186
40767451	哪只眼睛:发现:时间点:^患者:名义型:PhenX	4182948
40767455	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40767455	Frequently squinting PhenX	4180186
40767455	在过去的那12个月当中,您是否注意到您的孩子时常眯着眼或斜着眼看东西:发现:12个月:^患者:序数型:PhenX	4182948
40767457	Difficulty seeing PhenX	4180186
40767457	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen	4180186
40767457	在过去的那12个月当中,您的孩子是否看上去在看见东西方面存在困难:发现:12个月:^患者:序数型:PhenX	4182948
40767458	Close one eye bright light PhenX	4180186
40767458	Close one eye bright light; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767458	您的孩子是否在明亮的阳光下闭上一只眼睛:发现:时间点:^患者:序数型:PhenX	4182948
40767463	Finding; Findings; Last; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision problem treatment	4180186
40767463	Vision problem treatment PhenX	4180186
40767463	这个孩子是否曾经因为这种视力问题而接受过治疗:发现:时间点:^患者:序数型:PhenX	4182948
40767464	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision problem relatives	4180186
40767464	Vision problem relatives PhenX	4180186
40767464	他或她的任何其他亲戚现在或过去是否存在这种视力问题:发现:时间点:^患者:序数型:PhenX	4182948
40767467	Eye problem sisters PhenX	4180186
40767467	Cnt; Count; Eye problem sisters; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767467	他或她的姐妹当中有多少位当前存在、过去曾经存在或者被怀疑存在这种眼睛问题:数量(计数):时间点:^患者:定量型:PhenX	4182948
40767468	Eye problem brothers PhenX	4180186
40767468	Cnt; Count; Eye problem brothers; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767468	他或她的兄弟当中有多少位当前存在、过去曾经存在或者被怀疑存在这种眼睛问题:数量(计数):时间点:^患者:定量型:PhenX	4182948
40767469	Eye problem grandparents PhenX	4180186
40767469	Cnt; Count; Eye problem grandparents; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767469	他或她的祖父母和外父祖母当中有多少位当前存在、过去曾经存在或者被怀疑存在这种眼睛问题:数量(计数):时间点:^患者:定量型:PhenX	4182948
40767471	Child strabismus eye PhenX	4180186
40767471	Child strabismus eye; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767471	您的孩子是否患有斜视 - 也就是说,一只或两只眼睛向内侧偏斜（内转）、向外侧偏斜（外转）、向上侧偏斜（上转）和向下侧偏斜（下转）,或者交叉眼（内斜视、对眼或斗鸡眼）或外斜视（散开性斜视、斜白眼）:发现:时间点:^患者:序数型:PhenX	4182948
40767474	Finding; Findings; Myopia treatment; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
40767474	Myopia treatment PhenX	4180186
40767474	您的孩子当时究竟针对近视接受了什么治疗:发现:时间点:^患者:序数型:PhenX	4182948
40767476	1 year; 12Mos; Count/time; Last; Myopia Dr. times last 12Mo; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40767476	Myopia Dr. times last 12Mo nRate PhenX	4180186
40767476	在过去的那12个月当中,他或她有多少次因为自己的近视而去看过眼科医生:计数型速率:12个月:^患者:定量型:PhenX	4182948
40767482	Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40767482	Other glaucoma drops PhenX	4180186
40767482	您当前正在使用的其他青光眼滴眼剂:发现:时间点:^患者:名义型:PhenX	4182948
40767484	Dry eye medication currently; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rx; Screen	4180186
40767484	Dry eye medication currently PhenX	4180186
40767484	您是否因为干眼病当前已经规律地使用人工眼泪或处方药物达到3个月或更长的时间:发现:时间点:^患者:序数型:PhenX	4182948
40767488	1 year; 12Mos; Child difficulty seeing 12Mo; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
40767488	Child difficulty seeing 12Mo PhenX	4180186
40767488	在过去的那12个月当中,如果孩子不到12个月,则以孩子年龄的月数计算,您的孩子是否看上去在看见东西方面存在困难:发现:12个月:^患者:序数型:PhenX	4182948
40767490	Child eye problem dx date PhenX	4180186
40767490	Arterial Stenosis; Child eye problem dx date; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767490	您的孩子何时被首次诊断患有某种眼睛问题:时间戳:时间点:^患者:定量型:PhenX	4182948
40767491	Child amblyopia dx date PhenX	4180186
40767491	Arterial Stenosis; Child amblyopia dx date; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767491	您的孩子何时被首次诊断患有弱视:时间戳:时间点:^患者:定量型:PhenX	4182948
40767492	Child strabismus dx date PhenX	4180186
40767492	Arterial Stenosis; Child strabismus dx date; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767492	您的孩子何时被首次诊断患有斜视:时间戳:时间点:^患者:定量型:PhenX	4182948
40767493	Operation straighten eyes ever PhenX	4180186
40767493	Finding; Findings; Operation straighten eyes ever; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767493	他或她是否曾经接受过一次手术来矫直他或她的眼睛:发现:时间点:^患者:序数型:PhenX	4182948
40767494	Date and time; Operation straighten eyes date; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767494	Operation straighten eyes date PhenX	4180186
40767494	您的孩子是何时首次接受这种类型的手术的:时间戳:时间点:^患者:定量型:PhenX	4182948
40767498	Cigarettes before preg per D; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767498	Cigarettes before preg per D PhenX	4180186
40767498	在您怀孕之前的那3个月当中,在通常的一天里面,您当时抽多少支香烟:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767499	Cigarettes per D last 3Mo preg; Count/time; Dextro; Gestation; Gestations; Gravida; nRate; Number rate; Number Rate = Count/Time; Past; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
40767499	Cigarettes per D last 3Mo preg PhenX	4180186
40767499	在您怀孕期间过去的那3个月当中,在通常的一天里面,您当时抽多少支香烟:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767500	Alc drinks per W 3Mo before preg; Count/time; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767500	Alc drinks per W 3Mo before preg PhenX	4180186
40767500	在您妊娠之前的那三个月当中,您一般每星期喝掉多少杯酒精饮料:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767502	Bld mixed venous; Blood - mixed venous; Calc; Calculation; Chemistry; ctO2; Lung; O2; O2 Ct; O2CT; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volfr; Volume fraction	4180186
40767502	O2 Ct VFr BldMV Calc	4180186
40767502	氧含量:体积分数:时间点:混合静脉全血:定量型:计算法	4182948
40767504	O2 Ct VFr BldCoA Calc	4180186
40767504	Bld cord; Calc; Calculation; Chemistry; Cord arterial blood; Cord BldA; ctO2; O2; O2 Ct; O2CT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Volfr; Volume fraction	4180186
40767504	氧含量:体积分数:时间点:脐带动脉全血:定量型:计算法	4182948
40767505	City town Y end; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767505	City town Y end PhenX	4180186
40767505	您是何年从那座城市或城镇迁走的:日期:时间点:^患者:定量型:PhenX	4182948
40767506	Activ; Actvty; Daytime activity job 18; Finding; Findings; Movements; Nominal; Occupation; Point in time; Random; Work	4180186
40767506	Daytime activity job 18 PhenX	4180186
40767506	当您满18岁的时候,您主要的白天活动或工作是什么:发现:时间点:^患者:名义型:PhenX	4182948
40767509	Count/time; Dextro; Dir; Evening; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Point in time; QNT; Quan; Quant; Quantitative; Random; Work; Workday sunlight exposure H	4180186
40767509	Workday sunlight exposure H nRate PhenX	4180186
40767509	当您生活在自己的城市或城镇里从事着自己的职业时,在四月份到九月份里的一个典型的5天工作周当中,您是否在户外直接暴露在早上10点至下午4点之间的日光之下:计数型速率:时间点:^患者:定量型:PhenX	4182948
40767510	Sunlight protection PhenX	4180186
40767510	Finding; Findings; Nominal; Point in time; Random	4180186
40767510	日光防护:发现:时间点:^患者:名义型:PhenX	4182948
40767514	3; Dextro; Finding; Findings; Leisure over water &gt;3H; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tot; Totl	4180186
40767514	Leisure over water >3H PhenX	4180186
40767514	在您闲暇时间当中,您主要的白天活动当时是否使得您每天在水面上总共待3个小时或更长的时间,比如帆船运动、钓鱼或游泳:发现:时间点:^患者:序数型:PhenX	4182948
40767515	Dir; Finding; Findings; Leisure sunlight protection freq; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767515	Leisure sunlight protection freq PhenX	4180186
40767515	在您的闲暇时间当中,当您在户外直接暴露在阳光下面时,您多长时间才佩戴一次这种太阳镜:发现:时间点:^患者:序数型:PhenX	4182948
40767516	Both eyes eyesight; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767516	Both eyes eyesight PhenX	4180186
40767516	目前,在使用双眼（如果您佩戴眼镜或隐形眼镜的话,同时也佩戴上眼镜或隐形眼镜）时,您会说自己的视力是:发现:时间点:^患者:序数型:PhenX	4182948
40767522	Diabetic retinopathy ever PhenX	4180186
40767522	Diabetic retinopathy ever; Dis; Diseases; Dz; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767522	某位医生是否曾经告诉过您,糖尿病已经影响到您眼睛之中的血管,或者您已经存在糖尿病视网膜病变或患有糖尿病眼病:发现:时间点:^患者:序数型:PhenX	4182948
40767524	Diabet retinop laser surg times PhenX	4180186
40767524	Cnt; Count; Diabet retinop laser surg times; Dis; Diseases; Dz; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Surg; Tx	4180186
40767524	您进行过多少次不同的针对糖尿病眼病的激光治疗或外科手术:数量(计数):时间点:^患者:定量型:PhenX	4182948
40767526	Double vision ever PhenX	4180186
40767526	Double vision ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767526	您是否有过复视:发现:时间点:^患者:序数型:PhenX	4182948
40767529	Patch eye drops correction ever PhenX	4180186
40767529	Correctn; Enlon; Finding; Findings; Ordinal; Patch eye drops correction ever; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767529	您是否曾经为了矫正视力而佩戴过眼罩（遮盖法）或使用过滴眼液（阿托品压抑法）:发现:时间点:^患者:序数型:PhenX	4182948
40767530	Glasses contacts ever PhenX	4180186
40767530	Finding; Findings; Glasses contacts ever; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767530	您是否曾经佩戴过眼镜或隐形眼镜:发现:时间点:^患者:序数型:PhenX	4182948
40767532	bod; Bodies; Coloboma absence ocular tiss; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767532	Coloboma absence ocular tiss PhenX	4180186
40767532	您是否患有眼组织的缺损、缺如或缺陷,包括从视盘上的小凹陷,直到虹膜、睫状体、脉络膜、视网膜或视盘的广泛缺陷:发现:时间点:^患者:序数型:PhenX	4182948
40767533	Finding; Findings; Microphthalmia small eye; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767533	Microphthalmia small eye PhenX	4180186
40767533	您是否患有小眼畸形,即眼睛异常小:发现:时间点:^患者:序数型:PhenX	4182948
40767536	Retinal defects tears detachments PhenX	4180186
40767536	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Retinal defects tears detachments; Retinaldehyde; Retinene; Retinene 1; Screen; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
40767536	您是否患有任何的视网膜缺陷、视网膜裂孔、视网膜脱离等:发现:时间点:^患者:序数型:PhenX	4182948
40767537	Finding; Findings; Ordinal; Other visual impairment; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767537	Other visual impairment PhenX	4180186
40767537	您是否患有任何其他此前尚未记录的视力损害:发现:时间点:^患者:序数型:PhenX	4182948
40767538	Describe other visual impair PhenX	4180186
40767538	Finding; Findings; Nominal; Othr; Point in time; Random	4180186
40767538	请描述其他视力损害:发现:时间点:^患者:名义型:PhenX	4182948
40767539	Finding; Findings; Nominal; Point in time; Random; Rel	4180186
40767539	Relative with strabismus PhenX	4180186
40767539	患有斜视的亲戚:发现:时间点:^患者:名义型:PhenX	4182948
40767540	Finding; Findings; Nominal; Point in time; Random; Strabismus treatment; Tx	4180186
40767540	Strabismus treatment PhenX	4180186
40767540	与斜视相关的治疗:发现:时间点:^患者:名义型:PhenX	4182948
40767541	Strabismus treatment relative PhenX	4180186
40767541	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rel; Screen; Strabismus treatment relative; Tx	4180186
40767541	这位亲戚是否接受过这种斜视治疗:发现:时间点:^患者:序数型:PhenX	4182948
40767542	Other relative strabismus PhenX	4180186
40767542	Finding; Findings; Nominal; Other relative strabismus; Othr; Point in time; Random; Rel	4180186
40767542	患有斜视的其他亲属:发现:时间点:^患者:名义型:PhenX	4182948
40767543	ETDRS Visual Acuity Chart line; Finding; Findings; Nominal; Point in time; Random; Refraction; VA	4180186
40767543	ETDRS Visual Acuity Chart line PhenX	4180186
40767543	患者所读取的ETDRS视力表的行:发现:时间点:^患者:名义型:PhenX	4182948
40767545	Finding; Findings; Nominal; Point in time; Random; Visual acuity letter line	4180186
40767545	Visual acuity letter line PhenX	4180186
40767545	患者所读取的线上字母:发现:时间点:^患者:名义型:PhenX	4182948
40767546	Finding; Findings; No; Nominal; Num; Point in time; Random; Refraction	4180186
40767546	Equivalent visual acuity PhenX	4180186
40767546	根据基于正确读取字母个数的表格而换算的等价视力:发现:时间点:^患者:名义型:PhenX	4182948
40767547	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767547	Overall health PhenX	4180186
40767547	总体上,您会说自己整体的健康状况是:发现:时间点:^患者:序数型:PhenX	4182948
40767551	您当前是否开车,至少曾经有段时间:发现:时间点:^患者:序数型	4182948
40767551	Currently driving	4180186
40767551	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767554	在白天时间在熟悉的地方驾车方面,您有多大的困难:发现:时间点:^患者:序数型	4182948
40767554	Diff driving day familiar places	4180186
40767554	Diff driving day familiar places; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767555	Diff driving night; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767555	Diff driving night PhenX	4180186
40767555	在夜间驾驶方面,您有多大的困难:发现:时间点:^患者:序数型:PhenX	4182948
40767556	在困难情况下的驾驶方面,比如在坏天气里、在交通高峰时段、在高速公路上或者在城市交通条件下,您有多大的困难:发现:时间点:^患者:序数型	4182948
40767556	Arterial Stenosis; Difficult driving diff conditions; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767556	Difficult driving diff conditions	4180186
40767558	Finding; Findings; Job; Limited work due to vision; LMTED; LTD; Occupation; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767558	Limited work due to vision PhenX	4180186
40767558	您因为自己的视力而在自己能够工作或者进行其他活动上受到限制吗:发现:时间点:^患者:序数型:PhenX	4182948
40767562	Contact lense currently; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767562	Contact lense currently PhenX	4180186
40767562	您当前佩戴隐形眼镜吗:发现:时间点:^患者:序数型:PhenX	4182948
40767565	Contact lense type; Finding; Findings; Nominal; Point in time; Random	4180186
40767565	Contact lense type PhenX	4180186
40767565	您佩戴的是什么类型的隐形眼镜:发现:时间点:^患者:名义型:PhenX	4182948
40767566	Finding; Findings; Nominal; Point in time; Random	4180186
40767566	Measurement sequence PhenX	4180186
40767566	测量顺序:发现:时间点:^患者:名义型:PhenX	4182948
40767568	Finding; Findings; Next city town; Nominal; Point in time; Random	4180186
40767568	Next city town PhenX	4180186
40767568	接着您搬到了哪个城市或城镇:发现:时间点:^患者:名义型:PhenX	4182948
40767571	Contact lense sleep PhenX	4180186
40767571	Contact lense sleep; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767571	您睡觉的时候是否佩戴隐形眼镜:发现:时间点:^患者:序数型:PhenX	4182948
40767575	Finding; Findings; Glasses contact lense myopia; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767575	Glasses contact lense myopia PhenX	4180186
40767575	是否针对近视开出了眼镜或隐形眼镜处方:发现:时间点:^患者:序数型:PhenX	4182948
40767580	Glasses first date Glasses Rx PhenX	4180186
40767580	Glasses first date; Glasses Rx; Point in time; QNT; Quan; Quant; Quantitative; Random; Rx	4180186
40767580	首次处方日期:日期:时间点:眼镜处方:定量型:PhenX	4182948
40767581	Glasses first age; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767581	Glasses first age PhenX	4180186
40767581	首次处方时的年龄:时间:时间点:^患者:定量型:PhenX	4182948
40767582	Date stopped PhenX	4180186
40767582	Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767582	停止日期:日期:时间点:^患者:定量型:PhenX	4182948
40767583	Reason stopped PhenX	4180186
40767583	Finding; Findings; Nominal; Point in time; Random	4180186
40767583	关于停止的原因:发现:时间点:^患者:名义型:PhenX	4182948
40767584	Glasses freq PhenX	4180186
40767584	Finding; Findings; Glasses freq; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767584	您的孩子多久才佩戴一次他们的眼镜或隐形眼镜:发现:时间点:^患者:序数型:PhenX	4182948
40767585	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767585	Wear glasses PhenX	4180186
40767585	您是否佩戴任何种类的眼镜:发现:时间点:^患者:序数型:PhenX	4182948
40767587	Distance glasses age; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40767587	Distance glasses age PhenX	4180186
40767587	为了看清远处的东西而首次需要佩戴眼镜时您的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40767590	Glasses strength checked last PhenX	4180186
40767590	Date and time; Glasses strength checked last; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767590	您何时最后一次检查您眼镜的度数:时间戳:时间点:^患者:定量型:PhenX	4182948
40767591	Newspaper print read well PhenX	4180186
40767591	Finding; Findings; Newspaper print read well; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767591	在佩戴或不佩戴眼镜的情况下,您能够相当好地阅读报纸上的普通印刷体吗:发现:时间点:^患者:序数型:PhenX	4182948
40767592	Newspaper print read well last PhenX	4180186
40767592	Date and time; Newspaper print read well last; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40767592	您最后一次能够做这种事情是何时:时间戳:时间点:^患者:定量型:PhenX	4182948
40767593	Use magnifier read PhenX	4180186
40767593	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Use magnifier read	4180186
40767593	您在阅读时使用放大镜吗:发现:时间点:^患者:序数型:PhenX	4182948
40767594	Anxiety animal SCARED-R	4180186
40767594	Anxiety animal; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767594	我非常害怕某种自己不敢触摸的无害的动物:发现:时间点:^患者:序数型:SCARED-R	4182948
40767596	Anxiety doubt did something; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767596	Anxiety doubt did something SCARED-R	4180186
40767596	我怀疑自己是否真的做过某件事情:发现:时间点:^患者:序数型:SCARED-R	4182948
40767597	Anxiety sweat SCARED-R	4180186
40767597	Anxiety sweat; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767597	当惊恐的时候,我出汗很多:发现:时间点:^患者:序数型:SCARED-R	4182948
40767598	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767598	I am a worrier SCARED-R	4180186
40767598	我是个经常发愁的人:发现:时间点:^患者:序数型:SCARED-R	4182948
40767599	Anxiety operation; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767599	Anxiety operation SCARED-R	4180186
40767599	当我观看手术的时候,我感到害怕:发现:时间点:^患者:序数型:SCARED-R	4182948
40767600	Anxiety aversive event SCARED-R	4180186
40767600	Anxiety aversive event; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767600	我努力不去想某次我曾经经历过的令人厌恶的事件:发现:时间点:^患者:序数型:SCARED-R	4182948
40767601	Anxiety frightened no reason SCARED-R	4180186
40767601	Anxiety frightened no reason; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767601	我毫无原因地变得非常惊恐:发现:时间点:^患者:序数型:SCARED-R	4182948
40767602	Anxiety home alone SCARED-R	4180186
40767602	Anxiety home alone; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767602	我害怕独自在家:发现:时间点:^患者:序数型:SCARED-R	4182948
40767603	Scared think aversive event SCARED-R	4180186
40767603	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Scared think aversive event; Screen	4180186
40767603	当我重新想起自己曾经经历的某次非常令人厌恶的事件的时候,我变得害怕:发现:时间点:^患者:序数型:SCARED-R	4182948
40767604	Anxiety talk strangers SCARED-R	4180186
40767604	Anxiety talk strangers; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; T prime	4180186
40767604	我发现难于和自己不认识的人说话:发现:时间点:^患者:序数型:SCARED-R	4182948
40767606	Anxiety told worry too much SCARED-R	4180186
40767606	Anxiety told worry too much; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767606	人们告诉我说,我过于担心:发现:时间点:^患者:序数型:SCARED-R	4182948
40767607	Anxiety away from family SCARED-R	4180186
40767607	Anxiety away from family; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; T prime	4180186
40767607	我不喜欢远离家人:发现:时间点:^患者:序数型:SCARED-R	4182948
40767608	Anxiety don't like me; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767608	Anxiety don't like me SCARED-R	4180186
40767608	我担心他人不喜欢我:发现:时间点:^患者:序数型:SCARED-R	4182948
40767609	Anxiety pass out; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767609	Anxiety pass out SCARED-R	4180186
40767609	当惊恐的时候,我感到好像要昏倒了:发现:时间点:^患者:序数型:SCARED-R	4182948
40767612	Anxiety follow parents SCARED-R	4180186
40767612	Anxiety follow parents; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767612	无论父母去哪里,我都跟着他们:发现:时间点:^患者:序数型:SCARED-R	4182948
40767613	Anxiety frightening thoughts; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767613	Anxiety frightening thoughts SCARED-R	4180186
40767613	我有令自己害怕的想法:发现:时间点:^患者:序数型:SCARED-R	4182948
40767614	Anxiety look nervous; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767614	Anxiety look nervous SCARED-R	4180186
40767614	人们告诉我说,我看上去紧张不安:发现:时间点:^患者:序数型:SCARED-R	4182948
40767615	Anxiety nervous with strangers; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; T prime	4180186
40767615	Anxiety nervous with strangers SCARED-R	4180186
40767615	与我不太了解的人在一起时,我感到紧张不安:发现:时间点:^患者:序数型:SCARED-R	4182948
40767620	Anxiety dentist SCARED-R	4180186
40767620	Anxiety dentist; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767620	我害怕去看牙科医生:发现:时间点:^患者:序数型:SCARED-R	4182948
40767621	Anxiety good others; Arterial Stenosis; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767621	Anxiety good others SCARED-R	4180186
40767621	我担心是否与其他的孩子一样好:发现:时间点:^患者:序数型:SCARED-R	4182948
40767623	Anxiety thunder SCARED-R	4180186
40767623	Anxiety thunder; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767623	当空中响雷的时候,我变得害怕:发现:时间点:^患者:序数型:SCARED-R	4182948
40767625	Anxiety frightening dreams SCARED-R	4180186
40767625	Anxiety frightening dreams; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767625	我有关于某次我曾经经历过的令人厌恶的事件的恶梦:发现:时间点:^患者:序数型:SCARED-R	4182948
40767626	Anxiety clean tidy; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767626	Anxiety clean tidy SCARED-R	4180186
40767626	我希望东西干净整洁:发现:时间点:^患者:序数型:SCARED-R	4182948
40767627	Anxiety things unreal; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767627	Anxiety things unreal SCARED-R	4180186
40767627	当惊恐的时候,我感到事情并不是真的:发现:时间点:^患者:序数型:SCARED-R	4182948
40767628	Anxiety flying; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767628	Anxiety flying SCARED-R	4180186
40767628	当我乘坐飞机飞行的时候,我感到害怕:发现:时间点:^患者:序数型:SCARED-R	4182948
40767631	Anxiety scared of thoughts; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767631	Anxiety scared of thoughts SCARED-R	4180186
40767631	我做事情是为了少害怕自己的想法:发现:时间点:^患者:序数型:SCARED-R	4182948
40767634	Anxiety serious disease SCARED-R	4180186
40767634	Anxiety serious disease; Dis; Diseases; Dz; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767634	我害怕患有某种严重的疾病:发现:时间点:^患者:序数型:SCARED-R	4182948
40767635	Anxiety shaky SCARED-R	4180186
40767635	Anxiety shaky; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767635	我感到虚弱无力而又摇晃:发现:时间点:^患者:序数型:SCARED-R	4182948
40767637	Anxiety afraid of attacks SCARED-R	4180186
40767637	Anxiety afraid of attacks; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767637	我害怕焦虑发作:发现:时间点:^患者:序数型:SCARED-R	4182948
40767638	Anxiety bad things parents SCARED-R	4180186
40767638	Anxiety bad things parents; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767638	我担心自己父母身上发生糟糕的事情:发现:时间点:^患者:序数型:SCARED-R	4182948
40767641	Anxiety worry future; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767641	Anxiety worry future SCARED-R	4180186
40767641	我担心未来:发现:时间点:^患者:序数型:SCARED-R	4182948
40767643	Anxiety performance SCARED-R	4180186
40767643	Anxiety performance; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767643	我担心自己做事情到底有多好:发现:时间点:^患者:序数型:SCARED-R	4182948
40767644	Anxiety scared school SCARED-R	4180186
40767644	Anxiety scared school; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767644	我害怕去上学:发现:时间点:^患者:序数型:SCARED-R	4182948
40767645	Anxiety past events SCARED-R	4180186
40767645	Anxiety past events; Finding; Findings; Last; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767645	我担心过去发生了的那些事情:发现:时间点:^患者:序数型:SCARED-R	4182948
40767647	Anxiety unwanted thoughts; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767647	Anxiety unwanted thoughts SCARED-R	4180186
40767647	我有自己宁愿没有的想法:发现:时间点:^患者:序数型:SCARED-R	4182948
40767648	Anxiety afraid dark; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767648	Anxiety afraid dark SCARED-R	4180186
40767648	我怕黑:发现:时间点:^患者:序数型:SCARED-R	4182948
40767649	Anxiety thoughts bad events; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767649	Anxiety thoughts bad events SCARED-R	4180186
40767649	我有不由自主的关于某次我曾经经历过的令人厌恶的事件的想法:发现:时间点:^患者:序数型:SCARED-R	4182948
40767650	Anxiety animal others no fear SCARED-R	4180186
40767650	Anxiety animal others no fear; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767650	我害怕某种大多数孩子并不害怕的动物:发现:时间点:^患者:序数型:SCARED-R	4182948
40767654	Anxiety head stomachache school; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767654	Anxiety head stomachache school SCARED-R	4180186
40767654	我在学校上学的时候头痛或胃痛:发现:时间点:^患者:序数型:SCARED-R	4182948
40767655	Anxiety people don't know SCARED-R	4180186
40767655	Anxiety people don't know; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; T prime	4180186
40767655	我不喜欢与我不认识的人待在一起:发现:时间点:^患者:序数型:SCARED-R	4182948
40767658	Anxiety homesick SCARED-R	4180186
40767658	Anxiety homesick; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40767658	当我在远远离开家的地方睡觉的时候,我变得害怕:发现:时间点:^患者:序数型:SCARED-R	4182948
40767659	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chinese gooseberry; Dextro; f430; Immune globulin E; Immunoglobulin E; Kiwi; Kiwi (rAct d) 8; Kiwi fruit; Kiwifruit; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40767659	Kiwi (rAct d) 8 IgE Qn	4180186
40767659	美味猕猴桃 重组 (rAct d) 8 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767662	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cashew; Cashew nut; Cashew nut (rAna o) 2; f202; II; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40767662	Cashew nut (rAna o) 2 IgE Qn	4180186
40767662	腰果 重组 (rAna o) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767663	Brazil Nut (rBer e) 1 IgE Qn	4180186
40767663	2S albumin; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brazil nut; Brazil Nut (rBer e) 1; f018; f18; f354; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40767663	巴西坚果 重组 (rBer e) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767666	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f004; f4; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Triticum sativum; Wheat; Wheat (rTri a) 14	4180186
40767666	Wheat (rTri a) 14 IgE Qn	4180186
40767666	小麦 重组 (rTri a) 14 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767671	Goosefoot (rChe a) 1 IgE Qn	4180186
40767671	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Goosefoot; Goosefoot (rChe a) 1; i; Immune globulin E; Immunoglobulin E; Lamb's quarter; Lambs quarters; Lamb's quarters; Point in time; QNT; Quan; Quant; Quantitative; Quinoa; Random; Serum; SR; w010; w10	4180186
40767671	藜 重组 (rChe a) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767673	Dog (rCan f) 5 IgE Qn	4180186
40767673	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 5; e226; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40767673	狗 重组 (rCan f) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767677	A alternata; A alternata (rAlt a) 6; A tenuis; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; m006; m6; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40767677	A alternata (rAlt a) 6 IgE Qn	4180186
40767677	链格孢 重组 (rAlt a) 6 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767678	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C herbarum; C herbarum (rCla h) 8; Hormodendrum; Immune globulin E; Immunoglobulin E; m002; m2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40767678	C herbarum (rCla h) 8 IgE Qn	4180186
40767678	多主枝孢 (rCla h) 8 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767679	B tropicalis (rBlo t) 5 IgE Qn	4180186
40767679	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B tropicalis; B tropicalis (rBlo t) 5; d201; HDM; House dust mite; Immune globulin E; Immunoglobulin E; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T prime	4180186
40767679	热带无爪螨 重组 (rBlo t) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767681	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; d071; d71; Dextro; II; Immune globulin E; Immunoglobulin E; L destructor; L destructor (rLep d) 2; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite	4180186
40767681	L destructor (rLep d) 2 IgE Qn	4180186
40767681	害嗜鳞螨 重组 (rLep d) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767682	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B germanica; Cockroach; German cockroach; i; i006; i6; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Roach (rBla g) 1; Serum; SR	4180186
40767682	Roach (rBla g) 1 IgE Qn	4180186
40767682	德国小蠊 重组 (rBla g) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767683	Roach (rBla g) 2 IgE Qn	4180186
40767683	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B germanica; Cockroach; German cockroach; i006; i6; II; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Roach (rBla g) 2; Serum; SR	4180186
40767683	德国小蠊 重组 (rBla g) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767684	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B germanica; Cockroach; German cockroach; i006; i6; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Roach; Roach (rBla g) 5; Serum; SR	4180186
40767684	Roach (rBla g) 5 IgE Qn	4180186
40767684	德国小蠊 重组 (rBla g) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40767687	Race or ethnicity Fam Mem PhenX	4180186
40767687	Ethnicity; Fam Mem; Nominal; Point in time; Random; Typ	4180186
40767687	种族或民族:类型:时间点:^家庭成员:名义型:PhenX	4182948
40767692	CorePlaybook; Document; Echography; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; NDL; Needle place; Other; Playbook; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
40767692	US Guided Needle place	4180186
40767692	旨在置入针的引导:发现:时间点:XXX:文档型:超声	4182948
40767693	Vaccine fund pgm elig cat	4180186
40767693	Finding; Findings; Nominal; Point in time; Random; Vaccine fund pgm elig cat	4180186
40767693	疫苗资助计划资格类别:发现:时间点:^患者:名义型	4182948
40767695	Bronchogram; Bronchography; Broncogram; c; Contr; Contra; Contrst; CXR; Document; Films; Finding; Findings; Imaging; L; LT; Lung; Lung-L; Plain Films; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Respiratory; Thorax; View; VWS; W contr IB; WC; Xray; X-ray	4180186
40767695	XR Lung-L Views W contr IB	4180186
40767695	多重视图^采用支气管内对比剂:发现:时间点:胸部>肺.左侧:文档型:X射线摄影术	4182948
40767696	Bronchogram; Bronchography; Broncogram; c; Contr; Contra; Contrst; CXR; Document; Films; Finding; Findings; Imaging; Lung; Lung-R; Plain Films; Point in time; Pulmonary; Pulmonology; R; Rad; Radiology; Random; Respiratory; RT; Thorax; View; VWS; W contr IB; WC; Xray; X-ray	4180186
40767696	XR Lung-R Views W contr IB	4180186
40767696	多重视图^采用支气管内对比剂:发现:时间点:胸部>肺.右侧:文档型:X射线摄影术	4182948
40767699	Art; Arteriogram; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; IMA; Imaging; Internal Mammary Arteries; IT a; IT a-R; Mammary; Point in time; R; Rad; Radiology; Random; RFA; RT; Thorax; View; VWS; W contr IA; WC	4180186
40767699	RFA IT a-R Views W contr IA	4180186
40767699	多重视图^采用动脉注射对比剂:发现:时间点:胸部>胸廓内动脉.右侧:文档型:放射荧光透视法.血管造影术	4182948
40767700	Prefer do things with others AQ	4180186
40767700	Finding; Findings; Ordinal; PhenX; Point in time; Prefer do things with others; Ql; Qual; Qualitative; Random; Screen	4180186
40767700	我更喜欢与他人一起而不是独自去做事情:发现:时间点:^患者:序数型:AQ	4182948
40767701	Finding; Findings; Ordinal; PhenX; Point in time; Prefer do things same way; Ql; Qual; Qualitative; Random; Screen	4180186
40767701	Prefer do things same way AQ	4180186
40767701	我更喜欢采取同样的方式一遍一遍反复地去做事情:发现:时间点:^患者:序数型:AQ	4182948
40767705	Notice license plates AQ	4180186
40767705	Finding; Findings; No; Notice license plates; Num; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767705	我通常注意车牌号或者类似的信息串:发现:时间点:^患者:序数型:AQ	4182948
40767706	Finding; Findings; Ordinal; Othr; People call me impolite; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767706	People call me impolite AQ	4180186
40767706	他人频繁地告诉我,我所说的话不礼貌,尽管我认为那是礼貌的:发现:时间点:^患者:序数型:AQ	4182948
40767709	Keep track different conversations AQ	4180186
40767709	Finding; Findings; Keep track different conversations; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; S prime; Screen	4180186
40767709	在某个社交群体当中,我能够轻松地记住不同几个人的谈话:发现:时间点:^患者:序数型:AQ	4182948
40767710	Social situations easy AQ	4180186
40767710	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767710	我发现社交场合并非难事:发现:时间点:^患者:序数型:AQ	4182948
40767712	Library over party AQ	4180186
40767712	Finding; Findings; Library over party; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767712	我更喜欢去图书馆而不是参加聚会:发现:时间点:^患者:序数型:AQ	4182948
40767714	Drawn to people; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767714	Drawn to people AQ	4180186
40767714	我发现更加强烈地吸引自己的是人而不是东西:发现:时间点:^患者:序数型:AQ	4182948
40767716	Enjoy chit-chat AQ	4180186
40767716	Enjoy chit-chat; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767716	我喜欢社交聊天:发现:时间点:^患者:序数型:AQ	4182948
40767717	Dominate conversation; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767717	Dominate conversation AQ	4180186
40767717	当我说话的时候,对他人来说,要插上话并不总是轻松的事情:发现:时间点:^患者:序数型:AQ	4182948
40767718	Fascinated by numbers AQ	4180186
40767718	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767718	我为数字而着迷:发现:时间点:^患者:序数型:AQ	4182948
40767719	Diff understanding characters; Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767719	Diff understanding characters AQ	4180186
40767719	当我阅读一个故事的时候,我发现难于想出那些角色的意图:发现:时间点:^患者:序数型:AQ	4182948
40767720	Don't enjoy fiction; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767720	Don't enjoy fiction AQ	4180186
40767720	我尤其不喜欢阅读小说:发现:时间点:^患者:序数型:AQ	4182948
40767722	Notice patterns AQ	4180186
40767722	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767722	我总是注意事物之中的模式:发现:时间点:^患者:序数型:AQ	4182948
40767724	Daily routine AQ	4180186
40767724	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767724	在我的日常事务被打扰的时候,我并不会变得心烦意乱:发现:时间点:^患者:序数型:AQ	4182948
40767725	Difficulty with conversation AQ	4180186
40767725	Difficulty with conversation; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767725	我常常发现自己不知道如何将交谈继续下去:发现:时间点:^患者:序数型:AQ	4182948
40767728	Diff remembering phone numbers; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767728	Diff remembering phone numbers AQ	4180186
40767728	我并不非常善于记住电话号码:发现:时间点:^患者:序数型:AQ	4182948
40767730	Tell if boring others AQ	4180186
40767730	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Tell if boring others	4180186
40767730	我知道如何分辨听我说话的某个人是否正在变得感到厌倦:发现:时间点:^患者:序数型:AQ	4182948
40767731	Easy to multi-task AQ	4180186
40767731	Easy to multi-task; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767731	我发现容易同时做不止一件事情:发现:时间点:^患者:序数型:AQ	4182948
40767732	Difficulty phone conversations; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767732	Difficulty phone conversations AQ	4180186
40767732	当我在电话里讲话的时候,我不确定何时轮到我讲话:发现:时间点:^患者:序数型:AQ	4182948
40767739	Pretend with other children AQ	4180186
40767739	Finding; Findings; Ordinal; Othr; PhenX; Point in time; Pretend with other children; Ql; Qual; Qualitative; Random; Screen	4180186
40767739	当我小的时候,我常常喜欢与其他的孩子们玩包括装扮的游戏:发现:时间点:^患者:序数型:AQ	4182948
40767743	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767743	Enjoy social occasions AQ	4180186
40767743	我喜欢社交场合:发现:时间点:^患者:序数型:AQ	4182948
40767744	Difficult working out intentions; Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767744	Difficult working out intentions AQ	4180186
40767744	我发现难以弄清楚人的意图:发现:时间点:^患者:序数型:AQ	4182948
40767745	Anxious new situations; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767745	Anxious new situations AQ	4180186
40767745	新的情况让我焦虑:发现:时间点:^患者:序数型:AQ	4182948
40767746	Enjoy meeting new people AQ	4180186
40767746	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767746	我喜欢遇见新人:发现:时间点:^患者:序数型:AQ	4182948
40767748	Difficulty remember birth dates AQ	4180186
40767748	Difficulty remember birth dates; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767748	我并不非常善于记住别人的生日:发现:时间点:^患者:序数型:AQ	4182948
40767751	Child prefer do things same way; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767751	Child prefer do things same way AQ Adol	4180186
40767751	您的孩子更喜欢采取同样的方式一遍一遍反复地去做事情:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767752	Child easy create picture mind; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767752	Child easy create picture mind AQ Adol	4180186
40767752	如果试着去想象某种事物的话,您的孩子发觉要在自己脑子里建立一幅图像非常轻松:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767755	Child notices licwnse plates; Finding; Findings; No; Num; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767755	Child notices licwnse plates AQ Adol	4180186
40767755	您的孩子通常注意车牌号或者类似的信息串:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767759	Child track diff conversations; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767759	Child track diff conversations AQ Adol	4180186
40767759	在某个社交群体当中,您的孩子能够轻松地记住不同几个人的谈话:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767760	Child social situations easy; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767760	Child social situations easy AQ Adol	4180186
40767760	您的孩子发现社交场合并非难事:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767761	Child notice details; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767761	Child notice details AQ Adol	4180186
40767761	您的孩子倾向于注意他人并不注意的细节:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767762	Child library over party; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767762	Child library over party AQ Adol	4180186
40767762	您的孩子更喜欢去图书馆而不是参加聚会:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767763	Child make up stories easy AQ Adol	4180186
40767763	Child make up stories easy; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767763	您的孩子发现容易编造故事:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767764	Child drawn to people; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767764	Child drawn to people AQ Adol	4180186
40767764	您的孩子发现更加强烈地吸引自己的是人而不是东西:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767766	Child enjoy chit-chat; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767766	Child enjoy chit-chat AQ Adol	4180186
40767766	您的孩子喜欢社交聊天:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767767	Child dominate conversation AQ Adol	4180186
40767767	Child dominate conversation; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767767	当您的孩子说话的时候,对他人来说,要插上话并不总是轻松的事情:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767770	Child not enjoy reading; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767770	Child not enjoy reading AQ Adol	4180186
40767770	您的孩子并不是特别喜欢阅读小说:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767771	Child hard make friends AQ Adol	4180186
40767771	Child hard make friends; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767771	您的孩子发现难于结交新的朋友:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767772	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767772	Child notices patterns AQ Adol	4180186
40767772	您的孩子总是注意事物之中的模式:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767773	Child theatre over museum AQ Adol	4180186
40767773	Child theatre over museum; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767773	您的孩子更喜欢去看戏而不是去参观博物馆:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767776	Child read between lines; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767776	Child read between lines AQ Adol	4180186
40767776	您的孩子发现容易在别人与她或他说话的时候体会言外之意:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767777	Child whole picture over details; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767777	Child whole picture over details AQ Adol	4180186
40767777	您的孩子通常更多地将注意力集中于全貌而不是微小的细节:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767778	Child not remember phone numbers AQ Adol	4180186
40767778	Child not remember phone numbers; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767778	您的孩子并不非常善于记住电话号码:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767779	Appear; Appr; Child notice small changes; Finding; Findings; Ordinal; Persons; PhenX; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; T prime	4180186
40767779	Child notice small changes AQ Adol	4180186
40767779	您的孩子通常并不注意情况或者人的外表的微小变化:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767783	Child enjoy spontaneity AQ Adol	4180186
40767783	Child enjoy spontaneity; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767783	您的孩子喜欢自发地做事情:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767784	Child diff understand joke AQ Adol	4180186
40767784	Child diff understand joke; Finding; Findings; Ordinal; Past; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767784	您的孩子常常是最后一个理解玩笑要点的人:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767792	Child enjoy planning activities; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767792	Child enjoy planning activities AQ Adol	4180186
40767792	您的孩子喜欢仔细计划自己所参加的任何活动:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767793	Child enjoys social occasions AQ Adol	4180186
40767793	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767793	您的孩子喜欢社交场合:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767797	Child good diplomat AQ Adol	4180186
40767797	Child good diplomat; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767797	您的孩子是个很善于交际的人:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767798	Child diff remember birth dates; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767798	Child diff remember birth dates AQ Adol	4180186
40767798	您的孩子并不非常善于记住别人的生日:发现:时间点:^患者:序数型:AQ 青少年版	4182948
40767799	Join games CAST	4180186
40767799	Finding; Findings; Join games; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767799	您的孩子是否容易加入其他孩子一起做游戏:发现:时间点:^患者:序数型:CAST	4182948
40767800	Chat spontaneously; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767800	Chat spontaneously CAST	4180186
40767800	您的孩子是否自发地来找您聊天:发现:时间点:^患者:序数型:CAST	4182948
40767801	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767801	Speaking by 2 CAST	4180186
40767801	到2岁的时候,您的孩子是否会说话了:发现:时间点:^患者:序数型:CAST	4182948
40767804	Does child notice details; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767804	Does child notice details CAST	4180186
40767804	您的孩子是否看起来注意异乎寻常的细节:发现:时间点:^患者:序数型:CAST	4182948
40767805	Take things literally CAST	4180186
40767805	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767805	您的孩子是否倾向于对事情加以字面理解:发现:时间点:^患者:序数型:CAST	4182948
40767810	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Read at age level; Screen	4180186
40767810	Read at age level CAST	4180186
40767810	您的孩子能够阅读适合其年龄的读物吗:发现:时间点:^患者:序数型:CAST	4182948
40767811	Same interests as peers CAST	4180186
40767811	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Same interests as peers; Screen	4180186
40767811	您的孩子是否大多具有与其同辈人相同的兴趣:发现:时间点:^患者:序数型:CAST	4182948
40767812	Dominating interest; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767812	Dominating interest CAST	4180186
40767812	您的孩子是否有某种兴趣,从而花费过多的时间,以致于很少做别的事情:发现:时间点:^患者:序数型:CAST	4182948
40767813	Finding; Findings; Friends or acquaintances; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767813	Friends or acquaintances CAST	4180186
40767813	您的孩子是否拥有朋友,而不仅仅是认识的人:发现:时间点:^患者:序数型:CAST	4182948
40767816	Difficulty polite behavior; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767816	Difficulty polite behavior CAST	4180186
40767816	您的孩子是否在理解礼貌行为规则上存在困难:发现:时间点:^患者:序数型:CAST	4182948
40767821	Conversation turn-taking CAST	4180186
40767821	Conversation turn-taking; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767821	您的孩子在交谈当中是否善于话轮转换:发现:时间点:^患者:序数型:CAST	4182948
40767822	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767822	Engage in role-play CAST	4180186
40767822	您的孩子是否富于想象力地与其他孩子玩耍,并参加角色扮演:发现:时间点:^患者:序数型:CAST	4182948
40767828	You or I CAST	4180186
40767828	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; You or I	4180186
40767828	您的孩子是否有时当他或她意思是指我而说成是您或您的孩子:发现:时间点:^患者:序数型:CAST	4182948
40767829	Imagination or facts CAST	4180186
40767829	Arterial Stenosis; Finding; Findings; Imagination or facts; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767829	您的孩子是否更喜欢富于想象力的活动,如表演或讲故事而不是数数或罗列事实:发现:时间点:^患者:序数型:CAST	4182948
40767830	Does not explain topic CAST	4180186
40767830	Does not explain topic; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767830	您的孩子是否有时因为没有解释您的孩子所正在谈论的是什么而失去其听众:发现:时间点:^患者:序数型:CAST	4182948
40767831	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Ride bicycle; Screen	4180186
40767831	Ride bicycle CAST	4180186
40767831	您的孩子能够骑两轮自行车吗,即使是在配备辅轮的情况下:发现:时间点:^患者:序数型:CAST	4182948
40767832	Self imposed routine CAST	4180186
40767832	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Self imposed routine	4180186
40767832	您的孩子是否试图把惯例强加给自己或他人,以致于这引起种种问题:发现:时间点:^患者:序数型:CAST	4182948
40767833	Care how perceived; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767833	Care how perceived CAST	4180186
40767833	您的孩子是否在乎该团体之中其他人对他或她的认识如何:发现:时间点:^患者:序数型:CAST	4182948
40767835	Unusual phrases CAST	4180186
40767835	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767835	您的孩子是否有古怪或异乎寻常的习惯用语:发现:时间点:^患者:序数型:CAST	4182948
40767839	Diagnosed ADHD CAST	4180186
40767839	Diagnosed ADHD; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767839	您的孩子是否已经被诊断患有多动症 - 注意力缺陷多动障碍（ADHD）:发现:时间点:^患者:序数型:CAST	4182948
40767840	Dx hearing visual diff child CAST	4180186
40767840	Dx hearing visual diff child; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767840	您的孩子是否已经被诊断存在听力或视力困难:发现:时间点:^患者:序数型:CAST	4182948
40767842	Diagnosed physical disability CAST	4180186
40767842	Diagnosed physical disability; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767842	您的孩子是否已经被诊断患有身体残废:发现:时间点:^患者:序数型:CAST	4182948
40767843	Talkative BFI	4180186
40767843	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767843	我将自己看成是个喜欢说话的人:发现:时间点:^患者:序数型:BFI	4182948
40767844	Finds fault BFI	4180186
40767844	Arterial Stenosis; Finding; Findings; Finds fault; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767844	我将自己看成是个倾向于挑剔他人的人:发现:时间点:^患者:序数型:BFI	4182948
40767845	Arterial Stenosis; Finding; Findings; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Work; World Heatlth Organization	4180186
40767845	Thorough job BFI	4180186
40767845	我将自己看成是个做事彻底的人:发现:时间点:^患者:序数型:BFI	4182948
40767846	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767846	Depressed BFI	4180186
40767846	我将自己看作是个抑郁、伤感的人:发现:时间点:^患者:序数型:BFI	4182948
40767847	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767847	Original BFI	4180186
40767847	我将自己看成是个有独创性的人,善于想出新的点子:发现:时间点:^患者:序数型:BFI	4182948
40767849	Helpful BFI	4180186
40767849	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767849	我将自己看成是个对他人来说有帮助且不自私的人:发现:时间点:^患者:序数型:BFI	4182948
40767852	Curious BFI	4180186
40767852	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767852	我将自己看成是个对许多不同的事情都好奇的人:发现:时间点:^患者:序数型:BFI	4182948
40767855	Reliable worker BFI	4180186
40767855	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767855	我将自己看成是个属于可靠工作人员的人:发现:时间点:^患者:序数型:BFI	4182948
40767858	Generates enthusiasm BFI	4180186
40767858	Arterial Stenosis; Finding; Findings; Generates enthusiasm; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767858	我将自己看成是个表现出极大热情的人:发现:时间点:^患者:序数型:BFI	4182948
40767861	Worries BFI	4180186
40767861	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767861	我将自己看成是个非常忧虑的人:发现:时间点:^患者:序数型:BFI	4182948
40767862	Active imagination BFI	4180186
40767862	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767862	我将自己看成是个想象力活跃的人:发现:时间点:^患者:序数型:BFI	4182948
40767863	Myself quiet BFI	4180186
40767863	Arterial Stenosis; Finding; Findings; Myself quiet; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767863	我将自己看成是个倾向于沉默寡言的人:发现:时间点:^患者:序数型:BFI	4182948
40767864	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767864	Trusting BFI	4180186
40767864	我将自己看成是个一般来说相信他人的人:发现:时间点:^患者:序数型:BFI	4182948
40767865	Lazy BFI	4180186
40767865	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767865	我将自己看成是个倾向于懒惰的人:发现:时间点:^患者:序数型:BFI	4182948
40767867	Inventive BFI	4180186
40767867	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767867	我将自己看成是个善于发明的人:发现:时间点:^患者:序数型:BFI	4182948
40767868	Assertive BFI	4180186
40767868	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767868	我将自己看成是个性格刚毅坚定而自信的人:发现:时间点:^患者:序数型:BFI	4182948
40767870	Persevere BFI	4180186
40767870	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767870	我将自己看成是个坚持不懈直至完成任务的人:发现:时间点:^患者:序数型:BFI	4182948
40767871	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767871	Moody BFI	4180186
40767871	我将自己看成是个喜怒无常的人:发现:时间点:^患者:序数型:BFI	4182948
40767872	Artistic experiences BFI	4180186
40767872	Arterial Stenosis; Artistic experiences; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767872	我将自己看成是个重视艺术、审美体验的人:发现:时间点:^患者:序数型:BFI	4182948
40767874	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767874	Considerate BFI	4180186
40767874	我将自己看成是个体贴周到,对几乎每个人都和蔼的人:发现:时间点:^患者:序数型:BFI	4182948
40767875	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767875	Efficientl BFI	4180186
40767875	我将自己看成是个做事情效率高的人:发现:时间点:^患者:序数型:BFI	4182948
40767876	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767876	Remains calm BFI	4180186
40767876	我将自己看成是个在紧张情况下保持冷静的人:发现:时间点:^患者:序数型:BFI	4182948
40767877	Arterial Stenosis; Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; Prefers routine; Ql; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767877	Prefers routine BFI	4180186
40767877	我将自己看成是个更喜欢常规工作的人:发现:时间点:^患者:序数型:BFI	4182948
40767879	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767879	Rude to others BFI	4180186
40767879	我将自己看成是个有时对他人粗鲁的人:发现:时间点:^患者:序数型:BFI	4182948
40767881	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767881	Gets nervous BFI	4180186
40767881	我将自己看成是个容易变得神经紧张的人:发现:时间点:^患者:序数型:BFI	4182948
40767882	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Reflective; Screen; World Heatlth Organization	4180186
40767882	Reflective BFI	4180186
40767882	我将自己看成是个喜欢深思熟虑,的人:发现:时间点:^患者:序数型:BFI	4182948
40767884	Cooperates with others BFI	4180186
40767884	Arterial Stenosis; Cooperates with others; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; World Heatlth Organization	4180186
40767884	我将自己看成是个喜欢与他人合作的人:发现:时间点:^患者:序数型:BFI	4182948
40767886	Sophisticated art music literature BFI	4180186
40767886	Arterial Stenosis; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Sophisticated art music literature; World Heatlth Organization	4180186
40767886	我将自己看成是个在艺术、音乐或文学方面富有经验的人:发现:时间点:^患者:序数型:BFI	4182948
40767887	Nervous 30D K6	4180186
40767887	Finding; Findings; K6; Last; Nervous 30D; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40767887	在过去的那30天当中,您大约多长时间一次觉得神经紧张:发现:30天:^患者:序数型:凯斯勒心理困扰量表6项	4182948
40767888	Finding; Findings; Hopeless 30D; K6; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40767888	Hopeless 30D K6	4180186
40767888	在过去的那30天当中,您大约多长时间一次觉得绝望:发现:30天:^患者:序数型:凯斯勒心理困扰量表6项	4182948
40767890	Depressed 30D; Finding; Findings; K6; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40767890	Depressed 30D K6	4180186
40767890	在过去的那30天当中,您大约多长时间一次觉得如此抑郁,以致于没有任何事情能够使你振作起来:发现:30天:^患者:序数型:凯斯勒心理困扰量表6项	4182948
40767891	Feelings last 30D K6	4180186
40767891	Arterial Stenosis; Feelings last 30D; Finding; Findings; K6; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40767891	总体而言,在过去的那30天当中,对您而言,这些感觉究竟是出现得比平时更加频繁,与平时大致相同,还是比平时少见:发现:30天:^患者:序数型:凯斯勒心理困扰量表6项	4182948
40767892	Control; Count/time; Job; K6; Last; nRate; Number Ds of 30D worked; Number rate; Number Rate = Count/Time; Occupation; PhenX; QNT; Quan; Quant; Quantitative	4180186
40767892	Number Ds of 30D worked nRate K6	4180186
40767892	在过去的那30天当中,其中有多少天您因为这些感觉而彻底无法工作或者进行自己的正常活动:计数型速率:30天:^患者:定量型:凯斯勒心理困扰量表6项	4182948
40767893	Count/time; Dextro; Ds do only half; III; K6; Last; nRate; Number rate; Number Rate = Count/Time; PhenX; QNT; Quan; Quant; Quantitative	4180186
40767893	Ds do only half 30D nRate K6	4180186
40767893	不计您相应于第3项所报告的那些天数,在过去的30天当中,因为这些感觉,您有多少天能够从事仅仅一半或更少的您通常所能够从事的事情:计数型速率:30天:^患者:定量型:凯斯勒心理困扰量表6项	4182948
40767898	Experienced harmful events PhenX	4180186
40767898	Experienced harmful events; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767898	您是否经历过、目击过或以其他方式被卷入过任何可能会对您或其他某个人造成严重伤害,甚至是死亡的事件:发现:时间点:^患者:序数型:PhenX	4182948
40767899	Specify harmful events PhenX	4180186
40767899	Experienced harmful events; Finding; Findings; Nominal; Point in time; Random; Specify harmful events	4180186
40767899	请总体上说明您是否曾经经历过、目击过或者以其他方式参与过任何可能给您或别的某个人带来严重伤害或者甚至是死亡的事件:发现:时间点:^患者:名义型:PhenX	4182948
40767900	Event caused horror PhenX	4180186
40767900	Event caused horror; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767900	该事件是否造成了您有强烈的恐惧、无助或恐怖的感觉:发现:时间点:^患者:序数型:PhenX	4182948
40767901	Event caused horror specify; Finding; Findings; Nominal; Point in time; Random	4180186
40767901	Event caused horror specify PhenX	4180186
40767901	如果这一事件造成您存在强烈的害怕、无助或者恐怖的感觉的话,请加以详细说明:发现:时间点:^患者:名义型:PhenX	4182948
40767902	Bothered by event thoughts PhenX	4180186
40767902	Bothered by event thoughts; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767902	不断回想起或再次遇到关于您所经历或目击过的某一创伤事件的想法、梦境或影像,是否曾经困扰过您:发现:时间点:^患者:序数型:PhenX	4182948
40767903	Reliving event PhenX	4180186
40767903	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Reliving event; Screen	4180186
40767903	您是否曾经感到自己正在重温您所经历或目击过的某次创伤事件:发现:时间点:^患者:序数型:PhenX	4182948
40767905	Avoid thinking of event PhenX	4180186
40767905	Avoid thinking of event; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767905	总体而言,您是否尝试过避免想起或谈起该事件:发现:时间点:^患者:序数型:PhenX	4182948
40767908	Detached since event; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767908	Detached since event PhenX	4180186
40767908	自从该事件以来,您是否倾向于感到疏远他人:发现:时间点:^患者:序数型:PhenX	4182948
40767910	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767910	Unable to see a future PhenX	4180186
40767910	自从该事件以来,您是否发现自己无法看到自己的未来:发现:时间点:^患者:序数型:PhenX	4182948
40767912	Finding; Findings; Irritable since event; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767912	Irritable since event PhenX	4180186
40767912	自从该事件发生以来,除了抑郁或躁狂之外,您是否在易怒性或者愤怒爆发方面存在问题:发现:时间点:^患者:序数型:PhenX	4182948
40767913	Diff concentrating since event; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767913	Diff concentrating since event PhenX	4180186
40767913	自从该事件发生以来,除了抑郁或躁狂之外,您是否在集中注意力方面存在问题:发现:时间点:^患者:序数型:PhenX	4182948
40767916	Upset by symptoms PhenX	4180186
40767916	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sx; Upset by symptoms	4180186
40767916	您是否一直对存在这些症状很苦恼:发现:时间点:^患者:序数型:PhenX	4182948
40767917	FCN; Finding; Findings; Func; Funct; Job; Occupation; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Sx; Symptoms interfere with work	4180186
40767917	Symptoms interfere with work PhenX	4180186
40767917	这些症状是否干扰了您工作、与他人相处或者在生活其他方面发挥作用的能力:发现:时间点:^患者:序数型:PhenX	4182948
40767921	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Sx	4180186
40767921	Age of onset	4180186
40767921	症状起始年龄:时间:时间点:^患者:定量型	4182948
40767922	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Trouble wrapping up project	4180186
40767922	Trouble wrapping up project ASRS	4180186
40767922	一旦某个项目富有挑战性的部分完成之后,您在圆满完成其最终细节方面存在麻烦的情况多久出现一次:发现:时间点:^患者:序数型:ASRS	4182948
40767923	Difficulty getting organized ASRS	4180186
40767923	Difficulty getting organized; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767923	当您不得不去做某些需要组织整理的时候,您在让事物变得井然有序方面存在困难的情况多久出现一次:发现:时间点:^患者:序数型:ASRS	4182948
40767925	Procrastinate tasks ASRS	4180186
40767925	Finding; Findings; Ordinal; PhenX; Point in time; Procrastinate tasks; Ql; Qual; Qualitative; Random; Screen	4180186
40767925	当您有一项需要进行很多思考的任务时,您多久一次避免或延迟其开始:发现:时间点:^患者:序数型:ASRS	4182948
40767926	Fidget while sitting ASRS	4180186
40767926	Fidget while sitting; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767926	当您不得不长时间坐下了的时候,您多久出现一次手或脚的摆弄或扭动:发现:时间点:^患者:序数型:ASRS	4182948
40767929	Diff attention repetitive task; Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767929	Diff attention repetitive task ASRS	4180186
40767929	当您正在做枯燥乏味或重复性的工作的时候,您在保持自己的注意力方面存在困难的情况多久出现一次:发现:时间点:^患者:序数型:ASRS	4182948
40767930	Diff concentrating on conversation; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767930	Diff concentrating on conversation ASRS	4180186
40767930	即使是当有人直接对您讲话的时候,您在保持集中注意力关注他们对自己所说的内容方面存在困难的情况多久出现一次:发现:时间点:^患者:序数型:ASRS	4182948
40767931	Finding; Findings; Job; Misplace items home work; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767931	Misplace items home work ASRS	4180186
40767931	您多久出现一次在家中或工作时把东西放在一时记不起的地方或者难以找到东西的情况:发现:时间点:^患者:序数型:ASRS	4182948
40767933	Finding; Findings; Freq leave seat at meetings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767933	Freq leave seat at meetings ASRS	4180186
40767933	您多久出现一次在期望您保持就座状态的会议上或其他的情况下离开自己座位的情况:发现:时间点:^患者:序数型:ASRS	4182948
40767934	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Restless fidgety; Screen	4180186
40767934	Restless fidgety ASRS	4180186
40767934	您多久感到一次坐立不安或心烦意乱:发现:时间点:^患者:序数型:ASRS	4182948
40767935	Difficulty unwinding ASRS	4180186
40767935	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767935	当您有自己的时间的时候,您在减压或放松方面存在困难的情况多久出现一次:发现:时间点:^患者:序数型:ASRS	4182948
40767936	Finding; Findings; Freq talk too much; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767936	Freq talk too much ASRS	4180186
40767936	您多久发现一次自己在社交情境下说话过多:发现:时间点:^患者:序数型:ASRS	4182948
40767937	Finding; Findings; Finish others sentences; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767937	Finish others sentences ASRS	4180186
40767937	当您在交谈的时候,您多久发现一次您自己说完了您正在与之谈话的人在他们自己能够说完之前的那些语句:发现:时间点:^患者:序数型:ASRS	4182948
40767941	Sustain attention SWAN	4180186
40767941	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767941	与其他孩子相比,这个孩子持续关注任务或游戏活动吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767942	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767942	Listen when spoken to SWAN	4180186
40767942	与其他孩子相比,这个孩子在他人直接跟自己讲话时聆听吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767944	Finding; Findings; Ordinal; Organize tasks activities; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767944	Organize tasks activities SWAN	4180186
40767944	与其他孩子相比,这个孩子对任务和活动加以组织吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767946	Finding; Findings; Keep track activity items; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767946	Keep track activity items SWAN	4180186
40767946	与其他孩子相比,这个孩子随时跟踪和了解活动所必需的事情吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767947	Ignore extraneous stimuli SWAN	4180186
40767947	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767947	与其他孩子相比,这个孩子忽视外来刺激吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767948	Remember daily activities SWAN	4180186
40767948	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767948	与其他孩子相比,这个孩子是否记得住日常活动:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767951	Activ; Actvty; Finding; Findings; Movements; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767951	Modulate motor activity SWAN	4180186
40767951	与其他孩子相比,这个孩子调整运动活动,抑制不当的奔跑或攀爬吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767953	Activ; Actvty; Finding; Findings; Movements; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767953	Settle down SWAN	4180186
40767953	与其他孩子相比,这个孩子安静下来休息,控制持续不断的活动吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767956	Await turns; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767956	Await turns SWAN	4180186
40767956	与其他孩子相比,这个孩子等待轮到自己,排队等候并轮流来吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767957	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767957	Control interrupting SWAN	4180186
40767957	与其他孩子相比,这个孩子进入交谈和游戏,对插嘴、打断或打扰加以控制吗:发现:时间点:^患者:序数型:SWAN ADHD	4182948
40767958	Optimistic PhenX	4180186
40767958	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767958	我多半是乐观的:发现:时间点:^患者:序数型:PhenX	4182948
40767959	Finding; Findings; Ordinal; Other people feelings; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767959	Other people feelings PhenX	4180186
40767959	他人的感觉如何对我来说是重要的:发现:时间点:^患者:序数型:PhenX	4182948
40767960	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767960	Act on immediate needs PhenX	4180186
40767960	我经常依据迫切需要采取行动:发现:时间点:^患者:序数型:PhenX	4182948
40767961	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767961	Parachute PhenX	4180186
40767961	我没有从飞机上跳伞出去的强烈愿望:发现:时间点:^患者:序数型:PhenX	4182948
40767964	Deal with stress PhenX	4180186
40767964	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767964	我在应对压力方面准备充分:发现:时间点:^患者:序数型:PhenX	4182948
40767967	Easily scared PhenX	4180186
40767967	Easily scared; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767967	我容易变得害怕:发现:时间点:^患者:序数型:PhenX	4182948
40767970	Born leader PhenX	4180186
40767970	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767970	我是一个天生的领导者:发现:时间点:^患者:序数型:PhenX	4182948
40767972	Jump W/O thinking PhenX	4180186
40767972	Finding; Findings; Jump W/O thinking; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767972	我不假思索地做事情:发现:时间点:^患者:序数型:PhenX	4182948
40767974	Return insults PhenX	4180186
40767974	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767974	我对侮辱加以报复:发现:时间点:^患者:序数型:PhenX	4182948
40767976	Finding; Findings; Influence people; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767976	Influence people PhenX	4180186
40767976	我拥有影响人的诀窍:发现:时间点:^患者:序数型:PhenX	4182948
40767982	Arterial Stenosis; Finding; Findings; Not talented; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767982	Not talented PhenX	4180186
40767982	我并不认为自己是天才:发现:时间点:^患者:序数型:PhenX	4182948
40767983	Taunt others PhenX	4180186
40767983	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Taunt others	4180186
40767983	我只是为了把事情搅乱而嘲笑他人:发现:时间点:^患者:序数型:PhenX	4182948
40767984	Abuse trust PhenX	4180186
40767984	Abuse trust; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767984	人们经常滥用我的信任:发现:时间点:^患者:序数型:PhenX	4182948
40767986	Not worried hurting others PhenX	4180186
40767986	Finding; Findings; Not worried hurting others; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767986	我觉得没有必要担心自己所做的事情是否伤害了别人:发现:时间点:^患者:序数型:PhenX	4182948
40767988	Bore quickly; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767988	Bore quickly PhenX	4180186
40767988	我经常很快就变得厌烦并且丧失兴趣:发现:时间点:^患者:序数型:PhenX	4182948
40767989	Finding; Findings; Not traumatized like others; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767989	Not traumatized like others PhenX	4180186
40767989	我能够渡过那些会对他人造成创伤的事情:发现:时间点:^患者:序数型:PhenX	4182948
40767993	Finding; Findings; No sympathy for others; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767993	No sympathy for others PhenX	4180186
40767993	我对人们没有多大的同情心:发现:时间点:^患者:序数型:PhenX	4182948
40767994	Trouble not consider consequences PhenX	4180186
40767994	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Trouble not consider consequences	4180186
40767994	我因为没有考虑自己行动的后果而陷入困境:发现:时间点:^患者:序数型:PhenX	4182948
40767995	Convince others; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767995	Convince others PhenX	4180186
40767995	我能够说服人们去做我所希望的事情:发现:时间点:^患者:序数型:PhenX	4182948
40767997	Finding; Findings; Injured to see pain; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40767997	Injured to see pain PhenX	4180186
40767997	为了看到他人疼痛,我伤害了他们:发现:时间点:^患者:序数型:PhenX	4182948
40767998	Don't like lead groups; Finding; Findings; Ordinal; Painter's colic; PB; Plumbism; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40767998	Don't like lead groups PhenX	4180186
40767998	我不喜欢在群体当中领头:发现:时间点:^患者:序数型:PhenX	4182948
40768001	Easily embarrassed PhenX	4180186
40768001	Easily embarrassed; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen	4180186
40768001	让我尴尬并非难事:发现:时间点:^患者:序数型:PhenX	4182948
40768005	Don't mind hurting others PhenX	4180186
40768005	Don't mind hurting others; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768005	我不是很在乎自己所做的事情是否伤害了他人:发现:时间点:^患者:序数型:PhenX	4182948
40768009	Relate to people's emotions PhenX	4180186
40768009	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Relate to people's emotions; S prime; Screen	4180186
40768009	对我来说,理解他人的情感乃是容易的事情:发现:时间点:^患者:序数型:PhenX	4182948
40768010	Robbed someone PhenX	4180186
40768010	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768010	我抢劫了某个人:发现:时间点:^患者:序数型:PhenX	4182948
40768011	No worred about looking foolish PhenX	4180186
40768011	Finding; Findings; No worred about looking foolish; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768011	我从不担心在他人面前出洋相:发现:时间点:^患者:序数型:PhenX	4182948
40768012	Finding; Findings; Not bothered people hurting; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768012	Not bothered people hurting PhenX	4180186
40768012	当我周围的人正在疼痛的时候,并不让我烦恼:发现:时间点:^患者:序数型:PhenX	4182948
40768013	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Work problems irresponsible	4180186
40768013	Work problems irresponsible PhenX	4180186
40768013	我在工作中有过问题,因为我不负责任:发现:时间点:^患者:序数型:PhenX	4182948
40768015	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Stolen from vehicle	4180186
40768015	Stolen from vehicle PhenX	4180186
40768015	我从某辆机动车之中偷盗了某种东西:发现:时间点:^患者:序数型:PhenX	4182948
40768017	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; D (little u); Dextro; Du; Du sup(a); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Weak D	4180186
40768017	Deprecated Du sup(a) Ab SerPl Ql	4180186
40768020	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Gy sup(a); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768020	Gy sup(a) Ab SerPl Ql	4180186
40768020	Gy^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768021	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; e; He; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768021	He Ab SerPl Ql	4180186
40768021	He 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768023	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Kell Blood Group System; Ku; MNSs Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768023	Ku Ab SerPl Ql	4180186
40768023	Ku 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768029	little cE Ab SerPl Ql	4180186
40768029	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; c; little cE; little cE Ab; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Rh27; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768029	cE 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768030	Rh32 Ab SerPl Ql	4180186
40768030	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768030	Rh32 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768031	Sc1 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768031	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; c; i; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; S prime; Sc1; Scianna Blood Group System; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768031	Sc1 Ab SerPl Ql	4180186
40768034	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; MNSs Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; Tm	4180186
40768034	Tm Ab SerPl Ql	4180186
40768034	Tm 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768035	Tr sup(a) Ab SerPl Ql	4180186
40768035	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Right; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; Tr sup(a)	4180186
40768035	Tr^a 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768037	Wr sup(b) Ab SerPl Ql	4180186
40768037	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; R prime; Random; Right; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Wr sup(b)	4180186
40768037	Wr^b 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
40768038	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mycafungin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
40768038	Micafungin Susc Islt	4180186
40768038	米卡芬净:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
40768039	adj; Blood; Chemistry; Lung; O2; O2 partial pressure; p50; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; satn adj to 0.5; SO2; tO2; WB; Whole blood	4180186
40768039	pO2 satn adj to 0.5 Bld	4180186
40768039	氧^^饱和度调整至0.5的:分压:时间点:全血:定量型	4182948
40768040	Before; CHEMISTRY.CHALLENGE TESTING; HGF; Hyperglycemic factor; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768040	Glucagon pre chal SerPl-mCnc	4180186
40768040	胰高血糖素^在 XXX 刺激之前:质量浓度:时间点:血清/血浆:定量型	4182948
40768043	Glucagon sp3 p chal SerPl-mCnc	4180186
40768043	After; CHEMISTRY.CHALLENGE TESTING; HGF; Hyperglycemic factor; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR	4180186
40768043	胰高血糖素^在XXX刺激之后的第3个标本:质量浓度:时间点:血清/血浆:定量型	4182948
40768048	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; Level; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; Pro insulin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR; Substance concentration	4180186
40768048	Proinsulin sp1 p chal SerPl-sCnc	4180186
40768048	胰岛素原^在XXX刺激之后的第1个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40768051	Proinsulin sp4 p chal SerPl-sCnc	4180186
40768051	After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; Pro insulin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR; Substance concentration	4180186
40768051	胰岛素原^在XXX刺激之后的第4个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40768053	After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; Pro insulin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Substance concentration	4180186
40768053	Proinsulin sp6 p chal SerPl-sCnc	4180186
40768053	胰岛素原^在XXX刺激之后的第6个标本:物质的量浓度:时间点:血清/血浆:定量型	4182948
40768055	After; Androgen binding protein; Before; Bind; CHEMISTRY.CHALLENGE TESTING; Estradiol binding globulin; Gender; GLB; Glob; Glob%; Globul; Globulins; Horm; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SBP; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sex steroid binding globulin; Sex steroid binding protein; SHBG; SR; SSBG; Substance concentration; TeBG; Testosterone binding globulin; Testosterone/estradiol binding globulin	4180186
40768055	SHBG pre/p chal SerPl-sCnc	4180186
40768055	性激素结合球蛋白^在XXX刺激之前/之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
40768056	After; Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH	4180186
40768056	TSH pre/p chal SerPl-aCnc	4180186
40768056	促甲状腺激素^在XXX刺激之前/之后:任意型浓度:时间点:血清/血浆:定量型	4182948
40768060	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; Cortis F; F; FR; hydrocortisone; Mass fraction; Non-protein bound; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
40768060	Cortis F/Total MFr SerPl	4180186
40768060	皮质醇.游离型/皮质醇.总计:质量分数:时间点:血清/血浆:定量型	4182948
40768061	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768061	Seizure or convulsion PhenX	4180186
40768061	是否任何人曾经告诉过您,当您还是个孩子的时候,您曾经因为某次高热而发生过惊厥、抽搐、痉挛或癫痫发作:发现:时间点:^患者:序数型:PhenX	4182948
40768062	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768062	Seizure disorder or epilepsy PhenX	4180186
40768062	您是否患有,或者是否任何人曾经告诉您您患有某种癫痫症或者说癫痫:发现:时间点:^患者:序数型:PhenX	4182948
40768063	Other seizure PhenX	4180186
40768063	Finding; Findings; Ordinal; Other seizure; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768063	您是否有过,或者是否任何人曾经告诉您您有过某种在任何情况下的发作、抽搐、惊厥、惊风或发病:发现:时间点:^患者:序数型:PhenX	4182948
40768066	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768066	Daydream or stare into space PhenX	4180186
40768066	是否任何人曾经告诉过您,当您还是个小孩子的时候,与其他孩子相比,您做白日梦或凝视太空会更多些:发现:时间点:^患者:序数型:PhenX	4182948
40768067	bod; Bodies; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Strobe lights response	4180186
40768067	Strobe lights response PhenX	4180186
40768067	当您暴露于频闪灯、视频游戏、闪光灯或耀眼阳光的时候,您是否曾经注意到过任何异常的物体运动或感觉:发现:时间点:^患者:序数型:PhenX	4182948
40768068	Uncontrollable jerking clumsiness PhenX	4180186
40768068	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Uncontrollable jerking clumsiness	4180186
40768068	刚刚醒来之后,要么是早上,要么是小睡之后,您是否曾经注意到无法控制的猝然一动或者笨拙,诸如掉下东西或者东西突然从您的手中飞出:发现:时间点:^患者:序数型:PhenX	4182948
40768069	Other repeated unusual spells PhenX	4180186
40768069	Finding; Findings; Ordinal; Other repeated unusual spells; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768069	您是否有过任何其他类型的重复出现的异常发作时段:发现:时间点:^患者:序数型:PhenX	4182948
40768073	Severe headache pain type PhenX	4180186
40768073	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Severe headache pain type	4180186
40768073	下列哪一项陈述能够最佳地描述您的严重头痛的那种疼痛:发现:时间点:^患者:序数型:PhenX	4182948
40768075	Control; How long unable to work; Job; Occupation; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768075	How long unable to work PhenX	4180186
40768075	在过去的那30天当中,每次当您患有严重头痛的时候,您无法工作或进行正常活动持续多少时间:时间:时间点:^患者:定量型:PhenX	4182948
40768076	3 months; Count/time; Dextro; Headache freq last 3Mo; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative	4180186
40768076	Headache freq last 3Mo nRate PhenX	4180186
40768076	在过去的那3个月当中,有多少天您患有头痛,如果头痛持续不止一天的话,把每一天都计算在内:计数型速率:3个月:^患者:定量型:PhenX	4182948
40768078	# Ds reduced productiv; 3 months; Count/time; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative	4180186
40768078	# Ds reduced productiv nRate PhenX	4180186
40768078	因为自己的头痛,在过去3个月当中,有多少天您在工作时或上学时工作效率下降了一半或更多:计数型速率:3个月:^患者:定量型:PhenX	4182948
40768079	# Ds no housework; 3 months; Count/time; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative	4180186
40768079	# Ds no housework nRate PhenX	4180186
40768079	因为自己的头痛,在过去3个月当中,有多少天您没有做家务劳动:计数型速率:3个月:^患者:定量型:PhenX	4182948
40768081	3 months; Count/time; nRate; Number Ds missed activities; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative	4180186
40768081	Number Ds missed activities nRate PhenX	4180186
40768081	因为自己的头痛,在过去3个月当中,有多少天您错失了家庭、社交或休闲活动:计数型速率:3个月:^患者:定量型:PhenX	4182948
40768092	Finding; Findings; Moving vehicle head injury; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768092	Moving vehicle head injury PhenX	4180186
40768092	您是否曾经在轿车事故当中或者因为其他某种车辆事故而头部或颈部受伤,如摩托车、全地形汽车等等:发现:时间点:^患者:序数型:PhenX	4182948
40768095	Finding; Findings; Head injury fight; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768095	Head injury fight PhenX	4180186
40768095	您是否曾经在某次打斗当中因为遭到某人殴打或受到剧烈震荡或摇晃而头部或颈部受伤,或者曾经被枪射中头部:发现:时间点:^患者:序数型:PhenX	4182948
40768098	Other injuries LOC longest PhenX	4180186
40768098	Other injuries LOC longest; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768098	如果存在伴有意识丧失的损伤的话,那么,时间最长的击昏:时间:时间点:^患者:定量型:PhenX	4182948
40768101	LOC drug overdose PhenX	4180186
40768101	Cnt; Count; Drugs; LOC drug overdose; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768101	您是否曾经因为某次药物过量而丧失意识:数量(计数):时间点:^患者:序数型:PhenX	4182948
40768105	Arms wing position PhenX	4180186
40768105	Arms wing position; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768105	臂部保持环状姿势15秒钟:发现:时间点:^患者:序数型:PhenX	4182948
40768107	Drink from spoon PhenX	4180186
40768107	Add; Drink from spoon; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768107	将一汤匙水从桌面水平举到嘴边,然后再返回 - 再额外重复7次:发现:时间点:^患者:序数型:PhenX	4182948
40768110	Finger-nose-finger PhenX	4180186
40768110	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen	4180186
40768110	指鼻-指在右侧 - 8 次:发现:时间点:^患者:序数型:PhenX	4182948
40768113	Tap foot PhenX	4180186
40768113	Finding; Findings; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Tap foot	4180186
40768113	轻拍右脚 - 10 次:发现:时间点:^患者:序数型:PhenX	4182948
40768119	Social unreasonable CIDI-SF	4180186
40768119	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Social unreasonable	4180186
40768119	您的恐惧是否不合情理 - 也就是说,比它应该的程度强烈得多:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768120	Social fear stronger others CIDI-SF	4180186
40768120	Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Social fear stronger others	4180186
40768120	您的恐惧是否比同他人的强烈得多:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768122	Agoraphobia trapped CIDI-SF	4180186
40768122	Agoraphobia trapped; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768122	您是否担心自己可能会被困住而没有任何方法逃脱:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768127	Finding; Findings; Ordinal; Panic attack; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768127	Panic attack CIDI-SF	4180186
40768127	您是否曾经有一段时间或一阵时间突然自己觉得受惊、焦虑不安或者非常不自在:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768128	Panic attack random CIDI-SF	4180186
40768128	Finding; Findings; Ordinal; Panic attack random; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768128	您是否曾经有一阵时间并非处在在某种通常会造成您过度强烈恐惧的情况下:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768129	Finding; Findings; OCD unpleasant thoughts germs; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768129	OCD unpleasant thoughts germs CIDI-SF	4180186
40768129	拥有某些违背您的意愿而不断地进入您的脑海的,关于您自己的令人不快的想法是否曾经困扰过您:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768131	Finding; Findings; OCD thoughts unreasonable; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768131	OCD thoughts unreasonable CIDI-SF	4180186
40768131	对您来说在这些想法当中有些看来好象不合理:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768133	OCD tell professional thoughts CIDI-SF	4180186
40768133	Finding; Findings; OCD tell professional thoughts; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768133	您是否曾经将这些想法告诉过某位医生:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768134	Finding; Findings; Job; Occupation; OCD interfere w activities; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768134	OCD interfere w activities CIDI-SF	4180186
40768134	对于这些想法的思考是否干扰了您的生活或工作,或者造成了您与自己亲戚或朋友之间相处的困难,或者使您极其心烦意乱:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768135	Finding; Findings; OCD repeat actions; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768135	OCD repeat actions CIDI-SF	4180186
40768135	您是否曾经像那样一遍又一遍地做某件事情:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768141	Finding; Findings; Job; Occupation; OCD actions interfere activities; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768141	OCD actions interfere activities CIDI-SF	4180186
40768141	不得不做这些事情是否干扰了您的生活或工作,或者造成了您与自己亲戚或朋友之间相处的困难,或者使您极其心烦意乱:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768145	Finding; Findings; Mania intense energy and anxious; Ordinal; P prime; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768145	Mania intense energy and anxious P-GBI	4180186
40768145	您的孩子是否有过若干为期数天或更长的时期,当时其极其幸福且精力充沛,而同时又感到焦虑不安得多:发现:时间点:^患者:序数型:P-GBI	4182948
40768146	Finding; Findings; Mania intense energy and rage; Ordinal; P prime; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768146	Mania intense energy and rage P-GBI	4180186
40768146	是否有过若干为期数天或更长的时期,尽管您的孩子当时感到异常高兴且精力充沛,但其同时又不得不非常努力地控制其愤怒:发现:时间点:^患者:序数型:P-GBI	4182948
40768148	Mania feelings always extreme P-GBI	4180186
40768148	Finding; Findings; Mania feelings always extreme; Ordinal; P prime; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768148	您是否发现您孩子的情绪或活力一般来说都是要么好,要么坏,但很少见处在中等水平的时候:发现:时间点:^患者:序数型:P-GBI	4182948
40768150	Finding; Findings; Mania intense energy and irritable; Ordinal; P prime; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768150	Mania intense energy and irritable P-GBI	4180186
40768150	是否有过若干的时期,尽管您的孩子当时感到异常高兴且精力充沛,但几乎每件事情都令其心烦意乱并使其暴躁易怒或愤怒:发现:时间点:^患者:序数型:P-GBI	4182948
40768151	Mania feeling today HCL-32	4180186
40768151	Finding; Findings; Mania feeling today; Nominal; PhenX; Point in time; Random	4180186
40768151	与您平时的状态相比今天您感觉如何:发现:时间点:^患者:名义型:HCL-32	4182948
40768153	Mania other people reaction HCL-32	4180186
40768153	cmmt; cmnt; Com; Comm; Comments; Commt; Finding; Findings; Mania other people reaction; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Remarks; Screen	4180186
40768153	亲近您的人当时对于您极度兴奋状态的反应如何:发现:时间点:^患者:序数型:HCL-32	4182948
40768155	Highs last Y HCL-32	4180186
40768155	1 year; 12Mos; Finding; Findings; Highs last Y; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768155	在过去的那12个月当中,您是否体验过此类的极度兴奋状态:发现:12个月:^患者:序数型:HCL-32	4182948
40768156	1 year; 12Mos; Count/time; Dextro; Mania number Ds highs; nRate; Number rate; Number Rate = Count/Time; Past; PhenX; QNT; Quan; Quant; Quantitative	4180186
40768156	Mania number Ds highs nRate HCL-32	4180186
40768156	如果是的话,请估计一下您在过去的那12个月当中花费在极度兴奋状态上的时间有多少天:计数型速率:12个月:^患者:定量型:HCL-32	4182948
40768157	Bothered CES-DC	4180186
40768157	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768157	在过去的7天当中,我为那些平时并不让我困扰的事情所困扰:发现:时间点:^患者:序数型:CES-DC	4182948
40768159	Finding; Findings; Not happy; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768159	Not happy CES-DC	4180186
40768159	当时我无法感到快乐,即使是当我的家人或朋友试图帮助我感觉好点的时候:发现:时间点:^患者:序数型:CES-DC	4182948
40768160	Arterial Stenosis; Finding; Findings; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768160	Good as other kids CES-DC	4180186
40768160	我感到好像自己与其他的孩子一样不错:发现:时间点:^患者:序数型:CES-DC	4182948
40768165	Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; T prime; Things not work out right	4180186
40768165	Things not work out right CES-DC	4180186
40768165	我感到好像我之前所做的那些事情并没有产生正确的结果:发现:时间点:^患者:序数型:CES-DC	4182948
40768166	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768166	Scared CES-DC	4180186
40768166	当时我感到害怕:发现:时间点:^患者:序数型:CES-DC	4182948
40768167	Not sleep well CES-DC	4180186
40768167	Arterial Stenosis; Finding; Findings; Not sleep well; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768167	当时我的睡眠并不像平时那么好:发现:时间点:^患者:序数型:CES-DC	4182948
40768170	Felt lonely CES-DC	4180186
40768170	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768170	当时我感到孤独,就好像我没有任何的朋友:发现:时间点:^患者:序数型:CES-DC	4182948
40768171	Finding; Findings; Kids not friendly; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768171	Kids not friendly CES-DC	4180186
40768171	我感到好像我所认识的孩子们并不友好或者他们并不想和我在一起:发现:时间点:^患者:序数型:CES-DC	4182948
40768173	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768173	Felt like crying CES-DC	4180186
40768173	我想要哭:发现:时间点:^患者:序数型:CES-DC	4182948
40768175	People didn't like me CES-DC	4180186
40768175	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768175	我感到人们不喜欢我:发现:时间点:^患者:序数型:CES-DC	4182948
40768176	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768176	Hard to get started CES-DC	4180186
40768176	开始做事情乃是很困难的事情:发现:时间点:^患者:序数型:CES-DC	4182948
40768177	Depression 2W lifetime; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768177	Depression 2W lifetime CIDI-SF	4180186
40768177	在您的人生过程中,是否曾经有一段持续2星期或更长的时间,当时您感到悲伤、忧郁或抑郁:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768180	Depression how often CIDI-SF	4180186
40768180	Depression how often; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768180	您多久有一次这样的感觉:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768183	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Weight gain; Wt	4180186
40768183	Weight gain CIDI-SF	4180186
40768183	您的体重大约增加了多少:质量:时间点:^患者:定量型:CIDI-SF	4182948
40768185	Depression trouble sleeping QIDS	4180186
40768185	Depression trouble sleeping; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768185	与自己平时的情况相比,您在入睡方面当时是否存在更大的困难:发现:时间点:^患者:序数型:QIDS	4182948
40768186	Depression trouble concentrating CIDI-SF	4180186
40768186	Depression trouble concentrating; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768186	与通常相比您当时是否在集中注意力方面要困难得多:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768188	Depression thoughts of death CIDI-SF	4180186
40768188	Depression thoughts of death; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768188	您是否曾经对死亡考虑过很多 - 要么是您自己的死亡、别的某个人的死亡,要么是一般意义上的死亡:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768197	Finding; Findings; Last; Nominal; PhenX; Sleep during night	4180186
40768197	Sleep during night QIDS	4180186
40768197	过去的7天当中的夜间睡眠:发现:7天:^患者:名义型:QIDS	4182948
40768198	Waking too early QIDS	4180186
40768198	Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen; Waking too early	4180186
40768198	在过去的7天当中醒得过早:发现:7天:^患者:序数型:QIDS	4182948
40768200	Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768200	Feeling sad QIDS	4180186
40768200	在过去7天当中感到悲伤:发现:7天:^患者:序数型:QIDS	4182948
40768201	Decreased appetite past 7D; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768201	Decreased appetite past 7D QIDS	4180186
40768201	在过去7天当中的食欲下降:发现:7天:^患者:序数型:QIDS	4182948
40768202	Finding; Findings; Increased appetite past 7D; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768202	Increased appetite past 7D QIDS	4180186
40768202	在过去的7天当中的食欲增强:发现:7天:^患者:序数型:QIDS	4182948
40768203	14 days; 2 weeks; Decreased weight 2W; Finding; Findings; Ordinal; Past; PhenX; Ql; Qual; Qualitative; Screen; Weight loss; Wt	4180186
40768203	Decreased weight 2W [QIDS]	4180186
40768203	在过去的那2个星期之内的体重下降:发现:2星期:^患者:序数型:QIDS	4182948
40768208	Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768208	General interest QIDS	4180186
40768208	在过去7天当中的一般兴趣:发现:7天:^患者:序数型:QIDS	4182948
40768210	Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768210	Feeling slowed down QIDS	4180186
40768210	在过去7天当中感到慢了下来:发现:7天:^患者:序数型:QIDS	4182948
40768211	Finding; Findings; Last; Nominal; PhenX	4180186
40768211	Feeling restless QIDS	4180186
40768211	在过去7天当中感到焦躁不安:发现:7天:^患者:名义型:QIDS	4182948
40768214	Arterial Stenosis; Finding; Findings; Ordinal; Persons; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Weight self esteem; Wt	4180186
40768214	Weight self esteem EDDS	4180186
40768214	您的体重是否影响了您对自己作为一个人的看法或评判:发现:时间点:^患者:序数型:EDDS	4182948
40768215	Arterial Stenosis; Finding; Findings; Ordinal; Persons; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Shape self esteem	4180186
40768215	Shape self esteem EDDS	4180186
40768215	您的体型是否影响了您对自己作为一个人的看法或评判:发现:时间点:^患者:序数型:EDDS	4182948
40768216	Arterial Stenosis; Eaten large amt food; Finding; Findings; Last; Ordinal; Othr; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768216	Eaten large amt food EDDS	4180186
40768216	在过去的那6个月当中,有多少次您觉得您在特定情况下吃掉了他人会认为异常大量的食物 - 1夸脱（1.136升）冰激凌:发现:6个月:^患者:序数型:EDDS	4182948
40768219	3Mo D control loss EDDS	4180186
40768219	3 months; 3Mo D control loss; Count/time; Last; nRate; Number rate; Number Rate = Count/Time; PhenX; QNT; Quan; Quant; Quantitative	4180186
40768219	在过去的那3个月当中,您平均每个星期有多少天吃掉异常大量的食物并且体验到某种失控的感觉:计数型速率:3个月:^患者:定量型:EDDS	4182948
40768221	Limited do things because vision PhenX	4180186
40768221	Finding; Findings; Limited do things because vision; LMTED; LTD; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768221	您因为自己的视力而在自己所能够做的事情的种类上受到限制吗:发现:时间点:^患者:序数型:PhenX	4182948
40768223	Eyeball; Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
40768223	Corneal vertex Eye PhenX	4180186
40768223	采用Retinomax 验光仪所测量的角膜顶点距离:长度:时间点:眼睛:定量型:PhenX	4182948
40768224	GAD longest time worried; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768224	GAD longest time worried CIDI-SF	4180186
40768224	这种担心曾经持续过的最长时期是多长:时间:时间点:^患者:定量型:CIDI-SF	4182948
40768225	GADstronger worry than others CIDI-SF	4180186
40768225	Finding; Findings; GADstronger worry than others; Ordinal; Othr; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768225	在此期间您的担心比他人更重吗:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768226	Dextro; Finding; Findings; GAD worry most Ds; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768226	GAD worry most Ds CIDI-SF	4180186
40768226	您担心过大多数的日子吗:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768227	Arterial Stenosis; Finding; Findings; GAD worry one particular thing; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Work	4180186
40768227	GAD worry one particular thing CIDI-SF	4180186
40768227	您当时是不是通常担心某个特定的事物,如您的工作安全或某个您所爱的人不断恶化的健康状况,或者不止一件事情:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768230	Finding; Findings; GAD worry always on mind; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768230	GAD worry always on mind CIDI-SF	4180186
40768230	在过去的7天当中,多久出现一次您的担忧非常强烈以致于无论多么努力您都无法将其忘却掉的情况:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768232	Alc; alcoholic; Drug; Finding; Findings; GAD take medication; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768232	GAD take medication CIDI-SF	4180186
40768232	您是否曾经不止一次因为担心或者担心所引发的那些问题而服用药物或使用毒品或酒精:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768234	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Specific upset with self	4180186
40768234	Specific upset with self CIDI-SF	4180186
40768234	当您处在那种情况下的时候,您多久变得心烦一次:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768235	How long fears Mo CIDI-SF	4180186
40768235	How long fears Mo; month; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768235	您存在任何这些恐惧已经有多少个月了:时间:时间点:^患者:定量型:CIDI-SF	4182948
40768237	Upset with self ever CIDI-SF	4180186
40768237	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Upset with self ever	4180186
40768237	您是否曾经因为存在任何这些恐惧而对自己感到非常沮丧:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768240	Diabetes problem; Finding; Findings; Nominal; Point in time; Random	4180186
40768240	Diabetes problem PhenX	4180186
40768240	糖尿病相关问题:发现:时间点:^患者:名义型:PhenX	4182948
40768248	Point in time; QNT; Quan; Quant; Quantitative; Random; Time to wake up	4180186
40768248	Time to wake up PhenX	4180186
40768248	早上最初睁开眼之后,您需要多少小时和分钟从规律睡眠当中完全清醒过来:时间:时间点:^患者:定量型:PhenX	4182948
40768249	Alarm clock PhenX	4180186
40768249	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768249	您早上醒来要使用闹钟吗:发现:时间点:^患者:序数型:PhenX	4182948
40768252	Finding; Findings; Methods besides alarm other; Nominal; Othr; Point in time; Random	4180186
40768252	Methods besides alarm other PhenX	4180186
40768252	请描述用于醒来的其他方法:发现:时间点:^患者:名义型:PhenX	4182948
40768257	Count/time; Hs sleep needed; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768257	Hs sleep needed nRate PhenX	4180186
40768257	您认为要第二天感觉得到了彻底的休息,您需要每晚睡眠多少个小时:计数型速率:时间点:^患者:定量型:PhenX	4182948
40768258	Feel refreshed; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768258	Feel refreshed PhenX	4180186
40768258	在睡眠之后您是否感到清醒而又精神焕发:发现:时间点:^患者:序数型:PhenX	4182948
40768259	Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Point in time; QL; Qual; Qualitative; Random; Remember dreams; Screen	4180186
40768259	Remember dreams PhenX	4180186
40768259	您多久记起一次自己梦境,也就是那些出现在您的常规睡眠过程中而非打盹时的梦境:计数型速率:时间点:^患者:序数型:PhenX	4182948
40768261	Date and time; Dextro; Naptime; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40768261	Naptime PhenX	4180186
40768261	一天当中您通常在什么时间小睡:时间戳:时间点:^患者:定量型:PhenX	4182948
40768262	Amount sleep naptime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768262	Amount sleep naptime PhenX	4180186
40768262	当小睡一下的时候,您通常睡眠多少小时和分钟:时间:时间点:^患者:定量型:PhenX	4182948
40768263	Difficulty waking naps; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768263	Difficulty waking naps PhenX	4180186
40768263	您要从小睡中醒来是否存在极大的困难:发现:时间点:^患者:序数型:PhenX	4182948
40768266	Adapt sleep loss 3h; Finding; Findings; III; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768266	Adapt sleep loss 3h PhenX	4180186
40768266	对您来说要适应3个小时或更长时间的睡眠不足有多困难 - 比您平时以前夜间少睡3个小时或更多的小时数:发现:时间点:^患者:序数型:PhenX	4182948
40768267	Finding; Findings; Loss of sleep affect mood; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768267	Loss of sleep affect mood PhenX	4180186
40768267	这种睡眠上的缺乏是否影响第二天您的情绪:发现:时间点:^患者:序数型:PhenX	4182948
40768269	Prefer regular sleep schedule PhenX	4180186
40768269	Exchange; Finding; Findings; Ordinal; Point in time; Prefer regular sleep schedule; Ql; Qual; Qualitative; Random; Replace; Screen	4180186
40768269	您是否更喜欢保持规律的睡眠时间表 - 一个夜晚与下一个夜晚的变化不大的睡眠时间表:发现:时间点:^患者:序数型:PhenX	4182948
40768272	Dextro; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep loss affect mood how	4180186
40768272	Sleep loss affect mood how PhenX	4180186
40768272	就您的情绪而言,这种睡眠不足对您第二天的影响如何:发现:时间点:^患者:序数型:PhenX	4182948
40768273	Jet lag east PhenX	4180186
40768273	Jet lag east; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768273	当您乘坐飞机向西跨越几个时区旅行的时候感觉如何:时间:时间点:^患者:定量型:PhenX	4182948
40768274	Finding; Findings; Morning or evening person; Nominal; Persons; Point in time; Random	4180186
40768274	Morning or evening person PhenX	4180186
40768274	您觉得自己属于是早起的人 - 早起者、熬夜的人 - 夜猫子,或者两者都不是:发现:时间点:^患者:名义型:PhenX	4182948
40768278	Similar sleep wake time vacation PhenX	4180186
40768278	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Similar sleep wake time vacation	4180186
40768278	这些通常的入睡和醒来时间是不是始终一样 - 一周假期当中的每一天:发现:时间点:^患者:序数型:PhenX	4182948
40768279	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Wake on own vacation	4180186
40768279	Wake on own vacation PhenX	4180186
40768279	您是否是在没有闹钟或其他辅助手段的情况下自己醒来:发现:时间点:^患者:序数型:PhenX	4182948
40768280	Finding; Findings; Force self asleep early; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768280	Force self asleep early PhenX	4180186
40768280	您是否曾经试图强迫自己在比平时更早的上床睡觉时间入睡:发现:时间点:^患者:序数型:PhenX	4182948
40768281	Force self asleep early difficult PhenX	4180186
40768281	120 min; 120 minutes; 120min; 2 hours; Finding; Findings; Force self asleep early difficult; i; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768281	当您尝试将自己的睡眠时间表调整到某个较早的就寝时间时,至少1到2个小时,您是否在入睡方面存在困难:发现:时间点:^患者:序数型:PhenX	4182948
40768283	Last; Last Y longest period; QNT; Quan; Quant; Quantitative	4180186
40768283	Last Y longest period PhenX	4180186
40768283	在过去的那一年当中,大多数夜晚您都存在这些睡眠问题的最长时期是多长:时间:1年:^患者:定量型:PhenX	4182948
40768284	Age sleep W/O adjust schedule PhenX	4180186
40768284	Age sleep W/O adjust schedule; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768284	当您在试图调整自己的时间表但未能成功的情况下首次开始很晚才睡觉的时候,您的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40768288	Staying asleep work problems PhenX	4180186
40768288	FCN; Finding; Findings; Func; Funct; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Staying asleep work problems	4180186
40768288	您是否在夜间保持睡着状态方面频繁地出现过问题,而这对您第二天的职责行使带来了负面的影响:发现:时间点:^患者:序数型:PhenX	4182948
40768289	Back sleep work problems PhenX	4180186
40768289	Back sleep work problems; FCN; Finding; Findings; Func; Funct; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768289	您是否在半夜醒来之后再睡着方面频繁地出现过问题,而这对您第二天的职责行使带来了负面的影响:发现:时间点:^患者:序数型:PhenX	4182948
40768290	Past Y sleep difficulty PhenX	4180186
40768290	Finding; Findings; Last; Ordinal; Past Y sleep difficulty; Ql; Qual; Qualitative; Screen	4180186
40768290	在过去的那一年当中,您是否在入睡方面存在困难:发现:1年:^患者:序数型:PhenX	4182948
40768293	Look at clock PhenX	4180186
40768293	Finding; Findings; Look at clock; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768293	晚上无法入睡的时候您是否频繁地看时钟,以便看看自己到底多长时间还没有能够入睡:发现:时间点:^患者:序数型:PhenX	4182948
40768295	Finding; Findings; No explanation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768295	No explanation PhenX	4180186
40768295	您是否曾经在看上去没有任何原因或解释的情况下难以入睡或保持睡着状态:发现:时间点:^患者:序数型:PhenX	4182948
40768298	Before menstruation diff sleep; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768298	Before menstruation diff sleep PhenX	4180186
40768298	在月经之前的几天当中,您在睡眠方面的困难是否出现过或加重过:发现:时间点:^患者:序数型:PhenX	4182948
40768301	Age first sleep difficulty; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768301	Age first sleep difficulty PhenX	4180186
40768301	您首次经历睡眠方面的这种困难且至少持续1个月时的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40768302	Age last sleep difficulty PhenX	4180186
40768302	Age last sleep difficulty; Past; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768302	您最后一次经历失眠且至少持续1个月时您的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40768303	Current insomnia PhenX	4180186
40768303	Current insomnia; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768303	您当前患有失眠症吗:发现:时间点:^患者:序数型:PhenX	4182948
40768306	Control; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Sleepy interrupt activ times	4180186
40768306	Sleepy interrupt activ times nRate PhenX	4180186
40768306	您多久出现一次白天感到如此瞌睡以致于妨碍了您的正常活动的情况:计数型速率:时间点:^患者:定量型:PhenX	4182948
40768308	Freq desire to sleep PhenX	4180186
40768308	Freq desire to sleep; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768308	这种压倒一切想要去睡觉的欲望多久出现一次:时间:时间点:^患者:定量型:PhenX	4182948
40768311	Dextro; Finding; Findings; Nap refreshing; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768311	Nap refreshing PhenX	4180186
40768311	当您白天打瞌睡并小睡一下的时候,您发现这种睡眠令人精神振作吗:发现:时间点:^患者:序数型:PhenX	4182948
40768312	Finding; Findings; Nap refreshing describe; Nominal; Point in time; Random	4180186
40768312	Nap refreshing describe PhenX	4180186
40768312	请描述令人精神焕发的睡眠:发现:时间点:^患者:名义型:PhenX	4182948
40768315	Muscle weakness angry PhenX	4180186
40768315	Arterial Stenosis; bod; Bodies; Finding; Findings; Musc; Muscl; Muscle weakness angry; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768315	您的身体的任何部分,如腿部或面部,当您愤怒时,是否曾经经历过肌无力、肌肉力量丧失或肌肉软弱无力:发现:时间点:^患者:序数型:PhenX	4182948
40768316	Arterial Stenosis; bod; Bodies; Finding; Findings; Musc; Muscl; Muscle weakness joke; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768316	Muscle weakness joke PhenX	4180186
40768316	您的身体的任何部分,如腿部或面部,当您听笑话或说笑话时,是否曾经经历过肌无力、肌肉力量丧失或肌肉软弱无力:发现:时间点:^患者:序数型:PhenX	4182948
40768323	Sleep loss affect irritable PhenX	4180186
40768323	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep loss affect irritable	4180186
40768323	这种睡眠上的缺乏是否影响第二天您的暴躁易怒倾向:发现:时间点:^患者:序数型:PhenX	4182948
40768324	Clozapine metabolite; cloZAPine+Nor; cloZAPine+Nor pnl; Clozaril; Desmethylclozapine; DRUG/TOXICOLOGY; Drugs; FazaClo; Leponex; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders	4180186
40768324	cloZAPine+Nor pnl SerPl	4180186
40768324	氯氮平与去甲基氯氮平组套:-:时间点:血清/血浆:-	4182948
40768325	Antigen; Antigens; Australia antigen; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; GCMS; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf	4180186
40768325	HBV surface Ag SerPl Ql Cfm	4180186
40768325	乙型肝炎病毒表面 抗原:存在情况或阈值:时间点:血清/血浆:序数型:毒理学确认试验	4182948
40768326	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Creatinine 24H UR pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; QNT; Quan; Quant; Quantitative; UA; UCr; UniversalLabOrders; UR; Urn	4180186
40768326	Creatinine 24H UR pnl 24h Ur	4180186
40768326	24 小时尿液肌酐组套:-:24小时:尿液:定量型	4182948
40768327	Panic specific situations CIDI-SF	4180186
40768327	Finding; Findings; Ordinal; Panic specific situations; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
40768327	当您出现突然的焦虑发作时,它们是否通常出现在那些引起您过度恐惧的特殊情况下:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768329	Open close left hand PhenX	4180186
40768329	Finding; Findings; L; LT; Open close left hand; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Upper extremity	4180186
40768329	开与合 左手 - 10 次:发现:时间点:^患者:序数型:PhenX	4182948
40768332	Activity makes breathless PhenX	4180186
40768332	Activ; Activity makes breathless; Actvty; Finding; Findings; Movements; Nominal; Point in time; Random	4180186
40768332	这些天通常让您感觉喘不上气的活动:发现:时间点:^患者:名义型:PhenX	4182948
40768334	PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Rel; Relative mass concentration; RLMCNC	4180186
40768334	相对湿度:相对质量浓度:时间点:空气:定量型	4182948
40768335	Body Temperature Pressure Saturation; Fac; Fact; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto	4180186
40768335	BTPS factor PhenX	4180186
40768335	BTPS 因子:比率:时间点:^患者:定量型:PhenX	4182948
40768336	ADMIN; Ident; Identifier; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40768336	审核者姓名首字母:标识符:时间点:XXX:名义型	4182948
40768338	ADMIN; Location; Nominal; Point in time; Random	4180186
40768338	城市:位置:时间点:设施:名义型	4182948
40768340	ADMIN; Location; Nominal; Point in time; Random	4180186
40768340	国家:位置:时间点:设施:名义型	4182948
40768342	Facility Phone #	4180186
40768342	ADMIN; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
40768342	电话号码:电话号码:时间点:设施:名义型	4182948
40768343	ADMIN; Ident; Identifier; Nominal; Point in time; Random	4180186
40768343	测试设施名称:标识符:时间点:设施:名义型	4182948
40768344	Breathing; Lungs; Nominal; PhenX; Point in time; Random; RS; Typ	4180186
40768344	Test challenge type Respiratory	4180186
40768344	试验刺激类型:类型:时间点:呼吸系统:名义型	4182948
40768345	Extrapolated volume Respiratory	4180186
40768345	Breathing; Lungs; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; RS; Vol; Volume	4180186
40768345	外插容积:体积型属性:时间点:呼吸系统:定量型	4182948
40768347	Breathing; End tidal volume; Exp; FEV; FEV6; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; S prime; Vet; Vol; Vol exp; Volume	4180186
40768347	用力呼气 6.0 秒过程中所呼出的体积:体积型属性:时间点:呼吸系统:定量型:预计法	4182948
40768349	Breathing; End tidal volume; Exp; FEV; FEV1; FEV6; Forced expiratory volume in 1 second; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; S prime; Vet; Vol; Vol exp; Volume ratio	4180186
40768349	用力呼气 1.0 秒过程中所呼出的体积/用力呼气 6.0 秒过程中所呼出的体积:体积比率:时间点:呼吸系统:定量型:预计法	4182948
40768350	Original sampling interval PhenX	4180186
40768350	Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768350	原始采样时间间隔:时间:时间点:^患者:定量型:PhenX	4182948
40768352	Flow time data point PhenX	4180186
40768352	Cnt; Count; Dynamic; Nominal; Number; Point in time; Random	4180186
40768352	流量时间数据点:数量(计数):时间点:^患者:名义型:PhenX	4182948
40768353	Finding; Findings; Gender; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sex partner with vasectomy; World Heatlth Organization	4180186
40768353	Sex partner with vasectomy PhenX	4180186
40768353	您是否曾经与某位接受过输精管结扎术的伴侣进行过性交:发现:时间点:^患者:序数型:PhenX	4182948
40768354	Sex partner withdrawal PhenX	4180186
40768354	Finding; Findings; Gender; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sex partner withdrawal; World Heatlth Organization	4180186
40768354	您是否曾经与某位采用抽出或拔出方式的伴侣进行过性交:发现:时间点:^患者:序数型:PhenX	4182948
40768355	Doctor reported child vision prob PhenX	4180186
40768355	Finding; Findings; Nominal; Point in time; Random	4180186
40768355	报告孩子视力问题的医生:发现:时间点:^患者:名义型:PhenX	4182948
40768356	Finding; Findings; Nominal; Point in time; Random; Tx; Tx child receive Dr. reported	4180186
40768356	Tx child receive Dr. reported PhenX	4180186
40768356	您的孩子当时究竟针对医生所报告的这种视力问题接受了什么治疗:发现:时间点:^患者:名义型:PhenX	4182948
40768358	Dr. told child vision prob ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768358	Dr. told child vision prob ever PhenX	4180186
40768358	某位医生是否已经告诉您,您的孩子曾经存在这种视力问题:发现:时间点:^患者:序数型:PhenX	4182948
40768360	Blood relative eye problem; Finding; Findings; Nominal; Point in time; Random; Rel	4180186
40768360	Blood relative eye problem PhenX	4180186
40768360	存在眼睛问题的血缘关系:发现:时间点:^患者:名义型:PhenX	4182948
40768362	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Receive glaucoma tx; Screen; Treatment glaucoma; Tx	4180186
40768362	Receive glaucoma tx PhenX	4180186
40768362	您是否曾经接受过这种针对您的青光眼的治疗:发现:时间点:^患者:序数型:PhenX	4182948
40768364	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep loss affect irritable; Sleep loss affect irritable how	4180186
40768364	Sleep loss affect irritable how PhenX	4180186
40768364	就您暴躁易怒的倾向而言,这种睡眠不足对您第二天的影响如何:发现:时间点:^患者:序数型:PhenX	4182948
40768369	f052; f52; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep loss affect desire sweets	4180186
40768369	Sleep loss affect desire sweets PhenX	4180186
40768369	这种睡眠上的缺乏是否影响第二天您对于巧克力、糖果、甜点或甜食的欲望:发现:时间点:^患者:序数型:PhenX	4182948
40768370	f052; f52; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sleep loss affect desire sweets; Sleep loss affect sweets how	4180186
40768370	Sleep loss affect sweets how PhenX	4180186
40768370	就您对巧克力或甜食的食欲而言,这种睡眠不足对您第二天的影响如何:发现:时间点:^患者:序数型:PhenX	4182948
40768371	Finding; Findings; Nominal; Point in time; Random; Treatment glaucoma; Tx	4180186
40768371	Treatment glaucoma PhenX	4180186
40768371	针对您的青光眼的治疗:发现:时间点:^患者:名义型:PhenX	4182948
40768372	Things diff falling asleep PhenX	4180186
40768372	Finding; Findings; Nominal; Point in time; Random; Things diff falling asleep	4180186
40768372	因为在夜间入眠或保持睡着状态方面的困难而在白天时间里所经历的事情:发现:时间点:^患者:名义型:PhenX	4182948
40768373	Diff d/t falling asleep ever PhenX	4180186
40768373	Diff d/t falling asleep ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768373	您是否因为自己夜晚难以入睡或保持睡着状态而在白天时间里经历过任何这些事情:发现:时间点:^患者:序数型:PhenX	4182948
40768374	Difficulty anxiety PhenX	4180186
40768374	Difficulty anxiety; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768374	您是否在夜晚无法入睡的时候经历过针对夜晚不能睡觉的沮丧、紧张不安或者焦虑:发现:时间点:^患者:序数型:PhenX	4182948
40768376	Events with insomnia ever PhenX	4180186
40768376	Arterial Stenosis; Events with insomnia ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768376	您在失眠方面的困难是不是与任何这些事件或情况同时出现的:发现:时间点:^患者:序数型:PhenX	4182948
40768377	Other meds with insomnia PhenX	4180186
40768377	Drug; Finding; Findings; Ordinal; Other meds with insomnia; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768377	伴随失眠而出现的其他药物:发现:时间点:^患者:序数型:PhenX	4182948
40768378	Changing schedule with insomnia; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768378	Changing schedule with insomnia PhenX	4180186
40768378	伴随失眠而出现的变更时间表:发现:时间点:^患者:序数型:PhenX	4182948
40768387	Finding; Findings; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS); Upper extremity	4180186
40768387	Hand movements - left UPDRS	4180186
40768387	手部运动 - 左侧:发现:时间点:^患者:序数型:UPDRS	4182948
40768389	Finding; Findings; L; LT; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rapid alt hand move - L; Screen; Upper extremity	4180186
40768389	Rapid alt hand move - L	4180186
40768389	快速轮替手部运动 - 左侧:发现:时间点:^患者:序数型	4182948
40768390	Leg agility - right UPDRS	4180186
40768390	Finding; Findings; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768390	腿部敏捷性 - 右侧:发现:时间点:^患者:序数型:UPDRS	4182948
40768392	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768392	Arising from chair UPDRS	4180186
40768392	从椅子上起身:发现:时间点:^患者:序数型:UPDRS	4182948
40768394	Gait - parkinsons UPDRS	4180186
40768394	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768394	步态 - 帕金森病:发现:时间点:^患者:序数型:UPDRS	4182948
40768397	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
40768397	Motor symptoms - legs PhenX	4180186
40768397	运动症状 - 下肢:发现:时间点:^患者:序数型:PhenX	4182948
40768399	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768399	Pin sensibility PhenX	4180186
40768399	针刺敏感度:发现:时间点:^患者:序数型:PhenX	4182948
40768400	Vibration PhenX	4180186
40768400	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768400	震颤:发现:时间点:^患者:序数型:PhenX	4182948
40768401	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768401	Strength - legs PhenX	4180186
40768401	力量 - 腿部:发现:时间点:^患者:序数型:PhenX	4182948
40768402	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768402	Strength - arms PhenX	4180186
40768402	力量 - 上肢:发现:时间点:^患者:序数型:PhenX	4182948
40768403	Finding; Findings; Musc; Muscl; Nominal; Point in time; Random; Ulnar CMAP	4180186
40768403	Ulnar CMAP PhenX	4180186
40768403	尺神经复合肌肉动作电位:发现:时间点:^患者:名义型:PhenX	4182948
40768404	Finding; Findings; Musc; Muscl; Nominal; Point in time; Random; Ulnar CMAP; Ulnar CMAP median	4180186
40768404	Ulnar CMAP median PhenX	4180186
40768404	尺神经复合肌肉动作电位 - 中位数:发现:时间点:^患者:名义型:PhenX	4182948
40768408	Date stroke occurred PhenX	4180186
40768408	Date and time; Date stroke occurred; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40768408	首次卒中是何时发生的:时间戳:时间点:^患者:定量型:PhenX	4182948
40768409	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sudden loss of speech	4180186
40768409	Sudden loss of speech PhenX	4180186
40768409	您是否有过任何突然出现且持续至少24小时或更长时间的失语症或说话能力的变化:发现:时间点:^患者:序数型:PhenX	4182948
40768413	Things with change in speech PhenX	4180186
40768413	Exchange; Finding; Findings; Nominal; Point in time; Random; Replace; Things with change in speech	4180186
40768413	伴随言语改变期而出现的事情:发现:时间点:^患者:名义型:PhenX	4182948
40768415	Finding; Findings; Nominal; Point in time; Random	4180186
40768415	Side affected PhenX	4180186
40768415	所影响的侧:发现:时间点:^患者:名义型:PhenX	4182948
40768418	Things with vision loss blurring PhenX	4180186
40768418	Finding; Findings; Nominal; Point in time; Random; Things with vision loss blurring	4180186
40768418	伴随失明而出现的事情:发现:时间点:^患者:名义型:PhenX	4182948
40768419	Things vision loss occur PhenX	4180186
40768419	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Things vision loss occur	4180186
40768419	当时在您丧失视力的同时,是否还出现过任何下列这些情况:发现:时间点:^患者:序数型:PhenX	4182948
40768420	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768420	Double vision PhenX	4180186
40768420	您是否曾经经历过突然一阵的复视,且持续了24小时或更长的时间:发现:时间点:^患者:序数型:PhenX	4182948
40768423	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Things with double vision occur	4180186
40768423	Things with double vision occur PhenX	4180186
40768423	当您存在复视的时候,是否出现过任何这些事情:发现:时间点:^患者:序数型:PhenX	4182948
40768427	bod; Bodies; Body part affected; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768427	Body part affected PhenX	4180186
40768427	您身体的这一部分当时是否受到了影响:发现:时间点:^患者:序数型:PhenX	4182948
40768428	abn; abnorm; bod; Bodies; Finding; Findings; Nominal; Point in time; Random; Sensation spread; Started	4180186
40768428	Sensation spread PhenX	4180186
40768428	在这次发作期间,这种异常的感觉究竟是从您身体的某个部分开始再传播别的部分,还是其就待在同一个位置:发现:时间点:^患者:名义型:PhenX	4182948
40768429	Things with tingling PhenX	4180186
40768429	Finding; Findings; Nominal; Point in time; Random; Things with tingling	4180186
40768429	伴随刺痛感和感觉丧失而出现的事情:发现:时间点:^患者:名义型:PhenX	4182948
40768430	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Things with tingling occur	4180186
40768430	Things with tingling occur PhenX	4180186
40768430	当时在您存在麻木、刺痛感并且感觉丧失的同时,是否还出现过任何下列这些情况:发现:时间点:^患者:序数型:PhenX	4182948
40768432	Things with paralysis weakness PhenX	4180186
40768432	Finding; Findings; Nominal; Point in time; Random; Things with paralysis weakness	4180186
40768432	伴随瘫痪或虚弱而出现的事情:发现:时间点:^患者:名义型:PhenX	4182948
40768434	Sudden Dizzi Loss bal Spin PhenX	4180186
40768434	Bal; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sudden Dizzi Loss bal Spin	4180186
40768434	您是否出现过任何持续24小时或更长时间的眩晕、平衡失调或旋转感的突然发作:发现:时间点:^患者:序数型:PhenX	4182948
40768437	Bal; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Things dizziness balance occur	4180186
40768437	Things dizziness balance occur PhenX	4180186
40768437	当时在您存在头晕、丧失平衡或者晕眩感觉突然发作的同时,是否还出现过任何下列这些情况:发现:时间点:^患者:序数型:PhenX	4182948
40768438	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768438	Trouble seeing PhenX	4180186
40768438	您当时是否存在视力问题:发现:时间点:^患者:序数型:PhenX	4182948
40768442	Bx; Cerv; Cervical; Finding; Findings; Gyn; Gynecology; Narrative; OB; ObGyn; Obstetrics; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768442	Cervix Path Bx report	4180186
40768442	病理学活组织检查报告:发现:时间点:子宫颈:叙述型	4182948
40768445	ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Sal; Salmonel; Serotype; species; spp; Typ	4180186
40768445	Salmonella serovar Islt	4180186
40768445	沙门菌属单个未知种 血清型变种:类型:时间点:分离株:名义型	4182948
40768448	Blood; CELL MARKERS; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; Suppressor T cells; T cell; T prime; T4; T-4; T8; T-8; T-cell subsets CD4+CD8 pnl; Tsuppressor; UCHL-1; UniversalLabOrders; W3/25; WB; Whole blood	4180186
40768448	T-cell subsets CD4+CD8 pnl Bld	4180186
40768448	T-细胞亚群 CD4 与 CD8 组套:-:时间点:全血:-	4182948
40768451	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
40768451	N men Ag Tiss Ql ImStn	4180186
40768451	脑膜炎奈瑟菌 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
40768452	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chinese gooseberry; Dextro; Immune globulin E; Immunoglobulin E; Kiwellin; Kiwi; Kiwi (nAct d) 5; Kiwi fruit; Kiwifruit; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768452	Kiwi (nAct d) 5 IgE Qn	4180186
40768452	美味猕猴桃 原生 (nAct d) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768456	English Walnut (nJug r) 3 IgE Qn	4180186
40768456	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; English walnut; English Walnut (nJug r) 3; III; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Serum; SR	4180186
40768456	核桃 原生 (nJug r) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768461	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Buchwheat; Buckwheat; Buckwheat (nFag e) 2; f011; f11; II; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768461	Buckwheat (nFag e) 2 IgE Qn	4180186
40768461	荞麦 原生 (nFag e) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768463	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bermuda grass; Bermuda grass (nCyn d) 1; Dextro; g002; g2; g216; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768463	Bermuda grass (nCyn d) 1 IgE Qn	4180186
40768463	狗牙根 原生 (nCyn d) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768465	Japanese Cedar (nCry j) 1 IgE Qn	4180186
40768465	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; Immune globulin E; Immunoglobulin E; Japanese cedar; Japanese Cedar (nCry j) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sugi tree; t17	4180186
40768465	日本柳杉 原生 (nCry j) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768466	Arizona Cypress (nCup a) 1 IgE Qn	4180186
40768466	a256; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Arizona Cypress; Arizona Cypress (nCup a) 1; Autoantibodies; Autoantibody; Cupressus glabra; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt222; Serum; SR; t222; t226	4180186
40768466	亚利桑那柏树 原生 (nCup a) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768468	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black olive; f342; Immune globulin E; Immunoglobulin E; Olive; Olive (rOle e) 9; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768468	Olive (rOle e) 9 IgE Qn	4180186
40768468	油橄榄 重组 (rOle e) 9 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768469	London Plane (nPla a) 2 IgE Qn	4180186
40768469	a573; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; II; Immune globulin E; Immunoglobulin E; London plane; London Plane (nPla a) 2; Maple leaf sycamore; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t11	4180186
40768469	二球悬铃木 原生 (nPla a) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768470	Common ragweed (nAmb a) 1 IgE Qn	4180186
40768470	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common ragweed; Common ragweed (nAmb a) 1; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w230	4180186
40768470	艾叶破布草 原生 (nAmb a) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768471	Mugwort (nArt v) 3 IgE Qn	4180186
40768471	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; III; Immune globulin E; Immunoglobulin E; Mugwort; Mugwort (nArt v) 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w006; w233; w6	4180186
40768471	北艾 原生 (nArt v) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768472	Saltwort (nSal k) 1 IgE Qn	4180186
40768472	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Russian thistle; Salosola kali; Salsola pestifer; Saltwort; Saltwort (nSal k) 1; Saltwort (prickly); Serum; SR; w011; w11; w232	4180186
40768472	猪毛菜 原生 (nSal k) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768473	ABS; Aby; Alb; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken CSA (nGal d) 5; Dextro; f083; f83; Gallus spp; Immune globulin E; Immunoglobulin E; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ser; Serum; SR	4180186
40768473	Chicken CSA (nGal d) 5 IgE Qn	4180186
40768473	鸡 CSA (卵黄蛋白) 血清白蛋白 原生 (nGal d) 5 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768474	Shrimp (nPen m) 2 IgE Qn	4180186
40768474	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; II; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shrimp; Shrimp (nPen m) 2; SR	4180186
40768474	斑节对虾 原生 (nPen m) 2 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768475	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shrimp; Shrimp (nPen m) 4; SR	4180186
40768475	Shrimp (nPen m) 4 IgE Qn	4180186
40768475	斑节对虾 原生 (nPen m) 4 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768476	ABS; Aby; Alb; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Equus spp; Horse serum albumin (nEqu c) 3; III; Immune globulin E; Immunoglobulin E; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Ser; Serum; SR	4180186
40768476	Horse serum albumin (nEqu c) 3 IgE Qn	4180186
40768476	马血清白蛋白 原生 (nEqu c) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768477	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; Immune globulin E; Immunoglobulin E; Mice; Mouse lipocain (nMus m) 1; Murine; Mus musculus; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768477	Mouse lipocain (nMus m) 1 IgE Qn	4180186
40768477	小鼠脂钙蛋白 原生 (nMus m) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768478	a295; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; American house dust mite; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; D farinae; D farinae (nDer f) 1; d002; d2; Dermatophagoides farianae; HDM; House dust mite; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768478	D farinae (nDer f) 1 IgE Qn	4180186
40768478	粉尘螨 原生 (nDer f) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768479	Honey bee (nApi m) 4 IgE Qn	4180186
40768479	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honey bee (nApi m) 4; Honeybee; i001; i1; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
40768479	意大利蜜蜂 原生 (nApi m) 4 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
40768485	Art; Artery-L; Cardio; Cardiology; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; L; LT; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; RFA; Spec; Stent place; To be specified in another part of the message; Unspecified	4180186
40768485	RFA Guided Artery-L Stent place	4180186
40768485	旨在置入支架的引导:发现:时间点:XXX>动脉.左侧:文档型:放射荧光透视法.血管造影术	4182948
40768487	1V; 1V for cyst; Abd; Abdo; Abdomen+; Abdominal; Bil; Bilat; Both; Document; Film; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kdny-Bl; Kidney; Kidneys; Nephric; Nephrology; Point in time; Rad; RADIOLOGY; Random; Renal; Single View; VW	4180186
40768487	RF Kdny-Bl 1V for cyst	4180186
40768487	针对囊肿的视图:发现:时间点:腹部>肾脏.双侧:文档型:放射荧光透视法	4182948
40768492	Ang; Angio; Angiogram; Angm; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Films; Finding; Findings; Flr; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Plain Films; Point in time; R; Radiology; Random; RT; SS v; SS v-R; Ven; Venogram; Venography; Venous; View; VWS; W contr IV; WC; XRA; Xray; X-ray	4180186
40768492	Deprecated SS v-R XRA W contr IV	4180186
40768493	Ang; Angio; Angiogram; Angm; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Films; Finding; Findings; Flr; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Jugular v-R; Plain Films; Point in time; R; Radiology; Random; RT; SS v; SS v+Jugular v-R; SS v-R; Ven; Venogram; Venography; Venous; View; VWS; W contr IV; WC; XRA; Xray; X-ray	4180186
40768493	Deprecated SS v+Jugular v-R XRA W contr	4180186
40768495	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Nucynta; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tapal; UA; UR; Urn	4180186
40768495	Tapentadol Ur-mCnc	4180186
40768495	他喷他多:质量浓度:时间点:尿液:定量型	4182948
40768496	Nortapentadol Ur-mCnc	4180186
40768496	DMT; DRUG/TOXICOLOGY; Drugs; Fentanyl metabolite; Level; Mass concentration; N-Desmethyltapentadol; Point in time; QNT; Quan; Quant; Quantitative; Random; Tapentadol metabolite; UA; UR; Urn	4180186
40768496	去甲基他喷他多:质量浓度:时间点:尿液:定量型	4182948
40768498	Acute myelomonocytic leukemia; AF17q25; DNA methylation; Hereditary neuralgic amyotrophy; HNA; MLL septin-like fusion; Molecular genetics; Molecular pathology; MOLPATH; MSF; MSF1; NAPB; Ordinal; PCR; Pl; Plasma; Plsm; PNUTL4; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SeptD1; septin 9; SINT1	4180186
40768498	SEPT9 gene methylation Plas Ql	4180186
40768498	SEPT9 基因甲基化:存在情况或阈值:时间点:血浆:序数型:分子遗传学类实验室方法	4182948
40768499	Body bradykinesia - hypokinesia UPDRS	4180186
40768499	bod; Bodies; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768499	身体运动迟缓 - 运动功能减退:发现:时间点:^患者:序数型:UPDRS	4182948
40768500	Finding; Findings; Nominal; Parts of vision affected; Point in time; Random	4180186
40768500	Parts of vision affected PhenX	4180186
40768500	在该次发作期间,您的视觉的下列组成部分当中究竟哪些受到了影响:发现:时间点:^患者:名义型:PhenX	4182948
40768504	Cnt; Correctn; Count; Fac; Fact; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Ref values correction factor	4180186
40768504	Ref values correction factor PhenX	4180186
40768504	参考值校正系数:数量(计数):时间点:^患者:定量型:PhenX	4182948
40768505	Medication Dose-mCnc	4180186
40768505	Dose med or substance; DRUG DOSES; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768505	药物 XXX:质量浓度:时间点:剂量药物或剂量物质:定量型	4182948
40768507	Dynamic; Gases; Largest; Lung; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Time to PEF	4180186
40768507	Time to PEF	4180186
40768507	达到呼气气体流量最大值的时间:时间:时间点:^患者:定量型	4182948
40768508	Breathing; Dynamic; Exp; FEF 25%; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
40768508	用力呼气 25% 时的气体流量:体积速率:时间点:呼吸系统.气道:定量型	4182948
40768510	Breathing; Dynamic; Exp; FEF 75%; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
40768510	用力呼气 75% 时的气体流量:体积速率:时间点:呼吸系统.气道:定量型	4182948
40768512	Distressed scale PhenX	4180186
40768512	Cnt; Count; Distressed scale; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768512	您上床睡觉时间晚以及无法调整自己的时间表使您心烦意乱或痛苦的程度如何:数量(计数):时间点:^患者:序数型:PhenX	4182948
40768513	Social distress scale PhenX	4180186
40768513	Cnt; Count; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Social distress scale	4180186
40768513	哪个数字能够描述这种夜间倾向对您的社交生活或者您与朋友之间的关系产生影响的程度:数量(计数):时间点:^患者:序数型:PhenX	4182948
40768515	Cnt; Count; Job; No; Num; Number; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Work distress scale	4180186
40768515	Work distress scale PhenX	4180186
40768515	哪个数字能够描述这种夜间倾向对您在学校里或工作中的表现或者对您与自己的同事、雇主、教师或同学之间的关系产生影响的程度:数量(计数):时间点:^患者:序数型:PhenX	4182948
40768516	Finding; Findings; LOC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768516	LOC PhenX	4180186
40768516	当时您是否被击昏或者您是否失去了意识:发现:时间点:^患者:序数型:PhenX	4182948
40768517	LOC time; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768517	LOC time PhenX	4180186
40768517	当时您昏迷（即失去知觉）了多长时间:时间:时间点:^患者:定量型:PhenX	4182948
40768520	Address; Admin; ESRD; ESRD survey; Nominal; Point in time; Random; Survey	4180186
40768522	Admin; ESRD; ESRD survey; Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
40768523	Admin; Dialy; ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
40768525	ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
40768527	ESRD; ESRD survey; No; Nominal; Num; Phone #; Point in time; Principal interpreter; Principal result interpreter phone #; Random; Survey; Telecommunication number; Telephone number	4180186
40768529	ESRD; ESRD survey; Nominal; Point in time; Random; Survey; Typ	4180186
40768530	ESRD; ESRD survey; Ident; Identifier; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Survey; To be specified in another part of the message; Unspecified	4180186
40768531	Misc; Miscellaneous; Observation date; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
40768531	Observation date Spec	4180186
40768531	观察日期:日期:时间点:XXX:定量型	4182948
40768533	Behavior disorders relatives; Fam Mem; Finding; Findings; Nominal; Point in time; Random; Rel	4180186
40768533	Behavior disorders relatives Family	4180186
40768533	诊断或怀疑存在睡眠或行为障碍的亲戚:发现:时间点:^家庭成员:名义型:PhenX	4182948
40768535	Child not seem listen PhenX	4180186
40768535	Child not seem listen; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768535	当直接与其说话的时候,这个孩子常常看上去似乎没有在听:发现:时间点:^患者:序数型:PhenX	4182948
40768539	CARD.RISK; Cardio; Cardiology; Cnt; Count; CVD; CVD 10Y risk; Dextro; Dis; Diseases; Dz; General CVD 10Y risk; Heart Disease; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768539	General CVD 10Y risk	4180186
40768539	一般心血管疾病 10 年风险:数量(计数):时间点:^患者:定量型:Framingham.D'Agostino	4182948
40768540	CARD.RISK; Cardio; Cardiology; Cnt; Count; Heart Disease; IC 4Y risk; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768540	IC 4Y risk	4180186
40768540	间歇性跛行4年风险:数量(计数):时间点:^患者:定量型:Framingham.Murabito 1997	4182948
40768542	Afib 10Y risk; CARD.RISK; Cardio; Cardiology; Cnt; Count; Heart Disease; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768542	Afib 10Y risk	4180186
40768542	心房颤动 10 年风险:数量(计数):时间点:^患者:定量型:Framingham.Schnabel 2009	4182948
40768543	CARD.RISK; Cardio; Cardiology; CHD 10Y risk; Cnt; Count; Dis; Diseases; Dz; Heart Disease; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768543	CHD 10Y risk Reynolds.Ridker 2007	4180186
40768543	冠心病 10 年风险:数量(计数):时间点:^患者:定量型:Reynolds.Ridker 2007	4182948
40768548	CARD.RISK; Cardio; Cardiology; CHD 2Y risk; Cnt; Count; Dextro; Dis; Diseases; Dz; Heart Disease; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Recurring CHD 2Y risk	4180186
40768548	Recurring CHD 2Y risk	4180186
40768548	复发冠心病2年风险:数量(计数):时间点:^患者:定量型:Framingham.D'Agostino 2000	4182948
40768549	CARD.RISK; Cardio; Cardiology; Cnt; Count; Heart Disease; HF 4Y risk; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768549	HF 4Y risk	4180186
40768549	心力衰竭4年风险:数量(计数):时间点:^患者:定量型:Framingham.Kannel 1999	4182948
40768550	CARD.RISK; Cardio; Cardiology; Cnt; Count; Heart Disease; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Stroke post Afib 5Y risk	4180186
40768550	Stroke post Afib 5Y risk	4180186
40768550	心房颤动之后卒中 5 年风险:数量(计数):时间点:^患者:定量型:Framingham.Wang 2003	4182948
40768554	Testicle size peer compare PhenX	4180186
40768554	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Testicle size peer compare	4180186
40768554	您的睾丸大小当时开始增长。与您的朋友们相比,这项是:发现:时间点:^患者:序数型:PhenX	4182948
40768555	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Nominal; P prime; Point in time; Preg complication; Pregnancies; Random	4180186
40768555	Preg complication	4180186
40768555	妊娠并发症:发现:时间点:^患者:名义型	4182948
40768559	Child eye patch ever PhenX	4180186
40768559	Child eye patch ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768559	他或她是否曾经不得不戴上眼罩来改善他或她的视力:发现:时间点:^患者:序数型:PhenX	4182948
40768560	Ident; Identifier; IOP device; Model Cd; Nominal; Point in time; Random	4180186
40768560	IOP device Model Cd PhenX	4180186
40768560	厂商设备机型代码:标识符:时间点:眼内压装置:名义型:PhenX	4182948
40768561	Statistical reliability level PhenX	4180186
40768561	Cnt; Count; EYE; EYE.TONOMETRY; Glaucoma testing; Levels; Levl; LV; LVL; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768561	所测得的统计学可靠性水平:数量(计数):时间点:测量:定量型:PhenX	4182948
40768563	His her other relatives eye prob PhenX	4180186
40768563	Finding; Findings; His her other relatives eye prob; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768563	他或她的任何其他亲戚现在或过去是否存在这种眼睛问题:发现:时间点:^患者:序数型:PhenX	4182948
40768564	Condition difficulty breathing; Finding; Findings; Nominal; Point in time; Random	4180186
40768564	Condition difficulty breathing PhenX	4180186
40768564	引起呼吸困难的健康状况:发现:时间点:^患者:名义型:PhenX	4182948
40768566	1 year; 12Mos; Count/time; Dr. glaucoma past 12Mo; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative	4180186
40768566	Dr. glaucoma past 12Mo nRate PhenX	4180186
40768566	在过去的那12个月当中,您已经有多少次因为自己的青光眼而去看过眼科医生:计数型速率:12个月:^患者:定量型:PhenX	4182948
40768568	Retinal digi photog model Model #	4180186
40768568	Ident; Identifier; Model #; No; Nominal; Num; Point in time; Random; Retinal digi photog model	4180186
40768568	厂商型号:标识符:时间点:视网膜数字摄影装置:名义型	4182948
40768570	Anxiety small closed place SCARED-R	4180186
40768570	Anxiety small closed place; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen	4180186
40768570	在狭小密闭的空间当中,我变得害怕:发现:时间点:^患者:序数型:SCARED-R	4182948
40768574	Panic attack things CIDI-SF	4180186
40768574	Finding; Findings; Ordinal; Panic attack things; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768574	当您出现恐慌发作的时候,您是否经历过这种事情:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768575	Spherical power InvLen R eye	4180186
40768575	Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
40768575	球镜度:长度倒数:时间点:眼睛.右侧:定量型	4182948
40768577	Cylindrical power InvLen R eye	4180186
40768577	Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
40768577	柱镜度:长度倒数:时间点:眼睛.右侧:定量型	4182948
40768578	视力^经过最佳校正的:长度比率:时间点:眼睛.右侧:定量型	4182948
40768578	R eye VA--corr	4180186
40768578	EYE.REFRACTION; Eyeball; Length Ratio; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
40768579	Spherical power InvLen L eye	4180186
40768579	Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
40768579	球镜度:长度倒数:时间点:眼睛.左侧:定量型	4182948
40768580	CYL; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
40768580	Cylinder axis L eye	4180186
40768580	柱镜轴位:角度:时间点:眼睛.左侧:定量型	4182948
40768587	DIA; Diam; Diam pupil est; Eyeball; Length; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Ret dig photog; RT; Vision; Visual	4180186
40768587	Diam pupil est R eye Ret dig photog	4180186
40768587	估计瞳孔直径:长度:时间点:眼睛.右侧:定量型:视网膜数字摄影术	4182948
40768589	Eye fields photo L eye Ret dig photog	4180186
40768589	Eyeball; Finding; Findings; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; Random; Ret dig photog; Retinaldehyde; Retinene; Retinene 1; Vision; Visual; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
40768589	视网膜数字摄影术当中所拍摄的眼睛视野:发现:时间点:眼睛.左侧:名义型:视网膜数字摄影术	4182948
40768594	Worried anxious things ever CIDI-SF	4180186
40768594	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Worried anxious things ever	4180186
40768594	当您焦虑的时候,当时是否也同时出现了这种事情:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768596	Specific phobias ever CIDI-SF	4180186
40768596	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Specific phobias ever	4180186
40768596	您对这种特定的事物是否存在过度强烈的恐惧,或者要避开这种特定的事物:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768599	Social phobias CIDI-SF	4180186
40768599	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40768599	社交恐怖症:发现:时间点:^患者:名义型:CIDI-SF	4182948
40768600	Finding; Findings; Have social phobia ever; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768600	Have social phobia ever CIDI-SF	4180186
40768600	您对这种社会情境是否存在过度强烈的恐惧,或者要避免这种社会情境:发现:时间点:^患者:序数型:CIDI-SF	4182948
40768601	Life aspects HCL-32	4180186
40768601	Finding; Findings; Life aspects; Nominal; PhenX; Point in time; Random	4180186
40768601	您的人生的各个方面:发现:时间点:^患者:名义型:HCL-32	4182948
40768603	Mania behavior HCL-32	4180186
40768603	Finding; Findings; Mania behavior; Nominal; PhenX; Point in time; Random	4180186
40768603	极度兴奋状态时的行为或感觉:发现:时间点:^患者:名义型:HCL-32	4182948
40768604	Finding; Findings; Mania behavior ever; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768604	Mania behavior ever HCL-32	4180186
40768604	在某种极度兴奋的状态下,我存在这种行为或感觉:发现:时间点:^患者:序数型:HCL-32	4182948
40768607	Eat when not hungry EDDS	4180186
40768607	Eat when not hungry; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; T prime	4180186
40768607	在这些次发生暴食和体重失控的过程中,您是否当时在自己实际上并不感到饥饿的情况下吃下大量的食物:发现:时间点:^患者:序数型:EDDS	4182948
40768610	Feel very upset EDDS	4180186
40768610	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Wt; Wt gain	4180186
40768610	在这些次发生暴食和体重失控的过程中,您是否当时对您无法控制的暴食或最终造成体重增加而感到非常心烦意乱:发现:时间点:^患者:序数型:EDDS	4182948
40768613	3 months; Count/time; Fasted - times / W; II; Last; nRate; Number rate; Number Rate = Count/Time; PhenX; QNT; Quan; Quant; Quantitative; Wt; Wt gain	4180186
40768613	Fasted - times / W EDDS	4180186
40768613	在过去3个月当中,为了避免体重增加或者对抗进食的那些作用,您每星期平均进行过多少次禁食,并且连续省去至少2餐:计数型速率:3个月:^患者:定量型:EDDS	4182948
40768614	3 months; Count/time; EXCZ; Exercised times / W; Last; nRate; Number rate; Number Rate = Count/Time; PhenX; QNT; Quan; Quant; Quantitative	4180186
40768614	Exercised times / W EDDS	4180186
40768614	在过去3个月当中,您平均每星期多次专门为对抗暴食事件的影响而从事了过量的锻炼活动:计数型速率:3个月:^患者:定量型:EDDS	4182948
40768616	Birth control pills past 3Mo EDDS	4180186
40768616	3 months; Birth control pills past 3Mo; Contraception; Contraceptive Method; Finding; Findings; Last; Ordinal; PhenX; Ql; Qual; Qualitative; Screen	4180186
40768616	在过去3个月当中您一直在服用避孕药吗:发现:3个月:^患者:序数型:EDDS	4182948
40768619	Age of onset psych problems DI-PAD	4180186
40768619	Age of onset psych problems; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768619	最初心理问题出现时的年龄:时间:时间点:^患者:定量型:DI-PAD CGP 1.4版	4182948
40768620	Finding; Findings; Mode onset psych illness; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768620	Mode onset psych illness DI-PAD	4180186
40768620	精神病发作:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768621	Mode onset notes DI-PAD	4180186
40768621	Mode onset notes; Nominal; PhenX; Point in time; Random; Text	4180186
40768621	发病年龄与方式记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768623	Nominal; PhenX; Point in time; Random; Text	4180186
40768623	Psychological stressor notes DI-PAD	4180186
40768623	心理压力源记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768625	Finding; Findings; Job; Nominal; Occupation; PhenX; Point in time; Random	4180186
40768625	Premorbid work adjustment DI-PAD	4180186
40768625	发病前工作调整:发现:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768627	Nominal; PhenX; Point in time; Random; Text	4180186
40768627	Premorbid adjustment notes DI-PAD	4180186
40768627	发病前调整记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768628	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768628	Coarse brain disorder DI-PAD	4180186
40768628	发病之前的粗糙脑病:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768629	Coarse brain disorder notes DI-PAD	4180186
40768629	Nominal; PhenX; Point in time; Random; Text	4180186
40768629	粗糙脑病记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768630	Family hx of SCZ DI-PAD	4180186
40768630	Fam Mem; History; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; SCZ	4180186
40768630	精神分裂症:历史记录:时间点:^家庭成员:序数型:DI-PAD CGP 1.4版	4182948
40768632	Family hx notes DI-PAD	4180186
40768632	Family hx notes; Hx; Nominal; PhenX; Point in time; Random; Text	4180186
40768632	家族史记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768634	Dysphoria - irritable DI-PAD	4180186
40768634	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768634	烦躁不安 - 暴躁易怒不耐烦:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768635	Nominal; PhenX; Point in time; Random; Text	4180186
40768635	Dysphoria notes DI-PAD	4180186
40768635	烦躁不安记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768637	Nominal; PhenX; Point in time; Random; Text	4180186
40768637	Anhedonia notes DI-PAD	4180186
40768637	快感缺乏记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768638	Loss energy fatigue DI-PAD	4180186
40768638	Finding; Findings; Loss energy fatigue; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768638	精力缺乏或疲乏:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768639	Activ; Actvty; Finding; Findings; Movements; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768639	Slowed activity DI-PAD	4180186
40768639	减慢的活动:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768641	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768641	Altered libido DI-PAD	4180186
40768641	已改变的性欲:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768642	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768642	Excessive self reproach DI-PAD	4180186
40768642	过度自责:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768643	Depressive symptom notes DI-PAD	4180186
40768643	Nominal; PhenX; Point in time; Random; Sx; Text	4180186
40768643	抑郁症状记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768646	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768646	Decreased appetite DI-PAD	4180186
40768646	食欲下降:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768647	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Wt	4180186
40768647	Weight loss DI-PAD	4180186
40768647	体重减轻:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768648	Increased appetite DI-PAD	4180186
40768648	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768648	食欲增强:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768650	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768650	Initial insomnia DI-PAD	4180186
40768650	初期失眠症:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768651	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768651	Middle insomnia DI-PAD	4180186
40768651	中期失眠症:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768653	Hs normal sleep; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768653	Hs normal sleep DI-PAD	4180186
40768653	您通常睡眠多少个小时:时间:时间点:^患者:定量型:DI-PAD CGP 1.4版	4182948
40768654	Hs sleeping then; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768654	Hs sleeping then DI-PAD	4180186
40768654	那时您睡眠多少个小时:时间:时间点:^患者:定量型:DI-PAD CGP 1.4版	4182948
40768656	Diurnal variation depression DI-PAD	4180186
40768656	Diurnal variation depression; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768656	抑郁的昼夜变异:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768657	Appetite sleep chg notes; Exchange; Nominal; PhenX; Point in time; Random; Replace; Text	4180186
40768657	Appetite sleep chg notes DI-PAD	4180186
40768657	食欲或睡眠变化记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768658	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768658	Elevated mood DI-PAD	4180186
40768658	高涨的情绪:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768660	Elevated irritable mood notes DI-PAD	4180186
40768660	Elevated irritable mood notes; Nominal; PhenX; Point in time; Random; Text	4180186
40768660	高涨或暴躁易怒情绪记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768661	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768661	Pressured speech DI-PAD	4180186
40768661	强制言语:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768662	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768662	Racing thoughts DI-PAD	4180186
40768662	思维奔逸:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768663	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768663	Distractibility DI-PAD	4180186
40768663	注意力涣散:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768665	Activ; Actvty; Finding; Findings; Movements; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768665	Excessive activity DI-PAD	4180186
40768665	过多活动:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768666	Reckless activity DI-PAD	4180186
40768666	Activ; Actvty; Finding; Findings; Movements; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768666	粗心的活动:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768669	Hypomanic manic notes DI-PAD	4180186
40768669	Hypomanic manic notes; Nominal; PhenX; Point in time; Random; Sx; Text	4180186
40768669	轻度躁狂或躁狂症状记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768670	Finding; Findings; Hallucinations any; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768670	Hallucinations any DI-PAD	4180186
40768670	任何方式的幻觉:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768672	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Voices non-verbal hallucinations	4180186
40768672	Voices non-verbal hallucinations DI-PAD	4180186
40768672	不露声色的语音或非言语型幻觉:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768673	Command accusatory voices DI-PAD	4180186
40768673	Command accusatory voices; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768673	命令式、指责性、侮辱性或虐待性的嗓音:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768676	Nominal; PhenX; Point in time; Random; Text	4180186
40768676	Hallucination notes DI-PAD	4180186
40768676	幻觉记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768677	Thought insertion DI-PAD	4180186
40768677	Finding; Findings; insertions; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768677	思想插入:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768678	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768678	Thought broadcast DI-PAD	4180186
40768678	思想广播:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768680	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768680	Thought echo DI-PAD	4180186
40768680	思想化声:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768681	Subj thought disturb notes DI-PAD	4180186
40768681	Nominal; PhenX; Point in time; Random; Subj thought disturb notes; Text	4180186
40768681	主观思维障碍记录:文本型属性:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768682	Delusion screen DI-PAD	4180186
40768682	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
40768682	妄想筛查:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768683	Delusions guilt; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768683	Delusions guilt DI-PAD	4180186
40768683	罪恶妄想:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768684	Delusions poverty DI-PAD	4180186
40768684	Delusions poverty; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768684	贫穷妄想:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768686	Delusions passivity DI-PAD	4180186
40768686	Delusions passivity; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768686	被动妄想:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768687	Delusions influence; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768687	Delusions influence DI-PAD	4180186
40768687	影响妄想:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768688	Persecutory delusion DI-PAD	4180186
40768688	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768688	被害妄想:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768690	Delusional mood DI-PAD	4180186
40768690	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768690	妄想情绪:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768695	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Relat psych affective sympts; Screen; Sx	4180186
40768695	Relat psych affective sympts DI-PAD	4180186
40768695	精神病症状与情感症状之间的关系:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768699	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768699	Widespread delusion DI-PAD	4180186
40768699	广泛的妄想:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768701	Persecutory delusion halluc DI-PAD	4180186
40768701	Finding; Findings; Ordinal; Persecutory delusion halluc; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768701	被害型或嫉妒型妄想与幻觉:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768702	Illness duration DI-PAD	4180186
40768702	Durat; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768702	疾病持续时间:时间:时间点:^患者:定量型:DI-PAD CGP 1.4版	4182948
40768703	Impairment incapacity DI-PAD	4180186
40768703	Finding; Findings; Impairment incapacity; Nominal; PhenX; Point in time; Random	4180186
40768703	障碍或无能力:发现:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768707	Credibility information; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768707	Credibility information DI-PAD	4180186
40768707	可靠性:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768708	Catatonia DI-PAD	4180186
40768708	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768708	紧张症:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768709	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768709	Bizarre behavior DI-PAD	4180186
40768709	古怪行为:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768710	Agitated activity DI-PAD	4180186
40768710	Activ; Actvty; Finding; Findings; Movements; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768710	被激起的活动:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768713	Inappropriate affect DI-PAD	4180186
40768713	Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768713	不适当的作用:发现:时间点:^患者:序数型:DI-PAD CGP 1.4版	4182948
40768718	Finding; Findings; Nominal; PhenX; Point in time; Random	4180186
40768718	婚姻状况:发现:时间点:^患者:名义型:DI-PAD CGP 1.4版	4182948
40768720	Arm; EXT; Extr-R; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; RUE; Screen; UE; UE-R; Unified Parkinson's Disease Rating Scale (UPDRS); Up	4180186
40768720	Postural tremor UE-R UPDRS	4180186
40768720	姿势性震颤:发现:时间点:上肢.右侧:序数型:UPDRS	4182948
40768722	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768722	Speech - Parkinson's	4180186
40768722	言语:发现:时间点:^患者:序数型:UPDRS	4182948
40768723	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768723	Facial expression UPDRS	4180186
40768723	面部表情:发现:时间点:^患者:序数型:UPDRS	4182948
40768724	Tremor at rest Face UPDRS	4180186
40768724	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768724	静息状态下的震颤:发现:时间点:面部:序数型:UPDRS	4182948
40768726	Finding; Findings; Nominal; Point in time; Random; Upper extremity	4180186
40768726	Dominant hand PhenX	4180186
40768726	优势手:发现:时间点:^患者:名义型:PhenX	4182948
40768728	Finding; Findings; Nominal; Point in time; Random; Walking 20 ft turn	4180186
40768728	Walking 20 ft turn PhenX	4180186
40768728	行走 20 英尺 (6米) 并转身:发现:时间点:^患者:名义型:PhenX	4182948
40768729	Finding; Findings; Nominal; Point in time; Random	4180186
40768729	Tandem gait PhenX	4180186
40768729	持续10步的踵趾步态:发现:时间点:^患者:名义型:PhenX	4182948
40768732	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Stay home because eyesight	4180186
40768732	Stay home because eyesight PhenX	4180186
40768732	因为自己的视力,我大多数时间都待在家里:发现:时间点:^患者:序数型:PhenX	4182948
40768734	Finding; Findings; Less control because eyesight; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768734	Less control because eyesight PhenX	4180186
40768734	因为自己的视力,我对自己所做事情的控制少得多:发现:时间点:^患者:序数型:PhenX	4182948
40768737	Worry embarrass because eyesight PhenX	4180186
40768737	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Worry embarrass because eyesight	4180186
40768737	因为自己的视力,我担心是否做出将会让自己或他人尴尬的事情:发现:时间点:^患者:序数型:PhenX	4182948
40768739	Difficulty shaving makeup; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768739	Difficulty shaving makeup PhenX	4180186
40768739	因为自己视力的缘故,您在做诸如刮脸、梳头或化妆之类的事情上难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768747	Finding; Findings; Gestation; Gestations; Gravida; Nominal; Point in time; Pregnancies; Prevent pregnancy methods; Random	4180186
40768747	Prevent pregnancy methods PhenX	4180186
40768747	避孕方法:发现:时间点:^患者:名义型:PhenX	4182948
40768748	Prevent pregnancy methods ever PhenX	4180186
40768748	Finding; Findings; Gestation; Gestations; Gravida; Meth; Method of; Ordinal; Point in time; Pregnancies; Prevent pregnancy methods ever; Ql; Qual; Qualitative; Random; Screen	4180186
40768748	您是否曾经使用过这种方法来避免怀孕:发现:时间点:^患者:序数型:PhenX	4182948
40768749	Oral contraceptives 2Mo PhenX	4180186
40768749	Finding; Findings; Oral contraceptives 2Mo; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768749	您是否曾经出于任何原因（ 避孕或者说节育、痤疮或者说粉刺、月经不调或者说月经失调等等）使用过两个月或更长时间的口服避孕药:发现:时间点:^患者:序数型:PhenX	4182948
40768751	Cornea thickness L eye	4180186
40768751	Corneal; Eyeball; L; L eye; Length; LT; Occular; Oculis; Ophthalmologic; Optic globe; PhenX; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Vision; Visual	4180186
40768751	角膜厚度:长度:时间点:眼睛.左侧:定量型	4182948
40768756	Mother's sisters eye problem PhenX	4180186
40768756	Cnt; Count; Mother's sisters eye problem; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime	4180186
40768756	您母亲的姐妹当中有多少位已经存在或者被怀疑存在这种眼睛问题:数量(计数):时间点:^患者:定量型:PhenX	4182948
40768760	在阅读报纸上的普通印刷体文字方面,您有多大的困难:发现:时间点:^患者:序数型	4182948
40768760	Difficulty read newspapers; Finding; Findings; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768760	Difficulty read newspapers	4180186
40768761	在做那些需要您仔细观看的工作或业余爱好方面,比如烹调、针线活、修理家里的东西或者使用手动工具,您有多大的困难:发现:时间点:^患者:序数型	4182948
40768761	Arterial Stenosis; Difficulty see close; Finding; Findings; Job; Occupation; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen; Upper extremity	4180186
40768761	Difficulty see close	4180186
40768762	Difficulty find something shelf; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768762	Difficulty find something shelf PhenX	4180186
40768762	因为自己视力的缘故,您在在拥挤的架子上找到某种东西方面难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768763	Difficulty read signs; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768763	Difficulty read signs PhenX	4180186
40768763	在阅读或看懂街道指示牌（路标）或商店名称方面,您有多大的困难:发现:时间点:^患者:序数型:PhenX	4182948
40768764	Difficulty stairs dim light; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768764	Difficulty stairs dim light PhenX	4180186
40768764	因为自己视力的缘故,在昏暗的光线下或者在晚上,您在走下台阶、楼梯或路缘时难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768766	Difficulty see people react PhenX	4180186
40768766	Difficulty see people react; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768766	因为自己视力的缘故,您在看到人们对您所说的事情如何反应方面难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768767	Difficulty matching clothes PhenX	4180186
40768767	Difficulty matching clothes; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768767	因为自己视力的缘故,您在挑选和搭配衣服方面难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768768	Difficulty visit people; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768768	Difficulty visit people PhenX	4180186
40768768	因为自己视力的缘故,您在造访那些在自己家中、在聚会上或者在餐馆里的人们方面难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768769	Difficulty go out; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768769	Difficulty go out PhenX	4180186
40768769	因为自己视力的缘故,您在出门看电影、演出或体育赛事方面难度有多大:发现:时间点:^患者:序数型:PhenX	4182948
40768770	Difficulty small print; Finding; Findings; Ordinal; Patient Telephone; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768770	Difficulty small print PhenX	4180186
40768770	当佩戴眼镜的时候,在阅读电话簿、药瓶或者法律文书上的小字方面,您有多大的难度:发现:时间点:^患者:序数型:PhenX	4182948
40768778	Bed covers hurt; Finding; Findings; Integument; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768778	Bed covers hurt PhenX	4180186
40768778	当床罩接触您的皮肤时是否疼痛:发现:时间点:^患者:序数型:PhenX	4182948
40768779	Tell hot water from cold PhenX	4180186
40768779	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tell hot water from cold	4180186
40768779	当您进入浴盆或者淋浴的时候,您是否能够辨别清楚热水与冷水:发现:时间点:^患者:序数型:PhenX	4182948
40768780	Open sore PhenX	4180186
40768780	Finding; Findings; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768780	您的那只脚上是否曾经有过一个开放式的疮口:发现:时间点:^患者:序数型:PhenX	4182948
40768781	Diagnosed diabetic neuropathy; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768781	Diagnosed diabetic neuropathy PhenX	4180186
40768781	您的医生是否曾经告诉过您,您现在存在糖尿病神经病变:发现:时间点:^患者:序数型:PhenX	4182948
40768782	Weak all over PhenX	4180186
40768782	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768782	您是否大多数时间里感到全身虚弱无力:发现:时间点:^患者:序数型:PhenX	4182948
40768783	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
40768783	Symptoms worse at night PhenX	4180186
40768783	您的症状在晚上是否更糟糕:发现:时间点:^患者:序数型:PhenX	4182948
40768787	Amputation ever PhenX	4180186
40768787	Amputation ever; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768787	您是否曾经接受过某种截肢术:发现:时间点:^患者:序数型:PhenX	4182948
40768788	FDA insert Lot distribution data	4180186
40768788	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40768788	批配送数据:-:-:^FDA 包装说明书:叙述型	4182948
40768789	FDA insert Pharmacogenomics	4180186
40768789	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
40768789	药物基因组学小节:-:-:^FDA 包装说明书:叙述型	4182948
40768790	Bx; Finding; Findings; Lung; Narrative; Path; Path Bx report; Pathology; Point in time; Pulmonary; Pulmonology; Random; Report; Respiratory	4180186
40768790	Lung Path Bx report	4180186
40768790	病理学活组织检查报告:发现:时间点:肺:叙述型	4182948
40768791	BON; Bx; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768791	Bone Path Bx report	4180186
40768791	病理学活组织检查报告:发现:时间点:骨:叙述型	4182948
40768794	Bx; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768794	Peritoneum Path Bx report	4180186
40768794	病理学活组织检查报告:发现:时间点:腹膜:叙述型	4182948
40768797	Stom Path Bx report	4180186
40768797	Bx; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768797	病理学活组织检查报告:发现:时间点:胃:叙述型	4182948
40768798	Bx; Finding; Findings; Narrative; Pancr; Pancreatc; Pancreatic; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768798	Pancreas Path Bx report	4180186
40768798	病理学活组织检查报告:发现:时间点:胰:叙述型	4182948
40768803	Bx; Endocrine; Endocrinology; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report; Thy	4180186
40768803	Thyroid Path Bx report	4180186
40768803	病理学活组织检查报告:发现:时间点:甲状腺:叙述型	4182948
40768804	Tiss Path Bx report	4180186
40768804	Bx; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report; Tissue; Tissue, unspecified	4180186
40768804	病理学活组织检查报告:发现:时间点:组织与涂片:叙述型	4182948
40768806	Pleura Path Bx report	4180186
40768806	Bx; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768806	病理学活组织检查报告:发现:时间点:胸膜:叙述型	4182948
40768808	Bladder Path Bx report	4180186
40768808	Bx; Finding; Findings; Narrative; Path; Path Bx report; Pathology; Point in time; Random; Report	4180186
40768808	病理学活组织检查报告:发现:时间点:膀胱:叙述型	4182948
40768811	Chlordiazep/Creat Ur	4180186
40768811	Chlordiaz; Chlordiaze; Chlordiazep; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Librium; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
40768811	甲氨二氮卓/肌酐:质量比率:时间点:尿液:定量型	4182948
40768812	Actiq; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; Fentanyl metabolite; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sublimaze; UA; UR; Urn	4180186
40768812	fentaNYL+Norfentanyl Ur Ql Cfm	4180186
40768812	芬太尼+去甲基芬太尼:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
40768814	Addiction; Buprenorphine metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; NBU; norBUP; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
40768814	Norbuprenorphine SerPl Ql Cfm	4180186
40768814	去甲基丁丙诺啡:存在情况或阈值:时间点:血清/血浆:序数型:毒理学确认试验	4182948
40768816	100WBC; Atyp; Atypical Mononuc; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mononuc; Mononuc Cells; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive; WBC; WBCs; White blood cell; White blood cells	4180186
40768816	Atypical Mononuc/leuk NFr Fld Manual	4180186
40768816	单个核细胞.异型/100 个白细胞:计数型分数:时间点:体液:定量型:手工计数方法	4182948
40768819	#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Manl; Myel; Myelo; Myelocyte; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40768819	Myelocytes # Bld Fetus Manual	4180186
40768819	中幼粒细胞:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768821	#; ABS; absolute; absolutes; Bands; Blood; bnd; Cnt; Count; Count/volume; CT; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40768821	Neuts Band # Bld Fetus Manual	4180186
40768821	嗜中性粒细胞.带状核:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768822	#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Manl; Neut; Neutr; Neutrophil; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40768822	Neutrophils # Bld Fetus Manual	4180186
40768822	嗜中性粒细胞:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768824	#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Eos; Eosin; Eosino; Eosinophil; Eosins; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40768824	Eosinophil # Bld Fetus Manual	4180186
40768824	嗜酸性粒细胞:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768826	#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Manl; Mono; Monocyte; Monos; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
40768826	Monocytes # Bld Fetus Manual	4180186
40768826	单核细胞:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768827	#; ABS; absolute; absolutes; Atypical lymphocytes; Blood; Cnt; Count; Count/volume; CT; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Variant lymphocytes; Variant Lymphs; WB; Whole blood	4180186
40768827	Variant Lymphs # Bld Fetus Manual	4180186
40768827	淋巴细胞.异型:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768828	#; ABS; absolute; absolutes; Blood; Cnt; Count; Count/volume; CT; Fetal; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBC Other; WBCs; White blood cell; White blood cells; Whole blood	4180186
40768828	WBC Other # Bld Fetus Manual	4180186
40768828	其他白细胞:计数型浓度:时间点:全血^胎儿:定量型:手工计数方法	4182948
40768832	Pan; Panel; PANEL.PHENX; Panl; PhenX; Pnl; Point in time; Random	4180186
40768832	处方所规定的药物:-:时间点:^患者:-	4182948
40768834	14 days; 2 weeks; Avg number pills prescription; Count/time; Dextro; month; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative	4180186
40768834	Avg number pills prescription PhenX	4180186
40768834	在过去的那2个星期当中,平均来说,您当时每天、每星期或者每月服用多少这些药:计数型速率:2星期:^患者:定量型:PhenX	4182948
40768835	Finding; Findings; HCP told you that you have diabetes; Ordinal; PhenX; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768835	HCP told you that you have diabetes	4180186
40768835	医生或医疗保健服务专业人员是否曾经告知您患有糖尿病:发现:时间点:^患者:序数型	4182948
40768836	Diabetes medicine; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768836	Diabetes medicine PhenX	4180186
40768836	您正在服用糖尿病药物吗:发现:时间点:^患者:序数型:PhenX	4182948
40768837	Diabetes medicine type PhenX	4180186
40768837	Diabetes medicine type; Finding; Findings; Nominal; Point in time; Random	4180186
40768837	您正在服用针对糖尿病的什么药物:发现:时间点:^患者:名义型:PhenX	4182948
40768838	Diabetes age; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768838	Diabetes age PhenX	4180186
40768838	糖尿病首次治疗于多大年龄:时间:时间点:^患者:定量型:PhenX	4182948
40768839	Diabetes insulin PhenX	4180186
40768839	Diabetes insulin; Finding; Findings; HUM; Humulin; IH7; Insul; Lente; NPH; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Semilente; Sliding; Ultralente	4180186
40768839	胰岛素是否为您的首选糖尿病药物:发现:时间点:^患者:序数型:PhenX	4182948
40768840	Diabetes women pregnancy PhenX	4180186
40768840	Diabetes women pregnancy; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
40768840	糖尿病是否仅仅出现在妊娠过程中:发现:时间点:^患者:序数型:PhenX	4182948
40768841	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768841	Kidney failure PhenX	4180186
40768841	某位医务人员是否曾经告诉过您,您患有肾功能衰竭:发现:时间点:^患者:序数型:PhenX	4182948
40768843	Kidney failure age PhenX	4180186
40768843	Kidney failure age; Persons; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
40768843	首次某位医务人员告知您患有肾功能衰竭时您的年龄是多大:时间:时间点:^患者:定量型:PhenX	4182948
40768845	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768845	Kidney transplant PhenX	4180186
40768845	您是否曾经接受过肾脏移植:发现:时间点:^患者:序数型:PhenX	4182948
40768847	Consumed; Date and time; Drink; H+P; H+P.HX; Last ate/drank other than water; Othr; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40768847	Last ate or drank D/T	4180186
40768847	除白水外最后所吃过或喝过的任何东西:时间戳:时间点:^患者:定量型	4182948
40768849	Coffee tea time PhenX	4180186
40768849	Coffee tea time; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40768849	您何时喝过加有奶油和糖的咖啡或者茶:时间戳:时间点:^患者:定量型:PhenX	4182948
40768851	Alc; Alcohol time; alcoholic; Arterial Stenosis; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40768851	Alcohol time PhenX	4180186
40768851	您何时喝过啤酒、葡萄酒或烈性酒之类的酒精饮料:时间戳:时间点:^患者:定量型:PhenX	4182948
40768852	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768852	Gum PhenX	4180186
40768852	自从吃了东西或者喝过除普通水之外的任何饮料之后,您是否吃过口香糖、口气清新薄荷糖、止咳糖、止咳剂或者其他的止咳药或感冒药:发现:时间点:^患者:序数型:PhenX	4182948
40768854	Antacids PhenX	4180186
40768854	Finding; Findings; Laxative; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768854	自从吃了东西或者喝过除普通水之外的任何饮料之后,您是否服用过抗酸药、泻药或者止泻药:发现:时间点:^患者:序数型:PhenX	4182948
40768858	Diabetic pills PhenX	4180186
40768858	Finding; Findings; Low; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768858	您现在正在为降低自己的血糖水平而服用糖尿病药物吗:发现:时间点:^患者:序数型:PhenX	4182948
40768859	Hx of Hemophilia	4180186
40768859	H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768859	您是否患有血友病:历史记录:时间点:^患者:序数型	4182948
40768860	Cancer; Chemo; Chemotherapy rcvd past 4W; Chemotherapy rcvd past 4W or next 4W; Finding; Findings; Last; ONCOLOGY; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768860	Chemotherapy rcvd past 4W or next 4W	4180186
40768860	是否已经在过去的那4星期当中接受过癌症化学疗法,或者将会在未来4星期当中接受此类治疗:发现:时间点:^患者:序数型	4182948
40768861	Exclusion criteria glucose PhenX	4180186
40768861	Exclusion criteria glucose; Finding; Findings; Glu; Gluc; Glucoseur; Nominal; Point in time; Random	4180186
40768861	空腹血浆葡萄糖排除准则:发现:时间点:^患者:名义型:PhenX	4182948
40768862	Blood draw done PhenX	4180186
40768862	Blood draw done; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768862	是否已抽血:发现:时间点:^患者:序数型:PhenX	4182948
40768864	DS PhenX	4180186
40768864	Arterial Stenosis; DS; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768864	自从吃了东西或者喝过除普通水之外的任何饮料之后,您是否食用过维生素和矿物质之类的膳食补充剂:发现:时间点:^患者:序数型:PhenX	4182948
40768865	Arterial Stenosis; Date and time; DS time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
40768865	DS time PhenX	4180186
40768865	您何时服用过维生素和矿物质之类的膳食补充剂:时间戳:时间点:^患者:定量型:PhenX	4182948
40768868	Cnt; Count; Insomnia family impairment scale; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
40768868	Insomnia family impairment scale PhenX	4180186
40768868	哪个数字能够描述您的失眠对您与家庭成员之间的关系产生影响的程度:数量(计数):时间点:^患者:序数型:PhenX	4182948
40768872	Tremor at rest LE-L UPDRS	4180186
40768872	EXT; Extr-L; Finding; Findings; L; LE; Leg; LE-L; LLE; Low; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768872	静息状态下的震颤:发现:时间点:下肢.左侧:序数型:UPDRS	4182948
40768876	EXT; Extr-L; Finding; Findings; L; LE; Leg; LE-L; LLE; Low; LT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Unified Parkinson's Disease Rating Scale (UPDRS)	4180186
40768876	Rigidity - Parkinson's LE-L	4180186
40768876	强直:发现:时间点:下肢.左侧:序数型:UPDRS	4182948
40768878	Injury sequence PhenX	4180186
